id	sid	tid	token	lemma	pos
ajlm-804	1	1	abstract	abstract	ADJ
ajlm-804	1	2	introduction	introduction	NOUN
ajlm-804	1	3	methods	method	NOUN
ajlm-804	1	4	results	result	VERB
ajlm-804	1	5	discussion	discussion	NOUN
ajlm-804	1	6	trustworthiness	trustworthiness	NOUN
ajlm-804	1	7	acknowledgements	acknowledgement	NOUN
ajlm-804	1	8	references	reference	NOUN
ajlm-804	1	9	about	about	ADP
ajlm-804	1	10	the	the	DET
ajlm-804	1	11	author(s	author(s	PROPN
ajlm-804	1	12	)	)	PUNCT
ajlm-804	1	13	daniel	daniel	PROPN
ajlm-804	1	14	rhodes	rhode	VERB
ajlm-804	1	15	clinical	clinical	ADJ
ajlm-804	1	16	affairs	affair	NOUN
ajlm-804	1	17	,	,	PUNCT
ajlm-804	1	18	beckman	beckman	PROPN
ajlm-804	1	19	coulter	coulter	PROPN
ajlm-804	1	20	immunotech	immunotech	PROPN
ajlm-804	1	21	,	,	PUNCT
ajlm-804	1	22	marseille	marseille	PROPN
ajlm-804	1	23	,	,	PUNCT
ajlm-804	1	24	france	france	PROPN
ajlm-804	1	25	guislaine	guislaine	PROPN
ajlm-804	1	26	carcelain	carcelain	VERB
ajlm-804	1	27	immunology	immunology	NOUN
ajlm-804	1	28	laboratory	laboratory	NOUN
ajlm-804	1	29	,	,	PUNCT
ajlm-804	1	30	assistance	assistance	NOUN
ajlm-804	1	31	publique	publique	PROPN
ajlm-804	1	32	hopitaux	hopitaux	PROPN
ajlm-804	1	33	de	de	X
ajlm-804	1	34	paris	paris	PROPN
ajlm-804	1	35	,	,	PUNCT
ajlm-804	1	36	paris	paris	PROPN
ajlm-804	1	37	,	,	PUNCT
ajlm-804	1	38	france	france	PROPN
ajlm-804	1	39	mike	mike	PROPN
ajlm-804	1	40	keeney	keeney	PROPN
ajlm-804	1	41	lawson	lawson	PROPN
ajlm-804	1	42	health	health	PROPN
ajlm-804	1	43	research	research	PROPN
ajlm-804	1	44	institute	institute	PROPN
ajlm-804	1	45	,	,	PUNCT
ajlm-804	1	46	london	london	PROPN
ajlm-804	1	47	health	health	PROPN
ajlm-804	1	48	sciences	sciences	PROPN
ajlm-804	1	49	centre	centre	PROPN
ajlm-804	1	50	and	and	CCONJ
ajlm-804	1	51	st	st	PROPN
ajlm-804	1	52	.	.	PROPN
ajlm-804	1	53	joseph	joseph	PROPN
ajlm-804	1	54	’s	’s	PART
ajlm-804	1	55	health	health	PROPN
ajlm-804	1	56	care	care	PROPN
ajlm-804	1	57	,	,	PUNCT
ajlm-804	1	58	victoria	victoria	PROPN
ajlm-804	1	59	hospital	hospital	PROPN
ajlm-804	1	60	,	,	PUNCT
ajlm-804	1	61	london	london	PROPN
ajlm-804	1	62	,	,	PUNCT
ajlm-804	1	63	ontario	ontario	PROPN
ajlm-804	1	64	,	,	PUNCT
ajlm-804	1	65	canada	canada	PROPN
ajlm-804	1	66	christophe	christophe	PROPN
ajlm-804	1	67	parizot	parizot	PROPN
ajlm-804	1	68	department	department	PROPN
ajlm-804	1	69	of	of	ADP
ajlm-804	1	70	immunology	immunology	NOUN
ajlm-804	1	71	,	,	PUNCT
ajlm-804	1	72	university	university	NOUN
ajlm-804	1	73	hospital	hospital	NOUN
ajlm-804	1	74	,	,	PUNCT
ajlm-804	1	75	paris	paris	PROPN
ajlm-804	1	76	,	,	PUNCT
ajlm-804	1	77	france	france	PROPN
ajlm-804	1	78	dominika	dominika	PROPN
ajlm-804	1	79	benjamins	benjamins	PROPN
ajlm-804	1	80	london	london	PROPN
ajlm-804	1	81	health	health	PROPN
ajlm-804	1	82	sciences	sciences	PROPN
ajlm-804	1	83	centre	centre	PROPN
ajlm-804	1	84	,	,	PUNCT
ajlm-804	1	85	london	london	PROPN
ajlm-804	1	86	,	,	PUNCT
ajlm-804	1	87	ontario	ontario	PROPN
ajlm-804	1	88	,	,	PUNCT
ajlm-804	1	89	canada	canada	PROPN
ajlm-804	1	90	laurine	laurine	VERB
ajlm-804	1	91	genesta	genesta	PROPN
ajlm-804	1	92	biomnis	biomnis	PROPN
ajlm-804	1	93	laboratory	laboratory	PROPN
ajlm-804	1	94	,	,	PUNCT
ajlm-804	1	95	lyon	lyon	PROPN
ajlm-804	1	96	,	,	PUNCT
ajlm-804	1	97	france	france	PROPN
ajlm-804	1	98	jin	jin	PROPN
ajlm-804	1	99	zhang	zhang	PROPN
ajlm-804	1	100	life	life	PROPN
ajlm-804	1	101	science	science	PROPN
ajlm-804	1	102	flow	flow	NOUN
ajlm-804	1	103	cytometry	cytometry	NOUN
ajlm-804	1	104	,	,	PUNCT
ajlm-804	1	105	beckman	beckman	PROPN
ajlm-804	1	106	coulter	coulter	PROPN
ajlm-804	1	107	incorporated	incorporate	VERB
ajlm-804	1	108	,	,	PUNCT
ajlm-804	1	109	miami	miami	PROPN
ajlm-804	1	110	,	,	PUNCT
ajlm-804	1	111	florida	florida	PROPN
ajlm-804	1	112	,	,	PUNCT
ajlm-804	1	113	united	united	PROPN
ajlm-804	1	114	states	states	PROPN
ajlm-804	1	115	justin	justin	PROPN
ajlm-804	1	116	rohrbach	rohrbach	VERB
ajlm-804	1	117	clinical	clinical	ADJ
ajlm-804	1	118	affairs	affair	NOUN
ajlm-804	1	119	,	,	PUNCT
ajlm-804	1	120	beckman	beckman	PROPN
ajlm-804	1	121	coulter	coulter	PROPN
ajlm-804	1	122	incorporated	incorporate	VERB
ajlm-804	1	123	,	,	PUNCT
ajlm-804	1	124	miami	miami	PROPN
ajlm-804	1	125	,	,	PUNCT
ajlm-804	1	126	florida	florida	PROPN
ajlm-804	1	127	,	,	PUNCT
ajlm-804	1	128	united	united	PROPN
ajlm-804	1	129	states	states	PROPN
ajlm-804	1	130	denise	denise	PROPN
ajlm-804	1	131	lawrie	lawrie	PROPN
ajlm-804	1	132	national	national	PROPN
ajlm-804	1	133	health	health	PROPN
ajlm-804	1	134	laboratory	laboratory	PROPN
ajlm-804	1	135	service	service	PROPN
ajlm-804	1	136	,	,	PUNCT
ajlm-804	1	137	charlotte	charlotte	PROPN
ajlm-804	1	138	maxeke	maxeke	PROPN
ajlm-804	1	139	johannesburg	johannesburg	PROPN
ajlm-804	1	140	academic	academic	PROPN
ajlm-804	1	141	hospital	hospital	PROPN
ajlm-804	1	142	,	,	PUNCT
ajlm-804	1	143	johannesburg	johannesburg	PROPN
ajlm-804	1	144	,	,	PUNCT
ajlm-804	2	1	south	south	PROPN
ajlm-804	2	2	africa	africa	PROPN
ajlm-804	2	3	deborah	deborah	PROPN
ajlm-804	2	4	k.	k.	PROPN
ajlm-804	2	5	glencross	glencross	PROPN
ajlm-804	2	6	faculty	faculty	PROPN
ajlm-804	2	7	of	of	ADP
ajlm-804	2	8	health	health	NOUN
ajlm-804	2	9	sciences	sciences	PROPN
ajlm-804	2	10	,	,	PUNCT
ajlm-804	2	11	university	university	NOUN
ajlm-804	2	12	of	of	ADP
ajlm-804	2	13	the	the	DET
ajlm-804	2	14	witwatersrand	witwatersrand	NOUN
ajlm-804	2	15	,	,	PUNCT
ajlm-804	2	16	johannesburg	johannesburg	PROPN
ajlm-804	2	17	,	,	PUNCT
ajlm-804	2	18	south	south	PROPN
ajlm-804	2	19	africa	africa	PROPN
ajlm-804	2	20	national	national	PROPN
ajlm-804	2	21	health	health	PROPN
ajlm-804	2	22	laboratory	laboratory	PROPN
ajlm-804	2	23	services	services	PROPN
ajlm-804	2	24	,	,	PUNCT
ajlm-804	2	25	johannesburg	johannesburg	PROPN
ajlm-804	2	26	,	,	PUNCT
ajlm-804	2	27	south	south	PROPN
ajlm-804	2	28	africa	africa	PROPN
ajlm-804	2	29	citation	citation	PROPN
ajlm-804	2	30	rhodes	rhode	VERB
ajlm-804	2	31	d	d	PROPN
ajlm-804	2	32	,	,	PUNCT
ajlm-804	2	33	carcelain	carcelain	NOUN
ajlm-804	2	34	g	g	PROPN
ajlm-804	2	35	,	,	PUNCT
ajlm-804	2	36	keeney	keeney	PROPN
ajlm-804	2	37	m	m	PROPN
ajlm-804	2	38	,	,	PUNCT
ajlm-804	2	39	et	et	PROPN
ajlm-804	2	40	al	al	PROPN
ajlm-804	2	41	.	.	PROPN
ajlm-804	2	42	assessment	assessment	NOUN
ajlm-804	2	43	of	of	ADP
ajlm-804	2	44	the	the	DET
ajlm-804	2	45	aquios	aquio	NOUN
ajlm-804	2	46	flow	flow	NOUN
ajlm-804	2	47	cytometer	cytometer	NOUN
ajlm-804	2	48	–	–	PUNCT
ajlm-804	2	49	an	an	DET
ajlm-804	2	50	automated	automate	VERB
ajlm-804	2	51	sample	sample	NOUN
ajlm-804	2	52	preparation	preparation	NOUN
ajlm-804	2	53	system	system	NOUN
ajlm-804	2	54	for	for	ADP
ajlm-804	2	55	cd4	cd4	PROPN
ajlm-804	2	56	lymphocyte	lymphocyte	ADJ
ajlm-804	2	57	panleucogating	panleucogating	ADJ
ajlm-804	2	58	enumeration	enumeration	NOUN
ajlm-804	2	59	.	.	PUNCT
ajlm-804	3	1	afr	afr	PROPN
ajlm-804	3	2	j	j	PROPN
ajlm-804	3	3	lab	lab	PROPN
ajlm-804	3	4	med	med	PROPN
ajlm-804	3	5	.	.	PUNCT
ajlm-804	3	6	2019;8(1	2019;8(1	NOUN
ajlm-804	3	7	)	)	PUNCT
ajlm-804	3	8	,	,	PUNCT
ajlm-804	3	9	a804	a804	PROPN
ajlm-804	3	10	.	.	PUNCT
ajlm-804	3	11	https://doi.org/10.4102/ajlm.v8i1.804	https://doi.org/10.4102/ajlm.v8i1.804	NOUN
ajlm-804	3	12	original	original	ADJ
ajlm-804	3	13	research	research	NOUN
ajlm-804	3	14	assessment	assessment	NOUN
ajlm-804	3	15	of	of	ADP
ajlm-804	3	16	the	the	DET
ajlm-804	3	17	aquios	aquio	NOUN
ajlm-804	3	18	flow	flow	NOUN
ajlm-804	3	19	cytometer	cytometer	NOUN
ajlm-804	3	20	–	–	PUNCT
ajlm-804	3	21	an	an	DET
ajlm-804	3	22	automated	automate	VERB
ajlm-804	3	23	sample	sample	NOUN
ajlm-804	3	24	preparation	preparation	NOUN
ajlm-804	3	25	system	system	NOUN
ajlm-804	3	26	for	for	ADP
ajlm-804	3	27	cd4	cd4	PROPN
ajlm-804	3	28	lymphocyte	lymphocyte	ADJ
ajlm-804	3	29	panleucogating	panleucogate	VERB
ajlm-804	3	30	enumeration	enumeration	NOUN
ajlm-804	3	31	daniel	daniel	PROPN
ajlm-804	3	32	rhodes	rhodes	PROPN
ajlm-804	3	33	,	,	PUNCT
ajlm-804	3	34	guislaine	guislaine	NOUN
ajlm-804	3	35	carcelain	carcelain	NOUN
ajlm-804	3	36	,	,	PUNCT
ajlm-804	3	37	mike	mike	PROPN
ajlm-804	3	38	keeney	keeney	PROPN
ajlm-804	3	39	,	,	PUNCT
ajlm-804	3	40	christophe	christophe	PROPN
ajlm-804	3	41	parizot	parizot	NOUN
ajlm-804	3	42	,	,	PUNCT
ajlm-804	3	43	dominika	dominika	PROPN
ajlm-804	3	44	benjamins	benjamin	NOUN
ajlm-804	3	45	,	,	PUNCT
ajlm-804	3	46	laurine	laurine	VERB
ajlm-804	3	47	genesta	genesta	PROPN
ajlm-804	3	48	,	,	PUNCT
ajlm-804	3	49	jin	jin	PROPN
ajlm-804	3	50	zhang	zhang	PROPN
ajlm-804	3	51	,	,	PUNCT
ajlm-804	3	52	justin	justin	PROPN
ajlm-804	3	53	rohrbach	rohrbach	PROPN
ajlm-804	3	54	,	,	PUNCT
ajlm-804	3	55	denise	denise	PROPN
ajlm-804	3	56	lawrie	lawrie	PROPN
ajlm-804	3	57	,	,	PUNCT
ajlm-804	3	58	deborah	deborah	PROPN
ajlm-804	3	59	k.	k.	PROPN
ajlm-804	3	60	glencross	glencross	PROPN
ajlm-804	3	61	received	receive	VERB
ajlm-804	3	62	:	:	PUNCT
ajlm-804	3	63	13	13	NUM
ajlm-804	3	64	mar	mar	PROPN
ajlm-804	3	65	.	.	PROPN
ajlm-804	3	66	2018	2018	NUM
ajlm-804	3	67	;	;	PUNCT
ajlm-804	3	68	accepted	accept	VERB
ajlm-804	3	69	:	:	PUNCT
ajlm-804	3	70	18	18	NUM
ajlm-804	3	71	mar	mar	PROPN
ajlm-804	3	72	.	.	PROPN
ajlm-804	3	73	2019	2019	NUM
ajlm-804	3	74	;	;	PUNCT
ajlm-804	3	75	published	publish	VERB
ajlm-804	3	76	:	:	PUNCT
ajlm-804	3	77	05	05	NUM
ajlm-804	3	78	dec	dec	PROPN
ajlm-804	3	79	.	.	PROPN
ajlm-804	4	1	2019	2019	NUM
ajlm-804	4	2	copyright	copyright	NOUN
ajlm-804	4	3	:	:	PUNCT
ajlm-804	4	4	©	©	PROPN
ajlm-804	4	5	2019	2019	NUM
ajlm-804	4	6	.	.	PUNCT
ajlm-804	5	1	the	the	DET
ajlm-804	5	2	author(s	author(s	PROPN
ajlm-804	5	3	)	)	PUNCT
ajlm-804	5	4	.	.	PUNCT
ajlm-804	6	1	licensee	licensee	NOUN
ajlm-804	6	2	:	:	PUNCT
ajlm-804	6	3	aosis	aosis	NOUN
ajlm-804	6	4	.	.	PUNCT
ajlm-804	7	1	this	this	PRON
ajlm-804	7	2	is	be	AUX
ajlm-804	7	3	an	an	DET
ajlm-804	7	4	open	open	ADJ
ajlm-804	7	5	access	access	NOUN
ajlm-804	7	6	article	article	NOUN
ajlm-804	7	7	distributed	distribute	VERB
ajlm-804	7	8	under	under	ADP
ajlm-804	7	9	the	the	DET
ajlm-804	7	10	terms	term	NOUN
ajlm-804	7	11	of	of	ADP
ajlm-804	7	12	the	the	DET
ajlm-804	7	13	creative	creative	ADJ
ajlm-804	7	14	commons	common	NOUN
ajlm-804	7	15	attribution	attribution	NOUN
ajlm-804	7	16	license	license	NOUN
ajlm-804	7	17	,	,	PUNCT
ajlm-804	7	18	which	which	PRON
ajlm-804	7	19	permits	permit	VERB
ajlm-804	7	20	unrestricted	unrestricted	ADJ
ajlm-804	7	21	use	use	NOUN
ajlm-804	7	22	,	,	PUNCT
ajlm-804	7	23	distribution	distribution	NOUN
ajlm-804	7	24	,	,	PUNCT
ajlm-804	7	25	and	and	CCONJ
ajlm-804	7	26	reproduction	reproduction	NOUN
ajlm-804	7	27	in	in	ADP
ajlm-804	7	28	any	any	DET
ajlm-804	7	29	medium	medium	NOUN
ajlm-804	7	30	,	,	PUNCT
ajlm-804	7	31	provided	provide	VERB
ajlm-804	7	32	the	the	DET
ajlm-804	7	33	original	original	ADJ
ajlm-804	7	34	work	work	NOUN
ajlm-804	7	35	is	be	AUX
ajlm-804	7	36	properly	properly	ADV
ajlm-804	7	37	cited	cite	VERB
ajlm-804	7	38	.	.	PUNCT
ajlm-804	8	1	abstract	abstract	ADJ
ajlm-804	8	2	background	background	NOUN
ajlm-804	8	3	:	:	PUNCT
ajlm-804	8	4	flow	flow	NOUN
ajlm-804	8	5	cytometry	cytometry	NOUN
ajlm-804	8	6	has	have	AUX
ajlm-804	8	7	been	be	AUX
ajlm-804	8	8	the	the	DET
ajlm-804	8	9	approach	approach	NOUN
ajlm-804	8	10	of	of	ADP
ajlm-804	8	11	choice	choice	NOUN
ajlm-804	8	12	for	for	ADP
ajlm-804	8	13	enumerating	enumerate	VERB
ajlm-804	8	14	and	and	CCONJ
ajlm-804	8	15	documenting	document	VERB
ajlm-804	8	16	cd4	cd4	PROPN
ajlm-804	8	17	-	-	PUNCT
ajlm-804	8	18	cell	cell	NOUN
ajlm-804	8	19	decline	decline	NOUN
ajlm-804	8	20	in	in	ADP
ajlm-804	8	21	hiv	hiv	PROPN
ajlm-804	8	22	monitoring	monitoring	NOUN
ajlm-804	8	23	.	.	PUNCT
ajlm-804	9	1	beckman	beckman	PROPN
ajlm-804	9	2	coulter	coulter	PROPN
ajlm-804	9	3	has	have	AUX
ajlm-804	9	4	developed	develop	VERB
ajlm-804	9	5	a	a	DET
ajlm-804	9	6	single	single	ADJ
ajlm-804	9	7	platform	platform	NOUN
ajlm-804	9	8	test	test	NOUN
ajlm-804	9	9	for	for	ADP
ajlm-804	9	10	cd4	cd4	PROPN
ajlm-804	9	11	+	+	PROPN
ajlm-804	9	12	t	t	PROPN
ajlm-804	9	13	-	-	PUNCT
ajlm-804	9	14	cell	cell	NOUN
ajlm-804	9	15	lymphocyte	lymphocyte	ADJ
ajlm-804	9	16	count	count	NOUN
ajlm-804	9	17	and	and	CCONJ
ajlm-804	9	18	percentage	percentage	NOUN
ajlm-804	9	19	using	use	VERB
ajlm-804	9	20	panleucogating	panleucogate	VERB
ajlm-804	9	21	(	(	PUNCT
ajlm-804	9	22	plg	plg	NOUN
ajlm-804	9	23	)	)	PUNCT
ajlm-804	9	24	technology	technology	NOUN
ajlm-804	9	25	on	on	ADP
ajlm-804	9	26	the	the	DET
ajlm-804	9	27	automated	automate	VERB
ajlm-804	9	28	aquios	aquio	NOUN
ajlm-804	9	29	flow	flow	NOUN
ajlm-804	9	30	cytometer	cytometer	NOUN
ajlm-804	9	31	(	(	PUNCT
ajlm-804	9	32	aquios	aquio	NOUN
ajlm-804	9	33	plg	plg	NOUN
ajlm-804	9	34	)	)	PUNCT
ajlm-804	9	35	.	.	PUNCT
ajlm-804	10	1	objectives	objective	NOUN
ajlm-804	10	2	:	:	PUNCT
ajlm-804	10	3	this	this	DET
ajlm-804	10	4	study	study	NOUN
ajlm-804	10	5	compared	compare	VERB
ajlm-804	10	6	the	the	DET
ajlm-804	10	7	performance	performance	NOUN
ajlm-804	10	8	of	of	ADP
ajlm-804	10	9	aquios	aquio	NOUN
ajlm-804	10	10	plg	plg	NOUN
ajlm-804	10	11	with	with	ADP
ajlm-804	10	12	the	the	DET
ajlm-804	10	13	flowcare	flowcare	PROPN
ajlm-804	10	14	plg	plg	PROPN
ajlm-804	10	15	method	method	NOUN
ajlm-804	10	16	and	and	CCONJ
ajlm-804	10	17	performed	perform	VERB
ajlm-804	10	18	a	a	DET
ajlm-804	10	19	reference	reference	NOUN
ajlm-804	10	20	interval	interval	NOUN
ajlm-804	10	21	for	for	ADP
ajlm-804	10	22	comparison	comparison	NOUN
ajlm-804	10	23	with	with	ADP
ajlm-804	10	24	those	those	PRON
ajlm-804	10	25	previously	previously	ADV
ajlm-804	10	26	published	publish	VERB
ajlm-804	10	27	.	.	PUNCT
ajlm-804	11	1	methods	method	NOUN
ajlm-804	11	2	:	:	PUNCT
ajlm-804	11	3	the	the	DET
ajlm-804	11	4	study	study	NOUN
ajlm-804	11	5	was	be	AUX
ajlm-804	11	6	conducted	conduct	VERB
ajlm-804	11	7	between	between	ADP
ajlm-804	11	8	november	november	PROPN
ajlm-804	11	9	2014	2014	NUM
ajlm-804	11	10	and	and	CCONJ
ajlm-804	11	11	march	march	PROPN
ajlm-804	11	12	2015	2015	NUM
ajlm-804	11	13	at	at	ADP
ajlm-804	11	14	5	5	NUM
ajlm-804	11	15	different	different	ADJ
ajlm-804	11	16	centres	centre	NOUN
ajlm-804	11	17	located	locate	VERB
ajlm-804	11	18	in	in	ADP
ajlm-804	11	19	canada	canada	PROPN
ajlm-804	11	20	;	;	PUNCT
ajlm-804	11	21	paris	paris	PROPN
ajlm-804	11	22	,	,	PUNCT
ajlm-804	11	23	france	france	PROPN
ajlm-804	11	24	;	;	PUNCT
ajlm-804	11	25	lyon	lyon	PROPN
ajlm-804	11	26	,	,	PUNCT
ajlm-804	11	27	france	france	PROPN
ajlm-804	11	28	;	;	PUNCT
ajlm-804	11	29	the	the	DET
ajlm-804	11	30	united	united	PROPN
ajlm-804	11	31	states	states	PROPN
ajlm-804	11	32	;	;	PUNCT
ajlm-804	11	33	and	and	CCONJ
ajlm-804	11	34	south	south	PROPN
ajlm-804	11	35	africa	africa	PROPN
ajlm-804	11	36	.	.	PUNCT
ajlm-804	12	1	two	two	NUM
ajlm-804	12	2	-	-	PUNCT
ajlm-804	12	3	hundred	hundred	NUM
ajlm-804	12	4	and	and	CCONJ
ajlm-804	12	5	forty	forty	NUM
ajlm-804	12	6	samples	sample	NOUN
ajlm-804	12	7	from	from	ADP
ajlm-804	12	8	hiv	hiv	NOUN
ajlm-804	12	9	-	-	PUNCT
ajlm-804	12	10	positive	positive	ADJ
ajlm-804	12	11	adult	adult	NOUN
ajlm-804	12	12	and	and	CCONJ
ajlm-804	12	13	paediatric	paediatric	ADJ
ajlm-804	12	14	patients	patient	NOUN
ajlm-804	12	15	were	be	AUX
ajlm-804	12	16	used	use	VERB
ajlm-804	12	17	to	to	PART
ajlm-804	12	18	compare	compare	VERB
ajlm-804	12	19	the	the	DET
ajlm-804	12	20	performances	performance	NOUN
ajlm-804	12	21	of	of	ADP
ajlm-804	12	22	aquios	aquio	NOUN
ajlm-804	12	23	plg	plg	NOUN
ajlm-804	12	24	and	and	CCONJ
ajlm-804	12	25	flowcare	flowcare	PROPN
ajlm-804	12	26	plg	plg	PROPN
ajlm-804	12	27	on	on	ADP
ajlm-804	12	28	a	a	DET
ajlm-804	12	29	fc500	fc500	PROPN
ajlm-804	12	30	flow	flow	NOUN
ajlm-804	12	31	cytometer	cytometer	NOUN
ajlm-804	12	32	(	(	PUNCT
ajlm-804	12	33	flowcare	flowcare	PROPN
ajlm-804	12	34	plg	plg	PROPN
ajlm-804	12	35	)	)	PUNCT
ajlm-804	12	36	in	in	ADP
ajlm-804	12	37	determining	determine	VERB
ajlm-804	12	38	cd4	cd4	PROPN
ajlm-804	12	39	+	+	CCONJ
ajlm-804	12	40	absolute	absolute	ADJ
ajlm-804	12	41	count	count	NOUN
ajlm-804	12	42	and	and	CCONJ
ajlm-804	12	43	percentage	percentage	NOUN
ajlm-804	12	44	.	.	PUNCT
ajlm-804	13	1	a	a	DET
ajlm-804	13	2	reference	reference	NOUN
ajlm-804	13	3	interval	interval	NOUN
ajlm-804	13	4	was	be	AUX
ajlm-804	13	5	determined	determine	VERB
ajlm-804	13	6	using	use	VERB
ajlm-804	13	7	155	155	NUM
ajlm-804	13	8	samples	sample	NOUN
ajlm-804	13	9	from	from	ADP
ajlm-804	13	10	healthy	healthy	ADJ
ajlm-804	13	11	,	,	PUNCT
ajlm-804	13	12	non	non	ADJ
ajlm-804	13	13	-	-	ADJ
ajlm-804	13	14	hiv	hiv	ADJ
ajlm-804	13	15	adults	adult	NOUN
ajlm-804	13	16	.	.	PUNCT
ajlm-804	14	1	workflow	workflow	NOUN
ajlm-804	14	2	was	be	AUX
ajlm-804	14	3	investigated	investigate	VERB
ajlm-804	14	4	testing	test	VERB
ajlm-804	14	5	440	440	NUM
ajlm-804	14	6	samples	sample	NOUN
ajlm-804	14	7	over	over	ADP
ajlm-804	14	8	5	5	NUM
ajlm-804	14	9	days	day	NOUN
ajlm-804	14	10	.	.	PUNCT
ajlm-804	15	1	results	result	NOUN
ajlm-804	15	2	:	:	PUNCT
ajlm-804	15	3	mean	mean	VERB
ajlm-804	15	4	absolute	absolute	ADJ
ajlm-804	15	5	and	and	CCONJ
ajlm-804	15	6	relative	relative	ADJ
ajlm-804	15	7	count	count	NOUN
ajlm-804	15	8	bias	bias	NOUN
ajlm-804	15	9	between	between	ADP
ajlm-804	15	10	aquios	aquio	NOUN
ajlm-804	15	11	plg	plg	NOUN
ajlm-804	15	12	and	and	CCONJ
ajlm-804	15	13	flowcare	flowcare	PROPN
ajlm-804	15	14	plg	plg	PROPN
ajlm-804	15	15	was	be	AUX
ajlm-804	15	16	−41	−41	PROPN
ajlm-804	15	17	cells/µl	cells/µl	NOUN
ajlm-804	15	18	and	and	CCONJ
ajlm-804	15	19	−7.8	−7.8	PROPN
ajlm-804	15	20	%	%	NOUN
ajlm-804	15	21	.	.	PUNCT
ajlm-804	16	1	upward	upward	ADJ
ajlm-804	16	2	and	and	CCONJ
ajlm-804	16	3	downward	downward	ADJ
ajlm-804	16	4	misclassification	misclassification	NOUN
ajlm-804	16	5	at	at	ADP
ajlm-804	16	6	various	various	ADJ
ajlm-804	16	7	cd4	cd4	PROPN
ajlm-804	16	8	thresholds	threshold	NOUN
ajlm-804	16	9	was	be	AUX
ajlm-804	16	10	≤	≤	NUM
ajlm-804	16	11	2.4	2.4	NUM
ajlm-804	16	12	%	%	NOUN
ajlm-804	16	13	and	and	CCONJ
ajlm-804	16	14	≤	≤	ADJ
ajlm-804	16	15	11.1	11.1	NUM
ajlm-804	16	16	%	%	NOUN
ajlm-804	16	17	.	.	PUNCT
ajlm-804	17	1	the	the	DET
ajlm-804	17	2	95	95	NUM
ajlm-804	17	3	%	%	NOUN
ajlm-804	17	4	reference	reference	NOUN
ajlm-804	17	5	interval	interval	NOUN
ajlm-804	17	6	(	(	PUNCT
ajlm-804	17	7	2.5th	2.5th	NUM
ajlm-804	17	8	–	–	PUNCT
ajlm-804	17	9	97.5th	97.5th	NUM
ajlm-804	17	10	)	)	PUNCT
ajlm-804	17	11	for	for	ADP
ajlm-804	17	12	the	the	DET
ajlm-804	17	13	cd4	cd4	PROPN
ajlm-804	17	14	+	+	PROPN
ajlm-804	17	15	count	count	NOUN
ajlm-804	17	16	was	be	AUX
ajlm-804	17	17	453–1534	453–1534	NUM
ajlm-804	17	18	cells/µl	cells/µl	NOUN
ajlm-804	17	19	and	and	CCONJ
ajlm-804	17	20	the	the	DET
ajlm-804	17	21	percentage	percentage	NOUN
ajlm-804	17	22	was	be	AUX
ajlm-804	17	23	30.5	30.5	NUM
ajlm-804	17	24	%	%	NOUN
ajlm-804	17	25	–	–	PUNCT
ajlm-804	17	26	63.4	63.4	NUM
ajlm-804	17	27	%	%	NOUN
ajlm-804	17	28	.	.	PUNCT
ajlm-804	18	1	the	the	DET
ajlm-804	18	2	workflow	workflow	NOUN
ajlm-804	18	3	showed	show	VERB
ajlm-804	18	4	an	an	DET
ajlm-804	18	5	average	average	ADJ
ajlm-804	18	6	number	number	NOUN
ajlm-804	18	7	of	of	ADP
ajlm-804	18	8	hiv	hiv	PROPN
ajlm-804	18	9	samples	sample	NOUN
ajlm-804	18	10	tested	test	VERB
ajlm-804	18	11	as	as	ADP
ajlm-804	18	12	17.5	17.5	NUM
ajlm-804	18	13	per	per	ADP
ajlm-804	18	14	hour	hour	NOUN
ajlm-804	18	15	or	or	CCONJ
ajlm-804	18	16	122.5	122.5	NUM
ajlm-804	18	17	per	per	ADP
ajlm-804	18	18	8	8	NUM
ajlm-804	18	19	-	-	PUNCT
ajlm-804	18	20	hour	hour	NOUN
ajlm-804	18	21	shift	shift	NOUN
ajlm-804	18	22	for	for	ADP
ajlm-804	18	23	one	one	NUM
ajlm-804	18	24	technician	technician	NOUN
ajlm-804	18	25	,	,	PUNCT
ajlm-804	18	26	including	include	VERB
ajlm-804	18	27	passing	pass	VERB
ajlm-804	18	28	quality	quality	NOUN
ajlm-804	18	29	controls	control	NOUN
ajlm-804	18	30	.	.	PUNCT
ajlm-804	19	1	conclusion	conclusion	NOUN
ajlm-804	19	2	:	:	PUNCT
ajlm-804	19	3	the	the	DET
ajlm-804	19	4	aquios	aquio	NOUN
ajlm-804	19	5	plg	plg	NOUN
ajlm-804	19	6	merges	merge	VERB
ajlm-804	19	7	desirable	desirable	ADJ
ajlm-804	19	8	aspects	aspect	NOUN
ajlm-804	19	9	from	from	ADP
ajlm-804	19	10	conventional	conventional	ADJ
ajlm-804	19	11	flow	flow	NOUN
ajlm-804	19	12	cytometer	cytometer	NOUN
ajlm-804	19	13	systems	system	NOUN
ajlm-804	19	14	(	(	PUNCT
ajlm-804	19	15	high	high	ADJ
ajlm-804	19	16	throughput	throughput	NOUN
ajlm-804	19	17	,	,	PUNCT
ajlm-804	19	18	precision	precision	NOUN
ajlm-804	19	19	and	and	CCONJ
ajlm-804	19	20	accuracy	accuracy	NOUN
ajlm-804	19	21	,	,	PUNCT
ajlm-804	19	22	external	external	ADJ
ajlm-804	19	23	quality	quality	NOUN
ajlm-804	19	24	assessment	assessment	NOUN
ajlm-804	19	25	compatibility	compatibility	NOUN
ajlm-804	19	26	)	)	PUNCT
ajlm-804	19	27	with	with	ADP
ajlm-804	19	28	low	low	ADJ
ajlm-804	19	29	technical	technical	ADJ
ajlm-804	19	30	operating	operating	NOUN
ajlm-804	19	31	skill	skill	NOUN
ajlm-804	19	32	requirements	requirement	NOUN
ajlm-804	19	33	for	for	ADP
ajlm-804	19	34	automated	automate	VERB
ajlm-804	19	35	,	,	PUNCT
ajlm-804	19	36	single	single	ADJ
ajlm-804	19	37	platform	platform	NOUN
ajlm-804	19	38	systems	system	NOUN
ajlm-804	19	39	.	.	PUNCT
ajlm-804	20	1	keywords	keyword	NOUN
ajlm-804	20	2	:	:	PUNCT
ajlm-804	21	1	hiv	hiv	NOUN
ajlm-804	21	2	;	;	PUNCT
ajlm-804	21	3	cluster	cluster	NOUN
ajlm-804	21	4	of	of	ADP
ajlm-804	21	5	differentiation	differentiation	NOUN
ajlm-804	21	6	4	4	NUM
ajlm-804	21	7	,	,	PUNCT
ajlm-804	21	8	cd4	cd4	PROPN
ajlm-804	21	9	enumeration	enumeration	NOUN
ajlm-804	21	10	;	;	PUNCT
ajlm-804	21	11	panleucogating	panleucogate	VERB
ajlm-804	21	12	.	.	PUNCT
ajlm-804	22	1	introduction	introduction	NOUN
ajlm-804	22	2	flow	flow	NOUN
ajlm-804	22	3	cytometry	cytometry	NOUN
ajlm-804	22	4	has	have	AUX
ajlm-804	22	5	been	be	AUX
ajlm-804	22	6	the	the	DET
ajlm-804	22	7	system	system	NOUN
ajlm-804	22	8	of	of	ADP
ajlm-804	22	9	choice	choice	NOUN
ajlm-804	22	10	for	for	ADP
ajlm-804	22	11	cd4	cd4	PROPN
ajlm-804	22	12	lymphocyte	lymphocyte	ADJ
ajlm-804	22	13	enumeration	enumeration	NOUN
ajlm-804	22	14	and	and	CCONJ
ajlm-804	22	15	documentation	documentation	NOUN
ajlm-804	22	16	of	of	ADP
ajlm-804	22	17	the	the	DET
ajlm-804	22	18	decline	decline	NOUN
ajlm-804	22	19	of	of	ADP
ajlm-804	22	20	cd4	cd4	PROPN
ajlm-804	22	21	t	t	PROPN
ajlm-804	22	22	-	-	PUNCT
ajlm-804	22	23	cells	cell	NOUN
ajlm-804	22	24	associated	associate	VERB
ajlm-804	22	25	with	with	ADP
ajlm-804	22	26	immunosuppression	immunosuppression	NOUN
ajlm-804	22	27	and	and	CCONJ
ajlm-804	22	28	lowered	lower	VERB
ajlm-804	22	29	counts	count	NOUN
ajlm-804	22	30	in	in	ADP
ajlm-804	22	31	hiv	hiv	PROPN
ajlm-804	22	32	-	-	PUNCT
ajlm-804	22	33	positive	positive	ADJ
ajlm-804	22	34	patients.1,2,3	patients.1,2,3	NOUN
ajlm-804	22	35	many	many	ADJ
ajlm-804	22	36	diverse	diverse	ADJ
ajlm-804	22	37	cd4	cd4	PROPN
ajlm-804	22	38	systems	system	NOUN
ajlm-804	22	39	that	that	PRON
ajlm-804	22	40	offer	offer	VERB
ajlm-804	22	41	solutions	solution	NOUN
ajlm-804	22	42	to	to	PART
ajlm-804	22	43	improve	improve	VERB
ajlm-804	22	44	and	and	CCONJ
ajlm-804	22	45	ensure	ensure	VERB
ajlm-804	22	46	the	the	DET
ajlm-804	22	47	quality	quality	NOUN
ajlm-804	22	48	of	of	ADP
ajlm-804	22	49	testing	testing	NOUN
ajlm-804	22	50	and	and	CCONJ
ajlm-804	22	51	improve	improve	VERB
ajlm-804	22	52	access	access	NOUN
ajlm-804	22	53	to	to	ADP
ajlm-804	22	54	testing	testing	NOUN
ajlm-804	22	55	technologies	technology	NOUN
ajlm-804	22	56	have	have	AUX
ajlm-804	22	57	been	be	AUX
ajlm-804	22	58	described	describe	VERB
ajlm-804	22	59	over	over	ADP
ajlm-804	22	60	the	the	DET
ajlm-804	22	61	last	last	ADJ
ajlm-804	22	62	25	25	NUM
ajlm-804	22	63	years.4,5	years.4,5	NOUN
ajlm-804	22	64	in	in	ADP
ajlm-804	22	65	resource	resource	NOUN
ajlm-804	22	66	-	-	PUNCT
ajlm-804	22	67	limited	limit	VERB
ajlm-804	22	68	settings	setting	NOUN
ajlm-804	22	69	,	,	PUNCT
ajlm-804	22	70	there	there	PRON
ajlm-804	22	71	are	be	VERB
ajlm-804	22	72	many	many	ADJ
ajlm-804	22	73	instances	instance	NOUN
ajlm-804	22	74	where	where	SCONJ
ajlm-804	22	75	laboratory	laboratory	NOUN
ajlm-804	22	76	infrastructure	infrastructure	NOUN
ajlm-804	22	77	is	be	AUX
ajlm-804	22	78	a	a	DET
ajlm-804	22	79	limiting	limit	VERB
ajlm-804	22	80	factor	factor	NOUN
ajlm-804	22	81	.	.	PUNCT
ajlm-804	23	1	however	however	ADV
ajlm-804	23	2	,	,	PUNCT
ajlm-804	23	3	flow	flow	VERB
ajlm-804	23	4	cytometric	cytometric	ADJ
ajlm-804	23	5	systems	system	NOUN
ajlm-804	23	6	and	and	CCONJ
ajlm-804	23	7	simpler	simple	ADJ
ajlm-804	23	8	technologies	technology	NOUN
ajlm-804	23	9	(	(	PUNCT
ajlm-804	23	10	such	such	ADJ
ajlm-804	23	11	as	as	ADP
ajlm-804	23	12	point	point	NOUN
ajlm-804	23	13	-	-	PUNCT
ajlm-804	23	14	of	of	ADP
ajlm-804	23	15	-	-	PUNCT
ajlm-804	23	16	care	care	NOUN
ajlm-804	23	17	technologies	technology	NOUN
ajlm-804	23	18	)	)	PUNCT
ajlm-804	23	19	,	,	PUNCT
ajlm-804	23	20	when	when	SCONJ
ajlm-804	23	21	used	use	VERB
ajlm-804	23	22	in	in	ADP
ajlm-804	23	23	a	a	DET
ajlm-804	23	24	tiered	tiere	VERB
ajlm-804	23	25	laboratory	laboratory	NOUN
ajlm-804	23	26	approach	approach	NOUN
ajlm-804	23	27	,	,	PUNCT
ajlm-804	23	28	can	can	AUX
ajlm-804	23	29	offer	offer	VERB
ajlm-804	23	30	a	a	DET
ajlm-804	23	31	solution.6,7,8,9,10	solution.6,7,8,9,10	NOUN
ajlm-804	23	32	in	in	ADP
ajlm-804	23	33	such	such	DET
ajlm-804	23	34	an	an	DET
ajlm-804	23	35	approach	approach	NOUN
ajlm-804	23	36	,	,	PUNCT
ajlm-804	23	37	primary	primary	ADJ
ajlm-804	23	38	centres	centre	NOUN
ajlm-804	23	39	offer	offer	VERB
ajlm-804	23	40	simplified	simplified	ADJ
ajlm-804	23	41	testing	testing	NOUN
ajlm-804	23	42	and	and	CCONJ
ajlm-804	23	43	refer	refer	VERB
ajlm-804	23	44	testing	testing	NOUN
ajlm-804	23	45	for	for	ADP
ajlm-804	23	46	flow	flow	NOUN
ajlm-804	23	47	cytometry	cytometry	NOUN
ajlm-804	23	48	analysis	analysis	NOUN
ajlm-804	23	49	to	to	ADP
ajlm-804	23	50	secondary	secondary	ADJ
ajlm-804	23	51	or	or	CCONJ
ajlm-804	23	52	tertiary	tertiary	ADJ
ajlm-804	23	53	centres.11,12,13	centres.11,12,13	NOUN
ajlm-804	23	54	despite	despite	SCONJ
ajlm-804	23	55	the	the	DET
ajlm-804	23	56	relative	relative	ADJ
ajlm-804	23	57	technical	technical	ADJ
ajlm-804	23	58	complexity	complexity	NOUN
ajlm-804	23	59	,	,	PUNCT
ajlm-804	23	60	flow	flow	NOUN
ajlm-804	23	61	cytometry	cytometry	NOUN
ajlm-804	23	62	systems	system	NOUN
ajlm-804	23	63	,	,	PUNCT
ajlm-804	23	64	particularly	particularly	ADV
ajlm-804	23	65	those	those	PRON
ajlm-804	23	66	that	that	PRON
ajlm-804	23	67	require	require	VERB
ajlm-804	23	68	less	less	ADV
ajlm-804	23	69	technical	technical	ADJ
ajlm-804	23	70	expertise	expertise	NOUN
ajlm-804	23	71	,	,	PUNCT
ajlm-804	23	72	have	have	AUX
ajlm-804	23	73	been	be	AUX
ajlm-804	23	74	implemented	implement	VERB
ajlm-804	23	75	with	with	ADP
ajlm-804	23	76	success	success	NOUN
ajlm-804	23	77	in	in	ADP
ajlm-804	23	78	some	some	DET
ajlm-804	23	79	national	national	ADJ
ajlm-804	23	80	programmes.11,12	programmes.11,12	NOUN
ajlm-804	23	81	the	the	DET
ajlm-804	23	82	suitability	suitability	NOUN
ajlm-804	23	83	of	of	ADP
ajlm-804	23	84	proposed	propose	VERB
ajlm-804	23	85	instrumentation	instrumentation	NOUN
ajlm-804	23	86	must	must	AUX
ajlm-804	23	87	be	be	AUX
ajlm-804	23	88	assessed	assess	VERB
ajlm-804	23	89	in	in	ADP
ajlm-804	23	90	the	the	DET
ajlm-804	23	91	context	context	NOUN
ajlm-804	23	92	of	of	ADP
ajlm-804	23	93	the	the	DET
ajlm-804	23	94	destination	destination	NOUN
ajlm-804	23	95	laboratory	laboratory	NOUN
ajlm-804	23	96	.	.	PUNCT
ajlm-804	24	1	concerns	concern	NOUN
ajlm-804	24	2	such	such	ADJ
ajlm-804	24	3	as	as	ADP
ajlm-804	24	4	the	the	DET
ajlm-804	24	5	level	level	NOUN
ajlm-804	24	6	of	of	ADP
ajlm-804	24	7	technical	technical	ADJ
ajlm-804	24	8	skill	skill	NOUN
ajlm-804	24	9	required	require	VERB
ajlm-804	24	10	for	for	ADP
ajlm-804	24	11	operation	operation	NOUN
ajlm-804	24	12	(	(	PUNCT
ajlm-804	24	13	ease	ease	NOUN
ajlm-804	24	14	of	of	ADP
ajlm-804	24	15	use	use	NOUN
ajlm-804	24	16	,	,	PUNCT
ajlm-804	24	17	training	training	NOUN
ajlm-804	24	18	,	,	PUNCT
ajlm-804	24	19	and	and	CCONJ
ajlm-804	24	20	automation	automation	NOUN
ajlm-804	24	21	)	)	PUNCT
ajlm-804	24	22	,	,	PUNCT
ajlm-804	24	23	daily	daily	ADJ
ajlm-804	24	24	sample	sample	NOUN
ajlm-804	24	25	load	load	NOUN
ajlm-804	24	26	and	and	CCONJ
ajlm-804	24	27	turn	turn	NOUN
ajlm-804	24	28	-	-	PUNCT
ajlm-804	24	29	around	around	ADP
ajlm-804	24	30	time	time	NOUN
ajlm-804	24	31	requirements	requirement	NOUN
ajlm-804	24	32	,	,	PUNCT
ajlm-804	24	33	external	external	ADJ
ajlm-804	24	34	quality	quality	NOUN
ajlm-804	24	35	assessment	assessment	NOUN
ajlm-804	24	36	programme	programme	NOUN
ajlm-804	24	37	compatibility	compatibility	NOUN
ajlm-804	24	38	and	and	CCONJ
ajlm-804	24	39	quality	quality	NOUN
ajlm-804	24	40	control	control	NOUN
ajlm-804	24	41	reagent	reagent	ADJ
ajlm-804	24	42	availability	availability	NOUN
ajlm-804	24	43	,	,	PUNCT
ajlm-804	24	44	supplier	supplier	NOUN
ajlm-804	24	45	availability	availability	NOUN
ajlm-804	24	46	and	and	CCONJ
ajlm-804	24	47	support	support	NOUN
ajlm-804	24	48	,	,	PUNCT
ajlm-804	24	49	transit	transit	NOUN
ajlm-804	24	50	requirements	requirement	NOUN
ajlm-804	24	51	,	,	PUNCT
ajlm-804	24	52	infrastructure	infrastructure	NOUN
ajlm-804	24	53	,	,	PUNCT
ajlm-804	24	54	and	and	CCONJ
ajlm-804	24	55	cost	cost	NOUN
ajlm-804	24	56	per	per	ADP
ajlm-804	24	57	test	test	NOUN
ajlm-804	24	58	should	should	AUX
ajlm-804	24	59	be	be	AUX
ajlm-804	24	60	considered.11,14	considered.11,14	ADV
ajlm-804	24	61	the	the	DET
ajlm-804	24	62	panleucogating	panleucogating	NOUN
ajlm-804	24	63	(	(	PUNCT
ajlm-804	24	64	plg	plg	NOUN
ajlm-804	24	65	)	)	PUNCT
ajlm-804	24	66	cd4	cd4	PROPN
ajlm-804	24	67	counting	counting	NOUN
ajlm-804	24	68	method12,15,16	method12,15,16	NOUN
ajlm-804	24	69	incorporates	incorporate	VERB
ajlm-804	24	70	a	a	DET
ajlm-804	24	71	simple	simple	ADJ
ajlm-804	24	72	gating	gate	VERB
ajlm-804	24	73	strategy	strategy	NOUN
ajlm-804	24	74	with	with	ADP
ajlm-804	24	75	only	only	ADV
ajlm-804	24	76	cd45	cd45	PROPN
ajlm-804	24	77	and	and	CCONJ
ajlm-804	24	78	cd4	cd4	PROPN
ajlm-804	24	79	to	to	PART
ajlm-804	24	80	enumerate	enumerate	VERB
ajlm-804	24	81	cd4	cd4	PROPN
ajlm-804	24	82	lymphocytes	lymphocyte	NOUN
ajlm-804	24	83	.	.	PUNCT
ajlm-804	25	1	quality	quality	NOUN
ajlm-804	25	2	assessment	assessment	NOUN
ajlm-804	25	3	programmes	programme	NOUN
ajlm-804	25	4	reported	report	VERB
ajlm-804	25	5	improved	improved	ADJ
ajlm-804	25	6	performance	performance	NOUN
ajlm-804	25	7	of	of	ADP
ajlm-804	25	8	plg	plg	PROPN
ajlm-804	25	9	cd4	cd4	PROPN
ajlm-804	25	10	counting	counting	NOUN
ajlm-804	25	11	and	and	CCONJ
ajlm-804	25	12	revealed	reveal	VERB
ajlm-804	25	13	better	well	ADJ
ajlm-804	25	14	quality	quality	NOUN
ajlm-804	25	15	in	in	ADP
ajlm-804	25	16	both	both	CCONJ
ajlm-804	25	17	the	the	DET
ajlm-804	25	18	intraand	intraand	NOUN
ajlm-804	25	19	inter	inter	NOUN
ajlm-804	25	20	-	-	ADJ
ajlm-804	25	21	laboratory	laboratory	ADJ
ajlm-804	25	22	reported	report	VERB
ajlm-804	25	23	percent	percent	NOUN
ajlm-804	25	24	coefficient	coefficient	NOUN
ajlm-804	25	25	of	of	ADP
ajlm-804	25	26	variation	variation	NOUN
ajlm-804	25	27	outcomes.12,17	outcomes.12,17	NOUN
ajlm-804	25	28	decreased	decrease	VERB
ajlm-804	25	29	costs	cost	NOUN
ajlm-804	25	30	of	of	ADP
ajlm-804	25	31	the	the	DET
ajlm-804	25	32	simplified	simplified	ADJ
ajlm-804	25	33	system	system	NOUN
ajlm-804	25	34	also	also	ADV
ajlm-804	25	35	played	play	VERB
ajlm-804	25	36	an	an	DET
ajlm-804	25	37	important	important	ADJ
ajlm-804	25	38	role	role	NOUN
ajlm-804	25	39	in	in	ADP
ajlm-804	25	40	addressing	address	VERB
ajlm-804	25	41	some	some	PRON
ajlm-804	25	42	of	of	ADP
ajlm-804	25	43	the	the	DET
ajlm-804	25	44	aforementioned	aforementioned	ADJ
ajlm-804	25	45	concerns.16,18	concerns.16,18	NOUN
ajlm-804	25	46	this	this	DET
ajlm-804	25	47	method	method	NOUN
ajlm-804	25	48	was	be	AUX
ajlm-804	25	49	adopted	adopt	VERB
ajlm-804	25	50	as	as	ADP
ajlm-804	25	51	the	the	DET
ajlm-804	25	52	predicate	predicate	NOUN
ajlm-804	25	53	method	method	NOUN
ajlm-804	25	54	by	by	ADP
ajlm-804	25	55	the	the	DET
ajlm-804	25	56	south	south	ADJ
ajlm-804	25	57	african	african	ADJ
ajlm-804	25	58	national	national	PROPN
ajlm-804	25	59	health	health	PROPN
ajlm-804	25	60	laboratory	laboratory	PROPN
ajlm-804	25	61	service	service	NOUN
ajlm-804	25	62	(	(	PUNCT
ajlm-804	25	63	nhls	nhls	PROPN
ajlm-804	25	64	)	)	PUNCT
ajlm-804	25	65	in	in	ADP
ajlm-804	25	66	2004	2004	NUM
ajlm-804	25	67	.	.	PUNCT
ajlm-804	26	1	the	the	DET
ajlm-804	26	2	nhls	nhls	PROPN
ajlm-804	26	3	programme	programme	NOUN
ajlm-804	26	4	had	have	AUX
ajlm-804	26	5	grown	grow	VERB
ajlm-804	26	6	to	to	ADP
ajlm-804	26	7	35	35	NUM
ajlm-804	26	8	laboratories	laboratory	NOUN
ajlm-804	26	9	by	by	ADP
ajlm-804	26	10	2007,12	2007,12	NUM
ajlm-804	26	11	reaching	reach	VERB
ajlm-804	26	12	60	60	NUM
ajlm-804	26	13	networked	networked	ADJ
ajlm-804	26	14	cd4	cd4	PROPN
ajlm-804	26	15	laboratories	laboratory	NOUN
ajlm-804	26	16	by	by	ADP
ajlm-804	26	17	201411	201411	NUM
ajlm-804	26	18	in	in	ADP
ajlm-804	26	19	a	a	DET
ajlm-804	26	20	tiered	tiere	VERB
ajlm-804	26	21	system	system	NOUN
ajlm-804	26	22	utilising	utilise	VERB
ajlm-804	26	23	either	either	CCONJ
ajlm-804	26	24	beckman	beckman	PROPN
ajlm-804	26	25	coulter	coulter	PROPN
ajlm-804	26	26	fc500	fc500	PROPN
ajlm-804	26	27	(	(	PUNCT
ajlm-804	26	28	beckman	beckman	PROPN
ajlm-804	26	29	coulter	coulter	PROPN
ajlm-804	26	30	,	,	PUNCT
ajlm-804	26	31	inc	inc	PROPN
ajlm-804	26	32	.	.	PROPN
ajlm-804	26	33	,	,	PUNCT
ajlm-804	26	34	miami	miami	PROPN
ajlm-804	26	35	,	,	PUNCT
ajlm-804	26	36	florida	florida	PROPN
ajlm-804	26	37	,	,	PUNCT
ajlm-804	26	38	united	united	PROPN
ajlm-804	26	39	states	states	PROPN
ajlm-804	26	40	)	)	PUNCT
ajlm-804	26	41	or	or	CCONJ
ajlm-804	26	42	xl	xl	PROPN
ajlm-804	26	43	(	(	PUNCT
ajlm-804	26	44	beckman	beckman	PROPN
ajlm-804	26	45	coulter	coulter	PROPN
ajlm-804	26	46	,	,	PUNCT
ajlm-804	26	47	inc	inc	PROPN
ajlm-804	26	48	.	.	PROPN
ajlm-804	26	49	,	,	PUNCT
ajlm-804	26	50	miami	miami	PROPN
ajlm-804	26	51	,	,	PUNCT
ajlm-804	26	52	florida	florida	PROPN
ajlm-804	26	53	,	,	PUNCT
ajlm-804	26	54	united	united	PROPN
ajlm-804	26	55	states	states	PROPN
ajlm-804	26	56	)	)	PUNCT
ajlm-804	26	57	instruments	instrument	NOUN
ajlm-804	26	58	according	accord	VERB
ajlm-804	26	59	to	to	ADP
ajlm-804	26	60	service	service	NOUN
ajlm-804	26	61	workload	workload	NOUN
ajlm-804	26	62	requirements.11	requirements.11	VERB
ajlm-804	26	63	a	a	DET
ajlm-804	26	64	single	single	ADJ
ajlm-804	26	65	platform	platform	NOUN
ajlm-804	26	66	volumetric	volumetric	NOUN
ajlm-804	26	67	flow	flow	NOUN
ajlm-804	26	68	cytometer	cytometer	NOUN
ajlm-804	26	69	(	(	PUNCT
ajlm-804	26	70	aquios	aquio	NOUN
ajlm-804	26	71	,	,	PUNCT
ajlm-804	26	72	beckman	beckman	PROPN
ajlm-804	26	73	coulter	coulter	PROPN
ajlm-804	26	74	,	,	PUNCT
ajlm-804	26	75	inc	inc	PROPN
ajlm-804	26	76	.	.	PROPN
ajlm-804	26	77	,	,	PUNCT
ajlm-804	26	78	miami	miami	PROPN
ajlm-804	26	79	,	,	PUNCT
ajlm-804	26	80	florida	florida	PROPN
ajlm-804	26	81	,	,	PUNCT
ajlm-804	26	82	united	united	PROPN
ajlm-804	26	83	states	states	PROPN
ajlm-804	26	84	)	)	PUNCT
ajlm-804	26	85	was	be	AUX
ajlm-804	26	86	recently	recently	ADV
ajlm-804	26	87	developed	develop	VERB
ajlm-804	26	88	that	that	PRON
ajlm-804	26	89	utilises	utilise	VERB
ajlm-804	26	90	a	a	DET
ajlm-804	26	91	conventional	conventional	ADJ
ajlm-804	26	92	cd4	cd4	PROPN
ajlm-804	26	93	gating	gating	NOUN
ajlm-804	26	94	method	method	NOUN
ajlm-804	26	95	based	base	VERB
ajlm-804	26	96	on	on	ADP
ajlm-804	26	97	cd45	cd45	PROPN
ajlm-804	26	98	and	and	CCONJ
ajlm-804	26	99	cd3	cd3	VERB
ajlm-804	26	100	with	with	ADP
ajlm-804	26	101	both	both	CCONJ
ajlm-804	26	102	cd4	cd4	PROPN
ajlm-804	26	103	and	and	CCONJ
ajlm-804	26	104	cd8	cd8	PROPN
ajlm-804	26	105	for	for	ADP
ajlm-804	26	106	cd4	cd4	PROPN
ajlm-804	26	107	-	-	ADJ
ajlm-804	26	108	positive	positive	ADJ
ajlm-804	26	109	and	and	CCONJ
ajlm-804	26	110	cd8	cd8	PROPN
ajlm-804	26	111	-	-	ADJ
ajlm-804	26	112	positive	positive	ADJ
ajlm-804	26	113	t	t	NOUN
ajlm-804	26	114	-	-	PUNCT
ajlm-804	26	115	cell	cell	NOUN
ajlm-804	26	116	lymphocyte	lymphocyte	NOUN
ajlm-804	26	117	counts	count	NOUN
ajlm-804	26	118	and	and	CCONJ
ajlm-804	26	119	percentages	percentage	NOUN
ajlm-804	26	120	.	.	PUNCT
ajlm-804	27	1	this	this	DET
ajlm-804	27	2	system	system	NOUN
ajlm-804	27	3	was	be	AUX
ajlm-804	27	4	updated	update	VERB
ajlm-804	27	5	in	in	ADP
ajlm-804	27	6	2013	2013	NUM
ajlm-804	27	7	-	-	SYM
ajlm-804	27	8	2014	2014	NUM
ajlm-804	27	9	using	use	VERB
ajlm-804	27	10	bead	bead	NOUN
ajlm-804	27	11	-	-	PUNCT
ajlm-804	27	12	based	base	VERB
ajlm-804	27	13	counting	counting	NOUN
ajlm-804	27	14	for	for	ADP
ajlm-804	27	15	use	use	NOUN
ajlm-804	27	16	with	with	ADP
ajlm-804	27	17	the	the	DET
ajlm-804	27	18	current	current	ADJ
ajlm-804	27	19	south	south	ADJ
ajlm-804	27	20	african	african	ADJ
ajlm-804	27	21	laboratory	laboratory	NOUN
ajlm-804	27	22	network	network	NOUN
ajlm-804	27	23	plg	plg	PROPN
ajlm-804	27	24	predicate13,14	predicate13,14	ADV
ajlm-804	27	25	.	.	PUNCT
ajlm-804	28	1	the	the	DET
ajlm-804	28	2	aquios	aquio	NOUN
ajlm-804	28	3	system	system	NOUN
ajlm-804	28	4	is	be	AUX
ajlm-804	28	5	fully	fully	ADV
ajlm-804	28	6	automated	automate	VERB
ajlm-804	28	7	from	from	ADP
ajlm-804	28	8	sample	sample	NOUN
ajlm-804	28	9	preparation	preparation	NOUN
ajlm-804	28	10	to	to	PART
ajlm-804	28	11	flow	flow	VERB
ajlm-804	28	12	cytometry	cytometry	ADJ
ajlm-804	28	13	analysis	analysis	NOUN
ajlm-804	28	14	.	.	PUNCT
ajlm-804	29	1	it	it	PRON
ajlm-804	29	2	allows	allow	VERB
ajlm-804	29	3	for	for	ADP
ajlm-804	29	4	operator	operator	NOUN
ajlm-804	29	5	independent	independent	ADJ
ajlm-804	29	6	loading	loading	NOUN
ajlm-804	29	7	and	and	CCONJ
ajlm-804	29	8	testing	testing	NOUN
ajlm-804	29	9	for	for	ADP
ajlm-804	29	10	multiple	multiple	ADJ
ajlm-804	29	11	samples	sample	NOUN
ajlm-804	29	12	.	.	PUNCT
ajlm-804	30	1	it	it	PRON
ajlm-804	30	2	has	have	VERB
ajlm-804	30	3	pre	pre	ADJ
ajlm-804	30	4	-	-	ADJ
ajlm-804	30	5	configured	configure	VERB
ajlm-804	30	6	panels	panel	NOUN
ajlm-804	30	7	or	or	CCONJ
ajlm-804	30	8	protocols	protocol	NOUN
ajlm-804	30	9	that	that	PRON
ajlm-804	30	10	are	be	AUX
ajlm-804	30	11	not	not	PART
ajlm-804	30	12	modifiable	modifiable	ADJ
ajlm-804	30	13	by	by	ADP
ajlm-804	30	14	the	the	DET
ajlm-804	30	15	user	user	NOUN
ajlm-804	30	16	,	,	PUNCT
ajlm-804	30	17	enabling	enable	VERB
ajlm-804	30	18	standardised	standardised	ADJ
ajlm-804	30	19	testing	testing	NOUN
ajlm-804	30	20	.	.	PUNCT
ajlm-804	31	1	in	in	ADP
ajlm-804	31	2	line	line	NOUN
ajlm-804	31	3	with	with	ADP
ajlm-804	31	4	the	the	DET
ajlm-804	31	5	tiered	tiered	ADJ
ajlm-804	31	6	model	model	NOUN
ajlm-804	31	7	adopted	adopt	VERB
ajlm-804	31	8	by	by	ADP
ajlm-804	31	9	the	the	DET
ajlm-804	31	10	national	national	PROPN
ajlm-804	31	11	health	health	PROPN
ajlm-804	31	12	laboratory	laboratory	PROPN
ajlm-804	31	13	service	service	PROPN
ajlm-804	31	14	,	,	PUNCT
ajlm-804	31	15	plg	plg	NOUN
ajlm-804	31	16	testing	testing	NOUN
ajlm-804	31	17	on	on	ADP
ajlm-804	31	18	the	the	DET
ajlm-804	31	19	aquios	aquio	NOUN
ajlm-804	31	20	system	system	NOUN
ajlm-804	31	21	(	(	PUNCT
ajlm-804	31	22	aquios	aquio	NOUN
ajlm-804	31	23	plg	plg	NOUN
ajlm-804	31	24	)	)	PUNCT
ajlm-804	31	25	was	be	AUX
ajlm-804	31	26	proposed	propose	VERB
ajlm-804	31	27	as	as	SCONJ
ajlm-804	31	28	the	the	DET
ajlm-804	31	29	system	system	NOUN
ajlm-804	31	30	to	to	PART
ajlm-804	31	31	replace	replace	VERB
ajlm-804	31	32	aging	age	VERB
ajlm-804	31	33	and	and	CCONJ
ajlm-804	31	34	redundant	redundant	ADJ
ajlm-804	31	35	fc500	fc500	PROPN
ajlm-804	31	36	and	and	CCONJ
ajlm-804	31	37	xl	xl	PROPN
ajlm-804	31	38	flow	flow	NOUN
ajlm-804	31	39	cytometers	cytometer	NOUN
ajlm-804	31	40	operational	operational	ADJ
ajlm-804	31	41	within	within	ADP
ajlm-804	31	42	the	the	DET
ajlm-804	31	43	south	south	ADJ
ajlm-804	31	44	african	african	ADJ
ajlm-804	31	45	network	network	NOUN
ajlm-804	31	46	,	,	PUNCT
ajlm-804	31	47	as	as	ADV
ajlm-804	31	48	well	well	ADV
ajlm-804	31	49	as	as	ADP
ajlm-804	31	50	extend	extend	VERB
ajlm-804	31	51	its	its	PRON
ajlm-804	31	52	use	use	NOUN
ajlm-804	31	53	into	into	ADP
ajlm-804	31	54	small	small	ADJ
ajlm-804	31	55	laboratories	laboratory	NOUN
ajlm-804	31	56	that	that	PRON
ajlm-804	31	57	offered	offer	VERB
ajlm-804	31	58	basic	basic	ADJ
ajlm-804	31	59	clinical	clinical	ADJ
ajlm-804	31	60	pathology	pathology	NOUN
ajlm-804	31	61	but	but	CCONJ
ajlm-804	31	62	no	no	DET
ajlm-804	31	63	cd4	cd4	PROPN
ajlm-804	31	64	services.19	services.19	PRON
ajlm-804	31	65	the	the	DET
ajlm-804	31	66	objective	objective	NOUN
ajlm-804	31	67	of	of	ADP
ajlm-804	31	68	this	this	DET
ajlm-804	31	69	study	study	NOUN
ajlm-804	31	70	was	be	AUX
ajlm-804	31	71	to	to	PART
ajlm-804	31	72	compare	compare	VERB
ajlm-804	31	73	the	the	DET
ajlm-804	31	74	performance	performance	NOUN
ajlm-804	31	75	of	of	ADP
ajlm-804	31	76	aquios	aquio	NOUN
ajlm-804	31	77	plg	plg	NOUN
ajlm-804	31	78	with	with	ADP
ajlm-804	31	79	traditional	traditional	ADJ
ajlm-804	31	80	plg	plg	NOUN
ajlm-804	31	81	cd4	cd4	PROPN
ajlm-804	31	82	methods	method	NOUN
ajlm-804	31	83	generated	generate	VERB
ajlm-804	31	84	on	on	ADP
ajlm-804	31	85	the	the	DET
ajlm-804	31	86	fc500	fc500	PROPN
ajlm-804	31	87	instrument	instrument	NOUN
ajlm-804	31	88	at	at	ADP
ajlm-804	31	89	a	a	DET
ajlm-804	31	90	local	local	ADJ
ajlm-804	31	91	south	south	ADJ
ajlm-804	31	92	african	african	ADJ
ajlm-804	31	93	site	site	NOUN
ajlm-804	31	94	,	,	PUNCT
ajlm-804	31	95	as	as	ADV
ajlm-804	31	96	well	well	ADV
ajlm-804	31	97	as	as	ADP
ajlm-804	31	98	established	establish	VERB
ajlm-804	31	99	cd4	cd4	PROPN
ajlm-804	31	100	reference	reference	NOUN
ajlm-804	31	101	centre	centre	NOUN
ajlm-804	31	102	sites	site	NOUN
ajlm-804	31	103	in	in	ADP
ajlm-804	31	104	high	high	ADJ
ajlm-804	31	105	-	-	PUNCT
ajlm-804	31	106	income	income	NOUN
ajlm-804	31	107	countries	country	NOUN
ajlm-804	31	108	.	.	PUNCT
ajlm-804	32	1	additionally	additionally	ADV
ajlm-804	32	2	,	,	PUNCT
ajlm-804	32	3	normal	normal	ADJ
ajlm-804	32	4	samples	sample	NOUN
ajlm-804	32	5	were	be	AUX
ajlm-804	32	6	collected	collect	VERB
ajlm-804	32	7	and	and	CCONJ
ajlm-804	32	8	these	these	DET
ajlm-804	32	9	data	datum	NOUN
ajlm-804	32	10	were	be	AUX
ajlm-804	32	11	used	use	VERB
ajlm-804	32	12	to	to	PART
ajlm-804	32	13	calculate	calculate	VERB
ajlm-804	32	14	a	a	DET
ajlm-804	32	15	reference	reference	NOUN
ajlm-804	32	16	interval	interval	NOUN
ajlm-804	32	17	to	to	PART
ajlm-804	32	18	establish	establish	VERB
ajlm-804	32	19	whether	whether	SCONJ
ajlm-804	32	20	normal	normal	ADJ
ajlm-804	32	21	counts	count	NOUN
ajlm-804	32	22	generated	generate	VERB
ajlm-804	32	23	by	by	ADP
ajlm-804	32	24	aquios	aquio	NOUN
ajlm-804	32	25	plg	plg	NOUN
ajlm-804	32	26	matched	match	VERB
ajlm-804	32	27	other	other	ADJ
ajlm-804	32	28	published	publish	VERB
ajlm-804	32	29	reference	reference	NOUN
ajlm-804	32	30	intervals.20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42	intervals.20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42	VERB
ajlm-804	32	31	methods	method	NOUN
ajlm-804	32	32	ethical	ethical	ADJ
ajlm-804	32	33	considerations	consideration	NOUN
ajlm-804	32	34	all	all	DET
ajlm-804	32	35	sites	site	NOUN
ajlm-804	32	36	had	have	VERB
ajlm-804	32	37	ethics	ethic	NOUN
ajlm-804	32	38	committee	committee	NOUN
ajlm-804	32	39	or	or	CCONJ
ajlm-804	32	40	internal	internal	ADJ
ajlm-804	32	41	review	review	NOUN
ajlm-804	32	42	board	board	NOUN
ajlm-804	32	43	approval	approval	NOUN
ajlm-804	32	44	for	for	ADP
ajlm-804	32	45	the	the	DET
ajlm-804	32	46	collection	collection	NOUN
ajlm-804	32	47	of	of	ADP
ajlm-804	32	48	samples	sample	NOUN
ajlm-804	32	49	or	or	CCONJ
ajlm-804	32	50	use	use	NOUN
ajlm-804	32	51	of	of	ADP
ajlm-804	32	52	leftover	leftover	NOUN
ajlm-804	32	53	samples	sample	NOUN
ajlm-804	32	54	and	and	CCONJ
ajlm-804	32	55	use	use	NOUN
ajlm-804	32	56	of	of	ADP
ajlm-804	32	57	minimal	minimal	ADJ
ajlm-804	32	58	demographic	demographic	ADJ
ajlm-804	32	59	data	datum	NOUN
ajlm-804	32	60	of	of	ADP
ajlm-804	32	61	age	age	NOUN
ajlm-804	32	62	and	and	CCONJ
ajlm-804	32	63	gender	gender	NOUN
ajlm-804	32	64	or	or	CCONJ
ajlm-804	32	65	a	a	DET
ajlm-804	32	66	waiver	waiver	NOUN
ajlm-804	32	67	was	be	AUX
ajlm-804	32	68	in	in	ADP
ajlm-804	32	69	place	place	NOUN
ajlm-804	32	70	for	for	ADP
ajlm-804	32	71	use	use	NOUN
ajlm-804	32	72	of	of	ADP
ajlm-804	32	73	these	these	DET
ajlm-804	32	74	samples	sample	NOUN
ajlm-804	32	75	.	.	PUNCT
ajlm-804	33	1	use	use	NOUN
ajlm-804	33	2	of	of	ADP
ajlm-804	33	3	leftover	leftover	NOUN
ajlm-804	33	4	samples	sample	NOUN
ajlm-804	33	5	for	for	ADP
ajlm-804	33	6	research	research	NOUN
ajlm-804	33	7	purposes	purpose	NOUN
ajlm-804	33	8	was	be	AUX
ajlm-804	33	9	agreed	agree	VERB
ajlm-804	33	10	to	to	ADP
ajlm-804	33	11	at	at	ADP
ajlm-804	33	12	the	the	DET
ajlm-804	33	13	time	time	NOUN
ajlm-804	33	14	of	of	ADP
ajlm-804	33	15	routine	routine	ADJ
ajlm-804	33	16	laboratory	laboratory	NOUN
ajlm-804	33	17	blood	blood	NOUN
ajlm-804	33	18	draw	draw	NOUN
ajlm-804	33	19	.	.	PUNCT
ajlm-804	34	1	the	the	DET
ajlm-804	34	2	following	follow	VERB
ajlm-804	34	3	ethical	ethical	ADJ
ajlm-804	34	4	clearances	clearance	NOUN
ajlm-804	34	5	were	be	AUX
ajlm-804	34	6	in	in	ADP
ajlm-804	34	7	place	place	NOUN
ajlm-804	34	8	:	:	PUNCT
ajlm-804	34	9	south	south	PROPN
ajlm-804	34	10	africa	africa	PROPN
ajlm-804	34	11	(	(	PUNCT
ajlm-804	34	12	identification	identification	NOUN
ajlm-804	34	13	number	number	NOUN
ajlm-804	34	14	:	:	PUNCT
ajlm-804	34	15	m121020	m121020	NOUN
ajlm-804	34	16	)	)	PUNCT
ajlm-804	34	17	;	;	PUNCT
ajlm-804	34	18	france	france	PROPN
ajlm-804	34	19	(	(	PUNCT
ajlm-804	34	20	lyon	lyon	PROPN
ajlm-804	34	21	;	;	PUNCT
ajlm-804	34	22	identification	identification	NOUN
ajlm-804	34	23	number	number	NOUN
ajlm-804	34	24	:	:	PUNCT
ajlm-804	34	25	ac-2013	ac-2013	NOUN
ajlm-804	34	26	-	-	PUNCT
ajlm-804	34	27	1808	1808	NUM
ajlm-804	34	28	)	)	PUNCT
ajlm-804	34	29	;	;	PUNCT
ajlm-804	34	30	canada	canada	PROPN
ajlm-804	34	31	(	(	PUNCT
ajlm-804	34	32	identification	identification	NOUN
ajlm-804	34	33	number	number	NOUN
ajlm-804	34	34	:	:	PUNCT
ajlm-804	34	35	09763e	09763e	NOUN
ajlm-804	34	36	)	)	PUNCT
ajlm-804	34	37	;	;	PUNCT
ajlm-804	34	38	and	and	CCONJ
ajlm-804	34	39	the	the	DET
ajlm-804	34	40	united	united	PROPN
ajlm-804	34	41	states	states	PROPN
ajlm-804	34	42	(	(	PUNCT
ajlm-804	34	43	identification	identification	NOUN
ajlm-804	34	44	number	number	NOUN
ajlm-804	34	45	:	:	PUNCT
ajlm-804	34	46	10259	10259	NUM
ajlm-804	34	47	-	-	SYM
ajlm-804	34	48	05	05	NUM
ajlm-804	34	49	)	)	PUNCT
ajlm-804	34	50	.	.	PUNCT
ajlm-804	35	1	in	in	ADP
ajlm-804	35	2	france	france	PROPN
ajlm-804	35	3	(	(	PUNCT
ajlm-804	35	4	paris	paris	PROPN
ajlm-804	35	5	)	)	PUNCT
ajlm-804	35	6	,	,	PUNCT
ajlm-804	35	7	consent	consent	NOUN
ajlm-804	35	8	was	be	AUX
ajlm-804	35	9	given	give	VERB
ajlm-804	35	10	at	at	ADP
ajlm-804	35	11	the	the	DET
ajlm-804	35	12	time	time	NOUN
ajlm-804	35	13	of	of	ADP
ajlm-804	35	14	routine	routine	ADJ
ajlm-804	35	15	blood	blood	NOUN
ajlm-804	35	16	draw	draw	VERB
ajlm-804	35	17	for	for	ADP
ajlm-804	35	18	the	the	DET
ajlm-804	35	19	use	use	NOUN
ajlm-804	35	20	of	of	ADP
ajlm-804	35	21	leftover	leftover	NOUN
ajlm-804	35	22	samples	sample	NOUN
ajlm-804	35	23	for	for	ADP
ajlm-804	35	24	research	research	NOUN
ajlm-804	35	25	under	under	ADP
ajlm-804	35	26	a	a	DET
ajlm-804	35	27	waiver	waiver	NOUN
ajlm-804	35	28	according	accord	VERB
ajlm-804	35	29	to	to	ADP
ajlm-804	35	30	current	current	ADJ
ajlm-804	35	31	french	french	ADJ
ajlm-804	35	32	legislation	legislation	NOUN
ajlm-804	35	33	(	(	PUNCT
ajlm-804	35	34	loi	loi	PROPN
ajlm-804	35	35	jardé	jardé	PROPN
ajlm-804	35	36	,	,	PUNCT
ajlm-804	35	37	n	n	CCONJ
ajlm-804	35	38	°	°	PROPN
ajlm-804	35	39	2012	2012	NUM
ajlm-804	35	40	-	-	SYM
ajlm-804	35	41	300	300	NUM
ajlm-804	35	42	)	)	PUNCT
ajlm-804	35	43	.	.	PUNCT
ajlm-804	36	1	patients	patient	NOUN
ajlm-804	36	2	providing	provide	VERB
ajlm-804	36	3	samples	sample	NOUN
ajlm-804	36	4	for	for	ADP
ajlm-804	36	5	the	the	DET
ajlm-804	36	6	reference	reference	NOUN
ajlm-804	36	7	interval	interval	NOUN
ajlm-804	36	8	study	study	NOUN
ajlm-804	36	9	signed	sign	VERB
ajlm-804	36	10	a	a	DET
ajlm-804	36	11	consent	consent	NOUN
ajlm-804	36	12	form	form	NOUN
ajlm-804	36	13	.	.	PUNCT
ajlm-804	37	1	specimens	specimen	NOUN
ajlm-804	37	2	method	method	VERB
ajlm-804	37	3	comparison	comparison	NOUN
ajlm-804	37	4	patient	patient	NOUN
ajlm-804	37	5	samples	sample	NOUN
ajlm-804	37	6	were	be	AUX
ajlm-804	37	7	obtained	obtain	VERB
ajlm-804	37	8	from	from	ADP
ajlm-804	37	9	incoming	incoming	ADJ
ajlm-804	37	10	routine	routine	ADJ
ajlm-804	37	11	laboratory	laboratory	NOUN
ajlm-804	37	12	specimens	specimen	NOUN
ajlm-804	37	13	for	for	ADP
ajlm-804	37	14	cd4	cd4	PROPN
ajlm-804	37	15	testing	testing	NOUN
ajlm-804	37	16	between	between	ADP
ajlm-804	37	17	november	november	PROPN
ajlm-804	37	18	2014	2014	NUM
ajlm-804	37	19	and	and	CCONJ
ajlm-804	37	20	march	march	PROPN
ajlm-804	37	21	2015	2015	NUM
ajlm-804	37	22	from	from	ADP
ajlm-804	37	23	four	four	NUM
ajlm-804	37	24	different	different	ADJ
ajlm-804	37	25	centres	centre	NOUN
ajlm-804	37	26	located	locate	VERB
ajlm-804	37	27	in	in	ADP
ajlm-804	37	28	canada	canada	PROPN
ajlm-804	37	29	;	;	PUNCT
ajlm-804	37	30	paris	paris	PROPN
ajlm-804	37	31	,	,	PUNCT
ajlm-804	37	32	france	france	PROPN
ajlm-804	37	33	;	;	PUNCT
ajlm-804	37	34	lyon	lyon	PROPN
ajlm-804	37	35	,	,	PUNCT
ajlm-804	37	36	france	france	PROPN
ajlm-804	37	37	and	and	CCONJ
ajlm-804	37	38	south	south	PROPN
ajlm-804	37	39	africa	africa	PROPN
ajlm-804	37	40	.	.	PUNCT
ajlm-804	38	1	a	a	DET
ajlm-804	38	2	total	total	NOUN
ajlm-804	38	3	of	of	ADP
ajlm-804	38	4	270	270	NUM
ajlm-804	38	5	samples	sample	NOUN
ajlm-804	38	6	from	from	ADP
ajlm-804	38	7	hiv	hiv	NOUN
ajlm-804	38	8	-	-	PUNCT
ajlm-804	38	9	positive	positive	ADJ
ajlm-804	38	10	adult	adult	NOUN
ajlm-804	38	11	and	and	CCONJ
ajlm-804	38	12	paediatric	paediatric	ADJ
ajlm-804	38	13	patients	patient	NOUN
ajlm-804	38	14	were	be	AUX
ajlm-804	38	15	tested	test	VERB
ajlm-804	38	16	,	,	PUNCT
ajlm-804	38	17	ranging	range	VERB
ajlm-804	38	18	in	in	ADP
ajlm-804	38	19	age	age	NOUN
ajlm-804	38	20	from	from	ADP
ajlm-804	38	21	2	2	NUM
ajlm-804	38	22	months	month	NOUN
ajlm-804	38	23	to	to	ADP
ajlm-804	38	24	77	77	NUM
ajlm-804	38	25	years	year	NOUN
ajlm-804	38	26	.	.	PUNCT
ajlm-804	39	1	thirty	thirty	NUM
ajlm-804	39	2	samples	sample	NOUN
ajlm-804	39	3	(	(	PUNCT
ajlm-804	39	4	22	22	NUM
ajlm-804	39	5	adults	adult	NOUN
ajlm-804	39	6	,	,	PUNCT
ajlm-804	39	7	8	8	NUM
ajlm-804	39	8	children	child	NOUN
ajlm-804	39	9	)	)	PUNCT
ajlm-804	39	10	were	be	AUX
ajlm-804	39	11	excluded	exclude	VERB
ajlm-804	39	12	for	for	ADP
ajlm-804	39	13	the	the	DET
ajlm-804	39	14	following	follow	VERB
ajlm-804	39	15	reasons	reason	NOUN
ajlm-804	39	16	:	:	PUNCT
ajlm-804	39	17	cd4	cd4	PROPN
ajlm-804	39	18	<	<	X
ajlm-804	39	19	20	20	NUM
ajlm-804	39	20	cells/µl	cells/µl	NOUN
ajlm-804	39	21	(	(	PUNCT
ajlm-804	39	22	the	the	DET
ajlm-804	39	23	instrument	instrument	NOUN
ajlm-804	39	24	’s	’s	PART
ajlm-804	39	25	lower	low	ADJ
ajlm-804	39	26	limit	limit	NOUN
ajlm-804	39	27	of	of	ADP
ajlm-804	39	28	quantitation	quantitation	NOUN
ajlm-804	39	29	)	)	PUNCT
ajlm-804	39	30	(	(	PUNCT
ajlm-804	39	31	18	18	NUM
ajlm-804	39	32	samples	sample	NOUN
ajlm-804	39	33	)	)	PUNCT
ajlm-804	39	34	,	,	PUNCT
ajlm-804	39	35	operator	operator	NOUN
ajlm-804	39	36	error	error	NOUN
ajlm-804	39	37	with	with	ADP
ajlm-804	39	38	manual	manual	ADJ
ajlm-804	39	39	flowcount	flowcount	NOUN
ajlm-804	39	40	addition	addition	NOUN
ajlm-804	39	41	(	(	PUNCT
ajlm-804	39	42	fc500	fc500	PROPN
ajlm-804	39	43	)	)	PUNCT
ajlm-804	39	44	(	(	PUNCT
ajlm-804	39	45	4	4	NUM
ajlm-804	39	46	samples	sample	NOUN
ajlm-804	39	47	)	)	PUNCT
ajlm-804	39	48	,	,	PUNCT
ajlm-804	39	49	short	short	ADJ
ajlm-804	39	50	blood	blood	NOUN
ajlm-804	39	51	draw	draw	VERB
ajlm-804	39	52	(	(	PUNCT
ajlm-804	39	53	2	2	NUM
ajlm-804	39	54	samples	sample	NOUN
ajlm-804	39	55	)	)	PUNCT
ajlm-804	39	56	,	,	PUNCT
ajlm-804	39	57	reliability	reliability	NOUN
ajlm-804	39	58	quality	quality	NOUN
ajlm-804	39	59	control	control	NOUN
ajlm-804	39	60	failure	failure	NOUN
ajlm-804	39	61	(	(	PUNCT
ajlm-804	39	62	fc500	fc500	PROPN
ajlm-804	39	63	)	)	PUNCT
ajlm-804	39	64	(	(	PUNCT
ajlm-804	39	65	2	2	NUM
ajlm-804	39	66	samples	sample	NOUN
ajlm-804	39	67	)	)	PUNCT
ajlm-804	39	68	,	,	PUNCT
ajlm-804	39	69	clot	clot	NOUN
ajlm-804	39	70	(	(	PUNCT
ajlm-804	39	71	1	1	NUM
ajlm-804	39	72	sample	sample	NOUN
ajlm-804	39	73	)	)	PUNCT
ajlm-804	39	74	,	,	PUNCT
ajlm-804	39	75	clog	clog	VERB
ajlm-804	39	76	(	(	PUNCT
ajlm-804	39	77	1	1	NUM
ajlm-804	39	78	sample	sample	NOUN
ajlm-804	39	79	)	)	PUNCT
ajlm-804	39	80	,	,	PUNCT
ajlm-804	39	81	insufficient	insufficient	ADJ
ajlm-804	39	82	lymphocytes	lymphocyte	NOUN
ajlm-804	39	83	(	(	PUNCT
ajlm-804	39	84	1	1	NUM
ajlm-804	39	85	sample	sample	NOUN
ajlm-804	39	86	)	)	PUNCT
ajlm-804	39	87	and	and	CCONJ
ajlm-804	39	88	duplicate	duplicate	VERB
ajlm-804	39	89	patient	patient	NOUN
ajlm-804	39	90	(	(	PUNCT
ajlm-804	39	91	1	1	NUM
ajlm-804	39	92	sample	sample	NOUN
ajlm-804	39	93	)	)	PUNCT
ajlm-804	39	94	.	.	PUNCT
ajlm-804	40	1	testing	testing	NOUN
ajlm-804	40	2	was	be	AUX
ajlm-804	40	3	performed	perform	VERB
ajlm-804	40	4	in	in	ADP
ajlm-804	40	5	duplicate	duplicate	NOUN
ajlm-804	40	6	,	,	PUNCT
ajlm-804	40	7	with	with	ADP
ajlm-804	40	8	replicate	replicate	NOUN
ajlm-804	40	9	1	1	NUM
ajlm-804	40	10	used	use	VERB
ajlm-804	40	11	for	for	ADP
ajlm-804	40	12	analysis	analysis	NOUN
ajlm-804	40	13	,	,	PUNCT
ajlm-804	40	14	except	except	SCONJ
ajlm-804	40	15	for	for	ADP
ajlm-804	40	16	two	two	NUM
ajlm-804	40	17	samples	sample	NOUN
ajlm-804	40	18	,	,	PUNCT
ajlm-804	40	19	for	for	ADP
ajlm-804	40	20	which	which	PRON
ajlm-804	40	21	replicate	replicate	VERB
ajlm-804	40	22	2	2	NUM
ajlm-804	40	23	was	be	AUX
ajlm-804	40	24	used	use	VERB
ajlm-804	40	25	due	due	ADP
ajlm-804	40	26	to	to	ADP
ajlm-804	40	27	system	system	NOUN
ajlm-804	40	28	error	error	NOUN
ajlm-804	40	29	for	for	ADP
ajlm-804	40	30	replicate	replicate	ADJ
ajlm-804	40	31	1	1	NUM
ajlm-804	40	32	(	(	PUNCT
ajlm-804	40	33	1	1	NUM
ajlm-804	40	34	high	high	ADJ
ajlm-804	40	35	count	count	NOUN
ajlm-804	40	36	rate	rate	NOUN
ajlm-804	40	37	and	and	CCONJ
ajlm-804	40	38	1	1	NUM
ajlm-804	40	39	clog	clog	NOUN
ajlm-804	40	40	)	)	PUNCT
ajlm-804	40	41	.	.	PUNCT
ajlm-804	41	1	two	two	NUM
ajlm-804	41	2	hundred	hundred	NUM
ajlm-804	41	3	and	and	CCONJ
ajlm-804	41	4	forty	forty	NUM
ajlm-804	41	5	samples	sample	NOUN
ajlm-804	41	6	were	be	AUX
ajlm-804	41	7	included	include	VERB
ajlm-804	41	8	in	in	ADP
ajlm-804	41	9	the	the	DET
ajlm-804	41	10	final	final	ADJ
ajlm-804	41	11	analysis	analysis	NOUN
ajlm-804	41	12	with	with	ADP
ajlm-804	41	13	specimen	speciman	NOUN
ajlm-804	41	14	ages	age	NOUN
ajlm-804	41	15	at	at	ADP
ajlm-804	41	16	time	time	NOUN
ajlm-804	41	17	of	of	ADP
ajlm-804	41	18	testing	testing	NOUN
ajlm-804	41	19	ranging	range	VERB
ajlm-804	41	20	from	from	ADP
ajlm-804	41	21	20	20	NUM
ajlm-804	41	22	to	to	PART
ajlm-804	41	23	71	71	NUM
ajlm-804	41	24	hours	hour	NOUN
ajlm-804	41	25	from	from	ADP
ajlm-804	41	26	collection	collection	NOUN
ajlm-804	41	27	.	.	PUNCT
ajlm-804	42	1	reference	reference	NOUN
ajlm-804	42	2	interval	interval	NOUN
ajlm-804	42	3	in	in	ADP
ajlm-804	42	4	healthy	healthy	ADJ
ajlm-804	42	5	adults	adult	NOUN
ajlm-804	42	6	participants	participant	NOUN
ajlm-804	42	7	were	be	AUX
ajlm-804	42	8	enrolled	enrol	VERB
ajlm-804	42	9	between	between	ADP
ajlm-804	42	10	december	december	PROPN
ajlm-804	42	11	2014	2014	NUM
ajlm-804	42	12	and	and	CCONJ
ajlm-804	42	13	february	february	PROPN
ajlm-804	42	14	2015	2015	NUM
ajlm-804	42	15	from	from	ADP
ajlm-804	42	16	three	three	NUM
ajlm-804	42	17	centres	centre	NOUN
ajlm-804	42	18	located	locate	VERB
ajlm-804	42	19	in	in	ADP
ajlm-804	42	20	canada	canada	PROPN
ajlm-804	42	21	;	;	PUNCT
ajlm-804	42	22	paris	paris	PROPN
ajlm-804	42	23	,	,	PUNCT
ajlm-804	42	24	france	france	PROPN
ajlm-804	42	25	and	and	CCONJ
ajlm-804	42	26	the	the	DET
ajlm-804	42	27	united	united	PROPN
ajlm-804	42	28	states	states	PROPN
ajlm-804	42	29	.	.	PUNCT
ajlm-804	43	1	samples	sample	NOUN
ajlm-804	43	2	were	be	AUX
ajlm-804	43	3	obtained	obtain	VERB
ajlm-804	43	4	from	from	ADP
ajlm-804	43	5	:	:	PUNCT
ajlm-804	43	6	1	1	NUM
ajlm-804	43	7	)	)	PUNCT
ajlm-804	43	8	healthy	healthy	ADJ
ajlm-804	43	9	,	,	PUNCT
ajlm-804	43	10	non	non	ADJ
ajlm-804	43	11	-	-	ADJ
ajlm-804	43	12	hiv	hiv	ADJ
ajlm-804	43	13	patient	patient	ADJ
ajlm-804	43	14	donors	donor	NOUN
ajlm-804	43	15	who	who	PRON
ajlm-804	43	16	were	be	AUX
ajlm-804	43	17	either	either	CCONJ
ajlm-804	43	18	hospitalised	hospitalise	VERB
ajlm-804	43	19	patients	patient	NOUN
ajlm-804	43	20	or	or	CCONJ
ajlm-804	43	21	outpatients	outpatient	NOUN
ajlm-804	43	22	with	with	ADP
ajlm-804	43	23	no	no	DET
ajlm-804	43	24	haematological	haematological	ADJ
ajlm-804	43	25	disease	disease	NOUN
ajlm-804	43	26	upon	upon	SCONJ
ajlm-804	43	27	final	final	ADJ
ajlm-804	43	28	diagnosis	diagnosis	NOUN
ajlm-804	43	29	(	(	PUNCT
ajlm-804	43	30	canada	canada	PROPN
ajlm-804	43	31	)	)	PUNCT
ajlm-804	43	32	;	;	PUNCT
ajlm-804	43	33	2	2	X
ajlm-804	43	34	)	)	PUNCT
ajlm-804	43	35	leftover	leftover	NOUN
ajlm-804	43	36	samples	sample	NOUN
ajlm-804	43	37	from	from	ADP
ajlm-804	43	38	healthy	healthy	ADJ
ajlm-804	43	39	,	,	PUNCT
ajlm-804	43	40	non	non	ADJ
ajlm-804	43	41	-	-	ADJ
ajlm-804	43	42	hiv	hiv	ADJ
ajlm-804	43	43	volunteers	volunteer	NOUN
ajlm-804	43	44	donating	donate	VERB
ajlm-804	43	45	blood	blood	NOUN
ajlm-804	43	46	to	to	ADP
ajlm-804	43	47	the	the	DET
ajlm-804	43	48	etablissement	etablissement	PROPN
ajlm-804	43	49	francais	francais	PROPN
ajlm-804	43	50	du	du	PROPN
ajlm-804	43	51	sang	sing	VERB
ajlm-804	43	52	(	(	PUNCT
ajlm-804	43	53	paris	paris	PROPN
ajlm-804	43	54	,	,	PUNCT
ajlm-804	43	55	france	france	PROPN
ajlm-804	43	56	)	)	PUNCT
ajlm-804	43	57	;	;	PUNCT
ajlm-804	43	58	and	and	CCONJ
ajlm-804	43	59	3	3	X
ajlm-804	43	60	)	)	PUNCT
ajlm-804	43	61	self	self	NOUN
ajlm-804	43	62	-	-	PUNCT
ajlm-804	43	63	reported	report	VERB
ajlm-804	43	64	healthy	healthy	ADJ
ajlm-804	43	65	,	,	PUNCT
ajlm-804	43	66	non	non	ADJ
ajlm-804	43	67	-	-	ADJ
ajlm-804	43	68	hiv	hiv	ADJ
ajlm-804	43	69	participants	participant	NOUN
ajlm-804	43	70	enrolled	enrol	VERB
ajlm-804	43	71	through	through	ADP
ajlm-804	43	72	the	the	DET
ajlm-804	43	73	internal	internal	ADJ
ajlm-804	43	74	donor	donor	NOUN
ajlm-804	43	75	programme	programme	NOUN
ajlm-804	43	76	at	at	ADP
ajlm-804	43	77	beckman	beckman	PROPN
ajlm-804	43	78	coulter	coulter	PROPN
ajlm-804	43	79	(	(	PUNCT
ajlm-804	43	80	miami	miami	PROPN
ajlm-804	43	81	,	,	PUNCT
ajlm-804	43	82	florida	florida	PROPN
ajlm-804	43	83	,	,	PUNCT
ajlm-804	43	84	united	united	PROPN
ajlm-804	43	85	states	states	PROPN
ajlm-804	43	86	)	)	PUNCT
ajlm-804	43	87	.	.	PUNCT
ajlm-804	44	1	participants	participant	NOUN
ajlm-804	44	2	with	with	ADP
ajlm-804	44	3	cd4	cd4	PROPN
ajlm-804	44	4	<	<	X
ajlm-804	44	5	300	300	NUM
ajlm-804	44	6	cells/µl	cells/µl	NOUN
ajlm-804	44	7	were	be	AUX
ajlm-804	44	8	excluded	exclude	VERB
ajlm-804	44	9	so	so	ADV
ajlm-804	44	10	as	as	SCONJ
ajlm-804	44	11	not	not	PART
ajlm-804	44	12	to	to	PART
ajlm-804	44	13	include	include	VERB
ajlm-804	44	14	participants	participant	NOUN
ajlm-804	44	15	with	with	ADP
ajlm-804	44	16	potential	potential	ADJ
ajlm-804	44	17	idiopathic	idiopathic	ADJ
ajlm-804	44	18	cd4	cd4	PROPN
ajlm-804	44	19	+	+	PROPN
ajlm-804	44	20	lymphopenia.20,21	lymphopenia.20,21	VERB
ajlm-804	44	21	a	a	DET
ajlm-804	44	22	total	total	NOUN
ajlm-804	44	23	of	of	ADP
ajlm-804	44	24	173	173	NUM
ajlm-804	44	25	participant	participant	ADJ
ajlm-804	44	26	samples	sample	NOUN
ajlm-804	44	27	from	from	ADP
ajlm-804	44	28	healthy	healthy	ADJ
ajlm-804	44	29	adults	adult	NOUN
ajlm-804	44	30	aged	aged	ADJ
ajlm-804	44	31	18–65	18–65	NUM
ajlm-804	44	32	years	year	NOUN
ajlm-804	44	33	,	,	PUNCT
ajlm-804	44	34	with	with	SCONJ
ajlm-804	44	35	normal	normal	ADJ
ajlm-804	44	36	complete	complete	ADJ
ajlm-804	44	37	blood	blood	NOUN
ajlm-804	44	38	counts	count	NOUN
ajlm-804	44	39	and	and	CCONJ
ajlm-804	44	40	differential	differential	NOUN
ajlm-804	44	41	were	be	AUX
ajlm-804	44	42	tested	test	VERB
ajlm-804	44	43	.	.	PUNCT
ajlm-804	45	1	eighteen	eighteen	NUM
ajlm-804	45	2	samples	sample	NOUN
ajlm-804	45	3	were	be	AUX
ajlm-804	45	4	excluded	exclude	VERB
ajlm-804	45	5	for	for	ADP
ajlm-804	45	6	the	the	DET
ajlm-804	45	7	following	follow	VERB
ajlm-804	45	8	reasons	reason	NOUN
ajlm-804	45	9	:	:	PUNCT
ajlm-804	45	10	haematologic	haematologic	ADJ
ajlm-804	45	11	diagnosis	diagnosis	NOUN
ajlm-804	45	12	(	(	PUNCT
ajlm-804	45	13	10	10	NUM
ajlm-804	45	14	samples	sample	NOUN
ajlm-804	45	15	)	)	PUNCT
ajlm-804	45	16	,	,	PUNCT
ajlm-804	45	17	lymphopenia	lymphopenia	NOUN
ajlm-804	45	18	(	(	PUNCT
ajlm-804	45	19	3	3	NUM
ajlm-804	45	20	samples	sample	NOUN
ajlm-804	45	21	)	)	PUNCT
ajlm-804	45	22	,	,	PUNCT
ajlm-804	45	23	participants	participant	NOUN
ajlm-804	45	24	<	<	X
ajlm-804	45	25	18	18	NUM
ajlm-804	45	26	years	year	NOUN
ajlm-804	45	27	of	of	ADP
ajlm-804	45	28	age	age	NOUN
ajlm-804	45	29	(	(	PUNCT
ajlm-804	45	30	2	2	NUM
ajlm-804	45	31	samples	sample	NOUN
ajlm-804	45	32	)	)	PUNCT
ajlm-804	45	33	,	,	PUNCT
ajlm-804	45	34	lymphocytosis	lymphocytosis	X
ajlm-804	45	35	(	(	PUNCT
ajlm-804	45	36	1	1	NUM
ajlm-804	45	37	sample	sample	NOUN
ajlm-804	45	38	)	)	PUNCT
ajlm-804	45	39	,	,	PUNCT
ajlm-804	45	40	time	time	NOUN
ajlm-804	45	41	of	of	ADP
ajlm-804	45	42	collection	collection	NOUN
ajlm-804	45	43	missing	miss	VERB
ajlm-804	45	44	(	(	PUNCT
ajlm-804	45	45	1	1	NUM
ajlm-804	45	46	sample	sample	NOUN
ajlm-804	45	47	)	)	PUNCT
ajlm-804	45	48	and	and	CCONJ
ajlm-804	45	49	cd4	cd4	PROPN
ajlm-804	45	50	<	<	X
ajlm-804	45	51	300	300	NUM
ajlm-804	45	52	cells/µl	cells/µl	NOUN
ajlm-804	45	53	(	(	PUNCT
ajlm-804	45	54	1	1	NUM
ajlm-804	45	55	sample	sample	NOUN
ajlm-804	45	56	)	)	PUNCT
ajlm-804	45	57	.	.	PUNCT
ajlm-804	46	1	one	one	NUM
ajlm-804	46	2	hundred	hundred	NUM
ajlm-804	46	3	and	and	CCONJ
ajlm-804	46	4	fifty	fifty	NUM
ajlm-804	46	5	-	-	PUNCT
ajlm-804	46	6	five	five	NUM
ajlm-804	46	7	samples	sample	NOUN
ajlm-804	46	8	were	be	AUX
ajlm-804	46	9	included	include	VERB
ajlm-804	46	10	in	in	ADP
ajlm-804	46	11	the	the	DET
ajlm-804	46	12	final	final	ADJ
ajlm-804	46	13	analysis	analysis	NOUN
ajlm-804	46	14	,	,	PUNCT
ajlm-804	46	15	all	all	PRON
ajlm-804	46	16	tested	test	VERB
ajlm-804	46	17	within	within	ADP
ajlm-804	46	18	24	24	NUM
ajlm-804	46	19	hours	hour	NOUN
ajlm-804	46	20	of	of	ADP
ajlm-804	46	21	collection	collection	NOUN
ajlm-804	46	22	.	.	PUNCT
ajlm-804	47	1	workflow	workflow	NOUN
ajlm-804	47	2	samples	sample	NOUN
ajlm-804	47	3	were	be	AUX
ajlm-804	47	4	obtained	obtain	VERB
ajlm-804	47	5	from	from	ADP
ajlm-804	47	6	incoming	incoming	ADJ
ajlm-804	47	7	routine	routine	ADJ
ajlm-804	47	8	laboratory	laboratory	NOUN
ajlm-804	47	9	samples	sample	NOUN
ajlm-804	47	10	for	for	ADP
ajlm-804	47	11	cd4	cd4	PROPN
ajlm-804	47	12	testing	testing	NOUN
ajlm-804	47	13	at	at	ADP
ajlm-804	47	14	one	one	NUM
ajlm-804	47	15	centre	centre	NOUN
ajlm-804	47	16	in	in	ADP
ajlm-804	47	17	south	south	PROPN
ajlm-804	47	18	africa	africa	PROPN
ajlm-804	47	19	over	over	ADP
ajlm-804	47	20	five	five	NUM
ajlm-804	47	21	days	day	NOUN
ajlm-804	47	22	in	in	ADP
ajlm-804	47	23	february	february	PROPN
ajlm-804	47	24	2015	2015	NUM
ajlm-804	47	25	.	.	PUNCT
ajlm-804	48	1	a	a	DET
ajlm-804	48	2	total	total	NOUN
ajlm-804	48	3	of	of	ADP
ajlm-804	48	4	440	440	NUM
ajlm-804	48	5	participant	participant	NOUN
ajlm-804	48	6	samples	sample	NOUN
ajlm-804	48	7	were	be	AUX
ajlm-804	48	8	tested	test	VERB
ajlm-804	48	9	over	over	ADP
ajlm-804	48	10	five	five	NUM
ajlm-804	48	11	days	day	NOUN
ajlm-804	48	12	.	.	PUNCT
ajlm-804	49	1	laboratory	laboratory	NOUN
ajlm-804	49	2	prior	prior	ADV
ajlm-804	49	3	to	to	ADP
ajlm-804	49	4	each	each	DET
ajlm-804	49	5	day	day	NOUN
ajlm-804	49	6	’s	’s	PART
ajlm-804	49	7	testing	testing	NOUN
ajlm-804	49	8	,	,	PUNCT
ajlm-804	49	9	stabilised	stabilise	VERB
ajlm-804	49	10	blood	blood	NOUN
ajlm-804	49	11	products	product	NOUN
ajlm-804	49	12	immuno	immuno	ADJ
ajlm-804	49	13	-	-	PUNCT
ajlm-804	49	14	trol	trol	NOUN
ajlm-804	49	15	cells	cell	NOUN
ajlm-804	49	16	(	(	PUNCT
ajlm-804	49	17	normal	normal	ADJ
ajlm-804	49	18	cd4	cd4	PROPN
ajlm-804	49	19	count	count	NOUN
ajlm-804	49	20	)	)	PUNCT
ajlm-804	49	21	(	(	PUNCT
ajlm-804	49	22	beckman	beckman	PROPN
ajlm-804	49	23	coulter	coulter	PROPN
ajlm-804	49	24	,	,	PUNCT
ajlm-804	49	25	inc	inc	PROPN
ajlm-804	49	26	.	.	PROPN
ajlm-804	49	27	,	,	PUNCT
ajlm-804	49	28	miami	miami	PROPN
ajlm-804	49	29	,	,	PUNCT
ajlm-804	49	30	florida	florida	PROPN
ajlm-804	49	31	,	,	PUNCT
ajlm-804	49	32	united	united	PROPN
ajlm-804	49	33	states	states	PROPN
ajlm-804	49	34	)	)	PUNCT
ajlm-804	49	35	and	and	CCONJ
ajlm-804	49	36	immuno	immuno	ADJ
ajlm-804	49	37	-	-	PUNCT
ajlm-804	49	38	trol	trol	NOUN
ajlm-804	49	39	low	low	ADJ
ajlm-804	49	40	cells	cell	NOUN
ajlm-804	49	41	(	(	PUNCT
ajlm-804	49	42	beckman	beckman	PROPN
ajlm-804	49	43	coulter	coulter	PROPN
ajlm-804	49	44	,	,	PUNCT
ajlm-804	49	45	inc	inc	PROPN
ajlm-804	49	46	.	.	PROPN
ajlm-804	49	47	,	,	PUNCT
ajlm-804	49	48	miami	miami	PROPN
ajlm-804	49	49	,	,	PUNCT
ajlm-804	49	50	florida	florida	PROPN
ajlm-804	49	51	,	,	PUNCT
ajlm-804	49	52	united	united	PROPN
ajlm-804	49	53	states	states	PROPN
ajlm-804	49	54	)	)	PUNCT
ajlm-804	49	55	passed	pass	VERB
ajlm-804	49	56	their	their	PRON
ajlm-804	49	57	assay	assay	NOUN
ajlm-804	49	58	requirements	requirement	NOUN
ajlm-804	49	59	as	as	ADP
ajlm-804	49	60	quality	quality	NOUN
ajlm-804	49	61	control	control	NOUN
ajlm-804	49	62	material	material	NOUN
ajlm-804	49	63	.	.	PUNCT
ajlm-804	50	1	samples	sample	NOUN
ajlm-804	50	2	were	be	AUX
ajlm-804	50	3	collected	collect	VERB
ajlm-804	50	4	into	into	ADP
ajlm-804	50	5	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-804	50	6	acid	acid	NOUN
ajlm-804	50	7	vacutainers	vacutainer	NOUN
ajlm-804	50	8	and	and	CCONJ
ajlm-804	50	9	tested	test	VERB
ajlm-804	50	10	in	in	ADP
ajlm-804	50	11	duplicate	duplicate	NOUN
ajlm-804	50	12	on	on	ADP
ajlm-804	50	13	both	both	DET
ajlm-804	50	14	instruments	instrument	NOUN
ajlm-804	50	15	for	for	ADP
ajlm-804	50	16	method	method	ADJ
ajlm-804	50	17	comparison	comparison	NOUN
ajlm-804	50	18	and	and	CCONJ
ajlm-804	50	19	only	only	ADV
ajlm-804	50	20	on	on	ADP
ajlm-804	50	21	aquios	aquio	NOUN
ajlm-804	50	22	for	for	ADP
ajlm-804	50	23	reference	reference	NOUN
ajlm-804	50	24	interval	interval	NOUN
ajlm-804	50	25	.	.	PUNCT
ajlm-804	51	1	the	the	DET
ajlm-804	51	2	plg	plg	NOUN
ajlm-804	51	3	gating	gating	NOUN
ajlm-804	51	4	strategy	strategy	NOUN
ajlm-804	51	5	,	,	PUNCT
ajlm-804	51	6	used	use	VERB
ajlm-804	51	7	for	for	ADP
ajlm-804	51	8	both	both	DET
ajlm-804	51	9	instruments	instrument	NOUN
ajlm-804	51	10	,	,	PUNCT
ajlm-804	51	11	is	be	AUX
ajlm-804	51	12	detailed	detail	VERB
ajlm-804	51	13	in	in	ADP
ajlm-804	51	14	figure	figure	NOUN
ajlm-804	51	15	1	1	NUM
ajlm-804	51	16	.	.	PUNCT
ajlm-804	52	1	all	all	DET
ajlm-804	52	2	reagents	reagent	NOUN
ajlm-804	52	3	were	be	AUX
ajlm-804	52	4	supplied	supply	VERB
ajlm-804	52	5	by	by	ADP
ajlm-804	52	6	beckman	beckman	PROPN
ajlm-804	52	7	coulter	coulter	PROPN
ajlm-804	52	8	,	,	PUNCT
ajlm-804	52	9	inc	inc	PROPN
ajlm-804	52	10	.	.	PROPN
ajlm-804	52	11	,	,	PUNCT
ajlm-804	52	12	hialeah	hialeah	PROPN
ajlm-804	52	13	,	,	PUNCT
ajlm-804	52	14	florida	florida	PROPN
ajlm-804	52	15	,	,	PUNCT
ajlm-804	52	16	united	united	PROPN
ajlm-804	52	17	states	states	PROPN
ajlm-804	52	18	and	and	CCONJ
ajlm-804	52	19	immunotech	immunotech	PROPN
ajlm-804	52	20	,	,	PUNCT
ajlm-804	52	21	marseille	marseille	PROPN
ajlm-804	52	22	,	,	PUNCT
ajlm-804	52	23	france	france	PROPN
ajlm-804	52	24	.	.	PUNCT
ajlm-804	53	1	figure	figure	NOUN
ajlm-804	53	2	1	1	NUM
ajlm-804	53	3	:	:	PUNCT
ajlm-804	53	4	cd4	cd4	PROPN
ajlm-804	53	5	t	t	PROPN
ajlm-804	53	6	-	-	PUNCT
ajlm-804	53	7	cell	cell	NOUN
ajlm-804	53	8	enumeration	enumeration	NOUN
ajlm-804	53	9	by	by	ADP
ajlm-804	53	10	panleucogating	panleucogate	VERB
ajlm-804	53	11	with	with	ADP
ajlm-804	53	12	aquios	aquio	NOUN
ajlm-804	53	13	flow	flow	NOUN
ajlm-804	53	14	cytometer	cytometer	NOUN
ajlm-804	53	15	,	,	PUNCT
ajlm-804	53	16	canada	canada	PROPN
ajlm-804	53	17	;	;	PUNCT
ajlm-804	53	18	paris	paris	PROPN
ajlm-804	53	19	,	,	PUNCT
ajlm-804	53	20	france	france	PROPN
ajlm-804	53	21	;	;	PUNCT
ajlm-804	53	22	lyon	lyon	PROPN
ajlm-804	53	23	,	,	PUNCT
ajlm-804	53	24	france	france	PROPN
ajlm-804	53	25	;	;	PUNCT
ajlm-804	53	26	and	and	CCONJ
ajlm-804	53	27	south	south	PROPN
ajlm-804	53	28	africa	africa	PROPN
ajlm-804	53	29	,	,	PUNCT
ajlm-804	53	30	november	november	PROPN
ajlm-804	53	31	2014	2014	NUM
ajlm-804	53	32	to	to	ADP
ajlm-804	53	33	march	march	PROPN
ajlm-804	53	34	2015	2015	NUM
ajlm-804	53	35	.	.	PUNCT
ajlm-804	54	1	(	(	PUNCT
ajlm-804	54	2	a	a	X
ajlm-804	54	3	)	)	PUNCT
ajlm-804	54	4	cd45	cd45	PROPN
ajlm-804	54	5	versus	versus	ADP
ajlm-804	54	6	side	side	NOUN
ajlm-804	54	7	scatter	scatter	NOUN
ajlm-804	54	8	plot	plot	NOUN
ajlm-804	54	9	is	be	AUX
ajlm-804	54	10	used	use	VERB
ajlm-804	54	11	to	to	PART
ajlm-804	54	12	identify	identify	VERB
ajlm-804	54	13	total	total	ADJ
ajlm-804	54	14	leukocytes	leukocyte	NOUN
ajlm-804	54	15	(	(	PUNCT
ajlm-804	54	16	cd45	cd45	PROPN
ajlm-804	54	17	-	-	PUNCT
ajlm-804	54	18	positive	positive	NOUN
ajlm-804	54	19	)	)	PUNCT
ajlm-804	54	20	;	;	PUNCT
ajlm-804	54	21	(	(	PUNCT
ajlm-804	54	22	b	b	X
ajlm-804	54	23	)	)	PUNCT
ajlm-804	54	24	all	all	DET
ajlm-804	54	25	events	event	NOUN
ajlm-804	54	26	gated	gate	VERB
ajlm-804	54	27	in	in	ADP
ajlm-804	54	28	the	the	DET
ajlm-804	54	29	cd45	cd45	PROPN
ajlm-804	54	30	-	-	PUNCT
ajlm-804	54	31	positive	positive	ADJ
ajlm-804	54	32	region	region	NOUN
ajlm-804	54	33	(	(	PUNCT
ajlm-804	54	34	pan	pan	NOUN
ajlm-804	54	35	-	-	ADJ
ajlm-804	54	36	leucogate	leucogate	ADJ
ajlm-804	54	37	)	)	PUNCT
ajlm-804	54	38	are	be	AUX
ajlm-804	54	39	used	use	VERB
ajlm-804	54	40	to	to	PART
ajlm-804	54	41	plot	plot	VERB
ajlm-804	54	42	cd4	cd4	PROPN
ajlm-804	54	43	versus	versus	ADP
ajlm-804	54	44	side	side	NOUN
ajlm-804	54	45	scatter	scatter	NOUN
ajlm-804	54	46	to	to	PART
ajlm-804	54	47	identify	identify	VERB
ajlm-804	54	48	cd4	cd4	ADJ
ajlm-804	54	49	-	-	ADJ
ajlm-804	54	50	positive	positive	ADJ
ajlm-804	54	51	lymph	lymph	NOUN
ajlm-804	54	52	cells	cell	NOUN
ajlm-804	54	53	(	(	PUNCT
ajlm-804	54	54	cd4	cd4	ADJ
ajlm-804	54	55	-	-	ADJ
ajlm-804	54	56	positive	positive	ADJ
ajlm-804	54	57	count	count	NOUN
ajlm-804	54	58	/	/	SYM
ajlm-804	54	59	μl	μl	NOUN
ajlm-804	54	60	)	)	PUNCT
ajlm-804	54	61	.	.	PUNCT
ajlm-804	55	1	(	(	PUNCT
ajlm-804	55	2	c	c	X
ajlm-804	55	3	)	)	PUNCT
ajlm-804	55	4	lymphs	lymphs	PROPN
ajlm-804	55	5	gate	gate	NOUN
ajlm-804	55	6	from	from	ADP
ajlm-804	55	7	a	a	PRON
ajlm-804	55	8	is	be	AUX
ajlm-804	55	9	used	use	VERB
ajlm-804	55	10	to	to	PART
ajlm-804	55	11	plot	plot	VERB
ajlm-804	55	12	the	the	DET
ajlm-804	55	13	cd4	cd4	PROPN
ajlm-804	55	14	versus	versus	ADP
ajlm-804	55	15	side	side	NOUN
ajlm-804	55	16	scatter	scatter	NOUN
ajlm-804	55	17	to	to	PART
ajlm-804	55	18	calculate	calculate	VERB
ajlm-804	55	19	the	the	DET
ajlm-804	55	20	cd4	cd4	PROPN
ajlm-804	55	21	percentage	percentage	NOUN
ajlm-804	55	22	of	of	ADP
ajlm-804	55	23	lymphoid	lymphoid	ADJ
ajlm-804	55	24	cells	cell	NOUN
ajlm-804	55	25	(	(	PUNCT
ajlm-804	55	26	cd4	cd4	ADJ
ajlm-804	55	27	-	-	ADJ
ajlm-804	55	28	positive	positive	ADJ
ajlm-804	55	29	lymph	lymph	NOUN
ajlm-804	55	30	percent	percent	NOUN
ajlm-804	55	31	)	)	PUNCT
ajlm-804	55	32	.	.	PUNCT
ajlm-804	56	1	aquios	aquio	NOUN
ajlm-804	56	2	instrument	instrument	VERB
ajlm-804	56	3	cd4	cd4	PROPN
ajlm-804	56	4	+	+	PROPN
ajlm-804	56	5	counts	count	NOUN
ajlm-804	56	6	and	and	CCONJ
ajlm-804	56	7	percentages	percentage	NOUN
ajlm-804	56	8	were	be	AUX
ajlm-804	56	9	determined	determine	VERB
ajlm-804	56	10	using	use	VERB
ajlm-804	56	11	aquios	aquio	NOUN
ajlm-804	56	12	plg	plg	NOUN
ajlm-804	56	13	,	,	PUNCT
ajlm-804	56	14	as	as	ADP
ajlm-804	56	15	per	per	ADP
ajlm-804	56	16	manufacturer	manufacturer	NOUN
ajlm-804	56	17	’s	’s	PART
ajlm-804	56	18	instructions	instruction	NOUN
ajlm-804	56	19	for	for	ADP
ajlm-804	56	20	use	use	NOUN
ajlm-804	56	21	.	.	PUNCT
ajlm-804	57	1	each	each	DET
ajlm-804	57	2	site	site	NOUN
ajlm-804	57	3	had	have	VERB
ajlm-804	57	4	an	an	DET
ajlm-804	57	5	instrument	instrument	NOUN
ajlm-804	57	6	and	and	CCONJ
ajlm-804	57	7	all	all	DET
ajlm-804	57	8	required	required	ADJ
ajlm-804	57	9	reagents	reagent	NOUN
ajlm-804	57	10	.	.	PUNCT
ajlm-804	58	1	fc-500	fc-500	NOUN
ajlm-804	58	2	instrument	instrument	NOUN
ajlm-804	58	3	comparator	comparator	NOUN
ajlm-804	58	4	testing	testing	NOUN
ajlm-804	58	5	was	be	AUX
ajlm-804	58	6	done	do	VERB
ajlm-804	58	7	using	use	VERB
ajlm-804	58	8	flowcare	flowcare	PROPN
ajlm-804	58	9	plg	plg	PROPN
ajlm-804	58	10	cd4	cd4	PROPN
ajlm-804	58	11	reagent	reagent	NOUN
ajlm-804	58	12	on	on	ADP
ajlm-804	58	13	the	the	DET
ajlm-804	58	14	beckman	beckman	PROPN
ajlm-804	58	15	coulter	coulter	PROPN
ajlm-804	58	16	fc-500	fc-500	PROPN
ajlm-804	58	17	mcl	mcl	PROPN
ajlm-804	58	18	flow	flow	NOUN
ajlm-804	58	19	cytometer	cytometer	NOUN
ajlm-804	58	20	(	(	PUNCT
ajlm-804	58	21	flowcare	flowcare	PROPN
ajlm-804	58	22	plg	plg	PROPN
ajlm-804	58	23	)	)	PUNCT
ajlm-804	58	24	per	per	ADP
ajlm-804	58	25	the	the	DET
ajlm-804	58	26	manufacturer	manufacturer	NOUN
ajlm-804	58	27	’s	’s	PART
ajlm-804	58	28	instructions	instruction	NOUN
ajlm-804	58	29	for	for	ADP
ajlm-804	58	30	use	use	NOUN
ajlm-804	58	31	.	.	PUNCT
ajlm-804	59	1	all	all	DET
ajlm-804	59	2	required	required	ADJ
ajlm-804	59	3	reagents	reagent	NOUN
ajlm-804	59	4	were	be	AUX
ajlm-804	59	5	provided	provide	VERB
ajlm-804	59	6	.	.	PUNCT
ajlm-804	60	1	a	a	DET
ajlm-804	60	2	tq	tq	ADV
ajlm-804	60	3	-	-	PUNCT
ajlm-804	60	4	prep	prep	NOUN
ajlm-804	60	5	™	™	ADJ
ajlm-804	60	6	workstation	workstation	NOUN
ajlm-804	60	7	(	(	PUNCT
ajlm-804	60	8	beckman	beckman	PROPN
ajlm-804	60	9	coulter	coulter	PROPN
ajlm-804	60	10	,	,	PUNCT
ajlm-804	60	11	inc	inc	PROPN
ajlm-804	60	12	.	.	PROPN
ajlm-804	60	13	,	,	PUNCT
ajlm-804	60	14	miami	miami	PROPN
ajlm-804	60	15	,	,	PUNCT
ajlm-804	60	16	florida	florida	PROPN
ajlm-804	60	17	,	,	PUNCT
ajlm-804	60	18	united	united	PROPN
ajlm-804	60	19	states	states	PROPN
ajlm-804	60	20	)	)	PUNCT
ajlm-804	60	21	was	be	AUX
ajlm-804	60	22	used	use	VERB
ajlm-804	60	23	for	for	ADP
ajlm-804	60	24	red	red	ADJ
ajlm-804	60	25	cell	cell	NOUN
ajlm-804	60	26	lysing	lysing	NOUN
ajlm-804	60	27	.	.	PUNCT
ajlm-804	61	1	sites	site	NOUN
ajlm-804	61	2	either	either	CCONJ
ajlm-804	61	3	used	use	VERB
ajlm-804	61	4	a	a	DET
ajlm-804	61	5	prepplus	prepplus	ADJ
ajlm-804	61	6	™	™	ADJ
ajlm-804	61	7	2	2	NUM
ajlm-804	61	8	workstation	workstation	NOUN
ajlm-804	61	9	(	(	PUNCT
ajlm-804	61	10	beckman	beckman	PROPN
ajlm-804	61	11	coulter	coulter	PROPN
ajlm-804	61	12	,	,	PUNCT
ajlm-804	61	13	inc	inc	PROPN
ajlm-804	61	14	.	.	PROPN
ajlm-804	61	15	,	,	PUNCT
ajlm-804	61	16	miami	miami	PROPN
ajlm-804	61	17	,	,	PUNCT
ajlm-804	61	18	florida	florida	PROPN
ajlm-804	61	19	,	,	PUNCT
ajlm-804	61	20	united	united	PROPN
ajlm-804	61	21	states	states	PROPN
ajlm-804	61	22	)	)	PUNCT
ajlm-804	61	23	for	for	ADP
ajlm-804	61	24	specimen	speciman	NOUN
ajlm-804	61	25	preparation	preparation	NOUN
ajlm-804	61	26	or	or	CCONJ
ajlm-804	61	27	manual	manual	ADJ
ajlm-804	61	28	preparation	preparation	NOUN
ajlm-804	61	29	in	in	ADP
ajlm-804	61	30	place	place	NOUN
ajlm-804	61	31	of	of	ADP
ajlm-804	61	32	instrumentation	instrumentation	NOUN
ajlm-804	61	33	.	.	PUNCT
ajlm-804	62	1	statistical	statistical	ADJ
ajlm-804	62	2	analysis	analysis	NOUN
ajlm-804	62	3	clinical	clinical	ADJ
ajlm-804	62	4	and	and	CCONJ
ajlm-804	62	5	laboratory	laboratory	NOUN
ajlm-804	62	6	standards	standard	NOUN
ajlm-804	62	7	institute	institute	NOUN
ajlm-804	62	8	guidelines	guideline	VERB
ajlm-804	62	9	ep09	ep09	PROPN
ajlm-804	62	10	-	-	PUNCT
ajlm-804	62	11	a2	a2	PROPN
ajlm-804	62	12	and	and	CCONJ
ajlm-804	62	13	ep28	ep28	PROPN
ajlm-804	62	14	-	-	PUNCT
ajlm-804	62	15	a343,44	a343,44	PROPN
ajlm-804	62	16	for	for	ADP
ajlm-804	62	17	method	method	NOUN
ajlm-804	62	18	comparison43	comparison43	NOUN
ajlm-804	62	19	and	and	CCONJ
ajlm-804	62	20	reference	reference	NOUN
ajlm-804	62	21	interval	interval	NOUN
ajlm-804	62	22	determination44	determination44	NOUN
ajlm-804	62	23	were	be	AUX
ajlm-804	62	24	followed	follow	VERB
ajlm-804	62	25	.	.	PUNCT
ajlm-804	63	1	replicate	replicate	VERB
ajlm-804	63	2	1	1	NUM
ajlm-804	63	3	was	be	AUX
ajlm-804	63	4	used	use	VERB
ajlm-804	63	5	for	for	ADP
ajlm-804	63	6	analysis	analysis	NOUN
ajlm-804	63	7	,	,	PUNCT
ajlm-804	63	8	with	with	ADP
ajlm-804	63	9	replicate	replicate	NOUN
ajlm-804	63	10	2	2	NUM
ajlm-804	63	11	used	use	VERB
ajlm-804	63	12	for	for	ADP
ajlm-804	63	13	the	the	DET
ajlm-804	63	14	resolution	resolution	NOUN
ajlm-804	63	15	of	of	ADP
ajlm-804	63	16	replicate	replicate	ADJ
ajlm-804	63	17	1	1	NUM
ajlm-804	63	18	discrepancies	discrepancy	NOUN
ajlm-804	63	19	.	.	PUNCT
ajlm-804	64	1	for	for	ADP
ajlm-804	64	2	method	method	ADJ
ajlm-804	64	3	comparison	comparison	NOUN
ajlm-804	64	4	,	,	PUNCT
ajlm-804	64	5	the	the	DET
ajlm-804	64	6	number	number	NOUN
ajlm-804	64	7	and	and	CCONJ
ajlm-804	64	8	percentage	percentage	NOUN
ajlm-804	64	9	for	for	ADP
ajlm-804	64	10	sex	sex	NOUN
ajlm-804	64	11	,	,	PUNCT
ajlm-804	64	12	adult	adult	NOUN
ajlm-804	64	13	or	or	CCONJ
ajlm-804	64	14	paediatric	paediatric	ADJ
ajlm-804	64	15	specimens	specimen	NOUN
ajlm-804	64	16	,	,	PUNCT
ajlm-804	64	17	mean	mean	NOUN
ajlm-804	64	18	age	age	NOUN
ajlm-804	64	19	,	,	PUNCT
ajlm-804	64	20	cd4	cd4	PROPN
ajlm-804	64	21	count	count	NOUN
ajlm-804	64	22	and	and	CCONJ
ajlm-804	64	23	percentage	percentage	NOUN
ajlm-804	64	24	and	and	CCONJ
ajlm-804	64	25	cd4	cd4	PROPN
ajlm-804	64	26	count	count	NOUN
ajlm-804	64	27	range	range	NOUN
ajlm-804	64	28	were	be	AUX
ajlm-804	64	29	calculated	calculate	VERB
ajlm-804	64	30	.	.	PUNCT
ajlm-804	65	1	aquios	aquio	NOUN
ajlm-804	65	2	plg	plg	NOUN
ajlm-804	65	3	and	and	CCONJ
ajlm-804	65	4	flowcare	flowcare	PROPN
ajlm-804	65	5	plg	plg	PROPN
ajlm-804	65	6	results	result	NOUN
ajlm-804	65	7	were	be	AUX
ajlm-804	65	8	analysed	analyse	VERB
ajlm-804	65	9	using	use	VERB
ajlm-804	65	10	deming	deming	PROPN
ajlm-804	65	11	regression	regression	NOUN
ajlm-804	65	12	to	to	PART
ajlm-804	65	13	estimate	estimate	VERB
ajlm-804	65	14	bias	bias	NOUN
ajlm-804	65	15	at	at	ADP
ajlm-804	65	16	the	the	DET
ajlm-804	65	17	clinically	clinically	ADV
ajlm-804	65	18	relevant	relevant	ADJ
ajlm-804	65	19	cd4	cd4	ADJ
ajlm-804	65	20	-	-	ADJ
ajlm-804	65	21	positive	positive	ADJ
ajlm-804	65	22	levels	level	NOUN
ajlm-804	65	23	of	of	ADP
ajlm-804	65	24	50	50	NUM
ajlm-804	65	25	,	,	PUNCT
ajlm-804	65	26	100	100	NUM
ajlm-804	65	27	,	,	PUNCT
ajlm-804	65	28	200	200	NUM
ajlm-804	65	29	,	,	PUNCT
ajlm-804	65	30	350	350	NUM
ajlm-804	65	31	and	and	CCONJ
ajlm-804	65	32	500	500	NUM
ajlm-804	65	33	cells/µl	cells/µl	NOUN
ajlm-804	65	34	.	.	PUNCT
ajlm-804	66	1	weighted	weight	VERB
ajlm-804	66	2	deming	deming	PROPN
ajlm-804	66	3	regression	regression	NOUN
ajlm-804	66	4	was	be	AUX
ajlm-804	66	5	used	use	VERB
ajlm-804	66	6	for	for	ADP
ajlm-804	66	7	count	count	NOUN
ajlm-804	66	8	because	because	SCONJ
ajlm-804	66	9	the	the	DET
ajlm-804	66	10	variability	variability	NOUN
ajlm-804	66	11	(	(	PUNCT
ajlm-804	66	12	scatter	scatter	NOUN
ajlm-804	66	13	)	)	PUNCT
ajlm-804	66	14	of	of	ADP
ajlm-804	66	15	the	the	DET
ajlm-804	66	16	data	datum	NOUN
ajlm-804	66	17	depended	depend	VERB
ajlm-804	66	18	on	on	ADP
ajlm-804	66	19	the	the	DET
ajlm-804	66	20	range	range	NOUN
ajlm-804	66	21	of	of	ADP
ajlm-804	66	22	measurements	measurement	NOUN
ajlm-804	66	23	,	,	PUNCT
ajlm-804	66	24	while	while	SCONJ
ajlm-804	66	25	simple	simple	ADJ
ajlm-804	66	26	deming	deming	PROPN
ajlm-804	66	27	regression	regression	NOUN
ajlm-804	66	28	was	be	AUX
ajlm-804	66	29	used	use	VERB
ajlm-804	66	30	for	for	ADP
ajlm-804	66	31	percentages	percentage	NOUN
ajlm-804	66	32	.	.	PUNCT
ajlm-804	67	1	the	the	DET
ajlm-804	67	2	coefficient	coefficient	NOUN
ajlm-804	67	3	of	of	ADP
ajlm-804	67	4	determination	determination	NOUN
ajlm-804	67	5	,	,	PUNCT
ajlm-804	67	6	r2	r2	PROPN
ajlm-804	67	7	(	(	PUNCT
ajlm-804	67	8	pearson	pearson	PROPN
ajlm-804	67	9	correlation	correlation	NOUN
ajlm-804	67	10	squared	square	VERB
ajlm-804	67	11	)	)	PUNCT
ajlm-804	67	12	,	,	PUNCT
ajlm-804	67	13	was	be	AUX
ajlm-804	67	14	used	use	VERB
ajlm-804	67	15	to	to	PART
ajlm-804	67	16	measure	measure	VERB
ajlm-804	67	17	the	the	DET
ajlm-804	67	18	overall	overall	ADJ
ajlm-804	67	19	correlation	correlation	NOUN
ajlm-804	67	20	between	between	ADP
ajlm-804	67	21	the	the	DET
ajlm-804	67	22	two	two	NUM
ajlm-804	67	23	methods	method	NOUN
ajlm-804	67	24	.	.	PUNCT
ajlm-804	68	1	bland	bland	ADJ
ajlm-804	68	2	-	-	PUNCT
ajlm-804	68	3	altman	altman	NOUN
ajlm-804	68	4	analysis45	analysis45	NOUN
ajlm-804	68	5	was	be	AUX
ajlm-804	68	6	used	use	VERB
ajlm-804	68	7	to	to	PART
ajlm-804	68	8	calculate	calculate	VERB
ajlm-804	68	9	the	the	DET
ajlm-804	68	10	mean	mean	ADJ
ajlm-804	68	11	and	and	CCONJ
ajlm-804	68	12	median	median	ADJ
ajlm-804	68	13	difference	difference	NOUN
ajlm-804	68	14	between	between	ADP
ajlm-804	68	15	methods	method	NOUN
ajlm-804	68	16	.	.	PUNCT
ajlm-804	69	1	mean	mean	VERB
ajlm-804	69	2	and	and	CCONJ
ajlm-804	69	3	median	median	ADJ
ajlm-804	69	4	relative	relative	ADJ
ajlm-804	69	5	bias	bias	NOUN
ajlm-804	69	6	expressed	express	VERB
ajlm-804	69	7	as	as	SCONJ
ajlm-804	69	8	percent	percent	NOUN
ajlm-804	69	9	was	be	AUX
ajlm-804	69	10	also	also	ADV
ajlm-804	69	11	calculated	calculate	VERB
ajlm-804	69	12	.	.	PUNCT
ajlm-804	70	1	mean	mean	VERB
ajlm-804	70	2	and	and	CCONJ
ajlm-804	70	3	median	median	ADJ
ajlm-804	70	4	absolute	absolute	ADJ
ajlm-804	70	5	difference	difference	NOUN
ajlm-804	70	6	and	and	CCONJ
ajlm-804	70	7	relative	relative	ADJ
ajlm-804	70	8	difference	difference	NOUN
ajlm-804	70	9	were	be	AUX
ajlm-804	70	10	calculated	calculate	VERB
ajlm-804	70	11	by	by	ADP
ajlm-804	70	12	cd4	cd4	PROPN
ajlm-804	70	13	subgroups	subgroup	NOUN
ajlm-804	70	14	≤	≤	ADJ
ajlm-804	70	15	200	200	NUM
ajlm-804	70	16	,	,	PUNCT
ajlm-804	70	17	201–1000	201–1000	NUM
ajlm-804	70	18	,	,	PUNCT
ajlm-804	70	19	and	and	CCONJ
ajlm-804	70	20	>	>	PUNCT
ajlm-804	70	21	1000	1000	NUM
ajlm-804	70	22	cells/µl	cells/µl	NOUN
ajlm-804	70	23	and	and	CCONJ
ajlm-804	70	24	≤	≤	NUM
ajlm-804	70	25	350	350	NUM
ajlm-804	70	26	,	,	PUNCT
ajlm-804	70	27	351–1000	351–1000	NUM
ajlm-804	70	28	,	,	PUNCT
ajlm-804	70	29	and	and	CCONJ
ajlm-804	70	30	>	>	SYM
ajlm-804	70	31	1000	1000	NUM
ajlm-804	70	32	cells/µl	cells/µl	NOUN
ajlm-804	70	33	,	,	PUNCT
ajlm-804	70	34	where	where	SCONJ
ajlm-804	70	35	200	200	NUM
ajlm-804	70	36	cells/µl	cells/µl	NOUN
ajlm-804	70	37	and	and	CCONJ
ajlm-804	70	38	350	350	NUM
ajlm-804	70	39	cells/µl	cells/µl	NOUN
ajlm-804	70	40	represent	represent	VERB
ajlm-804	70	41	antiretroviral	antiretroviral	ADJ
ajlm-804	70	42	treatment	treatment	NOUN
ajlm-804	70	43	(	(	PUNCT
ajlm-804	70	44	art	art	NOUN
ajlm-804	70	45	)	)	PUNCT
ajlm-804	70	46	thresholds	threshold	NOUN
ajlm-804	70	47	and	and	CCONJ
ajlm-804	70	48	1000	1000	NUM
ajlm-804	70	49	cells/µl	cells/µl	NOUN
ajlm-804	70	50	was	be	AUX
ajlm-804	70	51	used	use	VERB
ajlm-804	70	52	to	to	PART
ajlm-804	70	53	control	control	VERB
ajlm-804	70	54	for	for	ADP
ajlm-804	70	55	variability	variability	NOUN
ajlm-804	70	56	of	of	ADP
ajlm-804	70	57	paediatric	paediatric	ADJ
ajlm-804	70	58	samples	sample	NOUN
ajlm-804	70	59	.	.	PUNCT
ajlm-804	71	1	upward	upward	ADJ
ajlm-804	71	2	and	and	CCONJ
ajlm-804	71	3	downward	downward	ADJ
ajlm-804	71	4	misclassification	misclassification	NOUN
ajlm-804	71	5	probabilities	probability	NOUN
ajlm-804	71	6	at	at	ADP
ajlm-804	71	7	art	art	NOUN
ajlm-804	71	8	thresholds	threshold	NOUN
ajlm-804	71	9	of	of	ADP
ajlm-804	71	10	100	100	NUM
ajlm-804	71	11	,	,	PUNCT
ajlm-804	71	12	200	200	NUM
ajlm-804	71	13	,	,	PUNCT
ajlm-804	71	14	350	350	NUM
ajlm-804	71	15	and	and	CCONJ
ajlm-804	71	16	500	500	NUM
ajlm-804	71	17	cells/µl	cells/µl	NOUN
ajlm-804	71	18	were	be	AUX
ajlm-804	71	19	determined	determine	VERB
ajlm-804	71	20	(	(	PUNCT
ajlm-804	71	21	the	the	DET
ajlm-804	71	22	method	method	NOUN
ajlm-804	71	23	has	have	AUX
ajlm-804	71	24	been	be	AUX
ajlm-804	71	25	described	describe	VERB
ajlm-804	71	26	elsewhere46	elsewhere46	NOUN
ajlm-804	71	27	)	)	PUNCT
ajlm-804	71	28	.	.	PUNCT
ajlm-804	72	1	upward	upward	ADJ
ajlm-804	72	2	misclassification	misclassification	NOUN
ajlm-804	72	3	represents	represent	VERB
ajlm-804	72	4	the	the	DET
ajlm-804	72	5	percentage	percentage	NOUN
ajlm-804	72	6	of	of	ADP
ajlm-804	72	7	additional	additional	ADJ
ajlm-804	72	8	patients	patient	NOUN
ajlm-804	72	9	who	who	PRON
ajlm-804	72	10	would	would	AUX
ajlm-804	72	11	fall	fall	VERB
ajlm-804	72	12	above	above	ADP
ajlm-804	72	13	a	a	DET
ajlm-804	72	14	defined	define	VERB
ajlm-804	72	15	threshold	threshold	NOUN
ajlm-804	72	16	with	with	ADP
ajlm-804	72	17	the	the	DET
ajlm-804	72	18	new	new	ADJ
ajlm-804	72	19	test	test	NOUN
ajlm-804	72	20	,	,	PUNCT
ajlm-804	72	21	whereas	whereas	SCONJ
ajlm-804	72	22	downward	downward	ADJ
ajlm-804	72	23	misclassification	misclassification	NOUN
ajlm-804	72	24	represents	represent	VERB
ajlm-804	72	25	the	the	DET
ajlm-804	72	26	percentage	percentage	NOUN
ajlm-804	72	27	of	of	ADP
ajlm-804	72	28	additional	additional	ADJ
ajlm-804	72	29	patients	patient	NOUN
ajlm-804	72	30	that	that	PRON
ajlm-804	72	31	would	would	AUX
ajlm-804	72	32	fall	fall	VERB
ajlm-804	72	33	below	below	ADP
ajlm-804	72	34	this	this	DET
ajlm-804	72	35	threshold	threshold	NOUN
ajlm-804	72	36	.	.	PUNCT
ajlm-804	73	1	mean	mean	ADJ
ajlm-804	73	2	percent	percent	NOUN
ajlm-804	73	3	similarity	similarity	NOUN
ajlm-804	73	4	with	with	ADP
ajlm-804	73	5	a	a	DET
ajlm-804	73	6	standard	standard	ADJ
ajlm-804	73	7	deviation	deviation	NOUN
ajlm-804	73	8	(	(	PUNCT
ajlm-804	73	9	sd	sd	NOUN
ajlm-804	73	10	)	)	PUNCT
ajlm-804	73	11	and	and	CCONJ
ajlm-804	73	12	coefficient	coefficient	NOUN
ajlm-804	73	13	of	of	ADP
ajlm-804	73	14	variance	variance	NOUN
ajlm-804	73	15	was	be	AUX
ajlm-804	73	16	also	also	ADV
ajlm-804	73	17	calculated	calculate	VERB
ajlm-804	73	18	(	(	PUNCT
ajlm-804	73	19	the	the	DET
ajlm-804	73	20	method	method	NOUN
ajlm-804	73	21	has	have	AUX
ajlm-804	73	22	been	be	AUX
ajlm-804	73	23	described	describe	VERB
ajlm-804	73	24	elsewhere47	elsewhere47	PROPN
ajlm-804	73	25	)	)	PUNCT
ajlm-804	73	26	.	.	PUNCT
ajlm-804	74	1	for	for	ADP
ajlm-804	74	2	the	the	DET
ajlm-804	74	3	reference	reference	NOUN
ajlm-804	74	4	interval	interval	NOUN
ajlm-804	74	5	,	,	PUNCT
ajlm-804	74	6	demographic	demographic	ADJ
ajlm-804	74	7	characteristics	characteristic	NOUN
ajlm-804	74	8	were	be	AUX
ajlm-804	74	9	calculated	calculate	VERB
ajlm-804	74	10	(	(	PUNCT
ajlm-804	74	11	number	number	NOUN
ajlm-804	74	12	and	and	CCONJ
ajlm-804	74	13	percentage	percentage	NOUN
ajlm-804	74	14	for	for	ADP
ajlm-804	74	15	sex	sex	NOUN
ajlm-804	74	16	and	and	CCONJ
ajlm-804	74	17	mean	mean	VERB
ajlm-804	74	18	±	±	NUM
ajlm-804	74	19	sd	sd	NOUN
ajlm-804	74	20	for	for	ADP
ajlm-804	74	21	age	age	NOUN
ajlm-804	74	22	)	)	PUNCT
ajlm-804	74	23	.	.	PUNCT
ajlm-804	75	1	mean	mean	VERB
ajlm-804	75	2	,	,	PUNCT
ajlm-804	75	3	sd	sd	NOUN
ajlm-804	75	4	,	,	PUNCT
ajlm-804	75	5	median	median	NOUN
ajlm-804	75	6	,	,	PUNCT
ajlm-804	75	7	and	and	CCONJ
ajlm-804	75	8	range	range	VERB
ajlm-804	75	9	for	for	ADP
ajlm-804	75	10	both	both	PRON
ajlm-804	75	11	cd4	cd4	ADJ
ajlm-804	75	12	-	-	ADJ
ajlm-804	75	13	positive	positive	ADJ
ajlm-804	75	14	count	count	NOUN
ajlm-804	75	15	and	and	CCONJ
ajlm-804	75	16	cd4	cd4	ADJ
ajlm-804	75	17	-	-	ADJ
ajlm-804	75	18	positive	positive	ADJ
ajlm-804	75	19	percentage	percentage	NOUN
ajlm-804	75	20	were	be	AUX
ajlm-804	75	21	calculated	calculate	VERB
ajlm-804	75	22	by	by	ADP
ajlm-804	75	23	sex	sex	NOUN
ajlm-804	75	24	and	and	CCONJ
ajlm-804	75	25	for	for	ADP
ajlm-804	75	26	total	total	ADJ
ajlm-804	75	27	participants	participant	NOUN
ajlm-804	75	28	.	.	PUNCT
ajlm-804	76	1	the	the	DET
ajlm-804	76	2	95	95	NUM
ajlm-804	76	3	%	%	NOUN
ajlm-804	76	4	(	(	PUNCT
ajlm-804	76	5	2.5th	2.5th	NUM
ajlm-804	76	6	–	–	PUNCT
ajlm-804	76	7	97.5th	97.5th	NUM
ajlm-804	76	8	)	)	PUNCT
ajlm-804	76	9	reference	reference	NOUN
ajlm-804	76	10	interval	interval	NOUN
ajlm-804	76	11	was	be	AUX
ajlm-804	76	12	determined	determine	VERB
ajlm-804	76	13	using	use	VERB
ajlm-804	76	14	non	non	ADJ
ajlm-804	76	15	-	-	ADJ
ajlm-804	76	16	parametric	parametric	ADJ
ajlm-804	76	17	methods	method	NOUN
ajlm-804	76	18	.	.	PUNCT
ajlm-804	77	1	statistical	statistical	ADJ
ajlm-804	77	2	differences	difference	NOUN
ajlm-804	77	3	in	in	ADP
ajlm-804	77	4	variables	variable	NOUN
ajlm-804	77	5	sex	sex	NOUN
ajlm-804	77	6	,	,	PUNCT
ajlm-804	77	7	adult	adult	NOUN
ajlm-804	77	8	or	or	CCONJ
ajlm-804	77	9	paediatric	paediatric	ADJ
ajlm-804	77	10	patient	patient	NOUN
ajlm-804	77	11	status	status	NOUN
ajlm-804	77	12	were	be	AUX
ajlm-804	77	13	determined	determine	VERB
ajlm-804	77	14	by	by	ADP
ajlm-804	77	15	t	t	NOUN
ajlm-804	77	16	-	-	PUNCT
ajlm-804	77	17	test	test	NOUN
ajlm-804	77	18	for	for	ADP
ajlm-804	77	19	the	the	DET
ajlm-804	77	20	means	mean	NOUN
ajlm-804	77	21	and	and	CCONJ
ajlm-804	77	22	non	non	ADJ
ajlm-804	77	23	-	-	ADJ
ajlm-804	77	24	parametric	parametric	ADJ
ajlm-804	77	25	mann	mann	PROPN
ajlm-804	77	26	whitney	whitney	PROPN
ajlm-804	77	27	u	u	PROPN
ajlm-804	77	28	test	test	VERB
ajlm-804	77	29	for	for	ADP
ajlm-804	77	30	the	the	DET
ajlm-804	77	31	medians	median	NOUN
ajlm-804	77	32	.	.	PUNCT
ajlm-804	78	1	for	for	ADP
ajlm-804	78	2	workflow	workflow	NOUN
ajlm-804	78	3	analysis	analysis	NOUN
ajlm-804	78	4	,	,	PUNCT
ajlm-804	78	5	time	time	NOUN
ajlm-804	78	6	to	to	PART
ajlm-804	78	7	first	first	ADJ
ajlm-804	78	8	result	result	VERB
ajlm-804	78	9	,	,	PUNCT
ajlm-804	78	10	average	average	ADJ
ajlm-804	78	11	sample	sample	NOUN
ajlm-804	78	12	results	result	NOUN
ajlm-804	78	13	per	per	ADP
ajlm-804	78	14	hour	hour	NOUN
ajlm-804	78	15	,	,	PUNCT
ajlm-804	78	16	and	and	CCONJ
ajlm-804	78	17	sample	sample	NOUN
ajlm-804	78	18	results	result	NOUN
ajlm-804	78	19	per	per	ADP
ajlm-804	78	20	8	8	NUM
ajlm-804	78	21	-	-	PUNCT
ajlm-804	78	22	hour	hour	NOUN
ajlm-804	78	23	shift	shift	NOUN
ajlm-804	78	24	were	be	AUX
ajlm-804	78	25	calculated	calculate	VERB
ajlm-804	78	26	.	.	PUNCT
ajlm-804	79	1	statistical	statistical	ADJ
ajlm-804	79	2	analysis	analysis	NOUN
ajlm-804	79	3	was	be	AUX
ajlm-804	79	4	performed	perform	VERB
ajlm-804	79	5	using	use	VERB
ajlm-804	79	6	microsoft	microsoft	PROPN
ajlm-804	79	7	excel	excel	PROPN
ajlm-804	79	8	(	(	PUNCT
ajlm-804	79	9	microsoft	microsoft	PROPN
ajlm-804	79	10	corporation	corporation	PROPN
ajlm-804	79	11	,	,	PUNCT
ajlm-804	79	12	redmond	redmond	PROPN
ajlm-804	79	13	,	,	PUNCT
ajlm-804	79	14	washington	washington	PROPN
ajlm-804	79	15	,	,	PUNCT
ajlm-804	79	16	united	united	PROPN
ajlm-804	79	17	states	states	PROPN
ajlm-804	79	18	)	)	PUNCT
ajlm-804	79	19	with	with	ADP
ajlm-804	79	20	analyse	analyse	PROPN
ajlm-804	79	21	-	-	PUNCT
ajlm-804	79	22	it	it	PRON
ajlm-804	79	23	.	.	PUNCT
ajlm-804	80	1	results	result	NOUN
ajlm-804	80	2	method	method	VERB
ajlm-804	80	3	comparison	comparison	NOUN
ajlm-804	80	4	two	two	NUM
ajlm-804	80	5	hundred	hundred	NUM
ajlm-804	80	6	and	and	CCONJ
ajlm-804	80	7	forty	forty	NUM
ajlm-804	80	8	specimens	specimen	NOUN
ajlm-804	80	9	were	be	AUX
ajlm-804	80	10	included	include	VERB
ajlm-804	80	11	in	in	ADP
ajlm-804	80	12	this	this	DET
ajlm-804	80	13	method	method	ADJ
ajlm-804	80	14	comparison	comparison	NOUN
ajlm-804	80	15	study	study	NOUN
ajlm-804	80	16	,	,	PUNCT
ajlm-804	80	17	92	92	NUM
ajlm-804	80	18	(	(	PUNCT
ajlm-804	80	19	38.7	38.7	NUM
ajlm-804	80	20	%	%	NOUN
ajlm-804	80	21	)	)	PUNCT
ajlm-804	80	22	were	be	AUX
ajlm-804	80	23	obtained	obtain	VERB
ajlm-804	80	24	from	from	ADP
ajlm-804	80	25	female	female	ADJ
ajlm-804	80	26	participants	participant	NOUN
ajlm-804	80	27	(	(	PUNCT
ajlm-804	80	28	mean	mean	VERB
ajlm-804	80	29	age	age	NOUN
ajlm-804	80	30	35.2	35.2	NUM
ajlm-804	80	31	years	year	NOUN
ajlm-804	80	32	)	)	PUNCT
ajlm-804	80	33	and	and	CCONJ
ajlm-804	80	34	146	146	NUM
ajlm-804	80	35	(	(	PUNCT
ajlm-804	80	36	61.3	61.3	NUM
ajlm-804	80	37	%	%	NOUN
ajlm-804	80	38	)	)	PUNCT
ajlm-804	80	39	were	be	AUX
ajlm-804	80	40	from	from	ADP
ajlm-804	80	41	male	male	ADJ
ajlm-804	80	42	participants	participant	NOUN
ajlm-804	80	43	(	(	PUNCT
ajlm-804	80	44	mean	mean	VERB
ajlm-804	80	45	age	age	NOUN
ajlm-804	80	46	42.6	42.6	NUM
ajlm-804	80	47	years	year	NOUN
ajlm-804	80	48	)	)	PUNCT
ajlm-804	80	49	;	;	PUNCT
ajlm-804	80	50	202	202	NUM
ajlm-804	80	51	(	(	PUNCT
ajlm-804	80	52	84.2	84.2	NUM
ajlm-804	80	53	%	%	NOUN
ajlm-804	80	54	)	)	PUNCT
ajlm-804	80	55	were	be	AUX
ajlm-804	80	56	adults	adult	NOUN
ajlm-804	80	57	and	and	CCONJ
ajlm-804	80	58	38	38	NUM
ajlm-804	80	59	(	(	PUNCT
ajlm-804	80	60	15.8	15.8	NUM
ajlm-804	80	61	%	%	NOUN
ajlm-804	80	62	)	)	PUNCT
ajlm-804	80	63	were	be	AUX
ajlm-804	80	64	children	child	NOUN
ajlm-804	80	65	.	.	PUNCT
ajlm-804	81	1	mean	mean	VERB
ajlm-804	81	2	cd4	cd4	PROPN
ajlm-804	81	3	count	count	NOUN
ajlm-804	81	4	and	and	CCONJ
ajlm-804	81	5	percentage	percentage	NOUN
ajlm-804	81	6	were	be	AUX
ajlm-804	81	7	not	not	PART
ajlm-804	81	8	significantly	significantly	ADV
ajlm-804	81	9	different	different	ADJ
ajlm-804	81	10	by	by	ADP
ajlm-804	81	11	sex	sex	NOUN
ajlm-804	81	12	(	(	PUNCT
ajlm-804	81	13	females	female	NOUN
ajlm-804	81	14	:	:	PUNCT
ajlm-804	81	15	339	339	NUM
ajlm-804	81	16	cells/µl	cells/µl	NOUN
ajlm-804	81	17	and	and	CCONJ
ajlm-804	81	18	22.65	22.65	NUM
ajlm-804	81	19	%	%	NOUN
ajlm-804	81	20	,	,	PUNCT
ajlm-804	81	21	males	male	NOUN
ajlm-804	81	22	:	:	PUNCT
ajlm-804	81	23	359	359	NUM
ajlm-804	81	24	cells/µl	cells/µl	NOUN
ajlm-804	81	25	and	and	CCONJ
ajlm-804	81	26	23.47	23.47	NUM
ajlm-804	81	27	%	%	NOUN
ajlm-804	81	28	;	;	PUNCT
ajlm-804	81	29	p	p	X
ajlm-804	81	30	>	>	X
ajlm-804	81	31	0.05	0.05	NUM
ajlm-804	81	32	)	)	PUNCT
ajlm-804	81	33	,	,	PUNCT
ajlm-804	81	34	but	but	CCONJ
ajlm-804	81	35	were	be	AUX
ajlm-804	81	36	by	by	ADP
ajlm-804	81	37	adult	adult	NOUN
ajlm-804	81	38	versus	versus	ADP
ajlm-804	81	39	paediatric	paediatric	ADJ
ajlm-804	81	40	participants	participant	NOUN
ajlm-804	81	41	(	(	PUNCT
ajlm-804	81	42	adults	adult	NOUN
ajlm-804	81	43	:	:	PUNCT
ajlm-804	81	44	361	361	NUM
ajlm-804	81	45	cells/µl	cells/µl	NOUN
ajlm-804	81	46	and	and	CCONJ
ajlm-804	81	47	22.20	22.20	NUM
ajlm-804	81	48	%	%	NOUN
ajlm-804	81	49	,	,	PUNCT
ajlm-804	81	50	children	child	NOUN
ajlm-804	81	51	:	:	PUNCT
ajlm-804	81	52	948	948	NUM
ajlm-804	81	53	cells/µl	cells/µl	NOUN
ajlm-804	81	54	and	and	CCONJ
ajlm-804	81	55	32.28	32.28	NUM
ajlm-804	81	56	%	%	NOUN
ajlm-804	81	57	;	;	PUNCT
ajlm-804	81	58	p	p	X
ajlm-804	81	59	<	<	X
ajlm-804	81	60	0.001	0.001	NUM
ajlm-804	81	61	)	)	PUNCT
ajlm-804	81	62	.	.	PUNCT
ajlm-804	82	1	the	the	DET
ajlm-804	82	2	cd4	cd4	PROPN
ajlm-804	82	3	count	count	NOUN
ajlm-804	82	4	range	range	NOUN
ajlm-804	82	5	showed	show	VERB
ajlm-804	82	6	a	a	DET
ajlm-804	82	7	higher	high	ADJ
ajlm-804	82	8	minimum	minimum	NOUN
ajlm-804	82	9	–	–	PUNCT
ajlm-804	82	10	maximum	maximum	ADJ
ajlm-804	82	11	for	for	ADP
ajlm-804	82	12	paediatric	paediatric	ADJ
ajlm-804	82	13	specimens	specimen	NOUN
ajlm-804	82	14	(	(	PUNCT
ajlm-804	82	15	46–2645	46–2645	NUM
ajlm-804	82	16	cells/µl	cells/µl	NOUN
ajlm-804	82	17	)	)	PUNCT
ajlm-804	82	18	than	than	ADP
ajlm-804	82	19	adult	adult	NOUN
ajlm-804	82	20	specimens	specimen	NOUN
ajlm-804	82	21	(	(	PUNCT
ajlm-804	82	22	24–1278	24–1278	NUM
ajlm-804	82	23	cells/µl	cells/µl	NOUN
ajlm-804	82	24	)	)	PUNCT
ajlm-804	82	25	.	.	PUNCT
ajlm-804	83	1	cd4	cd4	PROPN
ajlm-804	83	2	count	count	NOUN
ajlm-804	83	3	for	for	ADP
ajlm-804	83	4	all	all	DET
ajlm-804	83	5	specimens	specimen	NOUN
ajlm-804	83	6	showed	show	VERB
ajlm-804	83	7	an	an	DET
ajlm-804	83	8	r2	r2	NOUN
ajlm-804	83	9	=	=	NOUN
ajlm-804	83	10	0.992	0.992	NUM
ajlm-804	83	11	and	and	CCONJ
ajlm-804	83	12	mean	mean	ADJ
ajlm-804	83	13	bias	bias	NOUN
ajlm-804	83	14	of	of	ADP
ajlm-804	83	15	−41	−41	PROPN
ajlm-804	83	16	cells/µl	cells/µl	NOUN
ajlm-804	83	17	between	between	ADP
ajlm-804	83	18	aquios	aquio	NOUN
ajlm-804	83	19	plg	plg	NOUN
ajlm-804	83	20	and	and	CCONJ
ajlm-804	83	21	flowcare	flowcare	PROPN
ajlm-804	83	22	plg	plg	PROPN
ajlm-804	83	23	(	(	PUNCT
ajlm-804	83	24	figure	figure	NOUN
ajlm-804	83	25	2a	2a	NUM
ajlm-804	83	26	)	)	PUNCT
ajlm-804	83	27	.	.	PUNCT
ajlm-804	84	1	mean	mean	VERB
ajlm-804	84	2	relative	relative	ADJ
ajlm-804	84	3	bias	bias	NOUN
ajlm-804	84	4	was	be	AUX
ajlm-804	84	5	−7.8	−7.8	PROPN
ajlm-804	84	6	%	%	NOUN
ajlm-804	84	7	.	.	PUNCT
ajlm-804	85	1	of	of	ADP
ajlm-804	85	2	12	12	NUM
ajlm-804	85	3	samples	sample	NOUN
ajlm-804	85	4	with	with	ADP
ajlm-804	85	5	a	a	DET
ajlm-804	85	6	cd4	cd4	PROPN
ajlm-804	85	7	count	count	NOUN
ajlm-804	85	8	above	above	ADP
ajlm-804	85	9	1250	1250	NUM
ajlm-804	85	10	cells/µl	cells/µl	NOUN
ajlm-804	85	11	,	,	PUNCT
ajlm-804	85	12	11	11	NUM
ajlm-804	85	13	were	be	AUX
ajlm-804	85	14	from	from	ADP
ajlm-804	85	15	paediatric	paediatric	ADJ
ajlm-804	85	16	participants	participant	NOUN
ajlm-804	85	17	.	.	PUNCT
ajlm-804	86	1	for	for	ADP
ajlm-804	86	2	cd4	cd4	PROPN
ajlm-804	86	3	percentage	percentage	NOUN
ajlm-804	86	4	,	,	PUNCT
ajlm-804	86	5	r2	r2	PROPN
ajlm-804	86	6	was	be	AUX
ajlm-804	86	7	0.994	0.994	NUM
ajlm-804	86	8	and	and	CCONJ
ajlm-804	86	9	there	there	PRON
ajlm-804	86	10	was	be	VERB
ajlm-804	86	11	an	an	DET
ajlm-804	86	12	average	average	ADJ
ajlm-804	86	13	bias	bias	NOUN
ajlm-804	86	14	of	of	ADP
ajlm-804	86	15	−0.16	−0.16	NOUN
ajlm-804	86	16	%	%	NOUN
ajlm-804	86	17	(	(	PUNCT
ajlm-804	86	18	figure	figure	NOUN
ajlm-804	86	19	2b	2b	NOUN
ajlm-804	86	20	)	)	PUNCT
ajlm-804	86	21	.	.	PUNCT
ajlm-804	87	1	because	because	SCONJ
ajlm-804	87	2	the	the	DET
ajlm-804	87	3	mean	mean	NOUN
ajlm-804	87	4	cd4	cd4	PROPN
ajlm-804	87	5	count	count	NOUN
ajlm-804	87	6	between	between	ADP
ajlm-804	87	7	adults	adult	NOUN
ajlm-804	87	8	and	and	CCONJ
ajlm-804	87	9	children	child	NOUN
ajlm-804	87	10	was	be	AUX
ajlm-804	87	11	significantly	significantly	ADV
ajlm-804	87	12	different	different	ADJ
ajlm-804	87	13	,	,	PUNCT
ajlm-804	87	14	adult	adult	NOUN
ajlm-804	87	15	specimens	specimen	NOUN
ajlm-804	87	16	were	be	AUX
ajlm-804	87	17	analysed	analyse	VERB
ajlm-804	87	18	separately	separately	ADV
ajlm-804	87	19	,	,	PUNCT
ajlm-804	87	20	showing	show	VERB
ajlm-804	87	21	an	an	DET
ajlm-804	87	22	r2	r2	NOUN
ajlm-804	87	23	=	=	NOUN
ajlm-804	87	24	0.992	0.992	NUM
ajlm-804	87	25	and	and	CCONJ
ajlm-804	87	26	average	average	ADJ
ajlm-804	87	27	bias	bias	NOUN
ajlm-804	87	28	of	of	ADP
ajlm-804	87	29	−25	−25	ADJ
ajlm-804	87	30	cells/µl	cells/µl	NOUN
ajlm-804	87	31	(	(	PUNCT
ajlm-804	87	32	figure	figure	NOUN
ajlm-804	87	33	2c	2c	NUM
ajlm-804	87	34	)	)	PUNCT
ajlm-804	87	35	.	.	PUNCT
ajlm-804	88	1	mean	mean	VERB
ajlm-804	88	2	relative	relative	ADJ
ajlm-804	88	3	bias	bias	NOUN
ajlm-804	88	4	was	be	AUX
ajlm-804	88	5	−6.8	−6.8	NOUN
ajlm-804	88	6	%	%	NOUN
ajlm-804	88	7	.	.	PUNCT
ajlm-804	89	1	figure	figure	NOUN
ajlm-804	89	2	2	2	NUM
ajlm-804	89	3	:	:	PUNCT
ajlm-804	89	4	deming	deming	NOUN
ajlm-804	89	5	regression	regression	NOUN
ajlm-804	89	6	and	and	CCONJ
ajlm-804	89	7	bland	bland	ADJ
ajlm-804	89	8	-	-	PUNCT
ajlm-804	89	9	altman	altman	NOUN
ajlm-804	89	10	for	for	ADP
ajlm-804	89	11	aquios	aquio	NOUN
ajlm-804	89	12	panleucogating	panleucogate	VERB
ajlm-804	89	13	versus	versus	ADP
ajlm-804	89	14	flowcare	flowcare	NOUN
ajlm-804	89	15	panleucogating	panleucogating	NOUN
ajlm-804	89	16	,	,	PUNCT
ajlm-804	89	17	canada	canada	PROPN
ajlm-804	89	18	;	;	PUNCT
ajlm-804	89	19	paris	paris	PROPN
ajlm-804	89	20	,	,	PUNCT
ajlm-804	89	21	france	france	PROPN
ajlm-804	89	22	;	;	PUNCT
ajlm-804	89	23	lyon	lyon	PROPN
ajlm-804	89	24	,	,	PUNCT
ajlm-804	89	25	france	france	PROPN
ajlm-804	89	26	;	;	PUNCT
ajlm-804	89	27	and	and	CCONJ
ajlm-804	89	28	south	south	PROPN
ajlm-804	89	29	africa	africa	PROPN
ajlm-804	89	30	,	,	PUNCT
ajlm-804	89	31	november	november	PROPN
ajlm-804	89	32	2014	2014	NUM
ajlm-804	89	33	to	to	ADP
ajlm-804	89	34	march	march	PROPN
ajlm-804	89	35	2015	2015	NUM
ajlm-804	89	36	.	.	PUNCT
ajlm-804	90	1	(	(	PUNCT
ajlm-804	90	2	a	a	X
ajlm-804	90	3	)	)	PUNCT
ajlm-804	90	4	absolute	absolute	ADJ
ajlm-804	90	5	cd4	cd4	PROPN
ajlm-804	90	6	count	count	NOUN
ajlm-804	90	7	in	in	ADP
ajlm-804	90	8	cells	cell	NOUN
ajlm-804	90	9	/	/	SYM
ajlm-804	90	10	μl	μl	ADV
ajlm-804	90	11	for	for	ADP
ajlm-804	90	12	adults	adult	NOUN
ajlm-804	90	13	and	and	CCONJ
ajlm-804	90	14	children	child	NOUN
ajlm-804	90	15	,	,	PUNCT
ajlm-804	90	16	(	(	PUNCT
ajlm-804	90	17	b	b	X
ajlm-804	90	18	)	)	PUNCT
ajlm-804	90	19	percentage	percentage	NOUN
ajlm-804	90	20	of	of	ADP
ajlm-804	90	21	cd4	cd4	PROPN
ajlm-804	90	22	for	for	ADP
ajlm-804	90	23	adults	adult	NOUN
ajlm-804	90	24	and	and	CCONJ
ajlm-804	90	25	children	child	NOUN
ajlm-804	90	26	,	,	PUNCT
ajlm-804	90	27	(	(	PUNCT
ajlm-804	90	28	c	c	X
ajlm-804	90	29	)	)	PUNCT
ajlm-804	90	30	absolute	absolute	ADJ
ajlm-804	90	31	cd4	cd4	PROPN
ajlm-804	90	32	count	count	NOUN
ajlm-804	90	33	in	in	ADP
ajlm-804	90	34	cells	cell	NOUN
ajlm-804	90	35	/	/	SYM
ajlm-804	90	36	μl	μl	ADV
ajlm-804	90	37	for	for	ADP
ajlm-804	90	38	adults	adult	NOUN
ajlm-804	90	39	only	only	ADV
ajlm-804	90	40	.	.	PUNCT
ajlm-804	91	1	bias	bias	VERB
ajlm-804	91	2	analysis	analysis	NOUN
ajlm-804	91	3	by	by	ADP
ajlm-804	91	4	cd4	cd4	PROPN
ajlm-804	91	5	subgroups	subgroup	NOUN
ajlm-804	91	6	based	base	VERB
ajlm-804	91	7	on	on	ADP
ajlm-804	91	8	art	art	NOUN
ajlm-804	91	9	thresholds	threshold	NOUN
ajlm-804	91	10	of	of	ADP
ajlm-804	91	11	200	200	NUM
ajlm-804	91	12	cells	cell	NOUN
ajlm-804	91	13	per	per	ADP
ajlm-804	91	14	µl	µl	ADP
ajlm-804	91	15	and	and	CCONJ
ajlm-804	91	16	350	350	NUM
ajlm-804	91	17	cells	cell	NOUN
ajlm-804	91	18	per	per	ADP
ajlm-804	91	19	µl	µl	ADP
ajlm-804	91	20	showed	show	VERB
ajlm-804	91	21	relatively	relatively	ADV
ajlm-804	91	22	consistent	consistent	ADJ
ajlm-804	91	23	median	median	ADJ
ajlm-804	91	24	relative	relative	ADJ
ajlm-804	91	25	bias	bias	NOUN
ajlm-804	91	26	for	for	ADP
ajlm-804	91	27	samples	sample	NOUN
ajlm-804	91	28	below	below	ADP
ajlm-804	91	29	and	and	CCONJ
ajlm-804	91	30	above	above	ADP
ajlm-804	91	31	the	the	DET
ajlm-804	91	32	respective	respective	ADJ
ajlm-804	91	33	thresholds	threshold	NOUN
ajlm-804	91	34	:	:	PUNCT
ajlm-804	92	1	−7.8	−7.8	PROPN
ajlm-804	92	2	%	%	NOUN
ajlm-804	92	3	and	and	CCONJ
ajlm-804	92	4	−8.1	−8.1	NUM
ajlm-804	92	5	%	%	NOUN
ajlm-804	92	6	,	,	PUNCT
ajlm-804	92	7	and	and	CCONJ
ajlm-804	92	8	−7.9	−7.9	PROPN
ajlm-804	92	9	%	%	NOUN
ajlm-804	92	10	and	and	CCONJ
ajlm-804	92	11	−8.1	−8.1	NUM
ajlm-804	92	12	%	%	NOUN
ajlm-804	92	13	(	(	PUNCT
ajlm-804	92	14	table	table	NOUN
ajlm-804	92	15	1	1	NUM
ajlm-804	92	16	)	)	PUNCT
ajlm-804	92	17	.	.	PUNCT
ajlm-804	93	1	table	table	NOUN
ajlm-804	93	2	1	1	NUM
ajlm-804	93	3	:	:	PUNCT
ajlm-804	93	4	 	 	SPACE
ajlm-804	93	5	cd4	cd4	PROPN
ajlm-804	93	6	count	count	VERB
ajlm-804	93	7	absolute	absolute	ADJ
ajlm-804	93	8	and	and	CCONJ
ajlm-804	93	9	relative	relative	ADJ
ajlm-804	93	10	bias	bias	NOUN
ajlm-804	93	11	between	between	ADP
ajlm-804	93	12	aquios	aquio	NOUN
ajlm-804	93	13	panleucogating	panleucogate	VERB
ajlm-804	93	14	and	and	CCONJ
ajlm-804	93	15	flowcare	flowcare	NOUN
ajlm-804	93	16	panleucogating	panleucogate	VERB
ajlm-804	93	17	overall	overall	ADV
ajlm-804	93	18	,	,	PUNCT
ajlm-804	93	19	by	by	ADP
ajlm-804	93	20	cd4	cd4	PROPN
ajlm-804	93	21	subgroup	subgroup	NOUN
ajlm-804	93	22	and	and	CCONJ
ajlm-804	93	23	at	at	ADP
ajlm-804	93	24	clinically	clinically	ADV
ajlm-804	93	25	relevant	relevant	ADJ
ajlm-804	93	26	cd4	cd4	PROPN
ajlm-804	93	27	levels	level	NOUN
ajlm-804	93	28	,	,	PUNCT
ajlm-804	93	29	canada	canada	PROPN
ajlm-804	93	30	;	;	PUNCT
ajlm-804	93	31	paris	paris	PROPN
ajlm-804	93	32	,	,	PUNCT
ajlm-804	93	33	france	france	PROPN
ajlm-804	93	34	;	;	PUNCT
ajlm-804	93	35	lyon	lyon	PROPN
ajlm-804	93	36	,	,	PUNCT
ajlm-804	93	37	france	france	PROPN
ajlm-804	93	38	;	;	PUNCT
ajlm-804	93	39	and	and	CCONJ
ajlm-804	93	40	south	south	PROPN
ajlm-804	93	41	africa	africa	PROPN
ajlm-804	93	42	,	,	PUNCT
ajlm-804	93	43	november	november	PROPN
ajlm-804	93	44	2014	2014	NUM
ajlm-804	93	45	to	to	ADP
ajlm-804	93	46	march	march	PROPN
ajlm-804	93	47	2015	2015	NUM
ajlm-804	93	48	.	.	PUNCT
ajlm-804	94	1	upward	upward	ADJ
ajlm-804	94	2	misclassification	misclassification	NOUN
ajlm-804	94	3	ranged	range	VERB
ajlm-804	94	4	from	from	ADP
ajlm-804	94	5	0.0	0.0	NUM
ajlm-804	94	6	to	to	PART
ajlm-804	94	7	2.4	2.4	NUM
ajlm-804	94	8	%	%	NOUN
ajlm-804	94	9	and	and	CCONJ
ajlm-804	94	10	downward	downward	ADJ
ajlm-804	94	11	misclassification	misclassification	NOUN
ajlm-804	94	12	ranged	range	VERB
ajlm-804	94	13	from	from	ADP
ajlm-804	94	14	1.5	1.5	NUM
ajlm-804	94	15	to	to	ADP
ajlm-804	94	16	11.1	11.1	NUM
ajlm-804	94	17	%	%	NOUN
ajlm-804	94	18	,	,	PUNCT
ajlm-804	94	19	depending	depend	VERB
ajlm-804	94	20	on	on	ADP
ajlm-804	94	21	the	the	DET
ajlm-804	94	22	threshold	threshold	NOUN
ajlm-804	94	23	(	(	PUNCT
ajlm-804	94	24	table	table	NOUN
ajlm-804	94	25	2	2	NUM
ajlm-804	94	26	)	)	PUNCT
ajlm-804	94	27	.	.	PUNCT
ajlm-804	95	1	mean	mean	NOUN
ajlm-804	95	2	percent	percent	NOUN
ajlm-804	95	3	similarity	similarity	NOUN
ajlm-804	95	4	(	(	PUNCT
ajlm-804	95	5	sd	sd	NOUN
ajlm-804	95	6	,	,	PUNCT
ajlm-804	95	7	coefficient	coefficient	NOUN
ajlm-804	95	8	of	of	ADP
ajlm-804	95	9	variance	variance	NOUN
ajlm-804	95	10	)	)	PUNCT
ajlm-804	95	11	was	be	AUX
ajlm-804	95	12	96.1	96.1	NUM
ajlm-804	95	13	%	%	NOUN
ajlm-804	95	14	(	(	PUNCT
ajlm-804	95	15	6.1	6.1	NUM
ajlm-804	95	16	%	%	NOUN
ajlm-804	95	17	,	,	PUNCT
ajlm-804	95	18	6.3	6.3	NUM
ajlm-804	95	19	%	%	NOUN
ajlm-804	95	20	)	)	PUNCT
ajlm-804	95	21	for	for	ADP
ajlm-804	95	22	the	the	DET
ajlm-804	95	23	absolute	absolute	ADJ
ajlm-804	95	24	cd4	cd4	PROPN
ajlm-804	95	25	count	count	NOUN
ajlm-804	95	26	and	and	CCONJ
ajlm-804	95	27	99.5	99.5	NUM
ajlm-804	95	28	%	%	NOUN
ajlm-804	95	29	(	(	PUNCT
ajlm-804	95	30	3.9	3.9	NUM
ajlm-804	95	31	%	%	NOUN
ajlm-804	95	32	,	,	PUNCT
ajlm-804	95	33	4.0	4.0	NUM
ajlm-804	95	34	%	%	NOUN
ajlm-804	95	35	)	)	PUNCT
ajlm-804	95	36	for	for	ADP
ajlm-804	95	37	the	the	DET
ajlm-804	95	38	cd4	cd4	PROPN
ajlm-804	95	39	percentage	percentage	NOUN
ajlm-804	95	40	.	.	PUNCT
ajlm-804	95	41	table	table	NOUN
ajlm-804	95	42	2	2	NUM
ajlm-804	95	43	:	:	PUNCT
ajlm-804	95	44	 	 	SPACE
ajlm-804	95	45	misclassification	misclassification	NOUN
ajlm-804	95	46	percentages	percentage	NOUN
ajlm-804	95	47	at	at	ADP
ajlm-804	95	48	various	various	ADJ
ajlm-804	95	49	cd4	cd4	PROPN
ajlm-804	95	50	count	count	NOUN
ajlm-804	95	51	thresholds	thresholds	PROPN
ajlm-804	95	52	,	,	PUNCT
ajlm-804	95	53	canada	canada	PROPN
ajlm-804	95	54	;	;	PUNCT
ajlm-804	95	55	paris	paris	PROPN
ajlm-804	95	56	,	,	PUNCT
ajlm-804	95	57	france	france	PROPN
ajlm-804	95	58	;	;	PUNCT
ajlm-804	95	59	lyon	lyon	PROPN
ajlm-804	95	60	,	,	PUNCT
ajlm-804	95	61	france	france	PROPN
ajlm-804	95	62	;	;	PUNCT
ajlm-804	95	63	and	and	CCONJ
ajlm-804	95	64	south	south	PROPN
ajlm-804	95	65	africa	africa	PROPN
ajlm-804	95	66	,	,	PUNCT
ajlm-804	95	67	november	november	PROPN
ajlm-804	95	68	2014	2014	NUM
ajlm-804	95	69	to	to	ADP
ajlm-804	95	70	march	march	PROPN
ajlm-804	95	71	2015	2015	NUM
ajlm-804	95	72	.	.	PUNCT
ajlm-804	96	1	reference	reference	NOUN
ajlm-804	96	2	interval	interval	NOUN
ajlm-804	96	3	in	in	ADP
ajlm-804	96	4	healthy	healthy	ADJ
ajlm-804	96	5	adults	adult	NOUN
ajlm-804	96	6	demographic	demographic	ADJ
ajlm-804	96	7	characteristics	characteristic	NOUN
ajlm-804	96	8	for	for	ADP
ajlm-804	96	9	the	the	DET
ajlm-804	96	10	155	155	NUM
ajlm-804	96	11	samples	sample	NOUN
ajlm-804	96	12	included	include	VERB
ajlm-804	96	13	in	in	ADP
ajlm-804	96	14	the	the	DET
ajlm-804	96	15	reference	reference	NOUN
ajlm-804	96	16	interval	interval	NOUN
ajlm-804	96	17	analysis	analysis	NOUN
ajlm-804	96	18	showed	show	VERB
ajlm-804	96	19	the	the	DET
ajlm-804	96	20	proportions	proportion	NOUN
ajlm-804	96	21	of	of	ADP
ajlm-804	96	22	female	female	ADJ
ajlm-804	96	23	participants	participant	NOUN
ajlm-804	96	24	were	be	AUX
ajlm-804	96	25	paris	paris	PROPN
ajlm-804	96	26	,	,	PUNCT
ajlm-804	96	27	france	france	PROPN
ajlm-804	96	28	,	,	PUNCT
ajlm-804	96	29	0.73	0.73	NUM
ajlm-804	96	30	;	;	PUNCT
ajlm-804	96	31	canada	canada	PROPN
ajlm-804	96	32	,	,	PUNCT
ajlm-804	96	33	0.59	0.59	NUM
ajlm-804	96	34	;	;	PUNCT
ajlm-804	96	35	united	united	PROPN
ajlm-804	96	36	states	states	PROPN
ajlm-804	96	37	(	(	PUNCT
ajlm-804	96	38	0.39	0.39	NUM
ajlm-804	96	39	)	)	PUNCT
ajlm-804	96	40	.	.	PUNCT
ajlm-804	97	1	the	the	DET
ajlm-804	97	2	mean	mean	ADJ
ajlm-804	97	3	overall	overall	ADJ
ajlm-804	97	4	ages	age	NOUN
ajlm-804	97	5	were	be	AUX
ajlm-804	97	6	40	40	NUM
ajlm-804	97	7	years	year	NOUN
ajlm-804	97	8	(	(	PUNCT
ajlm-804	97	9	canada	canada	PROPN
ajlm-804	97	10	)	)	PUNCT
ajlm-804	97	11	;	;	PUNCT
ajlm-804	97	12	45	45	NUM
ajlm-804	97	13	years	year	NOUN
ajlm-804	97	14	(	(	PUNCT
ajlm-804	97	15	united	united	PROPN
ajlm-804	97	16	states	states	PROPN
ajlm-804	97	17	)	)	PUNCT
ajlm-804	97	18	;	;	PUNCT
ajlm-804	97	19	the	the	DET
ajlm-804	97	20	mean	mean	ADJ
ajlm-804	97	21	female	female	NOUN
ajlm-804	97	22	-	-	PUNCT
ajlm-804	97	23	to	to	ADP
ajlm-804	97	24	-	-	PUNCT
ajlm-804	97	25	male	male	ADJ
ajlm-804	97	26	ages	age	NOUN
ajlm-804	97	27	were	be	AUX
ajlm-804	97	28	36	36	NUM
ajlm-804	97	29	versus	versus	ADP
ajlm-804	97	30	45	45	NUM
ajlm-804	97	31	years	year	NOUN
ajlm-804	97	32	(	(	PUNCT
ajlm-804	97	33	canada	canada	PROPN
ajlm-804	97	34	)	)	PUNCT
ajlm-804	97	35	and	and	CCONJ
ajlm-804	97	36	52	52	NUM
ajlm-804	97	37	versus	versus	ADP
ajlm-804	97	38	41	41	NUM
ajlm-804	97	39	years	year	NOUN
ajlm-804	97	40	(	(	PUNCT
ajlm-804	97	41	united	united	PROPN
ajlm-804	97	42	states	states	PROPN
ajlm-804	97	43	)	)	PUNCT
ajlm-804	97	44	.	.	PUNCT
ajlm-804	98	1	specific	specific	ADJ
ajlm-804	98	2	age	age	NOUN
ajlm-804	98	3	data	datum	NOUN
ajlm-804	98	4	for	for	ADP
ajlm-804	98	5	samples	sample	NOUN
ajlm-804	98	6	from	from	ADP
ajlm-804	98	7	paris	paris	PROPN
ajlm-804	98	8	,	,	PUNCT
ajlm-804	98	9	france	france	PROPN
ajlm-804	98	10	were	be	AUX
ajlm-804	98	11	not	not	PART
ajlm-804	98	12	available	available	ADJ
ajlm-804	98	13	.	.	PUNCT
ajlm-804	99	1	the	the	DET
ajlm-804	99	2	mean	mean	ADJ
ajlm-804	99	3	cd4	cd4	ADJ
ajlm-804	99	4	-	-	ADJ
ajlm-804	99	5	positive	positive	ADJ
ajlm-804	99	6	count	count	NOUN
ajlm-804	99	7	±	±	NUM
ajlm-804	99	8	sd	sd	NOUN
ajlm-804	99	9	was	be	AUX
ajlm-804	99	10	higher	high	ADJ
ajlm-804	99	11	in	in	ADP
ajlm-804	99	12	canada	canada	PROPN
ajlm-804	99	13	(	(	PUNCT
ajlm-804	99	14	1009	1009	NUM
ajlm-804	99	15	±	±	NUM
ajlm-804	99	16	239	239	NUM
ajlm-804	99	17	cells/µl	cells/µl	NOUN
ajlm-804	99	18	)	)	PUNCT
ajlm-804	99	19	compared	compare	VERB
ajlm-804	99	20	to	to	ADP
ajlm-804	99	21	both	both	DET
ajlm-804	99	22	the	the	DET
ajlm-804	99	23	united	united	PROPN
ajlm-804	99	24	states	states	PROPN
ajlm-804	99	25	(	(	PUNCT
ajlm-804	99	26	866	866	NUM
ajlm-804	99	27	±	±	NUM
ajlm-804	99	28	221	221	NUM
ajlm-804	99	29	cells/µl	cells/µl	NOUN
ajlm-804	99	30	)	)	PUNCT
ajlm-804	99	31	and	and	CCONJ
ajlm-804	99	32	paris	paris	PROPN
ajlm-804	99	33	,	,	PUNCT
ajlm-804	99	34	france	france	PROPN
ajlm-804	99	35	(	(	PUNCT
ajlm-804	99	36	802	802	NUM
ajlm-804	99	37	±	±	NUM
ajlm-804	99	38	273	273	NUM
ajlm-804	99	39	cells/µl	cells/µl	NOUN
ajlm-804	99	40	)	)	PUNCT
ajlm-804	99	41	.	.	PUNCT
ajlm-804	100	1	similar	similar	ADJ
ajlm-804	100	2	results	result	NOUN
ajlm-804	100	3	were	be	AUX
ajlm-804	100	4	seen	see	VERB
ajlm-804	100	5	for	for	ADP
ajlm-804	100	6	the	the	DET
ajlm-804	100	7	mean	mean	ADJ
ajlm-804	100	8	cd4	cd4	ADJ
ajlm-804	100	9	-	-	ADJ
ajlm-804	100	10	positive	positive	ADJ
ajlm-804	100	11	count	count	NOUN
ajlm-804	100	12	by	by	ADP
ajlm-804	100	13	sex	sex	NOUN
ajlm-804	100	14	at	at	ADP
ajlm-804	100	15	each	each	DET
ajlm-804	100	16	site	site	NOUN
ajlm-804	100	17	.	.	PUNCT
ajlm-804	101	1	the	the	DET
ajlm-804	101	2	95	95	NUM
ajlm-804	101	3	%	%	NOUN
ajlm-804	101	4	reference	reference	NOUN
ajlm-804	101	5	intervals	interval	NOUN
ajlm-804	101	6	for	for	ADP
ajlm-804	101	7	both	both	DET
ajlm-804	101	8	absolute	absolute	ADJ
ajlm-804	101	9	cd4	cd4	ADJ
ajlm-804	101	10	-	-	ADJ
ajlm-804	101	11	positive	positive	ADJ
ajlm-804	101	12	counts	count	NOUN
ajlm-804	101	13	and	and	CCONJ
ajlm-804	101	14	percentages	percentage	NOUN
ajlm-804	101	15	by	by	ADP
ajlm-804	101	16	site	site	NOUN
ajlm-804	101	17	were	be	AUX
ajlm-804	101	18	similar	similar	ADJ
ajlm-804	101	19	and	and	CCONJ
ajlm-804	101	20	overlapped	overlapped	ADJ
ajlm-804	101	21	.	.	PUNCT
ajlm-804	102	1	the	the	DET
ajlm-804	102	2	mean	mean	ADJ
ajlm-804	102	3	cd4	cd4	PROPN
ajlm-804	102	4	absolute	absolute	ADJ
ajlm-804	102	5	count	count	NOUN
ajlm-804	102	6	and	and	CCONJ
ajlm-804	102	7	percentage	percentage	NOUN
ajlm-804	102	8	for	for	ADP
ajlm-804	102	9	female	female	ADJ
ajlm-804	102	10	and	and	CCONJ
ajlm-804	102	11	male	male	ADJ
ajlm-804	102	12	participants	participant	NOUN
ajlm-804	102	13	were	be	AUX
ajlm-804	102	14	not	not	PART
ajlm-804	102	15	different	different	ADJ
ajlm-804	102	16	statistically	statistically	ADV
ajlm-804	102	17	(	(	PUNCT
ajlm-804	102	18	p	p	NOUN
ajlm-804	102	19	=	=	NOUN
ajlm-804	102	20	0.61	0.61	NUM
ajlm-804	102	21	and	and	CCONJ
ajlm-804	102	22	0.48	0.48	NUM
ajlm-804	102	23	,	,	PUNCT
ajlm-804	102	24	respectively	respectively	ADV
ajlm-804	102	25	)	)	PUNCT
ajlm-804	102	26	(	(	PUNCT
ajlm-804	102	27	table	table	NOUN
ajlm-804	102	28	3	3	NUM
ajlm-804	102	29	)	)	PUNCT
ajlm-804	102	30	.	.	PUNCT
ajlm-804	103	1	the	the	DET
ajlm-804	103	2	overall	overall	ADJ
ajlm-804	103	3	mean	mean	NOUN
ajlm-804	103	4	cd4	cd4	PROPN
ajlm-804	103	5	positive	positive	ADJ
ajlm-804	103	6	count	count	NOUN
ajlm-804	103	7	±	±	NUM
ajlm-804	103	8	sd	sd	NOUN
ajlm-804	103	9	was	be	AUX
ajlm-804	103	10	888	888	NUM
ajlm-804	103	11	±	±	NUM
ajlm-804	103	12	255	255	NUM
ajlm-804	103	13	cells/µl	cells/µl	NOUN
ajlm-804	103	14	and	and	CCONJ
ajlm-804	103	15	mean	mean	VERB
ajlm-804	103	16	cd4	cd4	ADJ
ajlm-804	103	17	-	-	ADJ
ajlm-804	103	18	positive	positive	ADJ
ajlm-804	103	19	percentage	percentage	NOUN
ajlm-804	103	20	±	±	NOUN
ajlm-804	103	21	sd	sd	NOUN
ajlm-804	103	22	was	be	AUX
ajlm-804	103	23	46.82	46.82	NUM
ajlm-804	103	24	±	±	NUM
ajlm-804	103	25	7.86	7.86	NUM
ajlm-804	103	26	%	%	NOUN
ajlm-804	103	27	.	.	PUNCT
ajlm-804	104	1	the	the	DET
ajlm-804	104	2	95	95	NUM
ajlm-804	104	3	%	%	NOUN
ajlm-804	104	4	reference	reference	NOUN
ajlm-804	104	5	interval	interval	NOUN
ajlm-804	104	6	(	(	PUNCT
ajlm-804	104	7	2.5th	2.5th	NUM
ajlm-804	104	8	–	–	PUNCT
ajlm-804	104	9	97.5th	97.5th	NUM
ajlm-804	104	10	)	)	PUNCT
ajlm-804	104	11	for	for	ADP
ajlm-804	104	12	cd4	cd4	ADJ
ajlm-804	104	13	-	-	ADJ
ajlm-804	104	14	positive	positive	ADJ
ajlm-804	104	15	count	count	NOUN
ajlm-804	104	16	and	and	CCONJ
ajlm-804	104	17	percentage	percentage	NOUN
ajlm-804	104	18	was	be	AUX
ajlm-804	104	19	453–1534	453–1534	NUM
ajlm-804	104	20	cells/µl	cells/µl	NOUN
ajlm-804	104	21	and	and	CCONJ
ajlm-804	104	22	30.5	30.5	NUM
ajlm-804	104	23	%	%	NOUN
ajlm-804	104	24	–	–	PUNCT
ajlm-804	104	25	63.4	63.4	NUM
ajlm-804	104	26	%	%	NOUN
ajlm-804	104	27	(	(	PUNCT
ajlm-804	104	28	table	table	NOUN
ajlm-804	104	29	4	4	NUM
ajlm-804	104	30	)	)	PUNCT
ajlm-804	104	31	.	.	PUNCT
ajlm-804	105	1	recent	recent	ADJ
ajlm-804	105	2	,	,	PUNCT
ajlm-804	105	3	previously	previously	ADV
ajlm-804	105	4	established	establish	VERB
ajlm-804	105	5	reference	reference	NOUN
ajlm-804	105	6	interval	interval	NOUN
ajlm-804	105	7	results	result	NOUN
ajlm-804	105	8	for	for	ADP
ajlm-804	105	9	cd4	cd4	PROPN
ajlm-804	105	10	absolute	absolute	ADJ
ajlm-804	105	11	count	count	NOUN
ajlm-804	105	12	and	and	CCONJ
ajlm-804	105	13	percentage	percentage	NOUN
ajlm-804	105	14	from	from	ADP
ajlm-804	105	15	healthy	healthy	ADJ
ajlm-804	105	16	,	,	PUNCT
ajlm-804	105	17	non	non	ADJ
ajlm-804	105	18	-	-	ADJ
ajlm-804	105	19	hiv	hiv	ADJ
ajlm-804	105	20	individuals	individual	NOUN
ajlm-804	105	21	from	from	ADP
ajlm-804	105	22	different	different	ADJ
ajlm-804	105	23	parts	part	NOUN
ajlm-804	105	24	of	of	ADP
ajlm-804	105	25	the	the	DET
ajlm-804	105	26	world	world	NOUN
ajlm-804	105	27	using	use	VERB
ajlm-804	105	28	differing	differ	VERB
ajlm-804	105	29	instrument	instrument	NOUN
ajlm-804	105	30	platforms	platform	NOUN
ajlm-804	105	31	show	show	VERB
ajlm-804	105	32	consistent	consistent	ADJ
ajlm-804	105	33	results	result	NOUN
ajlm-804	105	34	(	(	PUNCT
ajlm-804	105	35	table	table	NOUN
ajlm-804	105	36	5	5	NUM
ajlm-804	105	37	)	)	PUNCT
ajlm-804	105	38	.	.	PUNCT
ajlm-804	106	1	table	table	NOUN
ajlm-804	106	2	3	3	NUM
ajlm-804	106	3	:	:	PUNCT
ajlm-804	106	4	 	 	SPACE
ajlm-804	106	5	demographic	demographic	ADJ
ajlm-804	106	6	characteristics	characteristic	NOUN
ajlm-804	106	7	and	and	CCONJ
ajlm-804	106	8	means	mean	NOUN
ajlm-804	106	9	,	,	PUNCT
ajlm-804	106	10	medians	median	NOUN
ajlm-804	106	11	,	,	PUNCT
ajlm-804	106	12	and	and	CCONJ
ajlm-804	106	13	ranges	range	VERB
ajlm-804	106	14	for	for	ADP
ajlm-804	106	15	cd4	cd4	PROPN
ajlm-804	106	16	and	and	CCONJ
ajlm-804	106	17	percentages	percentage	NOUN
ajlm-804	106	18	for	for	ADP
ajlm-804	106	19	a	a	DET
ajlm-804	106	20	healthy	healthy	ADJ
ajlm-804	106	21	adult	adult	NOUN
ajlm-804	106	22	reference	reference	NOUN
ajlm-804	106	23	interval	interval	NOUN
ajlm-804	106	24	,	,	PUNCT
ajlm-804	106	25	canada	canada	PROPN
ajlm-804	106	26	;	;	PUNCT
ajlm-804	106	27	paris	paris	PROPN
ajlm-804	106	28	,	,	PUNCT
ajlm-804	106	29	france	france	PROPN
ajlm-804	106	30	;	;	PUNCT
ajlm-804	106	31	and	and	CCONJ
ajlm-804	106	32	united	united	PROPN
ajlm-804	106	33	states	states	PROPN
ajlm-804	106	34	,	,	PUNCT
ajlm-804	106	35	december	december	PROPN
ajlm-804	106	36	2014	2014	NUM
ajlm-804	106	37	to	to	ADP
ajlm-804	106	38	february	february	PROPN
ajlm-804	106	39	2015	2015	NUM
ajlm-804	106	40	.	.	PUNCT
ajlm-804	107	1	table	table	NOUN
ajlm-804	107	2	4	4	NUM
ajlm-804	107	3	:	:	PUNCT
ajlm-804	107	4	 	 	SPACE
ajlm-804	107	5	95	95	NUM
ajlm-804	107	6	%	%	NOUN
ajlm-804	107	7	reference	reference	NOUN
ajlm-804	107	8	interval	interval	NOUN
ajlm-804	107	9	(	(	PUNCT
ajlm-804	107	10	2.5th	2.5th	NUM
ajlm-804	107	11	–	–	PUNCT
ajlm-804	107	12	97.5th	97.5th	NUM
ajlm-804	107	13	)	)	PUNCT
ajlm-804	107	14	for	for	ADP
ajlm-804	107	15	apparently	apparently	ADV
ajlm-804	107	16	healthy	healthy	ADJ
ajlm-804	107	17	adults	adult	NOUN
ajlm-804	107	18	,	,	PUNCT
ajlm-804	107	19	canada	canada	PROPN
ajlm-804	107	20	;	;	PUNCT
ajlm-804	107	21	paris	paris	PROPN
ajlm-804	107	22	,	,	PUNCT
ajlm-804	107	23	france	france	PROPN
ajlm-804	107	24	;	;	PUNCT
ajlm-804	107	25	and	and	CCONJ
ajlm-804	107	26	united	united	PROPN
ajlm-804	107	27	states	states	PROPN
ajlm-804	107	28	,	,	PUNCT
ajlm-804	107	29	december	december	PROPN
ajlm-804	107	30	2014	2014	NUM
ajlm-804	107	31	to	to	ADP
ajlm-804	107	32	february	february	PROPN
ajlm-804	107	33	2015	2015	NUM
ajlm-804	107	34	.	.	PUNCT
ajlm-804	108	1	table	table	NOUN
ajlm-804	108	2	5	5	NUM
ajlm-804	108	3	:	:	PUNCT
ajlm-804	108	4	 	 	SPACE
ajlm-804	108	5	comparison	comparison	NOUN
ajlm-804	108	6	of	of	ADP
ajlm-804	108	7	overall	overall	ADJ
ajlm-804	108	8	normal	normal	ADJ
ajlm-804	108	9	reference	reference	NOUN
ajlm-804	108	10	intervals	interval	NOUN
ajlm-804	108	11	(	(	PUNCT
ajlm-804	108	12	2.5th	2.5th	NUM
ajlm-804	108	13	–	–	PUNCT
ajlm-804	108	14	97.5th	97.5th	NUM
ajlm-804	108	15	)	)	PUNCT
ajlm-804	108	16	for	for	ADP
ajlm-804	108	17	cd4	cd4	PROPN
ajlm-804	108	18	lymphocytes	lymphocyte	NOUN
ajlm-804	108	19	in	in	ADP
ajlm-804	108	20	hiv	hiv	PROPN
ajlm-804	108	21	-	-	PUNCT
ajlm-804	108	22	negative	negative	ADJ
ajlm-804	108	23	adults	adult	NOUN
ajlm-804	108	24	,	,	PUNCT
ajlm-804	108	25	canada	canada	PROPN
ajlm-804	108	26	;	;	PUNCT
ajlm-804	108	27	paris	paris	PROPN
ajlm-804	108	28	,	,	PUNCT
ajlm-804	108	29	france	france	PROPN
ajlm-804	108	30	;	;	PUNCT
ajlm-804	108	31	lyon	lyon	PROPN
ajlm-804	108	32	,	,	PUNCT
ajlm-804	108	33	france	france	PROPN
ajlm-804	108	34	;	;	PUNCT
ajlm-804	108	35	and	and	CCONJ
ajlm-804	108	36	south	south	PROPN
ajlm-804	108	37	africa	africa	PROPN
ajlm-804	108	38	,	,	PUNCT
ajlm-804	108	39	november	november	PROPN
ajlm-804	108	40	2014	2014	NUM
ajlm-804	108	41	to	to	ADP
ajlm-804	108	42	march	march	PROPN
ajlm-804	108	43	2015	2015	NUM
ajlm-804	108	44	.	.	PUNCT
ajlm-804	109	1	as	as	ADP
ajlm-804	109	2	per	per	ADP
ajlm-804	109	3	protocol	protocol	NOUN
ajlm-804	109	4	analysis	analysis	NOUN
ajlm-804	109	5	that	that	PRON
ajlm-804	109	6	is	be	AUX
ajlm-804	109	7	presented	present	VERB
ajlm-804	109	8	in	in	ADP
ajlm-804	109	9	the	the	DET
ajlm-804	109	10	aquios	aquio	NOUN
ajlm-804	109	11	plg	plg	NOUN
ajlm-804	109	12	test	test	NOUN
ajlm-804	109	13	instructions	instruction	NOUN
ajlm-804	109	14	for	for	ADP
ajlm-804	109	15	use	use	NOUN
ajlm-804	109	16	,	,	PUNCT
ajlm-804	109	17	six	six	NUM
ajlm-804	109	18	participant	participant	ADJ
ajlm-804	109	19	samples	sample	NOUN
ajlm-804	109	20	from	from	ADP
ajlm-804	109	21	paris	paris	PROPN
ajlm-804	109	22	were	be	AUX
ajlm-804	109	23	excluded	exclude	VERB
ajlm-804	109	24	.	.	PUNCT
ajlm-804	110	1	these	these	DET
ajlm-804	110	2	samples	sample	NOUN
ajlm-804	110	3	had	have	VERB
ajlm-804	110	4	cd4	cd4	PROPN
ajlm-804	110	5	levels	level	NOUN
ajlm-804	110	6	of	of	ADP
ajlm-804	110	7	300–500	300–500	NUM
ajlm-804	110	8	cell/µl	cell/µl	PROPN
ajlm-804	110	9	.	.	PUNCT
ajlm-804	111	1	as	as	ADP
ajlm-804	111	2	per	per	ADP
ajlm-804	111	3	protocol	protocol	NOUN
ajlm-804	111	4	,	,	PUNCT
ajlm-804	111	5	samples	sample	NOUN
ajlm-804	111	6	with	with	ADP
ajlm-804	111	7	cd4	cd4	PROPN
ajlm-804	111	8	levels	level	NOUN
ajlm-804	111	9	<	<	X
ajlm-804	111	10	500	500	NUM
ajlm-804	111	11	cells/µl	cells/µl	NOUN
ajlm-804	111	12	required	require	VERB
ajlm-804	111	13	an	an	DET
ajlm-804	111	14	in	in	ADP
ajlm-804	111	15	-	-	PUNCT
ajlm-804	111	16	house	house	NOUN
ajlm-804	111	17	medical	medical	PROPN
ajlm-804	111	18	monitor	monitor	PROPN
ajlm-804	111	19	review	review	NOUN
ajlm-804	111	20	of	of	ADP
ajlm-804	111	21	the	the	DET
ajlm-804	111	22	complete	complete	ADJ
ajlm-804	111	23	blood	blood	NOUN
ajlm-804	111	24	count	count	NOUN
ajlm-804	111	25	with	with	ADP
ajlm-804	111	26	differential	differential	NOUN
ajlm-804	111	27	to	to	PART
ajlm-804	111	28	confirm	confirm	VERB
ajlm-804	111	29	haematological	haematological	ADJ
ajlm-804	111	30	normal	normal	ADJ
ajlm-804	111	31	status	status	NOUN
ajlm-804	111	32	and	and	CCONJ
ajlm-804	111	33	qualify	qualify	VERB
ajlm-804	111	34	for	for	ADP
ajlm-804	111	35	inclusion	inclusion	NOUN
ajlm-804	111	36	.	.	PUNCT
ajlm-804	112	1	the	the	DET
ajlm-804	112	2	complete	complete	ADJ
ajlm-804	112	3	blood	blood	NOUN
ajlm-804	112	4	count	count	NOUN
ajlm-804	112	5	with	with	ADP
ajlm-804	112	6	differential	differential	ADJ
ajlm-804	112	7	results	result	NOUN
ajlm-804	112	8	were	be	AUX
ajlm-804	112	9	not	not	PART
ajlm-804	112	10	provided	provide	VERB
ajlm-804	112	11	for	for	ADP
ajlm-804	112	12	samples	sample	NOUN
ajlm-804	112	13	from	from	ADP
ajlm-804	112	14	the	the	DET
ajlm-804	112	15	french	french	ADJ
ajlm-804	112	16	site	site	NOUN
ajlm-804	112	17	,	,	PUNCT
ajlm-804	112	18	so	so	SCONJ
ajlm-804	112	19	for	for	ADP
ajlm-804	112	20	the	the	DET
ajlm-804	112	21	per	per	ADP
ajlm-804	112	22	protocol	protocol	NOUN
ajlm-804	112	23	analysis	analysis	NOUN
ajlm-804	112	24	,	,	PUNCT
ajlm-804	112	25	those	those	PRON
ajlm-804	112	26	with	with	ADP
ajlm-804	112	27	cd4	cd4	PROPN
ajlm-804	112	28	<	<	X
ajlm-804	112	29	500	500	NUM
ajlm-804	112	30	cells/µl	cells/µl	NOUN
ajlm-804	112	31	were	be	AUX
ajlm-804	112	32	excluded	exclude	VERB
ajlm-804	112	33	,	,	PUNCT
ajlm-804	112	34	as	as	SCONJ
ajlm-804	112	35	it	it	PRON
ajlm-804	112	36	was	be	AUX
ajlm-804	112	37	not	not	PART
ajlm-804	112	38	possible	possible	ADJ
ajlm-804	112	39	to	to	PART
ajlm-804	112	40	exclude	exclude	VERB
ajlm-804	112	41	the	the	DET
ajlm-804	112	42	presence	presence	NOUN
ajlm-804	112	43	of	of	ADP
ajlm-804	112	44	idiopathic	idiopathic	ADJ
ajlm-804	112	45	cd4	cd4	ADJ
ajlm-804	112	46	-	-	ADJ
ajlm-804	112	47	positive	positive	ADJ
ajlm-804	112	48	t	t	PROPN
ajlm-804	112	49	-	-	PUNCT
ajlm-804	112	50	lymphocytopenia	lymphocytopenia	NOUN
ajlm-804	112	51	.	.	PUNCT
ajlm-804	113	1	for	for	ADP
ajlm-804	113	2	this	this	DET
ajlm-804	113	3	manuscript	manuscript	NOUN
ajlm-804	113	4	analysis	analysis	NOUN
ajlm-804	113	5	,	,	PUNCT
ajlm-804	113	6	these	these	DET
ajlm-804	113	7	samples	sample	NOUN
ajlm-804	113	8	with	with	ADP
ajlm-804	113	9	a	a	DET
ajlm-804	113	10	cd4	cd4	PROPN
ajlm-804	113	11	≥	≥	NOUN
ajlm-804	113	12	300	300	NUM
ajlm-804	113	13	−500	−500	NOUN
ajlm-804	113	14	cells/µl	cells/µl	NOUN
ajlm-804	113	15	were	be	AUX
ajlm-804	113	16	included	include	VERB
ajlm-804	113	17	for	for	ADP
ajlm-804	113	18	the	the	DET
ajlm-804	113	19	following	follow	VERB
ajlm-804	113	20	reasons	reason	NOUN
ajlm-804	113	21	:	:	PUNCT
ajlm-804	113	22	1	1	X
ajlm-804	113	23	)	)	PUNCT
ajlm-804	113	24	the	the	DET
ajlm-804	113	25	french	french	ADJ
ajlm-804	113	26	samples	sample	NOUN
ajlm-804	113	27	had	have	VERB
ajlm-804	113	28	a	a	DET
ajlm-804	113	29	confirmed	confirm	VERB
ajlm-804	113	30	haematologically	haematologically	ADV
ajlm-804	113	31	normal	normal	ADJ
ajlm-804	113	32	complete	complete	ADJ
ajlm-804	113	33	blood	blood	NOUN
ajlm-804	113	34	count	count	NOUN
ajlm-804	113	35	with	with	ADP
ajlm-804	113	36	differential	differential	NOUN
ajlm-804	113	37	performed	perform	VERB
ajlm-804	113	38	at	at	ADP
ajlm-804	113	39	the	the	DET
ajlm-804	113	40	etablissement	etablissement	PROPN
ajlm-804	113	41	francais	francais	PROPN
ajlm-804	113	42	du	du	PROPN
ajlm-804	113	43	sang	sing	VERB
ajlm-804	113	44	(	(	PUNCT
ajlm-804	113	45	although	although	SCONJ
ajlm-804	113	46	results	result	NOUN
ajlm-804	113	47	were	be	AUX
ajlm-804	113	48	not	not	PART
ajlm-804	113	49	available	available	ADJ
ajlm-804	113	50	to	to	ADP
ajlm-804	113	51	beckman	beckman	PROPN
ajlm-804	113	52	)	)	PUNCT
ajlm-804	113	53	,	,	PUNCT
ajlm-804	113	54	and	and	CCONJ
ajlm-804	113	55	2	2	X
ajlm-804	113	56	)	)	PUNCT
ajlm-804	113	57	the	the	DET
ajlm-804	113	58	centers	center	NOUN
ajlm-804	113	59	for	for	ADP
ajlm-804	113	60	disease	disease	NOUN
ajlm-804	113	61	control	control	NOUN
ajlm-804	113	62	does	do	AUX
ajlm-804	113	63	not	not	PART
ajlm-804	113	64	consider	consider	VERB
ajlm-804	113	65	a	a	DET
ajlm-804	113	66	decreased	decrease	VERB
ajlm-804	113	67	cd4	cd4	PROPN
ajlm-804	113	68	level	level	NOUN
ajlm-804	113	69	in	in	ADP
ajlm-804	113	70	healthy	healthy	ADJ
ajlm-804	113	71	,	,	PUNCT
ajlm-804	113	72	non	non	ADJ
ajlm-804	113	73	-	-	ADJ
ajlm-804	113	74	hiv	hiv	ADJ
ajlm-804	113	75	patients	patient	NOUN
ajlm-804	113	76	significant	significant	ADJ
ajlm-804	113	77	unless	unless	SCONJ
ajlm-804	113	78	<	<	X
ajlm-804	113	79	300	300	NUM
ajlm-804	113	80	cells/µl.17,18	cells/µl.17,18	NOUN
ajlm-804	113	81	as	as	SCONJ
ajlm-804	113	82	expected	expect	VERB
ajlm-804	113	83	,	,	PUNCT
ajlm-804	113	84	the	the	DET
ajlm-804	113	85	inclusion	inclusion	NOUN
ajlm-804	113	86	of	of	ADP
ajlm-804	113	87	these	these	DET
ajlm-804	113	88	samples	sample	NOUN
ajlm-804	113	89	decreased	decrease	VERB
ajlm-804	113	90	the	the	DET
ajlm-804	113	91	lower	low	ADJ
ajlm-804	113	92	reference	reference	NOUN
ajlm-804	113	93	interval	interval	NOUN
ajlm-804	113	94	value	value	NOUN
ajlm-804	113	95	from	from	ADP
ajlm-804	113	96	532	532	NUM
ajlm-804	113	97	cells/µl	cells/µl	NOUN
ajlm-804	113	98	to	to	ADP
ajlm-804	113	99	453	453	NUM
ajlm-804	113	100	cells/µl	cells/µl	NOUN
ajlm-804	113	101	.	.	PUNCT
ajlm-804	114	1	the	the	DET
ajlm-804	114	2	upper	upper	ADJ
ajlm-804	114	3	reference	reference	NOUN
ajlm-804	114	4	interval	interval	NOUN
ajlm-804	114	5	value	value	NOUN
ajlm-804	114	6	was	be	AUX
ajlm-804	114	7	not	not	PART
ajlm-804	114	8	affected	affect	VERB
ajlm-804	114	9	and	and	CCONJ
ajlm-804	114	10	thus	thus	ADV
ajlm-804	114	11	remained	remain	VERB
ajlm-804	114	12	unchanged	unchanged	ADJ
ajlm-804	114	13	.	.	PUNCT
ajlm-804	115	1	workflow	workflow	NOUN
ajlm-804	115	2	a	a	DET
ajlm-804	115	3	total	total	NOUN
ajlm-804	115	4	of	of	ADP
ajlm-804	115	5	440	440	NUM
ajlm-804	115	6	samples	sample	NOUN
ajlm-804	115	7	were	be	AUX
ajlm-804	115	8	tested	test	VERB
ajlm-804	115	9	over	over	ADP
ajlm-804	115	10	5	5	NUM
ajlm-804	115	11	days	day	NOUN
ajlm-804	115	12	(	(	PUNCT
ajlm-804	115	13	table	table	NOUN
ajlm-804	115	14	6	6	NUM
ajlm-804	115	15	)	)	PUNCT
ajlm-804	115	16	.	.	PUNCT
ajlm-804	116	1	the	the	DET
ajlm-804	116	2	average	average	ADJ
ajlm-804	116	3	time	time	NOUN
ajlm-804	116	4	to	to	ADP
ajlm-804	116	5	the	the	DET
ajlm-804	116	6	first	first	ADJ
ajlm-804	116	7	result	result	NOUN
ajlm-804	116	8	was	be	AUX
ajlm-804	116	9	39.2	39.2	NUM
ajlm-804	116	10	minutes	minute	NOUN
ajlm-804	116	11	.	.	PUNCT
ajlm-804	117	1	the	the	DET
ajlm-804	117	2	average	average	ADJ
ajlm-804	117	3	number	number	NOUN
ajlm-804	117	4	of	of	ADP
ajlm-804	117	5	samples	sample	NOUN
ajlm-804	117	6	processed	process	VERB
ajlm-804	117	7	per	per	ADP
ajlm-804	117	8	hour	hour	NOUN
ajlm-804	117	9	was	be	AUX
ajlm-804	117	10	17.5	17.5	NUM
ajlm-804	117	11	or	or	CCONJ
ajlm-804	117	12	122.5	122.5	NUM
ajlm-804	117	13	for	for	ADP
ajlm-804	117	14	an	an	DET
ajlm-804	117	15	8	8	NUM
ajlm-804	117	16	-	-	PUNCT
ajlm-804	117	17	hour	hour	NOUN
ajlm-804	117	18	shift	shift	NOUN
ajlm-804	117	19	,	,	PUNCT
ajlm-804	117	20	minus	minus	CCONJ
ajlm-804	117	21	1	1	NUM
ajlm-804	117	22	hour	hour	NOUN
ajlm-804	117	23	for	for	ADP
ajlm-804	117	24	start	start	NOUN
ajlm-804	117	25	-	-	PUNCT
ajlm-804	117	26	up	up	NOUN
ajlm-804	117	27	,	,	PUNCT
ajlm-804	117	28	quality	quality	NOUN
ajlm-804	117	29	control	control	NOUN
ajlm-804	117	30	testing	testing	NOUN
ajlm-804	117	31	and	and	CCONJ
ajlm-804	117	32	shut	shut	NOUN
ajlm-804	117	33	-	-	PUNCT
ajlm-804	117	34	down	down	NOUN
ajlm-804	117	35	.	.	PUNCT
ajlm-804	118	1	technician	technician	ADJ
ajlm-804	118	2	hands	hand	NOUN
ajlm-804	118	3	-	-	PUNCT
ajlm-804	118	4	on	on	ADP
ajlm-804	118	5	time	time	NOUN
ajlm-804	118	6	required	require	VERB
ajlm-804	118	7	one	one	NUM
ajlm-804	118	8	hour	hour	NOUN
ajlm-804	118	9	,	,	PUNCT
ajlm-804	118	10	including	include	VERB
ajlm-804	118	11	start	start	NOUN
ajlm-804	118	12	-	-	PUNCT
ajlm-804	118	13	up	up	NOUN
ajlm-804	118	14	,	,	PUNCT
ajlm-804	118	15	quality	quality	NOUN
ajlm-804	118	16	control	control	NOUN
ajlm-804	118	17	testing	testing	NOUN
ajlm-804	118	18	,	,	PUNCT
ajlm-804	118	19	sample	sample	NOUN
ajlm-804	118	20	testing	testing	NOUN
ajlm-804	118	21	and	and	CCONJ
ajlm-804	118	22	shut	shut	NOUN
ajlm-804	118	23	-	-	PUNCT
ajlm-804	118	24	down	down	NOUN
ajlm-804	118	25	.	.	PUNCT
ajlm-804	119	1	table	table	NOUN
ajlm-804	119	2	6	6	NUM
ajlm-804	119	3	:	:	PUNCT
ajlm-804	119	4	 	 	SPACE
ajlm-804	119	5	high	high	ADJ
ajlm-804	119	6	volume	volume	NOUN
ajlm-804	119	7	workflow	workflow	NOUN
ajlm-804	119	8	results	result	NOUN
ajlm-804	119	9	with	with	ADP
ajlm-804	119	10	aquios	aquio	NOUN
ajlm-804	119	11	panleucogating	panleucogate	VERB
ajlm-804	119	12	,	,	PUNCT
ajlm-804	119	13	south	south	PROPN
ajlm-804	119	14	africa	africa	PROPN
ajlm-804	119	15	,	,	PUNCT
ajlm-804	119	16	february	february	PROPN
ajlm-804	119	17	2015	2015	NUM
ajlm-804	119	18	.	.	PUNCT
ajlm-804	120	1	discussion	discussion	NOUN
ajlm-804	120	2	in	in	ADP
ajlm-804	120	3	this	this	DET
ajlm-804	120	4	study	study	NOUN
ajlm-804	120	5	,	,	PUNCT
ajlm-804	120	6	we	we	PRON
ajlm-804	120	7	compared	compare	VERB
ajlm-804	120	8	plg	plg	PROPN
ajlm-804	120	9	on	on	ADP
ajlm-804	120	10	the	the	DET
ajlm-804	120	11	aquios	aquio	NOUN
ajlm-804	120	12	flow	flow	NOUN
ajlm-804	120	13	cytometer	cytometer	NOUN
ajlm-804	120	14	versus	versus	ADP
ajlm-804	120	15	plg	plg	PROPN
ajlm-804	120	16	cd4	cd4	PROPN
ajlm-804	120	17	counts	count	NOUN
ajlm-804	120	18	generated	generate	VERB
ajlm-804	120	19	by	by	ADP
ajlm-804	120	20	fc500	fc500	PROPN
ajlm-804	120	21	instruments	instrument	NOUN
ajlm-804	120	22	.	.	PUNCT
ajlm-804	121	1	additionally	additionally	ADV
ajlm-804	121	2	,	,	PUNCT
ajlm-804	121	3	cd4	cd4	PROPN
ajlm-804	121	4	counts	count	NOUN
ajlm-804	121	5	generated	generate	VERB
ajlm-804	121	6	from	from	ADP
ajlm-804	121	7	normal	normal	ADJ
ajlm-804	121	8	individuals	individual	NOUN
ajlm-804	121	9	were	be	AUX
ajlm-804	121	10	used	use	VERB
ajlm-804	121	11	to	to	PART
ajlm-804	121	12	establish	establish	VERB
ajlm-804	121	13	and	and	CCONJ
ajlm-804	121	14	gain	gain	VERB
ajlm-804	121	15	insights	insight	NOUN
ajlm-804	121	16	into	into	ADP
ajlm-804	121	17	the	the	DET
ajlm-804	121	18	reference	reference	NOUN
ajlm-804	121	19	interval	interval	NOUN
ajlm-804	121	20	of	of	ADP
ajlm-804	121	21	the	the	DET
ajlm-804	121	22	cd4	cd4	PROPN
ajlm-804	121	23	counts	count	NOUN
ajlm-804	121	24	of	of	ADP
ajlm-804	121	25	patients	patient	NOUN
ajlm-804	121	26	tested	test	VERB
ajlm-804	121	27	by	by	ADP
ajlm-804	121	28	aquios	aquio	NOUN
ajlm-804	121	29	plg	plg	NOUN
ajlm-804	121	30	with	with	ADP
ajlm-804	121	31	respect	respect	NOUN
ajlm-804	121	32	to	to	ADP
ajlm-804	121	33	other	other	ADJ
ajlm-804	121	34	published	publish	VERB
ajlm-804	121	35	reference	reference	NOUN
ajlm-804	121	36	intervals	interval	NOUN
ajlm-804	121	37	.	.	PUNCT
ajlm-804	122	1	the	the	DET
ajlm-804	122	2	method	method	ADJ
ajlm-804	122	3	comparison	comparison	NOUN
ajlm-804	122	4	of	of	ADP
ajlm-804	122	5	aquios	aquio	NOUN
ajlm-804	122	6	plg	plg	PROPN
ajlm-804	122	7	to	to	PART
ajlm-804	122	8	flowcare	flowcare	PROPN
ajlm-804	122	9	plg	plg	PROPN
ajlm-804	122	10	showed	show	VERB
ajlm-804	122	11	a	a	DET
ajlm-804	122	12	mean	mean	ADJ
ajlm-804	122	13	absolute	absolute	ADJ
ajlm-804	122	14	count	count	NOUN
ajlm-804	122	15	bias	bias	NOUN
ajlm-804	122	16	of	of	ADP
ajlm-804	122	17	−41	−41	NOUN
ajlm-804	122	18	cells/µl	cells/µl	NOUN
ajlm-804	122	19	and	and	CCONJ
ajlm-804	122	20	a	a	DET
ajlm-804	122	21	mean	mean	ADJ
ajlm-804	122	22	relative	relative	ADJ
ajlm-804	122	23	bias	bias	NOUN
ajlm-804	122	24	of	of	ADP
ajlm-804	122	25	−7.8	−7.8	PROPN
ajlm-804	122	26	%	%	NOUN
ajlm-804	122	27	including	include	VERB
ajlm-804	122	28	both	both	CCONJ
ajlm-804	122	29	adult	adult	NOUN
ajlm-804	122	30	and	and	CCONJ
ajlm-804	122	31	paediatric	paediatric	ADJ
ajlm-804	122	32	hiv	hiv	PROPN
ajlm-804	122	33	samples	sample	NOUN
ajlm-804	122	34	.	.	PUNCT
ajlm-804	123	1	for	for	ADP
ajlm-804	123	2	adults	adult	NOUN
ajlm-804	123	3	only	only	ADV
ajlm-804	123	4	,	,	PUNCT
ajlm-804	123	5	a	a	DET
ajlm-804	123	6	mean	mean	ADJ
ajlm-804	123	7	absolute	absolute	ADJ
ajlm-804	123	8	count	count	NOUN
ajlm-804	123	9	bias	bias	NOUN
ajlm-804	123	10	of	of	ADP
ajlm-804	123	11	−25	−25	ADJ
ajlm-804	123	12	cells/µl	cells/µl	NOUN
ajlm-804	123	13	with	with	ADP
ajlm-804	123	14	a	a	DET
ajlm-804	123	15	mean	mean	ADJ
ajlm-804	123	16	relative	relative	ADJ
ajlm-804	123	17	bias	bias	NOUN
ajlm-804	123	18	of	of	ADP
ajlm-804	123	19	−6.8	−6.8	NOUN
ajlm-804	123	20	%	%	NOUN
ajlm-804	123	21	was	be	AUX
ajlm-804	123	22	observed	observe	VERB
ajlm-804	123	23	,	,	PUNCT
ajlm-804	123	24	similar	similar	ADJ
ajlm-804	123	25	to	to	ADP
ajlm-804	123	26	outcomes	outcome	NOUN
ajlm-804	123	27	noted	note	VERB
ajlm-804	123	28	in	in	ADP
ajlm-804	123	29	separate	separate	ADJ
ajlm-804	123	30	evaluations.48	evaluations.48	PROPN
ajlm-804	123	31	the	the	DET
ajlm-804	123	32	slight	slight	ADJ
ajlm-804	123	33	negative	negative	ADJ
ajlm-804	123	34	bias	bias	NOUN
ajlm-804	123	35	in	in	ADP
ajlm-804	123	36	our	our	PRON
ajlm-804	123	37	study	study	NOUN
ajlm-804	123	38	appears	appear	VERB
ajlm-804	123	39	to	to	PART
ajlm-804	123	40	be	be	AUX
ajlm-804	123	41	largely	largely	ADV
ajlm-804	123	42	platform	platform	NOUN
ajlm-804	123	43	related	related	ADJ
ajlm-804	123	44	and	and	CCONJ
ajlm-804	123	45	not	not	PART
ajlm-804	123	46	related	relate	VERB
ajlm-804	123	47	to	to	ADP
ajlm-804	123	48	the	the	DET
ajlm-804	123	49	gating	gate	VERB
ajlm-804	123	50	strategy	strategy	NOUN
ajlm-804	123	51	used	use	VERB
ajlm-804	123	52	.	.	PUNCT
ajlm-804	124	1	where	where	SCONJ
ajlm-804	124	2	different	different	ADJ
ajlm-804	124	3	gating	gate	VERB
ajlm-804	124	4	strategies	strategy	NOUN
ajlm-804	124	5	(	(	PUNCT
ajlm-804	124	6	aquios	aquio	NOUN
ajlm-804	124	7	tetra	tetra	NOUN
ajlm-804	124	8	,	,	PUNCT
ajlm-804	124	9	with	with	ADP
ajlm-804	124	10	primary	primary	ADJ
ajlm-804	124	11	cd45	cd45	PROPN
ajlm-804	124	12	bright	bright	NOUN
ajlm-804	124	13	and	and	CCONJ
ajlm-804	124	14	cd3	cd3	NOUN
ajlm-804	124	15	gating	gate	VERB
ajlm-804	124	16	to	to	PART
ajlm-804	124	17	define	define	VERB
ajlm-804	124	18	cd4	cd4	PROPN
ajlm-804	124	19	lymphocytes	lymphocyte	NOUN
ajlm-804	124	20	and	and	CCONJ
ajlm-804	124	21	aquios	aquio	NOUN
ajlm-804	124	22	plg	plg	PROPN
ajlm-804	124	23	which	which	PRON
ajlm-804	124	24	relies	rely	VERB
ajlm-804	124	25	only	only	ADV
ajlm-804	124	26	on	on	ADP
ajlm-804	124	27	cd45	cd45	PROPN
ajlm-804	124	28	total	total	NOUN
ajlm-804	124	29	and	and	CCONJ
ajlm-804	124	30	cd4	cd4	PROPN
ajlm-804	124	31	/	/	SYM
ajlm-804	124	32	ss	ss	NOUN
ajlm-804	124	33	to	to	PART
ajlm-804	124	34	discriminate	discriminate	VERB
ajlm-804	124	35	monocytes	monocyte	NOUN
ajlm-804	124	36	)	)	PUNCT
ajlm-804	124	37	were	be	AUX
ajlm-804	124	38	applied	apply	VERB
ajlm-804	124	39	on	on	ADP
ajlm-804	124	40	the	the	DET
ajlm-804	124	41	same	same	ADJ
ajlm-804	124	42	platform	platform	NOUN
ajlm-804	124	43	,	,	PUNCT
ajlm-804	124	44	a	a	DET
ajlm-804	124	45	bias	bias	NOUN
ajlm-804	124	46	of	of	ADP
ajlm-804	124	47	just	just	ADV
ajlm-804	124	48	10	10	NUM
ajlm-804	124	49	cells/µl	cells/µl	NOUN
ajlm-804	124	50	with	with	ADP
ajlm-804	124	51	an	an	DET
ajlm-804	124	52	r2	r2	NOUN
ajlm-804	124	53	of	of	ADP
ajlm-804	124	54	0.996	0.996	NUM
ajlm-804	124	55	(	(	PUNCT
ajlm-804	124	56	unpublished	unpublished	ADJ
ajlm-804	124	57	data	datum	NOUN
ajlm-804	124	58	)	)	PUNCT
ajlm-804	124	59	was	be	AUX
ajlm-804	124	60	noted	note	VERB
ajlm-804	124	61	.	.	PUNCT
ajlm-804	125	1	this	this	DET
ajlm-804	125	2	finding	finding	NOUN
ajlm-804	125	3	is	be	AUX
ajlm-804	125	4	similar	similar	ADJ
ajlm-804	125	5	to	to	ADP
ajlm-804	125	6	the	the	DET
ajlm-804	125	7	slight	slight	ADJ
ajlm-804	125	8	positive	positive	ADJ
ajlm-804	125	9	bias	bias	NOUN
ajlm-804	125	10	previously	previously	ADV
ajlm-804	125	11	reported	report	VERB
ajlm-804	125	12	where	where	SCONJ
ajlm-804	125	13	bead	bead	NOUN
ajlm-804	125	14	-	-	PUNCT
ajlm-804	125	15	based	base	VERB
ajlm-804	125	16	counting	counting	NOUN
ajlm-804	125	17	versus	versus	ADP
ajlm-804	125	18	volumetric	volumetric	NOUN
ajlm-804	125	19	-	-	PUNCT
ajlm-804	125	20	based	base	VERB
ajlm-804	125	21	counting	counting	NOUN
ajlm-804	125	22	comparison	comparison	NOUN
ajlm-804	125	23	was	be	AUX
ajlm-804	125	24	performed.6	performed.6	PROPN
ajlm-804	125	25	while	while	SCONJ
ajlm-804	125	26	the	the	DET
ajlm-804	125	27	mean	mean	ADJ
ajlm-804	125	28	and	and	CCONJ
ajlm-804	125	29	median	median	ADJ
ajlm-804	125	30	absolute	absolute	ADJ
ajlm-804	125	31	count	count	NOUN
ajlm-804	125	32	difference	difference	NOUN
ajlm-804	125	33	increases	increase	NOUN
ajlm-804	125	34	with	with	ADP
ajlm-804	125	35	the	the	DET
ajlm-804	125	36	cd4	cd4	PROPN
ajlm-804	125	37	level	level	NOUN
ajlm-804	125	38	,	,	PUNCT
ajlm-804	125	39	the	the	DET
ajlm-804	125	40	relative	relative	ADJ
ajlm-804	125	41	difference	difference	NOUN
ajlm-804	125	42	remained	remain	VERB
ajlm-804	125	43	stable	stable	ADJ
ajlm-804	125	44	(	(	PUNCT
ajlm-804	125	45	around	around	ADP
ajlm-804	125	46	8	8	NUM
ajlm-804	125	47	%	%	NOUN
ajlm-804	125	48	–	–	PUNCT
ajlm-804	125	49	11	11	NUM
ajlm-804	125	50	%	%	NOUN
ajlm-804	125	51	)	)	PUNCT
ajlm-804	125	52	across	across	ADP
ajlm-804	125	53	the	the	DET
ajlm-804	125	54	entire	entire	ADJ
ajlm-804	125	55	range	range	NOUN
ajlm-804	125	56	of	of	ADP
ajlm-804	125	57	samples	sample	NOUN
ajlm-804	125	58	tested	test	VERB
ajlm-804	125	59	,	,	PUNCT
ajlm-804	125	60	even	even	ADV
ajlm-804	125	61	at	at	ADP
ajlm-804	125	62	counts	count	NOUN
ajlm-804	125	63	above	above	ADP
ajlm-804	125	64	1000	1000	NUM
ajlm-804	125	65	cells/µl	cells/µl	NOUN
ajlm-804	125	66	(	(	PUNCT
ajlm-804	125	67	where	where	SCONJ
ajlm-804	125	68	clinical	clinical	ADJ
ajlm-804	125	69	importance	importance	NOUN
ajlm-804	125	70	is	be	AUX
ajlm-804	125	71	less	less	ADJ
ajlm-804	125	72	)	)	PUNCT
ajlm-804	125	73	.	.	PUNCT
ajlm-804	126	1	paediatric	paediatric	ADJ
ajlm-804	126	2	patients	patient	NOUN
ajlm-804	126	3	are	be	AUX
ajlm-804	126	4	known	know	VERB
ajlm-804	126	5	to	to	PART
ajlm-804	126	6	have	have	VERB
ajlm-804	126	7	higher	high	ADJ
ajlm-804	126	8	cd4	cd4	PROPN
ajlm-804	126	9	absolute	absolute	ADJ
ajlm-804	126	10	levels	level	NOUN
ajlm-804	126	11	and	and	CCONJ
ajlm-804	126	12	higher	high	ADJ
ajlm-804	126	13	variability	variability	NOUN
ajlm-804	126	14	in	in	ADP
ajlm-804	126	15	these	these	DET
ajlm-804	126	16	counts	count	NOUN
ajlm-804	126	17	than	than	SCONJ
ajlm-804	126	18	adults,49	adults,49	NOUN
ajlm-804	126	19	and	and	CCONJ
ajlm-804	126	20	this	this	PRON
ajlm-804	126	21	was	be	AUX
ajlm-804	126	22	seen	see	VERB
ajlm-804	126	23	in	in	ADP
ajlm-804	126	24	our	our	PRON
ajlm-804	126	25	study	study	NOUN
ajlm-804	126	26	as	as	ADV
ajlm-804	126	27	well	well	ADV
ajlm-804	126	28	,	,	PUNCT
ajlm-804	126	29	where	where	SCONJ
ajlm-804	126	30	mean	mean	NOUN
ajlm-804	126	31	and	and	CCONJ
ajlm-804	126	32	maximum	maximum	ADJ
ajlm-804	126	33	cd4	cd4	ADJ
ajlm-804	126	34	-	-	ADJ
ajlm-804	126	35	positive	positive	ADJ
ajlm-804	126	36	counts	count	NOUN
ajlm-804	126	37	were	be	AUX
ajlm-804	126	38	higher	high	ADJ
ajlm-804	126	39	for	for	ADP
ajlm-804	126	40	paediatrics	paediatric	NOUN
ajlm-804	126	41	than	than	ADP
ajlm-804	126	42	adults	adult	NOUN
ajlm-804	126	43	.	.	PUNCT
ajlm-804	127	1	misclassification	misclassification	NOUN
ajlm-804	127	2	probability	probability	NOUN
ajlm-804	127	3	measures	measure	NOUN
ajlm-804	127	4	are	be	AUX
ajlm-804	127	5	used	use	VERB
ajlm-804	127	6	to	to	PART
ajlm-804	127	7	determine	determine	VERB
ajlm-804	127	8	the	the	DET
ajlm-804	127	9	likelihood	likelihood	NOUN
ajlm-804	127	10	that	that	SCONJ
ajlm-804	127	11	a	a	DET
ajlm-804	127	12	patient	patient	NOUN
ajlm-804	127	13	’s	’s	PART
ajlm-804	127	14	result	result	NOUN
ajlm-804	127	15	for	for	SCONJ
ajlm-804	127	16	a	a	DET
ajlm-804	127	17	new	new	ADJ
ajlm-804	127	18	test	test	NOUN
ajlm-804	127	19	compared	compare	VERB
ajlm-804	127	20	to	to	ADP
ajlm-804	127	21	a	a	DET
ajlm-804	127	22	reference	reference	NOUN
ajlm-804	127	23	test	test	NOUN
ajlm-804	127	24	will	will	AUX
ajlm-804	127	25	be	be	AUX
ajlm-804	127	26	classified	classify	VERB
ajlm-804	127	27	above	above	ADP
ajlm-804	127	28	or	or	CCONJ
ajlm-804	127	29	below	below	ADP
ajlm-804	127	30	a	a	DET
ajlm-804	127	31	defined	define	VERB
ajlm-804	127	32	threshold	threshold	NOUN
ajlm-804	127	33	used	use	VERB
ajlm-804	127	34	in	in	ADP
ajlm-804	127	35	clinical	clinical	ADJ
ajlm-804	127	36	decision	decision	NOUN
ajlm-804	127	37	-	-	PUNCT
ajlm-804	127	38	making50,51	making50,51	NOUN
ajlm-804	127	39	these	these	DET
ajlm-804	127	40	measures	measure	NOUN
ajlm-804	127	41	provide	provide	VERB
ajlm-804	127	42	a	a	DET
ajlm-804	127	43	more	more	ADV
ajlm-804	127	44	direct	direct	ADJ
ajlm-804	127	45	interpretation	interpretation	NOUN
ajlm-804	127	46	for	for	ADP
ajlm-804	127	47	health	health	NOUN
ajlm-804	127	48	policy	policy	NOUN
ajlm-804	127	49	and	and	CCONJ
ajlm-804	127	50	management	management	NOUN
ajlm-804	127	51	decision	decision	NOUN
ajlm-804	127	52	making	make	VERB
ajlm-804	127	53	with	with	ADP
ajlm-804	127	54	regard	regard	NOUN
ajlm-804	127	55	to	to	ADP
ajlm-804	127	56	potential	potential	ADJ
ajlm-804	127	57	financial	financial	ADJ
ajlm-804	127	58	and	and	CCONJ
ajlm-804	127	59	healthcare	healthcare	NOUN
ajlm-804	127	60	impacts	impact	NOUN
ajlm-804	127	61	from	from	ADP
ajlm-804	127	62	implementation	implementation	NOUN
ajlm-804	127	63	of	of	ADP
ajlm-804	127	64	new	new	ADJ
ajlm-804	127	65	instrumentation.51	instrumentation.51	NOUN
ajlm-804	127	66	misclassification	misclassification	NOUN
ajlm-804	127	67	results	result	NOUN
ajlm-804	127	68	for	for	ADP
ajlm-804	127	69	cd4	cd4	PROPN
ajlm-804	127	70	should	should	AUX
ajlm-804	127	71	be	be	AUX
ajlm-804	127	72	interpreted	interpret	VERB
ajlm-804	127	73	for	for	ADP
ajlm-804	127	74	regions	region	NOUN
ajlm-804	127	75	where	where	SCONJ
ajlm-804	127	76	world	world	NOUN
ajlm-804	127	77	health	health	NOUN
ajlm-804	127	78	organization	organization	NOUN
ajlm-804	127	79	guidelines52	guidelines52	ADJ
ajlm-804	127	80	for	for	ADP
ajlm-804	127	81	universal	universal	ADJ
ajlm-804	127	82	testing	testing	NOUN
ajlm-804	127	83	and	and	CCONJ
ajlm-804	127	84	treatment	treatment	NOUN
ajlm-804	127	85	are	be	AUX
ajlm-804	127	86	not	not	PART
ajlm-804	127	87	applied	apply	VERB
ajlm-804	127	88	and	and	CCONJ
ajlm-804	127	89	where	where	SCONJ
ajlm-804	127	90	varying	vary	VERB
ajlm-804	127	91	treatment	treatment	NOUN
ajlm-804	127	92	thresholds	threshold	NOUN
ajlm-804	127	93	still	still	ADV
ajlm-804	127	94	exist	exist	VERB
ajlm-804	127	95	.	.	PUNCT
ajlm-804	128	1	our	our	PRON
ajlm-804	128	2	results	result	NOUN
ajlm-804	128	3	indicate	indicate	VERB
ajlm-804	128	4	that	that	SCONJ
ajlm-804	128	5	the	the	DET
ajlm-804	128	6	introduction	introduction	NOUN
ajlm-804	128	7	of	of	ADP
ajlm-804	128	8	aquios	aquio	NOUN
ajlm-804	128	9	plg	plg	PROPN
ajlm-804	128	10	may	may	AUX
ajlm-804	128	11	result	result	VERB
ajlm-804	128	12	in	in	ADP
ajlm-804	128	13	≤	≤	NUM
ajlm-804	128	14	2.4	2.4	NUM
ajlm-804	128	15	%	%	NOUN
ajlm-804	128	16	upward	upward	ADV
ajlm-804	128	17	and	and	CCONJ
ajlm-804	128	18	≤	≤	ADJ
ajlm-804	128	19	11.1	11.1	NUM
ajlm-804	128	20	%	%	NOUN
ajlm-804	128	21	downward	downward	ADJ
ajlm-804	128	22	misclassification	misclassification	NOUN
ajlm-804	128	23	.	.	PUNCT
ajlm-804	129	1	the	the	DET
ajlm-804	129	2	cd4	cd4	PROPN
ajlm-804	129	3	-	-	ADJ
ajlm-804	129	4	positive	positive	ADJ
ajlm-804	129	5	absolute	absolute	ADJ
ajlm-804	129	6	count	count	NOUN
ajlm-804	129	7	mean	mean	NOUN
ajlm-804	129	8	and	and	CCONJ
ajlm-804	129	9	95	95	NUM
ajlm-804	129	10	%	%	NOUN
ajlm-804	129	11	(	(	PUNCT
ajlm-804	129	12	2.5th	2.5th	NUM
ajlm-804	129	13	–	–	PUNCT
ajlm-804	129	14	97.5th	97.5th	NUM
ajlm-804	129	15	)	)	PUNCT
ajlm-804	129	16	reference	reference	NOUN
ajlm-804	129	17	interval	interval	NOUN
ajlm-804	129	18	among	among	ADP
ajlm-804	129	19	healthy	healthy	ADJ
ajlm-804	129	20	,	,	PUNCT
ajlm-804	129	21	non	non	ADJ
ajlm-804	129	22	-	-	ADJ
ajlm-804	129	23	hiv	hiv	ADJ
ajlm-804	129	24	adults	adult	NOUN
ajlm-804	129	25	from	from	ADP
ajlm-804	129	26	our	our	PRON
ajlm-804	129	27	study	study	NOUN
ajlm-804	129	28	were	be	AUX
ajlm-804	129	29	consistent	consistent	ADJ
ajlm-804	129	30	with	with	ADP
ajlm-804	129	31	previously	previously	ADV
ajlm-804	129	32	established	establish	VERB
ajlm-804	129	33	reference	reference	NOUN
ajlm-804	129	34	intervals	interval	NOUN
ajlm-804	129	35	in	in	ADP
ajlm-804	129	36	other	other	ADJ
ajlm-804	129	37	studies20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42	studies20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42	PROPN
ajlm-804	129	38	on	on	ADP
ajlm-804	129	39	healthy	healthy	ADJ
ajlm-804	129	40	individuals	individual	NOUN
ajlm-804	129	41	from	from	ADP
ajlm-804	129	42	different	different	ADJ
ajlm-804	129	43	parts	part	NOUN
ajlm-804	129	44	of	of	ADP
ajlm-804	129	45	the	the	DET
ajlm-804	129	46	world	world	NOUN
ajlm-804	129	47	(	(	PUNCT
ajlm-804	129	48	table	table	NOUN
ajlm-804	129	49	5	5	NUM
ajlm-804	129	50	)	)	PUNCT
ajlm-804	129	51	.	.	PUNCT
ajlm-804	130	1	this	this	DET
ajlm-804	130	2	consistency	consistency	NOUN
ajlm-804	130	3	of	of	ADP
ajlm-804	130	4	reference	reference	NOUN
ajlm-804	130	5	intervals	interval	NOUN
ajlm-804	130	6	established	establish	VERB
ajlm-804	130	7	the	the	DET
ajlm-804	130	8	equivalency	equivalency	NOUN
ajlm-804	130	9	of	of	ADP
ajlm-804	130	10	plg	plg	NOUN
ajlm-804	130	11	gating	gating	NOUN
ajlm-804	130	12	methods	method	NOUN
ajlm-804	130	13	in	in	ADP
ajlm-804	130	14	the	the	DET
ajlm-804	130	15	context	context	NOUN
ajlm-804	130	16	of	of	ADP
ajlm-804	130	17	reference	reference	NOUN
ajlm-804	130	18	intervals	interval	NOUN
ajlm-804	130	19	where	where	SCONJ
ajlm-804	130	20	typically	typically	ADV
ajlm-804	130	21	conventional	conventional	ADJ
ajlm-804	130	22	gating	gate	VERB
ajlm-804	130	23	strategies	strategy	NOUN
ajlm-804	130	24	were	be	AUX
ajlm-804	130	25	used	use	VERB
ajlm-804	130	26	.	.	PUNCT
ajlm-804	131	1	reference	reference	NOUN
ajlm-804	131	2	intervals	interval	NOUN
ajlm-804	131	3	enable	enable	VERB
ajlm-804	131	4	meaningful	meaningful	ADJ
ajlm-804	131	5	interpretation	interpretation	NOUN
ajlm-804	131	6	of	of	ADP
ajlm-804	131	7	a	a	DET
ajlm-804	131	8	patient	patient	NOUN
ajlm-804	131	9	’s	’s	PART
ajlm-804	131	10	laboratory	laboratory	NOUN
ajlm-804	131	11	results	result	NOUN
ajlm-804	131	12	.	.	PUNCT
ajlm-804	132	1	it	it	PRON
ajlm-804	132	2	is	be	AUX
ajlm-804	132	3	recommended	recommend	VERB
ajlm-804	132	4	that	that	SCONJ
ajlm-804	132	5	laboratories	laboratory	NOUN
ajlm-804	132	6	establish	establish	VERB
ajlm-804	132	7	local	local	ADJ
ajlm-804	132	8	reference	reference	NOUN
ajlm-804	132	9	ranges	range	VERB
ajlm-804	132	10	for	for	ADP
ajlm-804	132	11	clinical	clinical	ADJ
ajlm-804	132	12	use44,53	use44,53	ADJ
ajlm-804	132	13	due	due	ADJ
ajlm-804	132	14	to	to	ADP
ajlm-804	132	15	known	know	VERB
ajlm-804	132	16	differences	difference	NOUN
ajlm-804	132	17	relating	relate	VERB
ajlm-804	132	18	to	to	ADP
ajlm-804	132	19	location	location	NOUN
ajlm-804	132	20	,	,	PUNCT
ajlm-804	132	21	race	race	NOUN
ajlm-804	132	22	or	or	CCONJ
ajlm-804	132	23	ethnicity	ethnicity	NOUN
ajlm-804	132	24	,	,	PUNCT
ajlm-804	132	25	sex	sex	NOUN
ajlm-804	132	26	,	,	PUNCT
ajlm-804	132	27	age	age	NOUN
ajlm-804	132	28	,	,	PUNCT
ajlm-804	132	29	disease	disease	NOUN
ajlm-804	132	30	burden	burden	NOUN
ajlm-804	132	31	and	and	CCONJ
ajlm-804	132	32	drug	drug	NOUN
ajlm-804	132	33	intake.21,22,27,28,29,33,36,38,39,42,49,54	intake.21,22,27,28,29,33,36,38,39,42,49,54	PROPN
ajlm-804	132	34	in	in	ADP
ajlm-804	132	35	many	many	ADJ
ajlm-804	132	36	countries	country	NOUN
ajlm-804	132	37	,	,	PUNCT
ajlm-804	132	38	especially	especially	ADV
ajlm-804	132	39	lowand	lowand	ADJ
ajlm-804	132	40	middle	middle	ADJ
ajlm-804	132	41	-	-	PUNCT
ajlm-804	132	42	income	income	NOUN
ajlm-804	132	43	countries	country	NOUN
ajlm-804	132	44	,	,	PUNCT
ajlm-804	132	45	resources	resource	NOUN
ajlm-804	132	46	frequently	frequently	ADV
ajlm-804	132	47	limit	limit	VERB
ajlm-804	132	48	local	local	ADJ
ajlm-804	132	49	reference	reference	NOUN
ajlm-804	132	50	range	range	NOUN
ajlm-804	132	51	development24	development24	NOUN
ajlm-804	132	52	and	and	CCONJ
ajlm-804	132	53	there	there	PRON
ajlm-804	132	54	are	be	VERB
ajlm-804	132	55	few	few	ADJ
ajlm-804	132	56	published	publish	VERB
ajlm-804	132	57	reference	reference	NOUN
ajlm-804	132	58	interval	interval	NOUN
ajlm-804	132	59	datasets	dataset	NOUN
ajlm-804	132	60	.	.	PUNCT
ajlm-804	133	1	interpretation	interpretation	NOUN
ajlm-804	133	2	of	of	ADP
ajlm-804	133	3	reporting	reporting	NOUN
ajlm-804	133	4	is	be	AUX
ajlm-804	133	5	largely	largely	ADV
ajlm-804	133	6	based	base	VERB
ajlm-804	133	7	on	on	ADP
ajlm-804	133	8	reference	reference	NOUN
ajlm-804	133	9	ranges	range	NOUN
ajlm-804	133	10	published	publish	VERB
ajlm-804	133	11	from	from	ADP
ajlm-804	133	12	high	high	ADJ
ajlm-804	133	13	-	-	PUNCT
ajlm-804	133	14	income	income	NOUN
ajlm-804	133	15	,	,	PUNCT
ajlm-804	133	16	industrialised	industrialise	VERB
ajlm-804	133	17	areas	area	NOUN
ajlm-804	133	18	of	of	ADP
ajlm-804	133	19	north	north	PROPN
ajlm-804	133	20	america	america	PROPN
ajlm-804	133	21	and	and	CCONJ
ajlm-804	133	22	europe.24	europe.24	VERB
ajlm-804	133	23	our	our	PRON
ajlm-804	133	24	results	result	NOUN
ajlm-804	133	25	,	,	PUNCT
ajlm-804	133	26	however	however	ADV
ajlm-804	133	27	,	,	PUNCT
ajlm-804	133	28	indicate	indicate	VERB
ajlm-804	133	29	that	that	SCONJ
ajlm-804	133	30	cd4	cd4	PROPN
ajlm-804	133	31	results	result	NOUN
ajlm-804	133	32	across	across	ADP
ajlm-804	133	33	multiple	multiple	ADJ
ajlm-804	133	34	geographies	geography	NOUN
ajlm-804	133	35	,	,	PUNCT
ajlm-804	133	36	instruments	instrument	NOUN
ajlm-804	133	37	and	and	CCONJ
ajlm-804	133	38	platforms	platform	NOUN
ajlm-804	133	39	are	be	AUX
ajlm-804	133	40	quite	quite	ADV
ajlm-804	133	41	consistent	consistent	ADJ
ajlm-804	133	42	,	,	PUNCT
ajlm-804	133	43	including	include	VERB
ajlm-804	133	44	results	result	NOUN
ajlm-804	133	45	for	for	ADP
ajlm-804	133	46	cd4	cd4	PROPN
ajlm-804	133	47	obtained	obtain	VERB
ajlm-804	133	48	by	by	ADP
ajlm-804	133	49	plg	plg	NOUN
ajlm-804	133	50	on	on	ADP
ajlm-804	133	51	the	the	DET
ajlm-804	133	52	aquios	aquio	NOUN
ajlm-804	133	53	.	.	PUNCT
ajlm-804	134	1	the	the	DET
ajlm-804	134	2	circumstances	circumstance	NOUN
ajlm-804	134	3	and	and	CCONJ
ajlm-804	134	4	conditions	condition	NOUN
ajlm-804	134	5	for	for	ADP
ajlm-804	134	6	cd4	cd4	PROPN
ajlm-804	134	7	testing	testing	NOUN
ajlm-804	134	8	in	in	ADP
ajlm-804	134	9	laboratories	laboratory	NOUN
ajlm-804	134	10	vary	vary	VERB
ajlm-804	134	11	in	in	ADP
ajlm-804	134	12	lowand	lowand	ADJ
ajlm-804	134	13	middle	middle	ADJ
ajlm-804	134	14	-	-	PUNCT
ajlm-804	134	15	income	income	NOUN
ajlm-804	134	16	countries	country	NOUN
ajlm-804	134	17	.	.	PUNCT
ajlm-804	135	1	challenges	challenge	NOUN
ajlm-804	135	2	faced	face	VERB
ajlm-804	135	3	vary	vary	VERB
ajlm-804	135	4	and	and	CCONJ
ajlm-804	135	5	include	include	VERB
ajlm-804	135	6	a	a	DET
ajlm-804	135	7	basic	basic	ADJ
ajlm-804	135	8	lack	lack	NOUN
ajlm-804	135	9	of	of	ADP
ajlm-804	135	10	infrastructure	infrastructure	NOUN
ajlm-804	135	11	such	such	ADJ
ajlm-804	135	12	as	as	ADP
ajlm-804	135	13	an	an	DET
ajlm-804	135	14	unstable	unstable	ADJ
ajlm-804	135	15	electricity	electricity	NOUN
ajlm-804	135	16	supply	supply	NOUN
ajlm-804	135	17	,	,	PUNCT
ajlm-804	135	18	a	a	DET
ajlm-804	135	19	lack	lack	NOUN
ajlm-804	135	20	of	of	ADP
ajlm-804	135	21	cold	cold	ADJ
ajlm-804	135	22	storage	storage	NOUN
ajlm-804	135	23	facilities	facility	NOUN
ajlm-804	135	24	to	to	ADP
ajlm-804	135	25	a	a	DET
ajlm-804	135	26	paucity	paucity	NOUN
ajlm-804	135	27	of	of	ADP
ajlm-804	135	28	skills.55	skills.55	NOUN
ajlm-804	135	29	the	the	DET
ajlm-804	135	30	burden	burden	NOUN
ajlm-804	135	31	of	of	ADP
ajlm-804	135	32	hiv	hiv	PROPN
ajlm-804	135	33	disease	disease	NOUN
ajlm-804	135	34	may	may	AUX
ajlm-804	135	35	also	also	ADV
ajlm-804	135	36	frequently	frequently	ADV
ajlm-804	135	37	dictate	dictate	VERB
ajlm-804	135	38	high	high	ADJ
ajlm-804	135	39	workload	workload	NOUN
ajlm-804	135	40	volumes	volume	NOUN
ajlm-804	135	41	in	in	ADP
ajlm-804	135	42	certain	certain	ADJ
ajlm-804	135	43	countries.11,12	countries.11,12	ADJ
ajlm-804	135	44	manual	manual	ADJ
ajlm-804	135	45	sample	sample	NOUN
ajlm-804	135	46	preparation	preparation	NOUN
ajlm-804	135	47	requires	require	VERB
ajlm-804	135	48	multiple	multiple	ADJ
ajlm-804	135	49	pipetting	pipetting	NOUN
ajlm-804	135	50	,	,	PUNCT
ajlm-804	135	51	which	which	PRON
ajlm-804	135	52	in	in	ADP
ajlm-804	135	53	turn	turn	NOUN
ajlm-804	135	54	increases	increase	VERB
ajlm-804	135	55	pipetting	pipette	VERB
ajlm-804	135	56	errors	error	NOUN
ajlm-804	135	57	.	.	PUNCT
ajlm-804	136	1	however	however	ADV
ajlm-804	136	2	,	,	PUNCT
ajlm-804	136	3	automated	automated	ADJ
ajlm-804	136	4	sample	sample	NOUN
ajlm-804	136	5	preparation	preparation	NOUN
ajlm-804	136	6	lowers	lower	VERB
ajlm-804	136	7	percent	percent	NOUN
ajlm-804	136	8	coefficients	coefficient	NOUN
ajlm-804	136	9	of	of	ADP
ajlm-804	136	10	variance	variance	NOUN
ajlm-804	136	11	through	through	ADP
ajlm-804	136	12	the	the	DET
ajlm-804	136	13	reduction	reduction	NOUN
ajlm-804	136	14	of	of	ADP
ajlm-804	136	15	human	human	ADJ
ajlm-804	136	16	pipetting	pipetting	NOUN
ajlm-804	136	17	errors.12,56	errors.12,56	NOUN
ajlm-804	136	18	the	the	DET
ajlm-804	136	19	simplified	simplified	ADJ
ajlm-804	136	20	plg	plg	PROPN
ajlm-804	136	21	cd4	cd4	PROPN
ajlm-804	136	22	method12,16	method12,16	PROPN
ajlm-804	136	23	is	be	AUX
ajlm-804	136	24	the	the	DET
ajlm-804	136	25	predicate	predicate	ADJ
ajlm-804	136	26	system	system	NOUN
ajlm-804	136	27	of	of	ADP
ajlm-804	136	28	the	the	DET
ajlm-804	136	29	south	south	ADJ
ajlm-804	136	30	african	african	ADJ
ajlm-804	136	31	programme	programme	NOUN
ajlm-804	136	32	,	,	PUNCT
ajlm-804	136	33	and	and	CCONJ
ajlm-804	136	34	it	it	PRON
ajlm-804	136	35	combines	combine	VERB
ajlm-804	136	36	the	the	DET
ajlm-804	136	37	reliable	reliable	ADJ
ajlm-804	136	38	bead	bead	NOUN
ajlm-804	136	39	-	-	PUNCT
ajlm-804	136	40	based	base	VERB
ajlm-804	136	41	testing	testing	NOUN
ajlm-804	136	42	technology8	technology8	PROPN
ajlm-804	136	43	and	and	CCONJ
ajlm-804	136	44	a	a	DET
ajlm-804	136	45	gating	gate	VERB
ajlm-804	136	46	strategy.8,12,16,57	strategy.8,12,16,57	NOUN
ajlm-804	136	47	plg	plg	NOUN
ajlm-804	136	48	on	on	ADP
ajlm-804	136	49	the	the	DET
ajlm-804	136	50	aquios	aquio	NOUN
ajlm-804	136	51	platform	platform	NOUN
ajlm-804	136	52	is	be	AUX
ajlm-804	136	53	regarded	regard	VERB
ajlm-804	136	54	as	as	ADP
ajlm-804	136	55	a	a	DET
ajlm-804	136	56	suitable	suitable	ADJ
ajlm-804	136	57	candidate	candidate	NOUN
ajlm-804	136	58	for	for	ADP
ajlm-804	136	59	this	this	DET
ajlm-804	136	60	programme	programme	NOUN
ajlm-804	136	61	to	to	PART
ajlm-804	136	62	replace	replace	VERB
ajlm-804	136	63	older	old	ADJ
ajlm-804	136	64	aging	age	VERB
ajlm-804	136	65	equipment	equipment	NOUN
ajlm-804	136	66	currently	currently	ADV
ajlm-804	136	67	used12,48	used12,48	VERB
ajlm-804	136	68	it	it	PRON
ajlm-804	136	69	is	be	AUX
ajlm-804	136	70	envisaged	envisage	VERB
ajlm-804	136	71	that	that	SCONJ
ajlm-804	136	72	its	its	PRON
ajlm-804	136	73	user	user	NOUN
ajlm-804	136	74	-	-	PUNCT
ajlm-804	136	75	independent	independent	ADJ
ajlm-804	136	76	and	and	CCONJ
ajlm-804	136	77	on	on	ADP
ajlm-804	136	78	-	-	PUNCT
ajlm-804	136	79	board	board	NOUN
ajlm-804	136	80	sample	sample	NOUN
ajlm-804	136	81	preparation	preparation	NOUN
ajlm-804	136	82	features	feature	NOUN
ajlm-804	136	83	could	could	AUX
ajlm-804	136	84	improve	improve	VERB
ajlm-804	136	85	testing	test	VERB
ajlm-804	136	86	outcomes	outcome	NOUN
ajlm-804	136	87	in	in	ADP
ajlm-804	136	88	small	small	ADJ
ajlm-804	136	89	laboratory	laboratory	NOUN
ajlm-804	136	90	sites	site	NOUN
ajlm-804	136	91	with	with	ADP
ajlm-804	136	92	fewer	few	ADJ
ajlm-804	136	93	staff	staff	NOUN
ajlm-804	136	94	or	or	CCONJ
ajlm-804	136	95	less	less	ADV
ajlm-804	136	96	technical	technical	ADJ
ajlm-804	136	97	flow	flow	NOUN
ajlm-804	136	98	cytometry	cytometry	NOUN
ajlm-804	136	99	expertise	expertise	NOUN
ajlm-804	136	100	.	.	PUNCT
ajlm-804	137	1	thus	thus	ADV
ajlm-804	137	2	,	,	PUNCT
ajlm-804	137	3	this	this	PRON
ajlm-804	137	4	enables	enable	VERB
ajlm-804	137	5	them	they	PRON
ajlm-804	137	6	to	to	PART
ajlm-804	137	7	provide	provide	VERB
ajlm-804	137	8	local	local	ADJ
ajlm-804	137	9	cd4	cd4	PROPN
ajlm-804	137	10	services	service	NOUN
ajlm-804	137	11	even	even	ADV
ajlm-804	137	12	with	with	ADP
ajlm-804	137	13	workload	workload	NOUN
ajlm-804	137	14	equivalents	equivalent	NOUN
ajlm-804	137	15	of	of	ADP
ajlm-804	137	16	up	up	ADP
ajlm-804	137	17	to	to	PART
ajlm-804	137	18	100	100	NUM
ajlm-804	137	19	samples	sample	NOUN
ajlm-804	137	20	per	per	ADP
ajlm-804	137	21	day	day	NOUN
ajlm-804	137	22	and	and	CCONJ
ajlm-804	137	23	improve	improve	VERB
ajlm-804	137	24	local	local	ADJ
ajlm-804	137	25	service	service	NOUN
ajlm-804	137	26	delivery	delivery	NOUN
ajlm-804	137	27	turn	turn	NOUN
ajlm-804	137	28	-	-	PUNCT
ajlm-804	137	29	around	around	ADP
ajlm-804	137	30	times	time	NOUN
ajlm-804	137	31	in	in	ADP
ajlm-804	137	32	more	more	ADJ
ajlm-804	137	33	remote	remote	ADJ
ajlm-804	137	34	parts	part	NOUN
ajlm-804	137	35	of	of	ADP
ajlm-804	137	36	south	south	ADJ
ajlm-804	137	37	africa.11,19	africa.11,19	NOUN
ajlm-804	137	38	the	the	DET
ajlm-804	137	39	workflow	workflow	NOUN
ajlm-804	137	40	showed	show	VERB
ajlm-804	137	41	a	a	DET
ajlm-804	137	42	medium	medium	ADJ
ajlm-804	137	43	-	-	PUNCT
ajlm-804	137	44	high	high	ADJ
ajlm-804	137	45	throughput	throughput	NOUN
ajlm-804	137	46	level	level	NOUN
ajlm-804	137	47	.	.	PUNCT
ajlm-804	138	1	lower	low	ADJ
ajlm-804	138	2	throughput	throughput	NOUN
ajlm-804	138	3	(	(	PUNCT
ajlm-804	138	4	12	12	NUM
ajlm-804	138	5	samples	sample	NOUN
ajlm-804	138	6	per	per	ADP
ajlm-804	138	7	hour	hour	NOUN
ajlm-804	138	8	or	or	CCONJ
ajlm-804	138	9	96	96	NUM
ajlm-804	138	10	samples	sample	NOUN
ajlm-804	138	11	per	per	ADP
ajlm-804	138	12	shift	shift	NOUN
ajlm-804	138	13	tested	test	VERB
ajlm-804	138	14	)	)	PUNCT
ajlm-804	138	15	was	be	AUX
ajlm-804	138	16	seen	see	VERB
ajlm-804	138	17	in	in	ADP
ajlm-804	138	18	a	a	DET
ajlm-804	138	19	previous	previous	ADJ
ajlm-804	138	20	workflow	workflow	NOUN
ajlm-804	138	21	study	study	NOUN
ajlm-804	138	22	performed	perform	VERB
ajlm-804	138	23	in	in	ADP
ajlm-804	138	24	the	the	DET
ajlm-804	138	25	same	same	ADJ
ajlm-804	138	26	laboratory	laboratory	NOUN
ajlm-804	138	27	using	use	VERB
ajlm-804	138	28	manual	manual	ADJ
ajlm-804	138	29	preparation	preparation	NOUN
ajlm-804	138	30	and	and	CCONJ
ajlm-804	138	31	analysis	analysis	NOUN
ajlm-804	138	32	on	on	ADP
ajlm-804	138	33	a	a	DET
ajlm-804	138	34	fc-500	fc-500	NOUN
ajlm-804	138	35	flow	flow	NOUN
ajlm-804	138	36	cytometer	cytometer	NOUN
ajlm-804	138	37	,	,	PUNCT
ajlm-804	138	38	and	and	CCONJ
ajlm-804	138	39	,	,	PUNCT
ajlm-804	138	40	6	6	NUM
ajlm-804	138	41	hours	hour	NOUN
ajlm-804	138	42	of	of	ADP
ajlm-804	138	43	hands	hand	NOUN
ajlm-804	138	44	-	-	PUNCT
ajlm-804	138	45	on	on	ADP
ajlm-804	138	46	technician	technician	ADJ
ajlm-804	138	47	time	time	NOUN
ajlm-804	138	48	were	be	AUX
ajlm-804	138	49	required.58	required.58	VERB
ajlm-804	138	50	the	the	DET
ajlm-804	138	51	aquios	aquio	NOUN
ajlm-804	138	52	plg	plg	PROPN
ajlm-804	138	53	daily	daily	ADJ
ajlm-804	138	54	workflow	workflow	NOUN
ajlm-804	138	55	includes	include	VERB
ajlm-804	138	56	available	available	ADJ
ajlm-804	138	57	quality	quality	NOUN
ajlm-804	138	58	control	control	NOUN
ajlm-804	138	59	material	material	NOUN
ajlm-804	138	60	and	and	CCONJ
ajlm-804	138	61	the	the	DET
ajlm-804	138	62	system	system	NOUN
ajlm-804	138	63	works	work	VERB
ajlm-804	138	64	with	with	ADP
ajlm-804	138	65	stabilised	stabilise	VERB
ajlm-804	138	66	blood	blood	NOUN
ajlm-804	138	67	products	product	NOUN
ajlm-804	138	68	,	,	PUNCT
ajlm-804	138	69	making	make	VERB
ajlm-804	138	70	it	it	PRON
ajlm-804	138	71	compatible	compatible	ADJ
ajlm-804	138	72	with	with	ADP
ajlm-804	138	73	external	external	ADJ
ajlm-804	138	74	quality	quality	NOUN
ajlm-804	138	75	assessment	assessment	NOUN
ajlm-804	138	76	programmes	programme	NOUN
ajlm-804	138	77	.	.	PUNCT
ajlm-804	139	1	this	this	PRON
ajlm-804	139	2	allows	allow	VERB
ajlm-804	139	3	for	for	ADP
ajlm-804	139	4	ongoing	ongoing	ADJ
ajlm-804	139	5	monitoring	monitoring	NOUN
ajlm-804	139	6	of	of	ADP
ajlm-804	139	7	intraand	intraand	NOUN
ajlm-804	139	8	inter	inter	ADJ
ajlm-804	139	9	-	-	ADJ
ajlm-804	139	10	laboratory	laboratory	ADJ
ajlm-804	139	11	precision	precision	NOUN
ajlm-804	139	12	which	which	PRON
ajlm-804	139	13	is	be	AUX
ajlm-804	139	14	important	important	ADJ
ajlm-804	139	15	for	for	ADP
ajlm-804	139	16	quality	quality	NOUN
ajlm-804	139	17	management	management	NOUN
ajlm-804	139	18	of	of	ADP
ajlm-804	139	19	large	large	ADJ
ajlm-804	139	20	-	-	PUNCT
ajlm-804	139	21	scale	scale	NOUN
ajlm-804	139	22	country	country	NOUN
ajlm-804	139	23	-	-	PUNCT
ajlm-804	139	24	wide	wide	ADJ
ajlm-804	139	25	programmes.11,12	programmes.11,12	NOUN
ajlm-804	139	26	the	the	DET
ajlm-804	139	27	system	system	NOUN
ajlm-804	139	28	tracks	track	VERB
ajlm-804	139	29	quality	quality	NOUN
ajlm-804	139	30	control	control	NOUN
ajlm-804	139	31	results	result	NOUN
ajlm-804	139	32	and	and	CCONJ
ajlm-804	139	33	alerts	alert	VERB
ajlm-804	139	34	user	user	NOUN
ajlm-804	139	35	and	and	CCONJ
ajlm-804	139	36	technical	technical	ADJ
ajlm-804	139	37	support	support	NOUN
ajlm-804	139	38	staff	staff	NOUN
ajlm-804	139	39	of	of	ADP
ajlm-804	139	40	deviations	deviation	NOUN
ajlm-804	139	41	or	or	CCONJ
ajlm-804	139	42	trending	trending	NOUN
ajlm-804	139	43	.	.	PUNCT
ajlm-804	140	1	as	as	ADP
ajlm-804	140	2	a	a	DET
ajlm-804	140	3	single	single	ADJ
ajlm-804	140	4	platform	platform	NOUN
ajlm-804	140	5	system	system	NOUN
ajlm-804	140	6	with	with	ADP
ajlm-804	140	7	on	on	ADP
ajlm-804	140	8	-	-	PUNCT
ajlm-804	140	9	board	board	NOUN
ajlm-804	140	10	sample	sample	NOUN
ajlm-804	140	11	preparation	preparation	NOUN
ajlm-804	140	12	,	,	PUNCT
ajlm-804	140	13	no	no	DET
ajlm-804	140	14	additional	additional	ADJ
ajlm-804	140	15	laboratory	laboratory	NOUN
ajlm-804	140	16	equipment	equipment	NOUN
ajlm-804	140	17	was	be	AUX
ajlm-804	140	18	needed	need	VERB
ajlm-804	140	19	.	.	PUNCT
ajlm-804	141	1	lastly	lastly	ADV
ajlm-804	141	2	,	,	PUNCT
ajlm-804	141	3	it	it	PRON
ajlm-804	141	4	is	be	AUX
ajlm-804	141	5	important	important	ADJ
ajlm-804	141	6	to	to	PART
ajlm-804	141	7	briefly	briefly	ADV
ajlm-804	141	8	discuss	discuss	VERB
ajlm-804	141	9	the	the	DET
ajlm-804	141	10	relevance	relevance	NOUN
ajlm-804	141	11	of	of	ADP
ajlm-804	141	12	cd4	cd4	PROPN
ajlm-804	141	13	counting	counting	NOUN
ajlm-804	141	14	in	in	ADP
ajlm-804	141	15	the	the	DET
ajlm-804	141	16	face	face	NOUN
ajlm-804	141	17	of	of	ADP
ajlm-804	141	18	recent	recent	ADJ
ajlm-804	141	19	world	world	NOUN
ajlm-804	141	20	health	health	NOUN
ajlm-804	141	21	organization	organization	NOUN
ajlm-804	141	22	guidelines52	guidelines52	ADJ
ajlm-804	141	23	which	which	PRON
ajlm-804	141	24	recommend	recommend	VERB
ajlm-804	141	25	that	that	SCONJ
ajlm-804	141	26	all	all	DET
ajlm-804	141	27	patients	patient	NOUN
ajlm-804	141	28	who	who	PRON
ajlm-804	141	29	are	be	AUX
ajlm-804	141	30	hiv	hiv	NOUN
ajlm-804	141	31	-	-	PUNCT
ajlm-804	141	32	positive	positive	ADJ
ajlm-804	141	33	start	start	NOUN
ajlm-804	141	34	art	art	NOUN
ajlm-804	141	35	,	,	PUNCT
ajlm-804	141	36	irrespective	irrespective	ADV
ajlm-804	141	37	of	of	ADP
ajlm-804	141	38	their	their	PRON
ajlm-804	141	39	cd4	cd4	PROPN
ajlm-804	141	40	counts	count	NOUN
ajlm-804	141	41	.	.	PUNCT
ajlm-804	142	1	for	for	ADP
ajlm-804	142	2	the	the	DET
ajlm-804	142	3	past	past	ADJ
ajlm-804	142	4	30	30	NUM
ajlm-804	142	5	years	year	NOUN
ajlm-804	142	6	,	,	PUNCT
ajlm-804	142	7	medical	medical	ADJ
ajlm-804	142	8	personnel	personnel	NOUN
ajlm-804	142	9	caring	care	VERB
ajlm-804	142	10	for	for	ADP
ajlm-804	142	11	hiv	hiv	PROPN
ajlm-804	142	12	patients	patient	NOUN
ajlm-804	142	13	have	have	AUX
ajlm-804	142	14	used	use	VERB
ajlm-804	142	15	cd4	cd4	PROPN
ajlm-804	142	16	counts	count	NOUN
ajlm-804	142	17	as	as	ADP
ajlm-804	142	18	prognostic	prognostic	ADJ
ajlm-804	142	19	indicators	indicator	NOUN
ajlm-804	142	20	of	of	ADP
ajlm-804	142	21	disease	disease	NOUN
ajlm-804	142	22	progress3	progress3	NOUN
ajlm-804	142	23	or	or	CCONJ
ajlm-804	142	24	death.2	death.2	PROPN
ajlm-804	142	25	also	also	ADV
ajlm-804	142	26	,	,	PUNCT
ajlm-804	142	27	the	the	DET
ajlm-804	142	28	cd4	cd4	PROPN
ajlm-804	142	29	count	count	NOUN
ajlm-804	142	30	is	be	AUX
ajlm-804	142	31	used	use	VERB
ajlm-804	142	32	to	to	PART
ajlm-804	142	33	determine	determine	VERB
ajlm-804	142	34	eligibility	eligibility	NOUN
ajlm-804	142	35	for	for	ADP
ajlm-804	142	36	initiating	initiate	VERB
ajlm-804	142	37	art	art	NOUN
ajlm-804	142	38	,	,	PUNCT
ajlm-804	142	39	managing	manage	VERB
ajlm-804	142	40	and	and	CCONJ
ajlm-804	142	41	treating	treat	VERB
ajlm-804	142	42	opportunistic	opportunistic	ADJ
ajlm-804	142	43	infections	infection	NOUN
ajlm-804	142	44	and	and	CCONJ
ajlm-804	142	45	monitoring	monitor	VERB
ajlm-804	142	46	the	the	DET
ajlm-804	142	47	patient	patient	NOUN
ajlm-804	142	48	’s	’s	PART
ajlm-804	142	49	response	response	NOUN
ajlm-804	142	50	to	to	ADP
ajlm-804	142	51	art.59	art.59	NOUN
ajlm-804	142	52	it	it	PRON
ajlm-804	142	53	is	be	AUX
ajlm-804	142	54	widely	widely	ADV
ajlm-804	142	55	agreed	agree	VERB
ajlm-804	142	56	that	that	SCONJ
ajlm-804	142	57	hiv	hiv	PROPN
ajlm-804	142	58	viral	viral	ADJ
ajlm-804	142	59	load	load	NOUN
ajlm-804	142	60	testing	testing	NOUN
ajlm-804	142	61	is	be	AUX
ajlm-804	142	62	the	the	DET
ajlm-804	142	63	optimal	optimal	ADJ
ajlm-804	142	64	assay	assay	NOUN
ajlm-804	142	65	to	to	PART
ajlm-804	142	66	monitor	monitor	VERB
ajlm-804	142	67	the	the	DET
ajlm-804	142	68	response	response	NOUN
ajlm-804	142	69	to	to	ADP
ajlm-804	142	70	art	art	NOUN
ajlm-804	142	71	or	or	CCONJ
ajlm-804	142	72	determine	determine	VERB
ajlm-804	142	73	treatment	treatment	NOUN
ajlm-804	142	74	failure.60,61	failure.60,61	NOUN
ajlm-804	142	75	however	however	ADV
ajlm-804	142	76	,	,	PUNCT
ajlm-804	142	77	in	in	ADP
ajlm-804	142	78	light	light	NOUN
ajlm-804	142	79	of	of	ADP
ajlm-804	142	80	the	the	DET
ajlm-804	142	81	documented	document	VERB
ajlm-804	142	82	worldwide	worldwide	ADJ
ajlm-804	142	83	number	number	NOUN
ajlm-804	142	84	of	of	ADP
ajlm-804	142	85	individuals	individual	NOUN
ajlm-804	142	86	with	with	ADP
ajlm-804	142	87	advanced	advanced	ADJ
ajlm-804	142	88	hiv	hiv	PROPN
ajlm-804	142	89	disease61,62,63	disease61,62,63	ADJ
ajlm-804	142	90	and	and	CCONJ
ajlm-804	142	91	lack	lack	NOUN
ajlm-804	142	92	of	of	ADP
ajlm-804	142	93	funding	funding	NOUN
ajlm-804	142	94	and	and	CCONJ
ajlm-804	142	95	infrastructure	infrastructure	NOUN
ajlm-804	142	96	for	for	ADP
ajlm-804	142	97	routine	routine	ADJ
ajlm-804	142	98	viral	viral	ADJ
ajlm-804	142	99	load	load	NOUN
ajlm-804	142	100	testing	testing	NOUN
ajlm-804	142	101	in	in	ADP
ajlm-804	142	102	lowto	lowto	NOUN
ajlm-804	142	103	middle	middle	ADJ
ajlm-804	142	104	-	-	PUNCT
ajlm-804	142	105	income	income	NOUN
ajlm-804	142	106	geographies	geography	NOUN
ajlm-804	142	107	,	,	PUNCT
ajlm-804	142	108	cd4	cd4	PROPN
ajlm-804	142	109	counts	count	NOUN
ajlm-804	142	110	will	will	AUX
ajlm-804	142	111	continue	continue	VERB
ajlm-804	142	112	to	to	PART
ajlm-804	142	113	play	play	VERB
ajlm-804	142	114	an	an	DET
ajlm-804	142	115	important	important	ADJ
ajlm-804	142	116	role	role	NOUN
ajlm-804	142	117	in	in	ADP
ajlm-804	142	118	managing	manage	VERB
ajlm-804	142	119	hiv	hiv	PROPN
ajlm-804	142	120	patients	patient	NOUN
ajlm-804	142	121	in	in	ADP
ajlm-804	142	122	terms	term	NOUN
ajlm-804	142	123	of	of	ADP
ajlm-804	142	124	:	:	PUNCT
ajlm-804	142	125	stratifying	stratify	VERB
ajlm-804	142	126	long	long	ADJ
ajlm-804	142	127	-	-	PUNCT
ajlm-804	142	128	term	term	NOUN
ajlm-804	142	129	risk	risk	NOUN
ajlm-804	142	130	,	,	PUNCT
ajlm-804	142	131	fast	fast	ADV
ajlm-804	142	132	-	-	PUNCT
ajlm-804	142	133	tracking	tracking	NOUN
ajlm-804	142	134	onto	onto	ADP
ajlm-804	142	135	art	art	NOUN
ajlm-804	142	136	outside	outside	ADP
ajlm-804	142	137	the	the	DET
ajlm-804	142	138	standard	standard	NOUN
ajlm-804	142	139	of	of	ADP
ajlm-804	142	140	care64	care64	NOUN
ajlm-804	142	141	and	and	CCONJ
ajlm-804	142	142	identifying	identify	VERB
ajlm-804	142	143	patients	patient	NOUN
ajlm-804	142	144	with	with	ADP
ajlm-804	142	145	immunological	immunological	ADJ
ajlm-804	142	146	or	or	CCONJ
ajlm-804	142	147	clinical	clinical	ADJ
ajlm-804	142	148	failure.60,65,66	failure.60,65,66	ADP
ajlm-804	142	149	the	the	DET
ajlm-804	142	150	high	high	ADJ
ajlm-804	142	151	number	number	NOUN
ajlm-804	142	152	of	of	ADP
ajlm-804	142	153	individuals	individual	NOUN
ajlm-804	142	154	with	with	ADP
ajlm-804	142	155	advanced	advanced	ADJ
ajlm-804	142	156	hiv	hiv	PROPN
ajlm-804	142	157	disease	disease	NOUN
ajlm-804	142	158	also	also	ADV
ajlm-804	142	159	dictates	dictate	VERB
ajlm-804	142	160	that	that	SCONJ
ajlm-804	142	161	cd4	cd4	PROPN
ajlm-804	142	162	counts	count	NOUN
ajlm-804	142	163	should	should	AUX
ajlm-804	142	164	play	play	VERB
ajlm-804	142	165	an	an	DET
ajlm-804	142	166	important	important	ADJ
ajlm-804	142	167	role	role	NOUN
ajlm-804	142	168	in	in	ADP
ajlm-804	142	169	identifying	identify	VERB
ajlm-804	142	170	patients	patient	NOUN
ajlm-804	142	171	at	at	ADP
ajlm-804	142	172	risk	risk	NOUN
ajlm-804	142	173	of	of	ADP
ajlm-804	142	174	opportunistic	opportunistic	ADJ
ajlm-804	142	175	infections	infection	NOUN
ajlm-804	142	176	,	,	PUNCT
ajlm-804	142	177	such	such	ADJ
ajlm-804	142	178	as	as	ADP
ajlm-804	142	179	cryptococcal	cryptococcal	ADJ
ajlm-804	142	180	disease	disease	NOUN
ajlm-804	142	181	,	,	PUNCT
ajlm-804	142	182	prophylactic	prophylactic	ADJ
ajlm-804	142	183	treatment	treatment	NOUN
ajlm-804	142	184	for	for	ADP
ajlm-804	142	185	tuberculosis	tuberculosis	NOUN
ajlm-804	142	186	and	and	CCONJ
ajlm-804	142	187	pneumocystis	pneumocystis	ADJ
ajlm-804	142	188	pneumonia	pneumonia	NOUN
ajlm-804	142	189	.	.	PUNCT
ajlm-804	143	1	limitations	limitation	NOUN
ajlm-804	143	2	our	our	PRON
ajlm-804	143	3	study	study	NOUN
ajlm-804	143	4	utilised	utilise	VERB
ajlm-804	143	5	samples	sample	NOUN
ajlm-804	143	6	mainly	mainly	ADV
ajlm-804	143	7	from	from	ADP
ajlm-804	143	8	high	high	ADJ
ajlm-804	143	9	-	-	PUNCT
ajlm-804	143	10	income	income	NOUN
ajlm-804	143	11	,	,	PUNCT
ajlm-804	143	12	industrialised	industrialised	ADJ
ajlm-804	143	13	or	or	CCONJ
ajlm-804	143	14	urban	urban	ADJ
ajlm-804	143	15	areas	area	NOUN
ajlm-804	143	16	,	,	PUNCT
ajlm-804	143	17	and	and	CCONJ
ajlm-804	143	18	such	such	ADJ
ajlm-804	143	19	as	as	ADP
ajlm-804	143	20	may	may	AUX
ajlm-804	143	21	not	not	PART
ajlm-804	143	22	completely	completely	ADV
ajlm-804	143	23	represent	represent	VERB
ajlm-804	143	24	samples	sample	NOUN
ajlm-804	143	25	found	find	VERB
ajlm-804	143	26	in	in	ADP
ajlm-804	143	27	an	an	DET
ajlm-804	143	28	entirely	entirely	ADV
ajlm-804	143	29	african	african	ADJ
ajlm-804	143	30	population	population	NOUN
ajlm-804	143	31	.	.	PUNCT
ajlm-804	144	1	conclusion	conclusion	VERB
ajlm-804	144	2	the	the	DET
ajlm-804	144	3	aquios	aquio	NOUN
ajlm-804	144	4	plg	plg	NOUN
ajlm-804	144	5	merges	merge	VERB
ajlm-804	144	6	desirable	desirable	ADJ
ajlm-804	144	7	aspects	aspect	NOUN
ajlm-804	144	8	from	from	ADP
ajlm-804	144	9	conventional	conventional	ADJ
ajlm-804	144	10	flow	flow	NOUN
ajlm-804	144	11	cytometer	cytometer	NOUN
ajlm-804	144	12	systems	system	NOUN
ajlm-804	144	13	(	(	PUNCT
ajlm-804	144	14	high	high	ADJ
ajlm-804	144	15	throughput	throughput	NOUN
ajlm-804	144	16	,	,	PUNCT
ajlm-804	144	17	precision	precision	NOUN
ajlm-804	144	18	and	and	CCONJ
ajlm-804	144	19	accuracy	accuracy	NOUN
ajlm-804	144	20	,	,	PUNCT
ajlm-804	144	21	external	external	ADJ
ajlm-804	144	22	quality	quality	NOUN
ajlm-804	144	23	assessment	assessment	NOUN
ajlm-804	144	24	compatibility	compatibility	NOUN
ajlm-804	144	25	)	)	PUNCT
ajlm-804	144	26	with	with	ADP
ajlm-804	144	27	low	low	ADJ
ajlm-804	144	28	technical	technical	ADJ
ajlm-804	144	29	skill	skill	NOUN
ajlm-804	144	30	requirements	requirement	NOUN
ajlm-804	144	31	for	for	ADP
ajlm-804	144	32	automated	automate	VERB
ajlm-804	144	33	,	,	PUNCT
ajlm-804	144	34	single	single	ADJ
ajlm-804	144	35	platform	platform	NOUN
ajlm-804	144	36	systems	system	NOUN
ajlm-804	144	37	.	.	PUNCT
ajlm-804	145	1	trustworthiness	trustworthiness	NOUN
ajlm-804	145	2	the	the	DET
ajlm-804	145	3	findings	finding	NOUN
ajlm-804	145	4	of	of	ADP
ajlm-804	145	5	these	these	DET
ajlm-804	145	6	studies	study	NOUN
ajlm-804	145	7	should	should	AUX
ajlm-804	145	8	be	be	AUX
ajlm-804	145	9	used	use	VERB
ajlm-804	145	10	per	per	ADP
ajlm-804	145	11	the	the	DET
ajlm-804	145	12	scope	scope	NOUN
ajlm-804	145	13	of	of	ADP
ajlm-804	145	14	the	the	DET
ajlm-804	145	15	study	study	NOUN
ajlm-804	145	16	and	and	CCONJ
ajlm-804	145	17	with	with	ADP
ajlm-804	145	18	regard	regard	NOUN
ajlm-804	145	19	to	to	ADP
ajlm-804	145	20	the	the	DET
ajlm-804	145	21	indicated	indicate	VERB
ajlm-804	145	22	limitations	limitation	NOUN
ajlm-804	145	23	.	.	PUNCT
ajlm-804	146	1	the	the	DET
ajlm-804	146	2	results	result	NOUN
ajlm-804	146	3	review	review	VERB
ajlm-804	146	4	and	and	CCONJ
ajlm-804	146	5	release	release	NOUN
ajlm-804	146	6	on	on	ADP
ajlm-804	146	7	aquios	aquio	NOUN
ajlm-804	146	8	should	should	AUX
ajlm-804	146	9	be	be	AUX
ajlm-804	146	10	performed	perform	VERB
ajlm-804	146	11	by	by	ADP
ajlm-804	146	12	a	a	DET
ajlm-804	146	13	qualified	qualified	ADJ
ajlm-804	146	14	professional	professional	NOUN
ajlm-804	146	15	.	.	PUNCT
ajlm-804	147	1	acknowledgements	acknowledgement	NOUN
ajlm-804	147	2	the	the	DET
ajlm-804	147	3	authors	author	NOUN
ajlm-804	147	4	would	would	AUX
ajlm-804	147	5	like	like	VERB
ajlm-804	147	6	to	to	PART
ajlm-804	147	7	thank	thank	VERB
ajlm-804	147	8	the	the	DET
ajlm-804	147	9	technicians	technician	NOUN
ajlm-804	147	10	at	at	ADP
ajlm-804	147	11	each	each	DET
ajlm-804	147	12	testing	testing	NOUN
ajlm-804	147	13	site	site	NOUN
ajlm-804	147	14	for	for	ADP
ajlm-804	147	15	their	their	PRON
ajlm-804	147	16	detailed	detailed	ADJ
ajlm-804	147	17	and	and	CCONJ
ajlm-804	147	18	dedicated	dedicated	ADJ
ajlm-804	147	19	work	work	NOUN
ajlm-804	147	20	:	:	PUNCT
ajlm-804	147	21	paris	paris	PROPN
ajlm-804	147	22	,	,	PUNCT
ajlm-804	147	23	france	france	PROPN
ajlm-804	147	24	:	:	PUNCT
ajlm-804	147	25	isabelle	isabelle	PROPN
ajlm-804	147	26	mauger	mauger	PROPN
ajlm-804	147	27	and	and	CCONJ
ajlm-804	147	28	virginie	virginie	PROPN
ajlm-804	147	29	merere	merere	PROPN
ajlm-804	147	30	;	;	PUNCT
ajlm-804	147	31	lyon	lyon	PROPN
ajlm-804	147	32	,	,	PUNCT
ajlm-804	147	33	france	france	PROPN
ajlm-804	147	34	:	:	PUNCT
ajlm-804	147	35	sophie	sophie	PROPN
ajlm-804	147	36	tronchet	tronchet	PROPN
ajlm-804	147	37	,	,	PUNCT
ajlm-804	147	38	karin	karin	PROPN
ajlm-804	147	39	dumoulin	dumoulin	PROPN
ajlm-804	147	40	,	,	PUNCT
ajlm-804	147	41	audrey	audrey	PROPN
ajlm-804	147	42	milhau	milhau	PROPN
ajlm-804	147	43	and	and	CCONJ
ajlm-804	147	44	laura	laura	NOUN
ajlm-804	147	45	dinier	dinier	ADV
ajlm-804	147	46	;	;	PUNCT
ajlm-804	147	47	united	united	PROPN
ajlm-804	147	48	states	states	PROPN
ajlm-804	147	49	:	:	PUNCT
ajlm-804	147	50	nhuan	nhuan	PROPN
ajlm-804	147	51	ha	ha	INTJ
ajlm-804	147	52	;	;	PUNCT
ajlm-804	147	53	south	south	PROPN
ajlm-804	147	54	africa	africa	PROPN
ajlm-804	147	55	:	:	PUNCT
ajlm-804	147	56	keshendree	keshendree	PROPN
ajlm-804	147	57	moodley	moodley	NOUN
ajlm-804	147	58	.	.	PUNCT
ajlm-804	148	1	testing	testing	NOUN
ajlm-804	148	2	in	in	ADP
ajlm-804	148	3	canada	canada	PROPN
ajlm-804	148	4	was	be	AUX
ajlm-804	148	5	done	do	VERB
ajlm-804	148	6	by	by	ADP
ajlm-804	148	7	dominika	dominika	PROPN
ajlm-804	148	8	benjamins	benjamins	PROPN
ajlm-804	148	9	.	.	PUNCT
ajlm-804	149	1	thank	thank	VERB
ajlm-804	149	2	you	you	PRON
ajlm-804	149	3	to	to	ADP
ajlm-804	149	4	karen	karen	PROPN
ajlm-804	149	5	lo	lo	PROPN
ajlm-804	149	6	and	and	CCONJ
ajlm-804	149	7	robert	robert	PROPN
ajlm-804	149	8	magari	magari	PROPN
ajlm-804	149	9	for	for	ADP
ajlm-804	149	10	support	support	NOUN
ajlm-804	149	11	on	on	ADP
ajlm-804	149	12	the	the	DET
ajlm-804	149	13	statistical	statistical	ADJ
ajlm-804	149	14	analysis	analysis	NOUN
ajlm-804	149	15	.	.	PUNCT
ajlm-804	150	1	competing	compete	VERB
ajlm-804	150	2	interests	interest	NOUN
ajlm-804	150	3	d.k.g	d.k.g	ADV
ajlm-804	150	4	.	.	PUNCT
ajlm-804	151	1	is	be	AUX
ajlm-804	151	2	an	an	DET
ajlm-804	151	3	employee	employee	NOUN
ajlm-804	151	4	of	of	ADP
ajlm-804	151	5	the	the	DET
ajlm-804	151	6	south	south	ADJ
ajlm-804	151	7	african	african	ADJ
ajlm-804	151	8	national	national	PROPN
ajlm-804	151	9	health	health	PROPN
ajlm-804	151	10	laboratory	laboratory	PROPN
ajlm-804	151	11	service	service	NOUN
ajlm-804	151	12	and	and	CCONJ
ajlm-804	151	13	is	be	AUX
ajlm-804	151	14	the	the	DET
ajlm-804	151	15	named	name	VERB
ajlm-804	151	16	inventor	inventor	NOUN
ajlm-804	151	17	of	of	ADP
ajlm-804	151	18	a	a	DET
ajlm-804	151	19	family	family	NOUN
ajlm-804	151	20	of	of	ADP
ajlm-804	151	21	patents	patent	NOUN
ajlm-804	151	22	,	,	PUNCT
ajlm-804	151	23	including	include	VERB
ajlm-804	151	24	ep	ep	PROPN
ajlm-804	151	25	1	1	NUM
ajlm-804	151	26	405	405	NUM
ajlm-804	151	27	073	073	NUM
ajlm-804	151	28	and	and	CCONJ
ajlm-804	151	29	us	we	PRON
ajlm-804	151	30	7	7	NUM
ajlm-804	151	31	670	670	NUM
ajlm-804	151	32	793	793	NUM
ajlm-804	151	33	,	,	PUNCT
ajlm-804	151	34	covering	cover	VERB
ajlm-804	151	35	the	the	DET
ajlm-804	151	36	plg	plg	NOUN
ajlm-804	151	37	/	/	SYM
ajlm-804	151	38	cd4	cd4	PROPN
ajlm-804	151	39	method	method	NOUN
ajlm-804	151	40	of	of	ADP
ajlm-804	151	41	establishing	establish	VERB
ajlm-804	151	42	cd4	cd4	PROPN
ajlm-804	151	43	counts	count	NOUN
ajlm-804	151	44	in	in	ADP
ajlm-804	151	45	a	a	DET
ajlm-804	151	46	sample	sample	NOUN
ajlm-804	151	47	.	.	PUNCT
ajlm-804	152	1	this	this	DET
ajlm-804	152	2	patent	patent	NOUN
ajlm-804	152	3	family	family	NOUN
ajlm-804	152	4	is	be	AUX
ajlm-804	152	5	wholly	wholly	ADV
ajlm-804	152	6	owned	own	VERB
ajlm-804	152	7	by	by	ADP
ajlm-804	152	8	the	the	DET
ajlm-804	152	9	national	national	PROPN
ajlm-804	152	10	health	health	PROPN
ajlm-804	152	11	laboratory	laboratory	PROPN
ajlm-804	152	12	service	service	NOUN
ajlm-804	152	13	and	and	CCONJ
ajlm-804	152	14	is	be	AUX
ajlm-804	152	15	exclusively	exclusively	ADV
ajlm-804	152	16	licensed	license	VERB
ajlm-804	152	17	to	to	ADP
ajlm-804	152	18	beckman	beckman	PROPN
ajlm-804	152	19	coulter	coulter	PROPN
ajlm-804	152	20	.	.	PUNCT
ajlm-804	153	1	m.k	m.k	PROPN
ajlm-804	153	2	.	.	PROPN
ajlm-804	153	3	is	be	AUX
ajlm-804	153	4	a	a	DET
ajlm-804	153	5	consultant	consultant	NOUN
ajlm-804	153	6	for	for	ADP
ajlm-804	153	7	beckman	beckman	PROPN
ajlm-804	153	8	coulter	coulter	PROPN
ajlm-804	153	9	.	.	PUNCT
ajlm-804	154	1	d.r	d.r	PROPN
ajlm-804	154	2	.	.	PROPN
ajlm-804	154	3	,	,	PUNCT
ajlm-804	154	4	j.r	j.r	PROPN
ajlm-804	154	5	.	.	PROPN
ajlm-804	154	6	and	and	CCONJ
ajlm-804	154	7	j.z	j.z	PROPN
ajlm-804	154	8	.	.	PROPN
ajlm-804	154	9	are	be	AUX
ajlm-804	154	10	beckman	beckman	PROPN
ajlm-804	154	11	coulter	coulter	PROPN
ajlm-804	154	12	employees	employee	NOUN
ajlm-804	154	13	.	.	PUNCT
ajlm-804	155	1	no	no	DET
ajlm-804	155	2	other	other	ADJ
ajlm-804	155	3	authors	author	NOUN
ajlm-804	155	4	have	have	AUX
ajlm-804	155	5	declared	declare	VERB
ajlm-804	155	6	competing	compete	VERB
ajlm-804	155	7	interests	interest	NOUN
ajlm-804	155	8	.	.	PUNCT
ajlm-804	156	1	authors	author	NOUN
ajlm-804	156	2	’	'	PUNCT
ajlm-804	156	3	contributions	contribution	NOUN
ajlm-804	156	4	all	all	DET
ajlm-804	156	5	authors	author	NOUN
ajlm-804	156	6	contributed	contribute	VERB
ajlm-804	156	7	equally	equally	ADV
ajlm-804	156	8	to	to	ADP
ajlm-804	156	9	concept	concept	NOUN
ajlm-804	156	10	,	,	PUNCT
ajlm-804	156	11	design	design	NOUN
ajlm-804	156	12	,	,	PUNCT
ajlm-804	156	13	data	data	NOUN
ajlm-804	156	14	acquisition	acquisition	NOUN
ajlm-804	156	15	,	,	PUNCT
ajlm-804	156	16	critical	critical	ADJ
ajlm-804	156	17	review	review	NOUN
ajlm-804	156	18	of	of	ADP
ajlm-804	156	19	the	the	DET
ajlm-804	156	20	article	article	NOUN
ajlm-804	156	21	for	for	ADP
ajlm-804	156	22	intellectual	intellectual	ADJ
ajlm-804	156	23	content	content	NOUN
ajlm-804	156	24	,	,	PUNCT
ajlm-804	156	25	and	and	CCONJ
ajlm-804	156	26	approval	approval	NOUN
ajlm-804	156	27	of	of	ADP
ajlm-804	156	28	the	the	DET
ajlm-804	156	29	final	final	ADJ
ajlm-804	156	30	version	version	NOUN
ajlm-804	156	31	to	to	PART
ajlm-804	156	32	be	be	AUX
ajlm-804	156	33	submitted	submit	VERB
ajlm-804	156	34	.	.	PUNCT
ajlm-804	157	1	sources	source	NOUN
ajlm-804	157	2	of	of	ADP
ajlm-804	157	3	support	support	NOUN
ajlm-804	157	4	this	this	DET
ajlm-804	157	5	study	study	NOUN
ajlm-804	157	6	was	be	AUX
ajlm-804	157	7	supported	support	VERB
ajlm-804	157	8	and	and	CCONJ
ajlm-804	157	9	funded	fund	VERB
ajlm-804	157	10	by	by	ADP
ajlm-804	157	11	beckman	beckman	PROPN
ajlm-804	157	12	coulter	coulter	PROPN
ajlm-804	157	13	,	,	PUNCT
ajlm-804	157	14	inc	inc	PROPN
ajlm-804	157	15	.	.	PROPN
ajlm-804	158	1	(	(	PUNCT
ajlm-804	158	2	miami	miami	PROPN
ajlm-804	158	3	,	,	PUNCT
ajlm-804	158	4	florida	florida	PROPN
ajlm-804	158	5	,	,	PUNCT
ajlm-804	158	6	united	united	PROPN
ajlm-804	158	7	states	states	PROPN
ajlm-804	158	8	)	)	PUNCT
ajlm-804	158	9	which	which	PRON
ajlm-804	158	10	provided	provide	VERB
ajlm-804	158	11	reagents	reagent	NOUN
ajlm-804	158	12	,	,	PUNCT
ajlm-804	158	13	instruments	instrument	NOUN
ajlm-804	158	14	,	,	PUNCT
ajlm-804	158	15	and	and	CCONJ
ajlm-804	158	16	supplies	supply	NOUN
ajlm-804	158	17	.	.	PUNCT
ajlm-804	159	1	data	datum	NOUN
ajlm-804	159	2	availability	availability	NOUN
ajlm-804	159	3	statement	statement	NOUN
ajlm-804	159	4	all	all	DET
ajlm-804	159	5	relevant	relevant	ADJ
ajlm-804	159	6	data	datum	NOUN
ajlm-804	159	7	are	be	AUX
ajlm-804	159	8	within	within	ADP
ajlm-804	159	9	the	the	DET
ajlm-804	159	10	article	article	NOUN
ajlm-804	159	11	.	.	PUNCT
ajlm-804	160	1	disclaimer	disclaimer	VERB
ajlm-804	160	2	the	the	DET
ajlm-804	160	3	views	view	NOUN
ajlm-804	160	4	and	and	CCONJ
ajlm-804	160	5	opinions	opinion	NOUN
ajlm-804	160	6	expressed	express	VERB
ajlm-804	160	7	in	in	ADP
ajlm-804	160	8	this	this	DET
ajlm-804	160	9	article	article	NOUN
ajlm-804	160	10	are	be	AUX
ajlm-804	160	11	those	those	PRON
ajlm-804	160	12	of	of	ADP
ajlm-804	160	13	the	the	DET
ajlm-804	160	14	authors	author	NOUN
ajlm-804	160	15	and	and	CCONJ
ajlm-804	160	16	do	do	AUX
ajlm-804	160	17	not	not	PART
ajlm-804	160	18	necessarily	necessarily	ADV
ajlm-804	160	19	reflect	reflect	VERB
ajlm-804	160	20	the	the	DET
ajlm-804	160	21	official	official	ADJ
ajlm-804	160	22	policy	policy	NOUN
ajlm-804	160	23	or	or	CCONJ
ajlm-804	160	24	position	position	NOUN
ajlm-804	160	25	of	of	ADP
ajlm-804	160	26	any	any	DET
ajlm-804	160	27	affiliated	affiliated	ADJ
ajlm-804	160	28	agency	agency	NOUN
ajlm-804	160	29	of	of	ADP
ajlm-804	160	30	the	the	DET
ajlm-804	160	31	authors	author	NOUN
ajlm-804	160	32	.	.	PUNCT
ajlm-804	161	1	references	reference	NOUN
ajlm-804	161	2	prince	prince	VERB
ajlm-804	161	3	he	he	PRON
ajlm-804	161	4	,	,	PUNCT
ajlm-804	161	5	lesar	lesar	PROPN
ajlm-804	161	6	wj	wj	PROPN
ajlm-804	161	7	.	.	PUNCT
ajlm-804	162	1	simultaneous	simultaneous	ADJ
ajlm-804	162	2	determination	determination	NOUN
ajlm-804	162	3	of	of	ADP
ajlm-804	162	4	absolute	absolute	ADJ
ajlm-804	162	5	total	total	ADJ
ajlm-804	162	6	lymphocyte	lymphocyte	NOUN
ajlm-804	162	7	and	and	CCONJ
ajlm-804	162	8	cd4	cd4	PROPN
ajlm-804	162	9	+	+	ADJ
ajlm-804	162	10	lymphocyte	lymphocyte	ADJ
ajlm-804	162	11	levels	level	NOUN
ajlm-804	162	12	in	in	ADP
ajlm-804	162	13	peripheral	peripheral	ADJ
ajlm-804	162	14	blood	blood	NOUN
ajlm-804	162	15	by	by	ADP
ajlm-804	162	16	flow	flow	NOUN
ajlm-804	162	17	cytometry	cytometry	NOUN
ajlm-804	162	18	.	.	PUNCT
ajlm-804	163	1	am	be	AUX
ajlm-804	163	2	j	j	PROPN
ajlm-804	163	3	clin	clin	PROPN
ajlm-804	163	4	pathol	pathol	PROPN
ajlm-804	163	5	.	.	PUNCT
ajlm-804	164	1	1989;92(2):206–209	1989;92(2):206–209	X
ajlm-804	164	2	.	.	PUNCT
ajlm-804	165	1	https://doi.org/10.1093/ajcp/92.2.206	https://doi.org/10.1093/ajcp/92.2.206	X
ajlm-804	165	2	pedersen	pedersen	NOUN
ajlm-804	165	3	c	c	PROPN
ajlm-804	165	4	,	,	PUNCT
ajlm-804	165	5	gerstoft	gerstoft	PROPN
ajlm-804	165	6	j	j	PROPN
ajlm-804	165	7	,	,	PUNCT
ajlm-804	165	8	tauris	tauris	VERB
ajlm-804	165	9	p	p	X
ajlm-804	165	10	,	,	PUNCT
ajlm-804	165	11	et	et	PROPN
ajlm-804	165	12	al	al	PROPN
ajlm-804	165	13	.	.	PUNCT
ajlm-804	165	14	trends	trend	NOUN
ajlm-804	165	15	in	in	ADP
ajlm-804	165	16	survival	survival	NOUN
ajlm-804	165	17	of	of	ADP
ajlm-804	165	18	danish	danish	ADJ
ajlm-804	165	19	aids	aids	PROPN
ajlm-804	165	20	patients	patient	NOUN
ajlm-804	165	21	from	from	ADP
ajlm-804	165	22	1981	1981	NUM
ajlm-804	165	23	to	to	ADP
ajlm-804	165	24	1989	1989	NUM
ajlm-804	165	25	.	.	PUNCT
ajlm-804	166	1	aids	aids	PROPN
ajlm-804	166	2	.	.	PUNCT
ajlm-804	167	1	1990;4(11):1111–1116	1990;4(11):1111–1116	PROPN
ajlm-804	167	2	.	.	PUNCT
ajlm-804	168	1	https://doi.org/10.1097/00002030-199011000-00009	https://doi.org/10.1097/00002030-199011000-00009	PROPN
ajlm-804	168	2	lee	lee	PROPN
ajlm-804	168	3	ca	ca	PROPN
ajlm-804	168	4	,	,	PUNCT
ajlm-804	168	5	phillips	phillip	NOUN
ajlm-804	168	6	an	an	PROPN
ajlm-804	168	7	,	,	PUNCT
ajlm-804	168	8	elford	elford	PROPN
ajlm-804	168	9	j	j	PROPN
ajlm-804	168	10	,	,	PUNCT
ajlm-804	168	11	janossy	janossy	PROPN
ajlm-804	168	12	g	g	PROPN
ajlm-804	168	13	,	,	PUNCT
ajlm-804	168	14	griffiths	griffiths	PROPN
ajlm-804	168	15	p	p	PROPN
ajlm-804	168	16	,	,	PUNCT
ajlm-804	168	17	kernoff	kernoff	PROPN
ajlm-804	168	18	p.	p.	NOUN
ajlm-804	168	19	progression	progression	NOUN
ajlm-804	168	20	of	of	ADP
ajlm-804	168	21	hiv	hiv	PROPN
ajlm-804	168	22	disease	disease	NOUN
ajlm-804	168	23	in	in	ADP
ajlm-804	168	24	a	a	DET
ajlm-804	168	25	haemophilic	haemophilic	ADJ
ajlm-804	168	26	cohort	cohort	NOUN
ajlm-804	168	27	followed	follow	VERB
ajlm-804	168	28	for	for	ADP
ajlm-804	168	29	11	11	NUM
ajlm-804	168	30	years	year	NOUN
ajlm-804	168	31	and	and	CCONJ
ajlm-804	168	32	the	the	DET
ajlm-804	168	33	effect	effect	NOUN
ajlm-804	168	34	of	of	ADP
ajlm-804	168	35	treatment	treatment	NOUN
ajlm-804	168	36	.	.	PUNCT
ajlm-804	169	1	bmj	bmj	PROPN
ajlm-804	169	2	.	.	PUNCT
ajlm-804	170	1	1991;303(6810):1093–1096	1991;303(6810):1093–1096	NUM
ajlm-804	170	2	.	.	PUNCT
ajlm-804	171	1	https://doi.org/10.1136/bmj.303.6810.1093	https://doi.org/10.1136/bmj.303.6810.1093	PROPN
ajlm-804	171	2	mandy	mandy	PROPN
ajlm-804	171	3	f	f	PROPN
ajlm-804	171	4	,	,	PUNCT
ajlm-804	171	5	janossy	janossy	PROPN
ajlm-804	171	6	g	g	PROPN
ajlm-804	171	7	,	,	PUNCT
ajlm-804	171	8	bergeron	bergeron	PROPN
ajlm-804	171	9	m	m	PROPN
ajlm-804	171	10	,	,	PUNCT
ajlm-804	171	11	pilon	pilon	PROPN
ajlm-804	171	12	r	r	PROPN
ajlm-804	171	13	,	,	PUNCT
ajlm-804	171	14	faucher	faucher	ADJ
ajlm-804	171	15	s.	s.	PROPN
ajlm-804	171	16	affordable	affordable	PROPN
ajlm-804	171	17	cd4	cd4	PROPN
ajlm-804	171	18	t	t	PROPN
ajlm-804	171	19	-	-	PUNCT
ajlm-804	171	20	cell	cell	NOUN
ajlm-804	171	21	enumeration	enumeration	NOUN
ajlm-804	171	22	for	for	ADP
ajlm-804	171	23	resource	resource	NOUN
ajlm-804	171	24	-	-	PUNCT
ajlm-804	171	25	limited	limit	VERB
ajlm-804	171	26	regions	region	NOUN
ajlm-804	171	27	:	:	PUNCT
ajlm-804	171	28	a	a	DET
ajlm-804	171	29	status	status	NOUN
ajlm-804	171	30	report	report	NOUN
ajlm-804	171	31	for	for	ADP
ajlm-804	171	32	2008	2008	NUM
ajlm-804	171	33	.	.	PUNCT
ajlm-804	172	1	cytometry	cytometry	PROPN
ajlm-804	172	2	b	b	PROPN
ajlm-804	172	3	clin	clin	PROPN
ajlm-804	172	4	cytom	cytom	PROPN
ajlm-804	172	5	.	.	PUNCT
ajlm-804	173	1	2008;74	2008;74	NUM
ajlm-804	173	2	suppl	suppl	ADJ
ajlm-804	173	3	1	1	NUM
ajlm-804	173	4	:	:	PUNCT
ajlm-804	173	5	s27	s27	PROPN
ajlm-804	173	6	–	–	PUNCT
ajlm-804	173	7	s39	s39	X
ajlm-804	173	8	.	.	PUNCT
ajlm-804	173	9	https://doi.org/10.1002/cyto.b.20414	https://doi.org/10.1002/cyto.b.20414	PUNCT
ajlm-804	174	1	mandy	mandy	PROPN
ajlm-804	174	2	f	f	PROPN
ajlm-804	174	3	,	,	PUNCT
ajlm-804	174	4	nicholson	nicholson	PROPN
ajlm-804	174	5	j	j	PROPN
ajlm-804	174	6	,	,	PUNCT
ajlm-804	174	7	autran	autran	PROPN
ajlm-804	174	8	b	b	NUM
ajlm-804	174	9	,	,	PUNCT
ajlm-804	174	10	janossy	janossy	PROPN
ajlm-804	174	11	g.	g.	PROPN
ajlm-804	174	12	t	t	PROPN
ajlm-804	174	13	-	-	PUNCT
ajlm-804	174	14	cell	cell	NOUN
ajlm-804	174	15	subset	subset	NOUN
ajlm-804	174	16	counting	counting	NOUN
ajlm-804	174	17	and	and	CCONJ
ajlm-804	174	18	the	the	DET
ajlm-804	174	19	fight	fight	NOUN
ajlm-804	174	20	against	against	ADP
ajlm-804	174	21	aids	aid	NOUN
ajlm-804	174	22	:	:	PUNCT
ajlm-804	174	23	reflections	reflection	NOUN
ajlm-804	174	24	over	over	ADP
ajlm-804	174	25	a	a	DET
ajlm-804	174	26	20	20	NUM
ajlm-804	174	27	-	-	PUNCT
ajlm-804	174	28	year	year	NOUN
ajlm-804	174	29	struggle	struggle	NOUN
ajlm-804	174	30	.	.	PUNCT
ajlm-804	175	1	cytometry	cytometry	NOUN
ajlm-804	175	2	.	.	PUNCT
ajlm-804	176	1	2002;50(2):39–45	2002;50(2):39–45	X
ajlm-804	176	2	.	.	PUNCT
ajlm-804	176	3	https://doi.org/10.1002/cyto.10097	https://doi.org/10.1002/cyto.10097	PROPN
ajlm-804	177	1	janossy	janossy	PROPN
ajlm-804	177	2	g	g	PROPN
ajlm-804	177	3	,	,	PUNCT
ajlm-804	177	4	jani	jani	PROPN
ajlm-804	177	5	i	i	PROPN
ajlm-804	177	6	,	,	PUNCT
ajlm-804	177	7	gohde	gohde	PROPN
ajlm-804	177	8	w.	w.	PROPN
ajlm-804	177	9	affordable	affordable	ADJ
ajlm-804	177	10	cd4(+	cd4(+	PROPN
ajlm-804	177	11	)	)	PUNCT
ajlm-804	177	12	t	t	NOUN
ajlm-804	177	13	-	-	PUNCT
ajlm-804	177	14	cell	cell	NOUN
ajlm-804	177	15	counts	count	NOUN
ajlm-804	177	16	on	on	ADP
ajlm-804	177	17	‘	'	PUNCT
ajlm-804	177	18	single	single	ADJ
ajlm-804	177	19	-	-	PUNCT
ajlm-804	177	20	platform	platform	NOUN
ajlm-804	177	21	’	'	PUNCT
ajlm-804	177	22	flow	flow	NOUN
ajlm-804	177	23	cytometers	cytometer	NOUN
ajlm-804	177	24	i.	i.	PROPN
ajlm-804	177	25	primary	primary	NOUN
ajlm-804	177	26	cd4	cd4	PROPN
ajlm-804	177	27	gating	gating	NOUN
ajlm-804	177	28	.	.	PUNCT
ajlm-804	178	1	br	br	X
ajlm-804	178	2	j	j	PROPN
ajlm-804	178	3	haematol	haematol	NOUN
ajlm-804	178	4	.	.	PUNCT
ajlm-804	179	1	2000;111(4):1198–1208	2000;111(4):1198–1208	NUM
ajlm-804	179	2	.	.	PUNCT
ajlm-804	179	3	https://doi.org/10.1046/j.1365-2141.2000.02433.x	https://doi.org/10.1046/j.1365-2141.2000.02433.x	PROPN
ajlm-804	179	4	sherman	sherman	PROPN
ajlm-804	179	5	gg	gg	PROPN
ajlm-804	179	6	,	,	PUNCT
ajlm-804	179	7	galpin	galpin	NOUN
ajlm-804	179	8	js	js	PROPN
ajlm-804	179	9	,	,	PUNCT
ajlm-804	179	10	patel	patel	PROPN
ajlm-804	179	11	jm	jm	PROPN
ajlm-804	179	12	,	,	PUNCT
ajlm-804	179	13	mendelow	mendelow	PROPN
ajlm-804	179	14	bv	bv	PROPN
ajlm-804	179	15	,	,	PUNCT
ajlm-804	179	16	glencross	glencross	ADJ
ajlm-804	179	17	dk	dk	PROPN
ajlm-804	179	18	.	.	PUNCT
ajlm-804	180	1	cd4	cd4	PROPN
ajlm-804	180	2	+	+	PROPN
ajlm-804	180	3	t	t	PROPN
ajlm-804	180	4	cell	cell	NOUN
ajlm-804	180	5	enumeration	enumeration	NOUN
ajlm-804	180	6	in	in	ADP
ajlm-804	180	7	hiv	hiv	PROPN
ajlm-804	180	8	infection	infection	NOUN
ajlm-804	180	9	with	with	ADP
ajlm-804	180	10	limited	limited	ADJ
ajlm-804	180	11	resources	resource	NOUN
ajlm-804	180	12	.	.	PUNCT
ajlm-804	181	1	j	j	PROPN
ajlm-804	181	2	immunol	immunol	NOUN
ajlm-804	181	3	methods	method	NOUN
ajlm-804	181	4	.	.	PUNCT
ajlm-804	182	1	1999;222(1–2):209–217	1999;222(1–2):209–217	NUM
ajlm-804	182	2	.	.	PUNCT
ajlm-804	182	3	https://doi.org/10.1016/s0022-1759(98)00172-0	https://doi.org/10.1016/s0022-1759(98)00172-0	PROPN
ajlm-804	182	4	janossy	janossy	PROPN
ajlm-804	182	5	g	g	PROPN
ajlm-804	182	6	,	,	PUNCT
ajlm-804	182	7	jani	jani	PROPN
ajlm-804	182	8	iv	iv	PROPN
ajlm-804	182	9	,	,	PUNCT
ajlm-804	182	10	bradley	bradley	PROPN
ajlm-804	182	11	nj	nj	PROPN
ajlm-804	182	12	,	,	PUNCT
ajlm-804	182	13	bikoue	bikoue	PROPN
ajlm-804	182	14	a	a	PRON
ajlm-804	182	15	,	,	PUNCT
ajlm-804	182	16	pitfield	pitfield	PROPN
ajlm-804	182	17	t	t	PROPN
ajlm-804	182	18	,	,	PUNCT
ajlm-804	182	19	glencross	glencross	ADJ
ajlm-804	182	20	dk	dk	PROPN
ajlm-804	182	21	.	.	PROPN
ajlm-804	182	22	affordable	affordable	PROPN
ajlm-804	182	23	cd4(+)-t	cd4(+)-t	NOUN
ajlm-804	182	24	-	-	PUNCT
ajlm-804	182	25	cell	cell	NOUN
ajlm-804	182	26	counting	counting	NOUN
ajlm-804	182	27	by	by	ADP
ajlm-804	182	28	flow	flow	NOUN
ajlm-804	182	29	cytometry	cytometry	NOUN
ajlm-804	182	30	:	:	PUNCT
ajlm-804	183	1	cd45	cd45	PROPN
ajlm-804	183	2	gating	gate	VERB
ajlm-804	183	3	for	for	ADP
ajlm-804	183	4	volumetric	volumetric	ADJ
ajlm-804	183	5	analysis	analysis	NOUN
ajlm-804	183	6	.	.	PUNCT
ajlm-804	184	1	clin	clin	PROPN
ajlm-804	184	2	diagn	diagn	PROPN
ajlm-804	184	3	lab	lab	NOUN
ajlm-804	184	4	immunol	immunol	NOUN
ajlm-804	184	5	.	.	PUNCT
ajlm-804	185	1	2002;9(5):1085–1094	2002;9(5):1085–1094	X
ajlm-804	185	2	.	.	PUNCT
ajlm-804	186	1	https://doi.org/10.1128/cdli.9.5.1085-1094.2002	https://doi.org/10.1128/cdli.9.5.1085-1094.2002	PROPN
ajlm-804	186	2	glencross	glencross	PROPN
ajlm-804	186	3	dk	dk	PROPN
ajlm-804	186	4	,	,	PUNCT
ajlm-804	186	5	coetzee	coetzee	PROPN
ajlm-804	186	6	lm	lm	PROPN
ajlm-804	186	7	,	,	PUNCT
ajlm-804	186	8	faal	faal	PROPN
ajlm-804	186	9	m	m	PROPN
ajlm-804	186	10	,	,	PUNCT
ajlm-804	186	11	et	et	PROPN
ajlm-804	186	12	al	al	PROPN
ajlm-804	186	13	.	.	PUNCT
ajlm-804	187	1	pima	pima	PROPN
ajlm-804	187	2	™	™	PROPN
ajlm-804	187	3	cd4	cd4	PROPN
ajlm-804	187	4	counting	counting	NOUN
ajlm-804	187	5	accuracy	accuracy	NOUN
ajlm-804	187	6	depends	depend	VERB
ajlm-804	187	7	on	on	ADP
ajlm-804	187	8	rigid	rigid	ADJ
ajlm-804	187	9	finger	finger	NOUN
ajlm-804	187	10	-	-	PUNCT
ajlm-804	187	11	prick	prick	NOUN
ajlm-804	187	12	protocol	protocol	NOUN
ajlm-804	187	13	adherence	adherence	NOUN
ajlm-804	187	14	.	.	PUNCT
ajlm-804	188	1	2011	2011	NUM
ajlm-804	188	2	;	;	PUNCT
ajlm-804	188	3	5th	5th	ADJ
ajlm-804	188	4	sa	sa	PROPN
ajlm-804	188	5	aids	aids	PROPN
ajlm-804	188	6	conference	conference	PROPN
ajlm-804	188	7	,	,	PUNCT
ajlm-804	188	8	durban	durban	PROPN
ajlm-804	188	9	,	,	PUNCT
ajlm-804	188	10	jun	jun	PROPN
ajlm-804	188	11	7–10	7–10	PROPN
ajlm-804	188	12	.	.	PUNCT
ajlm-804	189	1	jani	jani	PROPN
ajlm-804	189	2	iv	iv	PROPN
ajlm-804	189	3	,	,	PUNCT
ajlm-804	189	4	sitoe	sitoe	PROPN
ajlm-804	189	5	ne	ne	PROPN
ajlm-804	189	6	,	,	PUNCT
ajlm-804	189	7	chongo	chongo	PROPN
ajlm-804	189	8	pl	pl	PROPN
ajlm-804	189	9	,	,	PUNCT
ajlm-804	189	10	et	et	PROPN
ajlm-804	189	11	al	al	PROPN
ajlm-804	189	12	.	.	PROPN
ajlm-804	189	13	accurate	accurate	PROPN
ajlm-804	189	14	cd4	cd4	PROPN
ajlm-804	189	15	t	t	PROPN
ajlm-804	189	16	-	-	PUNCT
ajlm-804	189	17	cell	cell	NOUN
ajlm-804	189	18	enumeration	enumeration	NOUN
ajlm-804	189	19	and	and	CCONJ
ajlm-804	189	20	antiretroviral	antiretroviral	ADJ
ajlm-804	189	21	drug	drug	NOUN
ajlm-804	189	22	toxicity	toxicity	NOUN
ajlm-804	189	23	monitoring	monitoring	NOUN
ajlm-804	189	24	in	in	ADP
ajlm-804	189	25	primary	primary	ADJ
ajlm-804	189	26	healthcare	healthcare	NOUN
ajlm-804	189	27	clinics	clinic	NOUN
ajlm-804	189	28	using	use	VERB
ajlm-804	189	29	point	point	NOUN
ajlm-804	189	30	-	-	PUNCT
ajlm-804	189	31	of	of	ADP
ajlm-804	189	32	-	-	PUNCT
ajlm-804	189	33	care	care	NOUN
ajlm-804	189	34	testing	testing	NOUN
ajlm-804	189	35	.	.	PUNCT
ajlm-804	190	1	aids	aids	PROPN
ajlm-804	190	2	.	.	PUNCT
ajlm-804	191	1	2011;25(6):807–812	2011;25(6):807–812	X
ajlm-804	191	2	.	.	PUNCT
ajlm-804	191	3	https://doi.org/10.1097/qad.0b013e328344f424	https://doi.org/10.1097/qad.0b013e328344f424	VERB
ajlm-804	191	4	glencross	glencross	ADJ
ajlm-804	191	5	dk	dk	NOUN
ajlm-804	191	6	,	,	PUNCT
ajlm-804	191	7	coetzee	coetzee	PROPN
ajlm-804	191	8	lm	lm	PROPN
ajlm-804	191	9	,	,	PUNCT
ajlm-804	191	10	cassim	cassim	PROPN
ajlm-804	191	11	n.	n.	PROPN
ajlm-804	191	12	an	an	DET
ajlm-804	191	13	integrated	integrate	VERB
ajlm-804	191	14	tiered	tiere	VERB
ajlm-804	191	15	service	service	NOUN
ajlm-804	191	16	delivery	delivery	NOUN
ajlm-804	191	17	model	model	NOUN
ajlm-804	191	18	(	(	PUNCT
ajlm-804	191	19	itsdm	itsdm	PROPN
ajlm-804	191	20	)	)	PUNCT
ajlm-804	191	21	based	base	VERB
ajlm-804	191	22	on	on	ADP
ajlm-804	191	23	local	local	ADJ
ajlm-804	191	24	cd4	cd4	PROPN
ajlm-804	191	25	testing	testing	NOUN
ajlm-804	191	26	demands	demand	NOUN
ajlm-804	191	27	can	can	AUX
ajlm-804	191	28	improve	improve	VERB
ajlm-804	191	29	turn	turn	NOUN
ajlm-804	191	30	-	-	PUNCT
ajlm-804	191	31	around	around	ADP
ajlm-804	191	32	times	time	NOUN
ajlm-804	191	33	and	and	CCONJ
ajlm-804	191	34	save	save	VERB
ajlm-804	191	35	costs	cost	NOUN
ajlm-804	191	36	whilst	whilst	SCONJ
ajlm-804	191	37	ensuring	ensure	VERB
ajlm-804	191	38	accessible	accessible	ADJ
ajlm-804	191	39	and	and	CCONJ
ajlm-804	191	40	scalable	scalable	ADJ
ajlm-804	191	41	cd4	cd4	PROPN
ajlm-804	191	42	services	service	NOUN
ajlm-804	191	43	across	across	ADP
ajlm-804	191	44	a	a	DET
ajlm-804	191	45	national	national	ADJ
ajlm-804	191	46	programme	programme	NOUN
ajlm-804	191	47	.	.	PUNCT
ajlm-804	192	1	plos	plos	PROPN
ajlm-804	192	2	one	one	NUM
ajlm-804	192	3	.	.	PUNCT
ajlm-804	193	1	2014;9(12):e114727	2014;9(12):e114727	NOUN
ajlm-804	193	2	.	.	PUNCT
ajlm-804	194	1	https://doi.org/10.1371/journal.pone.0114727	https://doi.org/10.1371/journal.pone.0114727	PROPN
ajlm-804	194	2	glencross	glencross	PROPN
ajlm-804	194	3	dk	dk	PROPN
ajlm-804	194	4	,	,	PUNCT
ajlm-804	194	5	janossy	janossy	NOUN
ajlm-804	194	6	g	g	PROPN
ajlm-804	194	7	,	,	PUNCT
ajlm-804	194	8	coetzee	coetzee	PROPN
ajlm-804	194	9	lm	lm	PROPN
ajlm-804	194	10	,	,	PUNCT
ajlm-804	194	11	et	et	PROPN
ajlm-804	194	12	al	al	PROPN
ajlm-804	194	13	.	.	PUNCT
ajlm-804	195	1	large	large	ADJ
ajlm-804	195	2	-	-	PUNCT
ajlm-804	195	3	scale	scale	NOUN
ajlm-804	195	4	affordable	affordable	ADJ
ajlm-804	195	5	panleucogated	panleucogate	VERB
ajlm-804	195	6	cd4	cd4	PROPN
ajlm-804	195	7	+	+	PROPN
ajlm-804	195	8	testing	testing	NOUN
ajlm-804	195	9	with	with	ADP
ajlm-804	195	10	proactive	proactive	ADJ
ajlm-804	195	11	internal	internal	ADJ
ajlm-804	195	12	and	and	CCONJ
ajlm-804	195	13	external	external	ADJ
ajlm-804	195	14	quality	quality	NOUN
ajlm-804	195	15	assessment	assessment	NOUN
ajlm-804	195	16	:	:	PUNCT
ajlm-804	195	17	in	in	ADP
ajlm-804	195	18	support	support	NOUN
ajlm-804	195	19	of	of	ADP
ajlm-804	195	20	the	the	DET
ajlm-804	195	21	south	south	ADJ
ajlm-804	195	22	african	african	ADJ
ajlm-804	195	23	national	national	PROPN
ajlm-804	195	24	comprehensive	comprehensive	PROPN
ajlm-804	195	25	care	care	NOUN
ajlm-804	195	26	,	,	PUNCT
ajlm-804	195	27	treatment	treatment	NOUN
ajlm-804	195	28	and	and	CCONJ
ajlm-804	195	29	management	management	NOUN
ajlm-804	195	30	programme	programme	NOUN
ajlm-804	195	31	for	for	ADP
ajlm-804	195	32	hiv	hiv	PROPN
ajlm-804	195	33	and	and	CCONJ
ajlm-804	195	34	aids	aids	PROPN
ajlm-804	195	35	.	.	PUNCT
ajlm-804	196	1	cytometry	cytometry	PROPN
ajlm-804	196	2	b	b	PROPN
ajlm-804	196	3	clin	clin	PROPN
ajlm-804	196	4	cytom	cytom	PROPN
ajlm-804	196	5	.	.	PUNCT
ajlm-804	197	1	2008;74	2008;74	NUM
ajlm-804	197	2	suppl	suppl	ADJ
ajlm-804	197	3	1	1	NUM
ajlm-804	197	4	:	:	PUNCT
ajlm-804	197	5	s40	s40	NOUN
ajlm-804	197	6	–	–	PUNCT
ajlm-804	197	7	s51	s51	X
ajlm-804	197	8	.	.	PUNCT
ajlm-804	198	1	https://doi.org/10.1002/cyto.b.20384	https://doi.org/10.1002/cyto.b.20384	X
ajlm-804	198	2	glencross	glencross	ADJ
ajlm-804	198	3	dk	dk	PROPN
ajlm-804	198	4	,	,	PUNCT
ajlm-804	198	5	mendelow	mendelow	PROPN
ajlm-804	198	6	bv	bv	PROPN
ajlm-804	198	7	,	,	PUNCT
ajlm-804	198	8	stevens	stevens	PROPN
ajlm-804	198	9	ws	ws	PROPN
ajlm-804	198	10	.	.	PUNCT
ajlm-804	198	11	laboratory	laboratory	NOUN
ajlm-804	198	12	monitoring	monitoring	NOUN
ajlm-804	198	13	of	of	ADP
ajlm-804	198	14	hiv	hiv	PROPN
ajlm-804	198	15	/	/	SYM
ajlm-804	198	16	aids	aids	PROPN
ajlm-804	198	17	in	in	ADP
ajlm-804	198	18	a	a	DET
ajlm-804	198	19	resource	resource	NOUN
ajlm-804	198	20	-	-	PUNCT
ajlm-804	198	21	poor	poor	ADJ
ajlm-804	198	22	setting	setting	NOUN
ajlm-804	198	23	.	.	PUNCT
ajlm-804	199	1	s	s	PROPN
ajlm-804	199	2	afr	afr	PROPN
ajlm-804	199	3	med	med	PROPN
ajlm-804	199	4	j.	j.	PROPN
ajlm-804	199	5	2003;93(4):262–263	2003;93(4):262–263	PROPN
ajlm-804	199	6	.	.	PUNCT
ajlm-804	199	7	glencross	glencross	PROPN
ajlm-804	199	8	dk	dk	PROPN
ajlm-804	199	9	,	,	PUNCT
ajlm-804	199	10	aggett	aggett	PROPN
ajlm-804	199	11	hm	hm	PROPN
ajlm-804	199	12	,	,	PUNCT
ajlm-804	199	13	stevens	stevens	PROPN
ajlm-804	199	14	ws	ws	PROPN
ajlm-804	199	15	,	,	PUNCT
ajlm-804	199	16	mandy	mandy	PROPN
ajlm-804	199	17	f.	f.	PROPN
ajlm-804	199	18	african	african	PROPN
ajlm-804	200	1	regional	regional	ADJ
ajlm-804	200	2	external	external	ADJ
ajlm-804	200	3	quality	quality	NOUN
ajlm-804	200	4	assessment	assessment	NOUN
ajlm-804	200	5	for	for	ADP
ajlm-804	200	6	cd4	cd4	PROPN
ajlm-804	200	7	t	t	PROPN
ajlm-804	200	8	-	-	PUNCT
ajlm-804	200	9	cell	cell	NOUN
ajlm-804	200	10	enumeration	enumeration	NOUN
ajlm-804	200	11	:	:	PUNCT
ajlm-804	200	12	development	development	NOUN
ajlm-804	200	13	,	,	PUNCT
ajlm-804	200	14	outcomes	outcome	NOUN
ajlm-804	200	15	,	,	PUNCT
ajlm-804	200	16	and	and	CCONJ
ajlm-804	200	17	performance	performance	NOUN
ajlm-804	200	18	of	of	ADP
ajlm-804	200	19	laboratories	laboratory	NOUN
ajlm-804	200	20	.	.	PUNCT
ajlm-804	201	1	cytometry	cytometry	PROPN
ajlm-804	201	2	b	b	PROPN
ajlm-804	201	3	clin	clin	PROPN
ajlm-804	201	4	cytom	cytom	PROPN
ajlm-804	201	5	.	.	PUNCT
ajlm-804	202	1	2008;74	2008;74	NUM
ajlm-804	202	2	suppl	suppl	ADJ
ajlm-804	202	3	1	1	NUM
ajlm-804	202	4	:	:	PUNCT
ajlm-804	202	5	s69	s69	PROPN
ajlm-804	202	6	–	–	PUNCT
ajlm-804	202	7	s79	s79	ADJ
ajlm-804	202	8	.	.	PUNCT
ajlm-804	203	1	https://doi.org/10.1002/cyto.b.20397	https://doi.org/10.1002/cyto.b.20397	AUX
ajlm-804	203	2	pattanapanyasat	pattanapanyasat	ADJ
ajlm-804	203	3	k	k	PROPN
ajlm-804	203	4	,	,	PUNCT
ajlm-804	203	5	shain	shain	PROPN
ajlm-804	203	6	h	h	PROPN
ajlm-804	203	7	,	,	PUNCT
ajlm-804	203	8	noulsri	noulsri	ADJ
ajlm-804	203	9	e	e	NOUN
ajlm-804	203	10	,	,	PUNCT
ajlm-804	203	11	et	et	PROPN
ajlm-804	203	12	al	al	PROPN
ajlm-804	203	13	.	.	PUNCT
ajlm-804	204	1	a	a	DET
ajlm-804	204	2	multicenter	multicenter	ADJ
ajlm-804	204	3	evaluation	evaluation	NOUN
ajlm-804	204	4	of	of	ADP
ajlm-804	204	5	the	the	DET
ajlm-804	204	6	panleucogating	panleucogating	NOUN
ajlm-804	204	7	method	method	NOUN
ajlm-804	204	8	and	and	CCONJ
ajlm-804	204	9	the	the	DET
ajlm-804	204	10	use	use	NOUN
ajlm-804	204	11	of	of	ADP
ajlm-804	204	12	generic	generic	ADJ
ajlm-804	204	13	monoclonal	monoclonal	NOUN
ajlm-804	204	14	antibody	antibody	NOUN
ajlm-804	204	15	reagents	reagent	NOUN
ajlm-804	204	16	for	for	ADP
ajlm-804	204	17	cd4	cd4	PROPN
ajlm-804	204	18	enumeration	enumeration	NOUN
ajlm-804	204	19	in	in	ADP
ajlm-804	204	20	hiv	hiv	PROPN
ajlm-804	204	21	-	-	PUNCT
ajlm-804	204	22	infected	infect	VERB
ajlm-804	204	23	patients	patient	NOUN
ajlm-804	204	24	in	in	ADP
ajlm-804	204	25	thailand	thailand	PROPN
ajlm-804	204	26	.	.	PUNCT
ajlm-804	205	1	cytometry	cytometry	PROPN
ajlm-804	205	2	b	b	PROPN
ajlm-804	205	3	clin	clin	PROPN
ajlm-804	205	4	cytom	cytom	NOUN
ajlm-804	205	5	.	.	PUNCT
ajlm-804	206	1	2005;65(1):29–36	2005;65(1):29–36	NUM
ajlm-804	206	2	.	.	PUNCT
ajlm-804	207	1	https://doi.org/10.1002/cyto.b.20052	https://doi.org/10.1002/cyto.b.20052	X
ajlm-804	207	2	glencross	glencross	PROPN
ajlm-804	207	3	dk	dk	PROPN
ajlm-804	207	4	,	,	PUNCT
ajlm-804	207	5	scott	scott	PROPN
ajlm-804	207	6	le	le	PROPN
ajlm-804	207	7	,	,	PUNCT
ajlm-804	207	8	jani	jani	PROPN
ajlm-804	207	9	iv	iv	PROPN
ajlm-804	207	10	,	,	PUNCT
ajlm-804	207	11	barnett	barnett	PROPN
ajlm-804	207	12	d	d	PROPN
ajlm-804	207	13	,	,	PUNCT
ajlm-804	207	14	janossy	janossy	PROPN
ajlm-804	207	15	g.	g.	PROPN
ajlm-804	207	16	cd45	cd45	PROPN
ajlm-804	207	17	-	-	PUNCT
ajlm-804	207	18	assisted	assist	VERB
ajlm-804	207	19	panleucogating	panleucogating	NOUN
ajlm-804	207	20	for	for	ADP
ajlm-804	207	21	accurate	accurate	ADJ
ajlm-804	207	22	,	,	PUNCT
ajlm-804	207	23	cost	cost	NOUN
ajlm-804	207	24	-	-	PUNCT
ajlm-804	207	25	effective	effective	ADJ
ajlm-804	207	26	dual	dual	ADJ
ajlm-804	207	27	-	-	PUNCT
ajlm-804	207	28	platform	platform	NOUN
ajlm-804	207	29	cd4	cd4	PROPN
ajlm-804	207	30	+	+	PROPN
ajlm-804	207	31	t	t	PROPN
ajlm-804	207	32	-	-	PUNCT
ajlm-804	207	33	cell	cell	NOUN
ajlm-804	207	34	enumeration	enumeration	NOUN
ajlm-804	207	35	.	.	PUNCT
ajlm-804	208	1	cytometry	cytometry	NOUN
ajlm-804	208	2	.	.	PUNCT
ajlm-804	209	1	2002;50(2):69–77	2002;50(2):69–77	NUM
ajlm-804	209	2	.	.	PUNCT
ajlm-804	210	1	https://doi.org/10.1002/cyto.10068	https://doi.org/10.1002/cyto.10068	PROPN
ajlm-804	210	2	denny	denny	PROPN
ajlm-804	210	3	tn	tn	PROPN
ajlm-804	210	4	,	,	PUNCT
ajlm-804	210	5	gelman	gelman	PROPN
ajlm-804	210	6	r	r	PROPN
ajlm-804	210	7	,	,	PUNCT
ajlm-804	210	8	bergeron	bergeron	PROPN
ajlm-804	210	9	m	m	PROPN
ajlm-804	210	10	,	,	PUNCT
ajlm-804	210	11	et	et	PROPN
ajlm-804	210	12	al	al	PROPN
ajlm-804	210	13	.	.	PUNCT
ajlm-804	211	1	a	a	DET
ajlm-804	211	2	north	north	ADJ
ajlm-804	211	3	american	american	ADJ
ajlm-804	211	4	multilaboratory	multilaboratory	NOUN
ajlm-804	211	5	study	study	NOUN
ajlm-804	211	6	of	of	ADP
ajlm-804	211	7	cd4	cd4	PROPN
ajlm-804	211	8	counts	count	NOUN
ajlm-804	211	9	using	use	VERB
ajlm-804	211	10	flow	flow	NOUN
ajlm-804	211	11	cytometric	cytometric	ADJ
ajlm-804	211	12	panleukogating	panleukogating	NOUN
ajlm-804	211	13	(	(	PUNCT
ajlm-804	211	14	plg	plg	NOUN
ajlm-804	211	15	):	):	PUNCT
ajlm-804	211	16	a	a	DET
ajlm-804	211	17	niaid	niaid	NOUN
ajlm-804	211	18	-	-	PUNCT
ajlm-804	211	19	daids	daid	NOUN
ajlm-804	211	20	immunology	immunology	NOUN
ajlm-804	211	21	quality	quality	NOUN
ajlm-804	211	22	assessment	assessment	NOUN
ajlm-804	211	23	program	program	NOUN
ajlm-804	211	24	study	study	NOUN
ajlm-804	211	25	.	.	PUNCT
ajlm-804	212	1	cytometry	cytometry	PROPN
ajlm-804	212	2	b	b	PROPN
ajlm-804	212	3	clin	clin	PROPN
ajlm-804	212	4	cytom	cytom	PROPN
ajlm-804	212	5	.	.	PUNCT
ajlm-804	213	1	2008;74	2008;74	NUM
ajlm-804	213	2	suppl	suppl	ADJ
ajlm-804	213	3	1	1	NUM
ajlm-804	213	4	:	:	PUNCT
ajlm-804	213	5	s52	s52	NOUN
ajlm-804	213	6	–	–	PUNCT
ajlm-804	213	7	s64	s64	NOUN
ajlm-804	213	8	.	.	PUNCT
ajlm-804	214	1	https://doi.org/10.1002/cyto.b.20417	https://doi.org/10.1002/cyto.b.20417	X
ajlm-804	214	2	cassim	cassim	PROPN
ajlm-804	214	3	n	n	CCONJ
ajlm-804	214	4	,	,	PUNCT
ajlm-804	214	5	coetzee	coetzee	PROPN
ajlm-804	214	6	lm	lm	PROPN
ajlm-804	214	7	,	,	PUNCT
ajlm-804	214	8	schnippel	schnippel	PROPN
ajlm-804	214	9	k	k	PROPN
ajlm-804	214	10	,	,	PUNCT
ajlm-804	214	11	glencross	glencross	ADJ
ajlm-804	214	12	dk	dk	PROPN
ajlm-804	214	13	.	.	PUNCT
ajlm-804	214	14	estimating	estimate	VERB
ajlm-804	214	15	implementation	implementation	NOUN
ajlm-804	214	16	and	and	CCONJ
ajlm-804	214	17	operational	operational	ADJ
ajlm-804	214	18	costs	cost	NOUN
ajlm-804	214	19	of	of	ADP
ajlm-804	214	20	an	an	DET
ajlm-804	214	21	integrated	integrate	VERB
ajlm-804	214	22	tiered	tiere	VERB
ajlm-804	214	23	cd4	cd4	PROPN
ajlm-804	214	24	service	service	NOUN
ajlm-804	214	25	including	include	VERB
ajlm-804	214	26	laboratory	laboratory	NOUN
ajlm-804	214	27	and	and	CCONJ
ajlm-804	214	28	point	point	NOUN
ajlm-804	214	29	of	of	ADP
ajlm-804	214	30	care	care	NOUN
ajlm-804	214	31	testing	testing	NOUN
ajlm-804	214	32	in	in	ADP
ajlm-804	214	33	a	a	DET
ajlm-804	214	34	remote	remote	ADJ
ajlm-804	214	35	health	health	NOUN
ajlm-804	214	36	district	district	NOUN
ajlm-804	214	37	in	in	ADP
ajlm-804	214	38	south	south	PROPN
ajlm-804	214	39	africa	africa	PROPN
ajlm-804	214	40	.	.	PUNCT
ajlm-804	215	1	plos	plos	PROPN
ajlm-804	215	2	one	one	NUM
ajlm-804	215	3	.	.	PUNCT
ajlm-804	216	1	2014;9(12):e115420	2014;9(12):e115420	NUM
ajlm-804	216	2	.	.	PUNCT
ajlm-804	217	1	https://doi.org/10.1371/journal.pone.0115420	https://doi.org/10.1371/journal.pone.0115420	NOUN
ajlm-804	217	2	coetzee	coetzee	PROPN
ajlm-804	217	3	lm	lm	PROPN
ajlm-804	217	4	,	,	PUNCT
ajlm-804	217	5	cassim	cassim	NOUN
ajlm-804	217	6	n	n	CCONJ
ajlm-804	217	7	,	,	PUNCT
ajlm-804	217	8	glencross	glencross	ADJ
ajlm-804	217	9	dk	dk	PROPN
ajlm-804	217	10	.	.	PROPN
ajlm-804	217	11	implementation	implementation	NOUN
ajlm-804	217	12	of	of	ADP
ajlm-804	217	13	a	a	DET
ajlm-804	217	14	new	new	ADJ
ajlm-804	217	15	‘	'	PUNCT
ajlm-804	217	16	community	community	NOUN
ajlm-804	217	17	’	'	PUNCT
ajlm-804	217	18	laboratory	laboratory	NOUN
ajlm-804	217	19	cd4	cd4	PROPN
ajlm-804	217	20	service	service	NOUN
ajlm-804	217	21	in	in	ADP
ajlm-804	217	22	a	a	DET
ajlm-804	217	23	rural	rural	ADJ
ajlm-804	217	24	health	health	NOUN
ajlm-804	217	25	district	district	NOUN
ajlm-804	217	26	in	in	ADP
ajlm-804	217	27	south	south	PROPN
ajlm-804	217	28	africa	africa	PROPN
ajlm-804	217	29	extends	extend	VERB
ajlm-804	217	30	laboratory	laboratory	NOUN
ajlm-804	217	31	services	service	NOUN
ajlm-804	217	32	and	and	CCONJ
ajlm-804	217	33	substantially	substantially	ADV
ajlm-804	217	34	improves	improve	VERB
ajlm-804	217	35	local	local	ADJ
ajlm-804	217	36	reporting	reporting	NOUN
ajlm-804	217	37	turnaround	turnaround	NOUN
ajlm-804	217	38	time	time	NOUN
ajlm-804	217	39	.	.	PUNCT
ajlm-804	218	1	s	s	PROPN
ajlm-804	218	2	afr	afr	PROPN
ajlm-804	218	3	med	med	PROPN
ajlm-804	218	4	j.	j.	PROPN
ajlm-804	218	5	2015;106(1):82–87	2015;106(1):82–87	PROPN
ajlm-804	218	6	.	.	PUNCT
ajlm-804	219	1	https://doi.org/10.7196/samj.2016.v106i1.10081	https://doi.org/10.7196/samj.2016.v106i1.10081	PROPN
ajlm-804	219	2	beckman	beckman	PROPN
ajlm-804	219	3	coulter	coulter	PROPN
ajlm-804	219	4	.	.	PUNCT
ajlm-804	220	1	aquios	aquio	NOUN
ajlm-804	220	2	tetra	tetra	NOUN
ajlm-804	220	3	system	system	NOUN
ajlm-804	220	4	guide	guide	NOUN
ajlm-804	220	5	.	.	PUNCT
ajlm-804	221	1	in	in	ADP
ajlm-804	221	2	:	:	PUNCT
ajlm-804	221	3	performance	performance	NOUN
ajlm-804	221	4	characteristics	characteristic	NOUN
ajlm-804	221	5	.	.	PUNCT
ajlm-804	222	1	april	april	PROPN
ajlm-804	222	2	2015;pp	2015;pp	NUM
ajlm-804	223	1	6	6	NUM
ajlm-804	223	2	-	-	SYM
ajlm-804	223	3	1	1	NUM
ajlm-804	223	4	to	to	PART
ajlm-804	223	5	6	6	NUM
ajlm-804	223	6	-	-	SYM
ajlm-804	223	7	1	1	NUM
ajlm-804	223	8	,	,	PUNCT
ajlm-804	223	9	accessed	access	VERB
ajlm-804	223	10	15	15	NUM
ajlm-804	223	11	dec	dec	PROPN
ajlm-804	223	12	2018	2018	NUM
ajlm-804	223	13	.	.	PUNCT
ajlm-804	224	1	available	available	ADJ
ajlm-804	224	2	from	from	ADP
ajlm-804	224	3	:	:	PUNCT
ajlm-804	224	4	https://www.beckmancoulter.com/wsrportal/techdocs?docname=b26364ab.pdf	https://www.beckmancoulter.com/wsrportal/techdocs?docname=b26364ab.pdf	ADJ
ajlm-804	224	5	jentsch	jentsch	PROPN
ajlm-804	224	6	-	-	PUNCT
ajlm-804	224	7	ullrich	ullrich	PROPN
ajlm-804	224	8	k	k	PROPN
ajlm-804	224	9	,	,	PUNCT
ajlm-804	224	10	koenigsmann	koenigsmann	PROPN
ajlm-804	224	11	m	m	PROPN
ajlm-804	224	12	,	,	PUNCT
ajlm-804	224	13	mohren	mohren	PROPN
ajlm-804	224	14	m	m	PROPN
ajlm-804	224	15	,	,	PUNCT
ajlm-804	224	16	franke	franke	PROPN
ajlm-804	224	17	a.	a.	NOUN
ajlm-804	224	18	lymphocyte	lymphocyte	PROPN
ajlm-804	224	19	subsets	subset	NOUN
ajlm-804	224	20	’	'	PUNCT
ajlm-804	224	21	reference	reference	NOUN
ajlm-804	224	22	ranges	range	VERB
ajlm-804	224	23	in	in	ADP
ajlm-804	224	24	an	an	DET
ajlm-804	224	25	ageand	ageand	NOUN
ajlm-804	224	26	gender	gender	NOUN
ajlm-804	224	27	-	-	PUNCT
ajlm-804	224	28	balanced	balance	VERB
ajlm-804	224	29	population	population	NOUN
ajlm-804	224	30	of	of	ADP
ajlm-804	224	31	100	100	NUM
ajlm-804	224	32	healthy	healthy	ADJ
ajlm-804	224	33	adults	adult	NOUN
ajlm-804	224	34	–	–	PUNCT
ajlm-804	224	35	a	a	DET
ajlm-804	224	36	monocentric	monocentric	ADJ
ajlm-804	224	37	german	german	ADJ
ajlm-804	224	38	study	study	NOUN
ajlm-804	224	39	.	.	PUNCT
ajlm-804	225	1	clin	clin	PROPN
ajlm-804	225	2	immunol	immunol	NOUN
ajlm-804	225	3	.	.	PUNCT
ajlm-804	226	1	2005;116(2):192–197	2005;116(2):192–197	X
ajlm-804	226	2	.	.	PUNCT
ajlm-804	227	1	https://doi.org/10.1016/j.clim.2005.03.020	https://doi.org/10.1016/j.clim.2005.03.020	NOUN
ajlm-804	227	2	santagostino	santagostino	PROPN
ajlm-804	227	3	a	a	NOUN
ajlm-804	227	4	,	,	PUNCT
ajlm-804	227	5	garbaccio	garbaccio	NOUN
ajlm-804	227	6	g	g	NOUN
ajlm-804	227	7	,	,	PUNCT
ajlm-804	227	8	pistorio	pistorio	PROPN
ajlm-804	227	9	a	a	X
ajlm-804	227	10	,	,	PUNCT
ajlm-804	227	11	et	et	PROPN
ajlm-804	227	12	al	al	PROPN
ajlm-804	227	13	.	.	PUNCT
ajlm-804	228	1	an	an	DET
ajlm-804	228	2	italian	italian	ADJ
ajlm-804	228	3	national	national	ADJ
ajlm-804	228	4	multicenter	multicenter	NOUN
ajlm-804	228	5	study	study	NOUN
ajlm-804	228	6	for	for	ADP
ajlm-804	228	7	the	the	DET
ajlm-804	228	8	definition	definition	NOUN
ajlm-804	228	9	of	of	ADP
ajlm-804	228	10	reference	reference	NOUN
ajlm-804	228	11	ranges	range	VERB
ajlm-804	228	12	for	for	ADP
ajlm-804	228	13	normal	normal	ADJ
ajlm-804	228	14	values	value	NOUN
ajlm-804	228	15	of	of	ADP
ajlm-804	228	16	peripheral	peripheral	ADJ
ajlm-804	228	17	blood	blood	NOUN
ajlm-804	228	18	lymphocyte	lymphocyte	ADJ
ajlm-804	228	19	subsets	subset	NOUN
ajlm-804	228	20	in	in	ADP
ajlm-804	228	21	healthy	healthy	ADJ
ajlm-804	228	22	adults	adult	NOUN
ajlm-804	228	23	.	.	PUNCT
ajlm-804	229	1	haematologica	haematologica	PROPN
ajlm-804	229	2	.	.	PUNCT
ajlm-804	230	1	1999;84(6):499–504	1999;84(6):499–504	NUM
ajlm-804	230	2	.	.	PUNCT
ajlm-804	230	3	moreno	moreno	PROPN
ajlm-804	230	4	-	-	PUNCT
ajlm-804	230	5	galvan	galvan	PROPN
ajlm-804	230	6	m	m	PROPN
ajlm-804	230	7	,	,	PUNCT
ajlm-804	230	8	palafox	palafox	PROPN
ajlm-804	230	9	a.	a.	NOUN
ajlm-804	230	10	cd4	cd4	PROPN
ajlm-804	230	11	+	+	PROPN
ajlm-804	230	12	cd8	cd8	PROPN
ajlm-804	230	13	+	+	PROPN
ajlm-804	230	14	t	t	PROPN
ajlm-804	230	15	cell	cell	NOUN
ajlm-804	230	16	reference	reference	NOUN
ajlm-804	230	17	values	value	NOUN
ajlm-804	230	18	in	in	ADP
ajlm-804	230	19	the	the	DET
ajlm-804	230	20	mexico	mexico	PROPN
ajlm-804	230	21	city	city	NOUN
ajlm-804	230	22	population	population	NOUN
ajlm-804	230	23	.	.	PUNCT
ajlm-804	231	1	clin	clin	PROPN
ajlm-804	231	2	vac	vac	PROPN
ajlm-804	231	3	immunol	immunol	NOUN
ajlm-804	231	4	.	.	PUNCT
ajlm-804	232	1	2013;20(2):306–308	2013;20(2):306–308	X
ajlm-804	232	2	.	.	PUNCT
ajlm-804	233	1	https://doi.org/10.1128/cvi.00523-12	https://doi.org/10.1128/cvi.00523-12	NOUN
ajlm-804	233	2	lawrie	lawrie	PROPN
ajlm-804	233	3	d	d	PROPN
ajlm-804	233	4	,	,	PUNCT
ajlm-804	233	5	coetzee	coetzee	PROPN
ajlm-804	233	6	lm	lm	PROPN
ajlm-804	233	7	,	,	PUNCT
ajlm-804	233	8	becker	becker	PROPN
ajlm-804	234	1	p	p	X
ajlm-804	234	2	,	,	PUNCT
ajlm-804	234	3	mahlangu	mahlangu	PROPN
ajlm-804	234	4	j	j	PROPN
ajlm-804	234	5	,	,	PUNCT
ajlm-804	234	6	stevens	stevens	PROPN
ajlm-804	234	7	w	w	PROPN
ajlm-804	234	8	,	,	PUNCT
ajlm-804	234	9	glencross	glencross	ADJ
ajlm-804	234	10	dk	dk	PROPN
ajlm-804	234	11	.	.	PROPN
ajlm-804	235	1	local	local	ADJ
ajlm-804	235	2	reference	reference	NOUN
ajlm-804	235	3	ranges	range	VERB
ajlm-804	235	4	for	for	ADP
ajlm-804	235	5	full	full	ADJ
ajlm-804	235	6	blood	blood	NOUN
ajlm-804	235	7	count	count	NOUN
ajlm-804	235	8	and	and	CCONJ
ajlm-804	235	9	cd4	cd4	PROPN
ajlm-804	235	10	lymphocyte	lymphocyte	ADJ
ajlm-804	235	11	count	count	NOUN
ajlm-804	235	12	testing	testing	NOUN
ajlm-804	235	13	.	.	PUNCT
ajlm-804	236	1	s	s	PROPN
ajlm-804	236	2	afr	afr	PROPN
ajlm-804	236	3	med	med	PROPN
ajlm-804	236	4	j.	j.	PROPN
ajlm-804	236	5	2009;99(4):243–248	2009;99(4):243–248	PROPN
ajlm-804	236	6	.	.	PUNCT
ajlm-804	237	1	bussmann	bussmann	PROPN
ajlm-804	237	2	h	h	PROPN
ajlm-804	237	3	,	,	PUNCT
ajlm-804	237	4	wester	wester	PROPN
ajlm-804	237	5	cw	cw	NOUN
ajlm-804	237	6	,	,	PUNCT
ajlm-804	237	7	masupu	masupu	VERB
ajlm-804	237	8	kv	kv	PROPN
ajlm-804	237	9	,	,	PUNCT
ajlm-804	237	10	et	et	PROPN
ajlm-804	237	11	al	al	PROPN
ajlm-804	237	12	.	.	PROPN
ajlm-804	237	13	low	low	PROPN
ajlm-804	237	14	cd4	cd4	PROPN
ajlm-804	237	15	+	+	PROPN
ajlm-804	237	16	t	t	PROPN
ajlm-804	237	17	-	-	PUNCT
ajlm-804	237	18	lymphocyte	lymphocyte	ADJ
ajlm-804	237	19	values	value	NOUN
ajlm-804	237	20	in	in	ADP
ajlm-804	237	21	human	human	ADJ
ajlm-804	237	22	immunodeficiency	immunodeficiency	NOUN
ajlm-804	237	23	virus	virus	NOUN
ajlm-804	237	24	-	-	PUNCT
ajlm-804	237	25	negative	negative	ADJ
ajlm-804	237	26	adults	adult	NOUN
ajlm-804	237	27	in	in	ADP
ajlm-804	237	28	botswana	botswana	PROPN
ajlm-804	237	29	.	.	PUNCT
ajlm-804	238	1	clin	clin	PROPN
ajlm-804	238	2	diagn	diagn	PROPN
ajlm-804	238	3	lab	lab	NOUN
ajlm-804	238	4	immunol	immunol	NOUN
ajlm-804	238	5	.	.	PUNCT
ajlm-804	239	1	2004;11(5):930–935	2004;11(5):930–935	X
ajlm-804	239	2	.	.	PUNCT
ajlm-804	240	1	https://doi.org/10.1128/cdli.11.5.930-935.2004	https://doi.org/10.1128/cdli.11.5.930-935.2004	VERB
ajlm-804	240	2	crampin	crampin	NOUN
ajlm-804	240	3	ac	ac	NOUN
ajlm-804	240	4	,	,	PUNCT
ajlm-804	240	5	mwaungulu	mwaungulu	PROPN
ajlm-804	240	6	fd	fd	PROPN
ajlm-804	240	7	,	,	PUNCT
ajlm-804	240	8	ambrose	ambrose	PROPN
ajlm-804	240	9	lr	lr	PROPN
ajlm-804	240	10	,	,	PUNCT
ajlm-804	240	11	longwe	longwe	PROPN
ajlm-804	240	12	h	h	PROPN
ajlm-804	240	13	,	,	PUNCT
ajlm-804	240	14	french	french	ADJ
ajlm-804	240	15	n.	n.	PROPN
ajlm-804	240	16	normal	normal	ADJ
ajlm-804	240	17	range	range	NOUN
ajlm-804	240	18	of	of	ADP
ajlm-804	240	19	cd4	cd4	PROPN
ajlm-804	240	20	cell	cell	NOUN
ajlm-804	240	21	counts	count	NOUN
ajlm-804	240	22	and	and	CCONJ
ajlm-804	240	23	temporal	temporal	ADJ
ajlm-804	240	24	changes	change	NOUN
ajlm-804	240	25	in	in	ADP
ajlm-804	240	26	two	two	NUM
ajlm-804	240	27	hiv	hiv	PROPN
ajlm-804	240	28	negative	negative	ADJ
ajlm-804	240	29	malawian	malawian	ADJ
ajlm-804	240	30	populations	population	NOUN
ajlm-804	240	31	.	.	PUNCT
ajlm-804	241	1	open	open	ADJ
ajlm-804	241	2	aids	aids	PROPN
ajlm-804	241	3	j.	j.	PROPN
ajlm-804	241	4	2011;5:74–79	2011;5:74–79	NUM
ajlm-804	241	5	.	.	PUNCT
ajlm-804	242	1	https://doi.org/10.2174/1874613601105010074	https://doi.org/10.2174/1874613601105010074	PROPN
ajlm-804	242	2	ngowi	ngowi	NOUN
ajlm-804	242	3	bj	bj	VERB
ajlm-804	242	4	,	,	PUNCT
ajlm-804	242	5	mfinanga	mfinanga	VERB
ajlm-804	242	6	sg	sg	PROPN
ajlm-804	242	7	,	,	PUNCT
ajlm-804	242	8	bruun	bruun	PROPN
ajlm-804	242	9	jn	jn	PROPN
ajlm-804	242	10	,	,	PUNCT
ajlm-804	242	11	morkve	morkve	VERB
ajlm-804	242	12	o.	o.	ADJ
ajlm-804	242	13	immunohaematological	immunohaematological	ADJ
ajlm-804	242	14	reference	reference	NOUN
ajlm-804	242	15	values	value	NOUN
ajlm-804	242	16	in	in	ADP
ajlm-804	242	17	human	human	ADJ
ajlm-804	242	18	immunodeficiency	immunodeficiency	NOUN
ajlm-804	242	19	virus	virus	NOUN
ajlm-804	242	20	-	-	PUNCT
ajlm-804	242	21	negative	negative	ADJ
ajlm-804	242	22	adolescent	adolescent	ADJ
ajlm-804	242	23	and	and	CCONJ
ajlm-804	242	24	adults	adult	NOUN
ajlm-804	242	25	in	in	ADP
ajlm-804	242	26	rural	rural	ADJ
ajlm-804	242	27	northern	northern	ADJ
ajlm-804	242	28	tanzania	tanzania	PROPN
ajlm-804	242	29	.	.	PUNCT
ajlm-804	243	1	bmc	bmc	PROPN
ajlm-804	243	2	infect	infect	PROPN
ajlm-804	243	3	dis	dis	PROPN
ajlm-804	243	4	.	.	PUNCT
ajlm-804	244	1	2009;9:1	2009;9:1	NOUN
ajlm-804	244	2	.	.	PUNCT
ajlm-804	245	1	https://doi.org/10.1186/1471-2334-9-1	https://doi.org/10.1186/1471-2334-9-1	ADV
ajlm-804	245	2	saathoff	saathoff	PROPN
ajlm-804	245	3	e	e	PROPN
ajlm-804	245	4	,	,	PUNCT
ajlm-804	245	5	schneider	schneider	PROPN
ajlm-804	245	6	p	p	PROPN
ajlm-804	245	7	,	,	PUNCT
ajlm-804	245	8	kleinfeldt	kleinfeldt	ADJ
ajlm-804	245	9	v	v	PROPN
ajlm-804	245	10	,	,	PUNCT
ajlm-804	245	11	et	et	PROPN
ajlm-804	245	12	al	al	PROPN
ajlm-804	245	13	.	.	PROPN
ajlm-804	245	14	laboratory	laboratory	NOUN
ajlm-804	245	15	reference	reference	NOUN
ajlm-804	245	16	values	value	NOUN
ajlm-804	245	17	for	for	ADP
ajlm-804	245	18	healthy	healthy	ADJ
ajlm-804	245	19	adults	adult	NOUN
ajlm-804	245	20	from	from	ADP
ajlm-804	245	21	southern	southern	ADJ
ajlm-804	245	22	tanzania	tanzania	PROPN
ajlm-804	245	23	.	.	PUNCT
ajlm-804	246	1	trop	trop	PROPN
ajlm-804	246	2	med	med	PROPN
ajlm-804	246	3	int	int	PROPN
ajlm-804	246	4	health	health	NOUN
ajlm-804	246	5	.	.	PUNCT
ajlm-804	247	1	2008;13(5):612–625	2008;13(5):612–625	NUM
ajlm-804	247	2	.	.	PUNCT
ajlm-804	248	1	https://doi.org/10.1111/j.1365-3156.2008.02047.x	https://doi.org/10.1111/j.1365-3156.2008.02047.x	PROPN
ajlm-804	248	2	urassa	urassa	NOUN
ajlm-804	248	3	wk	wk	PROPN
ajlm-804	248	4	,	,	PUNCT
ajlm-804	248	5	mbena	mbena	NOUN
ajlm-804	248	6	em	em	PRON
ajlm-804	248	7	,	,	PUNCT
ajlm-804	248	8	swai	swai	PROPN
ajlm-804	248	9	ab	ab	PROPN
ajlm-804	248	10	,	,	PUNCT
ajlm-804	248	11	gaines	gaines	PROPN
ajlm-804	248	12	h	h	PROPN
ajlm-804	248	13	,	,	PUNCT
ajlm-804	248	14	mhalu	mhalu	NOUN
ajlm-804	248	15	fs	fs	PROPN
ajlm-804	248	16	,	,	PUNCT
ajlm-804	248	17	biberfeld	biberfeld	PROPN
ajlm-804	248	18	g.	g.	PROPN
ajlm-804	248	19	lymphocyte	lymphocyte	PROPN
ajlm-804	248	20	subset	subset	VERB
ajlm-804	248	21	enumeration	enumeration	NOUN
ajlm-804	248	22	in	in	ADP
ajlm-804	248	23	hiv	hiv	PROPN
ajlm-804	248	24	seronegative	seronegative	ADJ
ajlm-804	248	25	and	and	CCONJ
ajlm-804	248	26	hiv-1	hiv-1	PUNCT
ajlm-804	248	27	seropositive	seropositive	ADJ
ajlm-804	248	28	adults	adult	NOUN
ajlm-804	248	29	in	in	ADP
ajlm-804	248	30	dar	dar	PROPN
ajlm-804	248	31	es	es	NOUN
ajlm-804	248	32	salaam	salaam	PROPN
ajlm-804	248	33	,	,	PUNCT
ajlm-804	248	34	tanzania	tanzania	PROPN
ajlm-804	248	35	:	:	PUNCT
ajlm-804	248	36	determination	determination	NOUN
ajlm-804	248	37	of	of	ADP
ajlm-804	248	38	reference	reference	NOUN
ajlm-804	248	39	values	value	NOUN
ajlm-804	248	40	in	in	ADP
ajlm-804	248	41	males	male	NOUN
ajlm-804	248	42	and	and	CCONJ
ajlm-804	248	43	females	female	NOUN
ajlm-804	248	44	and	and	CCONJ
ajlm-804	248	45	comparison	comparison	NOUN
ajlm-804	248	46	of	of	ADP
ajlm-804	248	47	two	two	NUM
ajlm-804	248	48	flow	flow	NOUN
ajlm-804	248	49	cytometric	cytometric	ADJ
ajlm-804	248	50	methods	method	NOUN
ajlm-804	248	51	.	.	PUNCT
ajlm-804	249	1	j	j	PROPN
ajlm-804	249	2	immunol	immunol	NOUN
ajlm-804	249	3	methods	method	NOUN
ajlm-804	249	4	.	.	PUNCT
ajlm-804	250	1	2003;277(1–2):65–74	2003;277(1–2):65–74	NUM
ajlm-804	250	2	.	.	NOUN
ajlm-804	251	1	https://doi.org/10.1016/s0022-1759(03)00174-1	https://doi.org/10.1016/s0022-1759(03)00174-1	NOUN
ajlm-804	251	2	bosire	bosire	VERB
ajlm-804	251	3	em	em	PRON
ajlm-804	251	4	,	,	PUNCT
ajlm-804	251	5	nyamache	nyamache	PROPN
ajlm-804	251	6	ak	ak	PROPN
ajlm-804	251	7	,	,	PUNCT
ajlm-804	251	8	gicheru	gicheru	ADJ
ajlm-804	251	9	mm	mm	PROPN
ajlm-804	251	10	,	,	PUNCT
ajlm-804	251	11	khamadi	khamadi	PROPN
ajlm-804	251	12	sa	sa	PROPN
ajlm-804	251	13	,	,	PUNCT
ajlm-804	251	14	lihana	lihana	PROPN
ajlm-804	251	15	rw	rw	NOUN
ajlm-804	251	16	,	,	PUNCT
ajlm-804	251	17	okoth	okoth	NOUN
ajlm-804	251	18	v.	v.	ADP
ajlm-804	251	19	population	population	NOUN
ajlm-804	251	20	specific	specific	ADJ
ajlm-804	251	21	reference	reference	NOUN
ajlm-804	251	22	ranges	range	VERB
ajlm-804	251	23	of	of	ADP
ajlm-804	251	24	cd3	cd3	PROPN
ajlm-804	251	25	,	,	PUNCT
ajlm-804	251	26	cd4	cd4	PROPN
ajlm-804	251	27	and	and	CCONJ
ajlm-804	251	28	cd8	cd8	PROPN
ajlm-804	251	29	lymphocyte	lymphocyte	ADJ
ajlm-804	251	30	subsets	subset	NOUN
ajlm-804	251	31	among	among	ADP
ajlm-804	251	32	healthy	healthy	ADJ
ajlm-804	251	33	kenyans	kenyans	PROPN
ajlm-804	251	34	.	.	PUNCT
ajlm-804	252	1	aids	aids	PROPN
ajlm-804	252	2	res	re	NOUN
ajlm-804	252	3	ther	ther	ADV
ajlm-804	252	4	.	.	PUNCT
ajlm-804	253	1	2013;10(1):24	2013;10(1):24	X
ajlm-804	253	2	.	.	PUNCT
ajlm-804	254	1	https://doi.org/10.1186/1742-6405-10-24	https://doi.org/10.1186/1742-6405-10-24	PROPN
ajlm-804	254	2	kibaya	kibaya	NOUN
ajlm-804	254	3	rs	rs	PROPN
ajlm-804	254	4	,	,	PUNCT
ajlm-804	254	5	bautista	bautista	PROPN
ajlm-804	254	6	ct	ct	PROPN
ajlm-804	254	7	,	,	PUNCT
ajlm-804	254	8	sawe	sawe	PROPN
ajlm-804	254	9	fk	fk	INTJ
ajlm-804	254	10	,	,	PUNCT
ajlm-804	254	11	et	et	PROPN
ajlm-804	254	12	al	al	PROPN
ajlm-804	254	13	.	.	PROPN
ajlm-804	254	14	reference	reference	NOUN
ajlm-804	254	15	ranges	range	VERB
ajlm-804	254	16	for	for	ADP
ajlm-804	254	17	the	the	DET
ajlm-804	254	18	clinical	clinical	ADJ
ajlm-804	254	19	laboratory	laboratory	NOUN
ajlm-804	254	20	derived	derive	VERB
ajlm-804	254	21	from	from	ADP
ajlm-804	254	22	a	a	DET
ajlm-804	254	23	rural	rural	ADJ
ajlm-804	254	24	population	population	NOUN
ajlm-804	254	25	in	in	ADP
ajlm-804	254	26	kericho	kericho	PROPN
ajlm-804	254	27	,	,	PUNCT
ajlm-804	254	28	kenya	kenya	PROPN
ajlm-804	254	29	.	.	PUNCT
ajlm-804	255	1	plos	plos	PROPN
ajlm-804	255	2	one	one	NUM
ajlm-804	255	3	.	.	PUNCT
ajlm-804	256	1	2008;3(10):e3327	2008;3(10):e3327	NUM
ajlm-804	256	2	.	.	PUNCT
ajlm-804	257	1	https://doi.org/10.1371/journal.pone.0003327	https://doi.org/10.1371/journal.pone.0003327	PROPN
ajlm-804	257	2	karita	karita	PROPN
ajlm-804	257	3	e	e	PROPN
ajlm-804	257	4	,	,	PUNCT
ajlm-804	257	5	ketter	ketter	NOUN
ajlm-804	257	6	n	n	CCONJ
ajlm-804	257	7	,	,	PUNCT
ajlm-804	257	8	price	price	NOUN
ajlm-804	257	9	ma	ma	PROPN
ajlm-804	257	10	,	,	PUNCT
ajlm-804	257	11	et	et	PROPN
ajlm-804	257	12	al	al	PROPN
ajlm-804	257	13	.	.	PUNCT
ajlm-804	257	14	clsi	clsi	NOUN
ajlm-804	257	15	-	-	PUNCT
ajlm-804	257	16	derived	derive	VERB
ajlm-804	257	17	hematology	hematology	NOUN
ajlm-804	257	18	and	and	CCONJ
ajlm-804	257	19	biochemistry	biochemistry	NOUN
ajlm-804	257	20	reference	reference	NOUN
ajlm-804	257	21	intervals	interval	NOUN
ajlm-804	257	22	for	for	ADP
ajlm-804	257	23	healthy	healthy	ADJ
ajlm-804	257	24	adults	adult	NOUN
ajlm-804	257	25	in	in	ADP
ajlm-804	257	26	eastern	eastern	ADJ
ajlm-804	257	27	and	and	CCONJ
ajlm-804	257	28	southern	southern	PROPN
ajlm-804	257	29	africa	africa	PROPN
ajlm-804	257	30	.	.	PUNCT
ajlm-804	258	1	plos	plos	PROPN
ajlm-804	258	2	one	one	NUM
ajlm-804	258	3	.	.	PUNCT
ajlm-804	259	1	2009;4(2):e4401	2009;4(2):e4401	NUM
ajlm-804	259	2	.	.	PUNCT
ajlm-804	260	1	https://doi.org/10.1371/journal.pone.0004401	https://doi.org/10.1371/journal.pone.0004401	NOUN
ajlm-804	260	2	nanzigu	nanzigu	PROPN
ajlm-804	260	3	s	s	PROPN
ajlm-804	260	4	,	,	PUNCT
ajlm-804	260	5	waako	waako	PROPN
ajlm-804	260	6	p	p	NOUN
ajlm-804	260	7	,	,	PUNCT
ajlm-804	260	8	petzold	petzold	PROPN
ajlm-804	260	9	m	m	PROPN
ajlm-804	260	10	,	,	PUNCT
ajlm-804	260	11	et	et	PROPN
ajlm-804	260	12	al	al	PROPN
ajlm-804	260	13	.	.	PUNCT
ajlm-804	261	1	cd4	cd4	PROPN
ajlm-804	261	2	-	-	PUNCT
ajlm-804	261	3	t	t	PROPN
ajlm-804	261	4	-	-	PUNCT
ajlm-804	261	5	lymphocyte	lymphocyte	NOUN
ajlm-804	261	6	reference	reference	NOUN
ajlm-804	261	7	ranges	range	VERB
ajlm-804	261	8	in	in	ADP
ajlm-804	261	9	uganda	uganda	PROPN
ajlm-804	261	10	and	and	CCONJ
ajlm-804	261	11	its	its	PRON
ajlm-804	261	12	influencing	influence	VERB
ajlm-804	261	13	factors	factor	NOUN
ajlm-804	261	14	.	.	PUNCT
ajlm-804	262	1	labmedicine	labmedicine	NOUN
ajlm-804	262	2	.	.	PUNCT
ajlm-804	263	1	2011;42(2):94–100	2011;42(2):94–100	NUM
ajlm-804	263	2	.	.	X
ajlm-804	264	1	https://doi.org/10.1309/lmft0vce1ugo9ygd	https://doi.org/10.1309/lmft0vce1ugo9ygd	PROPN
ajlm-804	264	2	gize	gize	VERB
ajlm-804	264	3	a	a	PRON
ajlm-804	264	4	,	,	PUNCT
ajlm-804	264	5	mathewos	mathewos	ADJ
ajlm-804	264	6	b	b	NUM
ajlm-804	264	7	,	,	PUNCT
ajlm-804	264	8	moges	moges	PROPN
ajlm-804	264	9	b	b	PROPN
ajlm-804	264	10	,	,	PUNCT
ajlm-804	264	11	workineh	workineh	PROPN
ajlm-804	264	12	m	m	PROPN
ajlm-804	264	13	,	,	PUNCT
ajlm-804	264	14	gedefaw	gedefaw	NOUN
ajlm-804	264	15	l.	l.	PROPN
ajlm-804	264	16	establishment	establishment	NOUN
ajlm-804	264	17	of	of	ADP
ajlm-804	264	18	normal	normal	ADJ
ajlm-804	264	19	reference	reference	NOUN
ajlm-804	264	20	intervals	interval	NOUN
ajlm-804	264	21	for	for	ADP
ajlm-804	264	22	cd3(+	cd3(+	NOUN
ajlm-804	264	23	)	)	PUNCT
ajlm-804	264	24	,	,	PUNCT
ajlm-804	264	25	cd4(+	cd4(+	NOUN
ajlm-804	264	26	)	)	PUNCT
ajlm-804	264	27	,	,	PUNCT
ajlm-804	264	28	cd8(+	cd8(+	PROPN
ajlm-804	264	29	)	)	PUNCT
ajlm-804	264	30	,	,	PUNCT
ajlm-804	264	31	and	and	CCONJ
ajlm-804	264	32	cd4(+	cd4(+	VERB
ajlm-804	264	33	)	)	PUNCT
ajlm-804	264	34	to	to	PART
ajlm-804	264	35	cd8(+	cd8(+	VERB
ajlm-804	264	36	)	)	PUNCT
ajlm-804	264	37	ratio	ratio	NOUN
ajlm-804	264	38	of	of	ADP
ajlm-804	264	39	t	t	PROPN
ajlm-804	264	40	lymphocytes	lymphocyte	VERB
ajlm-804	264	41	in	in	ADP
ajlm-804	264	42	hiv	hiv	PROPN
ajlm-804	264	43	negative	negative	ADJ
ajlm-804	264	44	adults	adult	NOUN
ajlm-804	264	45	from	from	ADP
ajlm-804	264	46	university	university	NOUN
ajlm-804	264	47	of	of	ADP
ajlm-804	264	48	gondar	gondar	PROPN
ajlm-804	264	49	hospital	hospital	NOUN
ajlm-804	264	50	,	,	PUNCT
ajlm-804	264	51	north	north	NOUN
ajlm-804	264	52	west	west	PROPN
ajlm-804	264	53	ethiopia	ethiopia	PROPN
ajlm-804	264	54	.	.	PUNCT
ajlm-804	265	1	aids	aids	PROPN
ajlm-804	265	2	res	re	NOUN
ajlm-804	265	3	treat	treat	NOUN
ajlm-804	265	4	.	.	PUNCT
ajlm-804	266	1	2014;2014:267450	2014;2014:267450	NUM
ajlm-804	266	2	.	.	PUNCT
ajlm-804	267	1	https://doi.org/10.1155/2014/267450	https://doi.org/10.1155/2014/267450	NOUN
ajlm-804	267	2	tsegaye	tsegaye	NOUN
ajlm-804	267	3	a	a	PRON
ajlm-804	267	4	,	,	PUNCT
ajlm-804	267	5	messele	messele	PROPN
ajlm-804	267	6	t	t	PROPN
ajlm-804	267	7	,	,	PUNCT
ajlm-804	267	8	tilahun	tilahun	PROPN
ajlm-804	267	9	t	t	PROPN
ajlm-804	267	10	,	,	PUNCT
ajlm-804	267	11	et	et	PROPN
ajlm-804	267	12	al	al	PROPN
ajlm-804	267	13	.	.	PROPN
ajlm-804	268	1	immunohematological	immunohematological	ADJ
ajlm-804	268	2	reference	reference	NOUN
ajlm-804	268	3	ranges	range	VERB
ajlm-804	268	4	for	for	ADP
ajlm-804	268	5	adult	adult	NOUN
ajlm-804	268	6	ethiopians	ethiopians	PROPN
ajlm-804	268	7	.	.	PUNCT
ajlm-804	269	1	clin	clin	PROPN
ajlm-804	269	2	diagn	diagn	PROPN
ajlm-804	269	3	lab	lab	NOUN
ajlm-804	269	4	immunol	immunol	NOUN
ajlm-804	269	5	.	.	PUNCT
ajlm-804	270	1	1999;6(3):410–414	1999;6(3):410–414	NUM
ajlm-804	270	2	.	.	X
ajlm-804	270	3	oladepo	oladepo	PROPN
ajlm-804	270	4	dk	dk	PROPN
ajlm-804	270	5	,	,	PUNCT
ajlm-804	270	6	idigbe	idigbe	NOUN
ajlm-804	270	7	eo	eo	NOUN
ajlm-804	270	8	,	,	PUNCT
ajlm-804	270	9	audu	audu	NOUN
ajlm-804	270	10	ra	ra	PROPN
ajlm-804	270	11	,	,	PUNCT
ajlm-804	270	12	et	et	PROPN
ajlm-804	270	13	al	al	PROPN
ajlm-804	270	14	.	.	PUNCT
ajlm-804	270	15	establishment	establishment	NOUN
ajlm-804	270	16	of	of	ADP
ajlm-804	270	17	reference	reference	NOUN
ajlm-804	270	18	values	value	NOUN
ajlm-804	270	19	of	of	ADP
ajlm-804	270	20	cd4	cd4	PROPN
ajlm-804	270	21	and	and	CCONJ
ajlm-804	270	22	cd8	cd8	PROPN
ajlm-804	270	23	lymphocyte	lymphocyte	ADJ
ajlm-804	270	24	subsets	subset	NOUN
ajlm-804	270	25	in	in	ADP
ajlm-804	270	26	healthy	healthy	ADJ
ajlm-804	270	27	nigerian	nigerian	ADJ
ajlm-804	270	28	adults	adult	NOUN
ajlm-804	270	29	.	.	PUNCT
ajlm-804	271	1	clin	clin	PROPN
ajlm-804	271	2	vaccine	vaccine	NOUN
ajlm-804	271	3	immunol	immunol	NOUN
ajlm-804	271	4	.	.	PUNCT
ajlm-804	272	1	2009;16(9):1374–1377	2009;16(9):1374–1377	NUM
ajlm-804	272	2	.	.	PUNCT
ajlm-804	273	1	https://doi.org/10.1128/cvi.00378-08	https://doi.org/10.1128/cvi.00378-08	PROPN
ajlm-804	273	2	klose	klose	PROPN
ajlm-804	273	3	n	n	PROPN
ajlm-804	273	4	,	,	PUNCT
ajlm-804	273	5	coulibaly	coulibaly	NOUN
ajlm-804	273	6	b	b	NOUN
ajlm-804	273	7	,	,	PUNCT
ajlm-804	273	8	tebit	tebit	NOUN
ajlm-804	273	9	dm	dm	PROPN
ajlm-804	273	10	,	,	PUNCT
ajlm-804	273	11	et	et	PROPN
ajlm-804	273	12	al	al	PROPN
ajlm-804	273	13	.	.	PROPN
ajlm-804	274	1	immunohematological	immunohematological	ADJ
ajlm-804	274	2	reference	reference	NOUN
ajlm-804	274	3	values	value	NOUN
ajlm-804	274	4	for	for	ADP
ajlm-804	274	5	healthy	healthy	ADJ
ajlm-804	274	6	adults	adult	NOUN
ajlm-804	274	7	in	in	ADP
ajlm-804	274	8	burkina	burkina	PROPN
ajlm-804	274	9	faso	faso	PROPN
ajlm-804	274	10	.	.	PUNCT
ajlm-804	275	1	clin	clin	PROPN
ajlm-804	275	2	vaccine	vaccine	NOUN
ajlm-804	275	3	immunol	immunol	NOUN
ajlm-804	275	4	.	.	PUNCT
ajlm-804	276	1	2007;14(6):782–784	2007;14(6):782–784	NUM
ajlm-804	276	2	.	.	PUNCT
ajlm-804	277	1	https://doi.org/10.1128/cvi.00044-07	https://doi.org/10.1128/cvi.00044-07	PROPN
ajlm-804	277	2	murugavel	murugavel	VERB
ajlm-804	277	3	kg	kg	PROPN
ajlm-804	277	4	,	,	PUNCT
ajlm-804	277	5	balakrishnan	balakrishnan	PROPN
ajlm-804	277	6	p	p	NOUN
ajlm-804	277	7	,	,	PUNCT
ajlm-804	277	8	mohanakrishnan	mohanakrishnan	PROPN
ajlm-804	277	9	j	j	PROPN
ajlm-804	277	10	,	,	PUNCT
ajlm-804	277	11	et	et	PROPN
ajlm-804	277	12	al	al	PROPN
ajlm-804	277	13	.	.	PUNCT
ajlm-804	278	1	establishment	establishment	NOUN
ajlm-804	278	2	of	of	ADP
ajlm-804	278	3	t	t	PROPN
ajlm-804	278	4	-	-	PUNCT
ajlm-804	278	5	lymphocyte	lymphocyte	NOUN
ajlm-804	278	6	subset	subset	NOUN
ajlm-804	278	7	reference	reference	NOUN
ajlm-804	278	8	intervals	interval	NOUN
ajlm-804	278	9	in	in	ADP
ajlm-804	278	10	a	a	DET
ajlm-804	278	11	healthy	healthy	ADJ
ajlm-804	278	12	adult	adult	NOUN
ajlm-804	278	13	population	population	NOUN
ajlm-804	278	14	in	in	ADP
ajlm-804	278	15	chennai	chennai	PROPN
ajlm-804	278	16	,	,	PUNCT
ajlm-804	278	17	india	india	PROPN
ajlm-804	278	18	.	.	PUNCT
ajlm-804	279	1	indian	indian	PROPN
ajlm-804	279	2	j	j	PROPN
ajlm-804	279	3	med	med	PROPN
ajlm-804	279	4	res	re	NOUN
ajlm-804	279	5	.	.	PUNCT
ajlm-804	280	1	2009;129(1):59–63	2009;129(1):59–63	NUM
ajlm-804	280	2	.	.	PUNCT
ajlm-804	280	3	uppal	uppal	PROPN
ajlm-804	280	4	ss	ss	PROPN
ajlm-804	280	5	,	,	PUNCT
ajlm-804	280	6	verma	verma	PROPN
ajlm-804	280	7	s	s	PART
ajlm-804	280	8	,	,	PUNCT
ajlm-804	280	9	dhot	dhot	ADJ
ajlm-804	280	10	ps	ps	NOUN
ajlm-804	280	11	.	.	NOUN
ajlm-804	280	12	normal	normal	ADJ
ajlm-804	280	13	values	value	NOUN
ajlm-804	280	14	of	of	ADP
ajlm-804	280	15	cd4	cd4	PROPN
ajlm-804	280	16	and	and	CCONJ
ajlm-804	280	17	cd8	cd8	PROPN
ajlm-804	280	18	lymphocyte	lymphocyte	ADJ
ajlm-804	280	19	subsets	subset	NOUN
ajlm-804	280	20	in	in	ADP
ajlm-804	280	21	healthy	healthy	ADJ
ajlm-804	280	22	indian	indian	ADJ
ajlm-804	280	23	adults	adult	NOUN
ajlm-804	280	24	and	and	CCONJ
ajlm-804	280	25	the	the	DET
ajlm-804	280	26	effects	effect	NOUN
ajlm-804	280	27	of	of	ADP
ajlm-804	280	28	sex	sex	NOUN
ajlm-804	280	29	,	,	PUNCT
ajlm-804	280	30	age	age	NOUN
ajlm-804	280	31	,	,	PUNCT
ajlm-804	280	32	ethnicity	ethnicity	NOUN
ajlm-804	280	33	,	,	PUNCT
ajlm-804	280	34	and	and	CCONJ
ajlm-804	280	35	smoking	smoking	NOUN
ajlm-804	280	36	.	.	PUNCT
ajlm-804	281	1	cytometry	cytometry	PROPN
ajlm-804	281	2	b	b	PROPN
ajlm-804	281	3	clin	clin	PROPN
ajlm-804	281	4	cytom	cytom	NOUN
ajlm-804	281	5	.	.	PUNCT
ajlm-804	282	1	2003;52(1):32–36	2003;52(1):32–36	NUM
ajlm-804	282	2	.	.	PUNCT
ajlm-804	282	3	https://doi.org/10.1002/cyto.b.10011	https://doi.org/10.1002/cyto.b.10011	PUNCT
ajlm-804	282	4	chng	chng	PROPN
ajlm-804	282	5	wj	wj	PROPN
ajlm-804	282	6	,	,	PUNCT
ajlm-804	282	7	tan	tan	PROPN
ajlm-804	282	8	gb	gb	PROPN
ajlm-804	282	9	,	,	PUNCT
ajlm-804	282	10	kuperan	kuperan	VERB
ajlm-804	282	11	p.	p.	NOUN
ajlm-804	282	12	establishment	establishment	NOUN
ajlm-804	282	13	of	of	ADP
ajlm-804	282	14	adult	adult	NOUN
ajlm-804	282	15	peripheral	peripheral	ADJ
ajlm-804	282	16	blood	blood	NOUN
ajlm-804	282	17	lymphocyte	lymphocyte	NOUN
ajlm-804	282	18	subset	subset	NOUN
ajlm-804	282	19	reference	reference	NOUN
ajlm-804	282	20	range	range	VERB
ajlm-804	282	21	for	for	ADP
ajlm-804	282	22	an	an	DET
ajlm-804	282	23	asian	asian	ADJ
ajlm-804	282	24	population	population	NOUN
ajlm-804	282	25	by	by	ADP
ajlm-804	282	26	single	single	ADJ
ajlm-804	282	27	-	-	PUNCT
ajlm-804	282	28	platform	platform	NOUN
ajlm-804	282	29	flow	flow	NOUN
ajlm-804	282	30	cytometry	cytometry	NOUN
ajlm-804	282	31	:	:	PUNCT
ajlm-804	282	32	influence	influence	NOUN
ajlm-804	282	33	of	of	ADP
ajlm-804	282	34	age	age	NOUN
ajlm-804	282	35	,	,	PUNCT
ajlm-804	282	36	sex	sex	NOUN
ajlm-804	282	37	,	,	PUNCT
ajlm-804	282	38	and	and	CCONJ
ajlm-804	282	39	race	race	NOUN
ajlm-804	282	40	and	and	CCONJ
ajlm-804	282	41	comparison	comparison	NOUN
ajlm-804	282	42	with	with	ADP
ajlm-804	282	43	other	other	ADJ
ajlm-804	282	44	published	publish	VERB
ajlm-804	282	45	studies	study	NOUN
ajlm-804	282	46	.	.	PUNCT
ajlm-804	283	1	clin	clin	PROPN
ajlm-804	283	2	diagn	diagn	PROPN
ajlm-804	283	3	lab	lab	NOUN
ajlm-804	283	4	immunol	immunol	NOUN
ajlm-804	283	5	.	.	PUNCT
ajlm-804	284	1	2004;11(1):168–173	2004;11(1):168–173	NUM
ajlm-804	284	2	.	.	PUNCT
ajlm-804	285	1	https://doi.org/10.1128/cdli.11.1.168-173.2004	https://doi.org/10.1128/cdli.11.1.168-173.2004	PROPN
ajlm-804	285	2	wong	wong	PROPN
ajlm-804	285	3	ws	ws	PROPN
ajlm-804	285	4	,	,	PUNCT
ajlm-804	285	5	lo	lo	PROPN
ajlm-804	285	6	aw	aw	INTJ
ajlm-804	285	7	,	,	PUNCT
ajlm-804	285	8	siu	siu	NOUN
ajlm-804	285	9	lp	lp	PROPN
ajlm-804	285	10	,	,	PUNCT
ajlm-804	285	11	et	et	PROPN
ajlm-804	285	12	al	al	PROPN
ajlm-804	285	13	.	.	PROPN
ajlm-804	285	14	reference	reference	NOUN
ajlm-804	285	15	ranges	range	VERB
ajlm-804	285	16	for	for	ADP
ajlm-804	285	17	lymphocyte	lymphocyte	ADJ
ajlm-804	285	18	subsets	subset	NOUN
ajlm-804	285	19	among	among	ADP
ajlm-804	285	20	healthy	healthy	ADJ
ajlm-804	285	21	hong	hong	PROPN
ajlm-804	285	22	kong	kong	PROPN
ajlm-804	285	23	chinese	chinese	ADJ
ajlm-804	285	24	adults	adult	NOUN
ajlm-804	285	25	by	by	ADP
ajlm-804	285	26	single	single	ADJ
ajlm-804	285	27	-	-	PUNCT
ajlm-804	285	28	platform	platform	NOUN
ajlm-804	285	29	flow	flow	NOUN
ajlm-804	285	30	cytometry	cytometry	NOUN
ajlm-804	285	31	.	.	PUNCT
ajlm-804	286	1	clin	clin	PROPN
ajlm-804	286	2	vaccine	vaccine	NOUN
ajlm-804	286	3	immunol	immunol	NOUN
ajlm-804	286	4	.	.	PUNCT
ajlm-804	287	1	2013;20(4):602–606	2013;20(4):602–606	X
ajlm-804	287	2	.	.	PUNCT
ajlm-804	288	1	https://doi.org/10.1128/cvi.00476-12	https://doi.org/10.1128/cvi.00476-12	PROPN
ajlm-804	288	2	jiang	jiang	PROPN
ajlm-804	288	3	w	w	PROPN
ajlm-804	288	4	,	,	PUNCT
ajlm-804	288	5	kang	kang	PROPN
ajlm-804	288	6	l	l	PROPN
ajlm-804	288	7	,	,	PUNCT
ajlm-804	288	8	lu	lu	PROPN
ajlm-804	288	9	hz	hz	VERB
ajlm-804	288	10	,	,	PUNCT
ajlm-804	288	11	et	et	PROPN
ajlm-804	288	12	al	al	PROPN
ajlm-804	288	13	.	.	PROPN
ajlm-804	289	1	normal	normal	ADJ
ajlm-804	289	2	values	value	NOUN
ajlm-804	289	3	for	for	ADP
ajlm-804	289	4	cd4	cd4	PROPN
ajlm-804	289	5	and	and	CCONJ
ajlm-804	289	6	cd8	cd8	PROPN
ajlm-804	289	7	lymphocyte	lymphocyte	ADJ
ajlm-804	289	8	subsets	subset	NOUN
ajlm-804	289	9	in	in	ADP
ajlm-804	289	10	healthy	healthy	ADJ
ajlm-804	289	11	chinese	chinese	ADJ
ajlm-804	289	12	adults	adult	NOUN
ajlm-804	289	13	from	from	ADP
ajlm-804	289	14	shanghai	shanghai	PROPN
ajlm-804	289	15	.	.	PUNCT
ajlm-804	290	1	clin	clin	PROPN
ajlm-804	290	2	diagn	diagn	PROPN
ajlm-804	290	3	lab	lab	NOUN
ajlm-804	290	4	immunol	immunol	NOUN
ajlm-804	290	5	.	.	PUNCT
ajlm-804	291	1	2004;11(4):811–813	2004;11(4):811–813	NUM
ajlm-804	291	2	.	.	PUNCT
ajlm-804	291	3	https://doi.org/10.1128/cdli.11.4.811-813.2004	https://doi.org/10.1128/cdli.11.4.811-813.2004	PROPN
ajlm-804	291	4	clinical	clinical	ADJ
ajlm-804	291	5	laboratory	laboratory	NOUN
ajlm-804	291	6	standards	standard	NOUN
ajlm-804	291	7	institute	institute	PROPN
ajlm-804	291	8	(	(	PUNCT
ajlm-804	291	9	clsi	clsi	PROPN
ajlm-804	291	10	)	)	PUNCT
ajlm-804	291	11	.	.	PUNCT
ajlm-804	292	1	method	method	PROPN
ajlm-804	292	2	comparison	comparison	NOUN
ajlm-804	292	3	and	and	CCONJ
ajlm-804	292	4	bias	bias	NOUN
ajlm-804	292	5	estimation	estimation	NOUN
ajlm-804	292	6	using	use	VERB
ajlm-804	292	7	patient	patient	ADJ
ajlm-804	292	8	samples	sample	NOUN
ajlm-804	292	9	.	.	PUNCT
ajlm-804	293	1	2nd	2nd	ADJ
ajlm-804	293	2	ed	ed	NOUN
ajlm-804	293	3	.	.	PUNCT
ajlm-804	293	4	clsi	clsi	PROPN
ajlm-804	293	5	guideline	guideline	NOUN
ajlm-804	293	6	ep09	ep09	PROPN
ajlm-804	293	7	-	-	PUNCT
ajlm-804	293	8	a2	a2	PROPN
ajlm-804	293	9	.	.	PUNCT
ajlm-804	294	1	wayne	wayne	PROPN
ajlm-804	294	2	,	,	PUNCT
ajlm-804	294	3	pa	pa	PROPN
ajlm-804	294	4	:	:	PUNCT
ajlm-804	294	5	clsi	clsi	ADJ
ajlm-804	294	6	;	;	PUNCT
ajlm-804	294	7	2002	2002	NUM
ajlm-804	294	8	.	.	PUNCT
ajlm-804	295	1	clinical	clinical	ADJ
ajlm-804	295	2	laboratory	laboratory	NOUN
ajlm-804	295	3	standards	standards	PROPN
ajlm-804	295	4	institute	institute	PROPN
ajlm-804	295	5	(	(	PUNCT
ajlm-804	295	6	clsi	clsi	PROPN
ajlm-804	295	7	)	)	PUNCT
ajlm-804	295	8	.	.	PUNCT
ajlm-804	296	1	defining	define	VERB
ajlm-804	296	2	,	,	PUNCT
ajlm-804	296	3	establishing	establish	VERB
ajlm-804	296	4	,	,	PUNCT
ajlm-804	296	5	and	and	CCONJ
ajlm-804	296	6	verifying	verifying	NOUN
ajlm-804	296	7	reference	reference	NOUN
ajlm-804	296	8	intervals	interval	NOUN
ajlm-804	296	9	in	in	ADP
ajlm-804	296	10	the	the	DET
ajlm-804	296	11	clinical	clinical	ADJ
ajlm-804	296	12	laboratory	laboratory	NOUN
ajlm-804	296	13	.	.	PUNCT
ajlm-804	297	1	3rd	3rd	ADJ
ajlm-804	297	2	ed	ed	NOUN
ajlm-804	297	3	.	.	PUNCT
ajlm-804	298	1	clsi	clsi	PROPN
ajlm-804	298	2	guideline	guideline	NOUN
ajlm-804	298	3	c28	c28	NOUN
ajlm-804	298	4	-	-	PUNCT
ajlm-804	298	5	a3	a3	NOUN
ajlm-804	298	6	.	.	PUNCT
ajlm-804	299	1	wayne	wayne	PROPN
ajlm-804	299	2	,	,	PUNCT
ajlm-804	299	3	pa	pa	PROPN
ajlm-804	299	4	:	:	PUNCT
ajlm-804	299	5	clsi	clsi	ADJ
ajlm-804	299	6	;	;	PUNCT
ajlm-804	299	7	2010	2010	NUM
ajlm-804	299	8	.	.	PUNCT
ajlm-804	300	1	bland	bland	PROPN
ajlm-804	300	2	jm	jm	PROPN
ajlm-804	300	3	,	,	PUNCT
ajlm-804	300	4	altman	altman	PROPN
ajlm-804	300	5	dg	dg	PROPN
ajlm-804	300	6	.	.	PUNCT
ajlm-804	301	1	statistical	statistical	ADJ
ajlm-804	301	2	methods	method	NOUN
ajlm-804	301	3	for	for	ADP
ajlm-804	301	4	assessing	assess	VERB
ajlm-804	301	5	agreement	agreement	NOUN
ajlm-804	301	6	between	between	ADP
ajlm-804	301	7	two	two	NUM
ajlm-804	301	8	methods	method	NOUN
ajlm-804	301	9	of	of	ADP
ajlm-804	301	10	clinical	clinical	ADJ
ajlm-804	301	11	measurement	measurement	NOUN
ajlm-804	301	12	.	.	PUNCT
ajlm-804	302	1	lancet	lancet	PROPN
ajlm-804	302	2	.	.	PUNCT
ajlm-804	303	1	1986;327(8476):307–310	1986;327(8476):307–310	X
ajlm-804	303	2	.	.	PUNCT
ajlm-804	304	1	https://doi.org/10.1016/s0140-6736(86)90837-8	https://doi.org/10.1016/s0140-6736(86)90837-8	PROPN
ajlm-804	304	2	bwana	bwana	PROPN
ajlm-804	304	3	p	p	PROPN
ajlm-804	304	4	,	,	PUNCT
ajlm-804	304	5	vojnov	vojnov	NOUN
ajlm-804	304	6	l	l	PROPN
ajlm-804	304	7	,	,	PUNCT
ajlm-804	304	8	adhiambo	adhiambo	PROPN
ajlm-804	304	9	m	m	PROPN
ajlm-804	304	10	,	,	PUNCT
ajlm-804	304	11	et	et	PROPN
ajlm-804	304	12	al	al	PROPN
ajlm-804	304	13	.	.	PUNCT
ajlm-804	305	1	the	the	DET
ajlm-804	305	2	bd	bd	PROPN
ajlm-804	305	3	facs	facs	PROPN
ajlm-804	305	4	presto	presto	PROPN
ajlm-804	305	5	point	point	NOUN
ajlm-804	305	6	of	of	ADP
ajlm-804	305	7	care	care	NOUN
ajlm-804	305	8	cd4	cd4	PROPN
ajlm-804	305	9	test	test	NOUN
ajlm-804	305	10	accurately	accurately	ADV
ajlm-804	305	11	enumerates	enumerate	VERB
ajlm-804	305	12	cd4	cd4	PROPN
ajlm-804	305	13	+	+	PROPN
ajlm-804	305	14	t	t	NOUN
ajlm-804	305	15	cell	cell	NOUN
ajlm-804	305	16	counts	count	NOUN
ajlm-804	305	17	.	.	PUNCT
ajlm-804	306	1	plos	plos	PROPN
ajlm-804	306	2	one	one	NUM
ajlm-804	306	3	.	.	PUNCT
ajlm-804	307	1	2015;10(12):e0145586	2015;10(12):e0145586	PROPN
ajlm-804	307	2	.	.	PUNCT
ajlm-804	308	1	https://doi.org/10.137/journal.pone.0145586	https://doi.org/10.137/journal.pone.0145586	PROPN
ajlm-804	308	2	scott	scott	PROPN
ajlm-804	308	3	le	le	PROPN
ajlm-804	308	4	,	,	PUNCT
ajlm-804	308	5	galpin	galpin	PROPN
ajlm-804	308	6	js	js	PROPN
ajlm-804	308	7	,	,	PUNCT
ajlm-804	308	8	glencross	glencross	ADJ
ajlm-804	308	9	dk	dk	PROPN
ajlm-804	308	10	.	.	PROPN
ajlm-804	308	11	multiple	multiple	ADJ
ajlm-804	308	12	method	method	PROPN
ajlm-804	308	13	comparison	comparison	NOUN
ajlm-804	308	14	:	:	PUNCT
ajlm-804	308	15	statistical	statistical	ADJ
ajlm-804	308	16	model	model	NOUN
ajlm-804	308	17	using	use	VERB
ajlm-804	308	18	percentage	percentage	NOUN
ajlm-804	308	19	similarity	similarity	NOUN
ajlm-804	308	20	.	.	PUNCT
ajlm-804	309	1	cytometry	cytometry	PROPN
ajlm-804	309	2	b	b	PROPN
ajlm-804	309	3	clin	clin	PROPN
ajlm-804	309	4	cytom	cytom	NOUN
ajlm-804	309	5	.	.	PUNCT
ajlm-804	310	1	2003;54b(1):46–53	2003;54b(1):46–53	X
ajlm-804	310	2	.	.	PUNCT
ajlm-804	311	1	https://doi.org/10.1002/cyto.b.10016	https://doi.org/10.1002/cyto.b.10016	X
ajlm-804	311	2	coetzee	coetzee	PROPN
ajlm-804	311	3	lm	lm	PROPN
ajlm-804	311	4	,	,	PUNCT
ajlm-804	311	5	glencross	glencross	ADJ
ajlm-804	311	6	dk	dk	PROPN
ajlm-804	311	7	.	.	PROPN
ajlm-804	311	8	performance	performance	NOUN
ajlm-804	311	9	verification	verification	NOUN
ajlm-804	311	10	of	of	ADP
ajlm-804	311	11	the	the	DET
ajlm-804	311	12	new	new	ADJ
ajlm-804	311	13	fully	fully	ADV
ajlm-804	311	14	automated	automate	VERB
ajlm-804	311	15	aquios	aquio	NOUN
ajlm-804	311	16	flow	flow	NOUN
ajlm-804	311	17	cytometer	cytometer	NOUN
ajlm-804	311	18	panleucogate	panleucogate	NOUN
ajlm-804	311	19	(	(	PUNCT
ajlm-804	311	20	plg	plg	NOUN
ajlm-804	311	21	)	)	PUNCT
ajlm-804	311	22	platform	platform	NOUN
ajlm-804	311	23	for	for	ADP
ajlm-804	311	24	cd4	cd4	PROPN
ajlm-804	311	25	-	-	PUNCT
ajlm-804	311	26	t	t	PROPN
ajlm-804	311	27	-	-	PUNCT
ajlm-804	311	28	lympocyte	lympocyte	NOUN
ajlm-804	311	29	enumeration	enumeration	NOUN
ajlm-804	311	30	in	in	ADP
ajlm-804	311	31	south	south	PROPN
ajlm-804	311	32	africa	africa	PROPN
ajlm-804	311	33	.	.	PUNCT
ajlm-804	312	1	plos	plos	PROPN
ajlm-804	312	2	one	one	NUM
ajlm-804	312	3	.	.	PUNCT
ajlm-804	313	1	2017;12(11):e0187456	2017;12(11):e0187456	NOUN
ajlm-804	313	2	.	.	PUNCT
ajlm-804	314	1	https://doi.org/10.1371/journal.pone.0187456	https://doi.org/10.1371/journal.pone.0187456	NOUN
ajlm-804	314	2	comans	coman	NOUN
ajlm-804	314	3	-	-	PUNCT
ajlm-804	314	4	bitter	bitter	ADJ
ajlm-804	314	5	wm	wm	PROPN
ajlm-804	314	6	,	,	PUNCT
ajlm-804	314	7	de	de	X
ajlm-804	314	8	groot	groot	PROPN
ajlm-804	314	9	r	r	PROPN
ajlm-804	314	10	,	,	PUNCT
ajlm-804	314	11	van	van	PROPN
ajlm-804	314	12	den	den	PROPN
ajlm-804	314	13	beemd	beemd	PROPN
ajlm-804	314	14	r	r	PROPN
ajlm-804	314	15	,	,	PUNCT
ajlm-804	314	16	et	et	PROPN
ajlm-804	314	17	al	al	PROPN
ajlm-804	314	18	.	.	PUNCT
ajlm-804	315	1	immunophenotyping	immunophenotype	VERB
ajlm-804	315	2	of	of	ADP
ajlm-804	315	3	blood	blood	NOUN
ajlm-804	315	4	lymphocytes	lymphocyte	VERB
ajlm-804	315	5	in	in	ADP
ajlm-804	315	6	childhood	childhood	NOUN
ajlm-804	315	7	.	.	PUNCT
ajlm-804	316	1	reference	reference	NOUN
ajlm-804	316	2	values	value	NOUN
ajlm-804	316	3	for	for	ADP
ajlm-804	316	4	lymphocyte	lymphocyte	ADJ
ajlm-804	316	5	subpopulations	subpopulation	NOUN
ajlm-804	316	6	.	.	PUNCT
ajlm-804	317	1	j	j	PROPN
ajlm-804	317	2	pediatr	pediatr	PROPN
ajlm-804	317	3	.	.	PUNCT
ajlm-804	318	1	1997;130(3):388–393	1997;130(3):388–393	NUM
ajlm-804	318	2	.	.	PUNCT
ajlm-804	318	3	https://doi.org/10.1016/s0022-3476(97)70200-2	https://doi.org/10.1016/s0022-3476(97)70200-2	PROPN
ajlm-804	318	4	peeling	peel	VERB
ajlm-804	318	5	rw	rw	NOUN
ajlm-804	318	6	,	,	PUNCT
ajlm-804	318	7	sollis	solli	VERB
ajlm-804	318	8	ka	ka	PROPN
ajlm-804	318	9	,	,	PUNCT
ajlm-804	318	10	glover	glover	PROPN
ajlm-804	318	11	s	s	PROPN
ajlm-804	318	12	,	,	PUNCT
ajlm-804	318	13	et	et	PROPN
ajlm-804	318	14	al	al	PROPN
ajlm-804	318	15	.	.	PUNCT
ajlm-804	319	1	cd4	cd4	PROPN
ajlm-804	319	2	enumeration	enumeration	NOUN
ajlm-804	319	3	technologies	technology	NOUN
ajlm-804	319	4	:	:	PUNCT
ajlm-804	319	5	a	a	DET
ajlm-804	319	6	systematic	systematic	ADJ
ajlm-804	319	7	review	review	NOUN
ajlm-804	319	8	of	of	ADP
ajlm-804	319	9	test	test	NOUN
ajlm-804	319	10	performance	performance	NOUN
ajlm-804	319	11	for	for	ADP
ajlm-804	319	12	determining	determine	VERB
ajlm-804	319	13	eligibility	eligibility	NOUN
ajlm-804	319	14	for	for	ADP
ajlm-804	319	15	antiretroviral	antiretroviral	ADJ
ajlm-804	319	16	therapy	therapy	NOUN
ajlm-804	319	17	.	.	PUNCT
ajlm-804	320	1	plos	plos	PROPN
ajlm-804	320	2	one	one	NUM
ajlm-804	320	3	.	.	PUNCT
ajlm-804	321	1	2015;10(3):e0115019	2015;10(3):e0115019	NUM
ajlm-804	321	2	.	.	PUNCT
ajlm-804	322	1	https://doi.org/10.1371/journal.pone.0115019	https://doi.org/10.1371/journal.pone.0115019	PROPN
ajlm-804	322	2	stevens	stevens	PROPN
ajlm-804	322	3	w	w	PROPN
ajlm-804	322	4	,	,	PUNCT
ajlm-804	322	5	gelman	gelman	PROPN
ajlm-804	322	6	r	r	NOUN
ajlm-804	322	7	,	,	PUNCT
ajlm-804	322	8	glencross	glencross	ADJ
ajlm-804	322	9	dk	dk	PROPN
ajlm-804	322	10	,	,	PUNCT
ajlm-804	322	11	scott	scott	PROPN
ajlm-804	322	12	le	le	PROPN
ajlm-804	322	13	,	,	PUNCT
ajlm-804	322	14	crowe	crowe	PROPN
ajlm-804	322	15	sm	sm	PROPN
ajlm-804	322	16	,	,	PUNCT
ajlm-804	322	17	spira	spira	PROPN
ajlm-804	322	18	t.	t.	PROPN
ajlm-804	322	19	evaluating	evaluate	VERB
ajlm-804	322	20	new	new	ADJ
ajlm-804	322	21	cd4	cd4	PROPN
ajlm-804	322	22	enumeration	enumeration	NOUN
ajlm-804	322	23	technologies	technology	NOUN
ajlm-804	322	24	for	for	ADP
ajlm-804	322	25	resource	resource	NOUN
ajlm-804	322	26	-	-	PUNCT
ajlm-804	322	27	constrained	constrain	VERB
ajlm-804	322	28	countries	country	NOUN
ajlm-804	322	29	.	.	PUNCT
ajlm-804	323	1	nat	nat	PROPN
ajlm-804	323	2	rev	rev	PROPN
ajlm-804	323	3	microbiol	microbiol	PROPN
ajlm-804	323	4	.	.	PUNCT
ajlm-804	324	1	2008;6	2008;6	NUM
ajlm-804	324	2	:	:	PUNCT
ajlm-804	324	3	s29	s29	NOUN
ajlm-804	324	4	–	–	PUNCT
ajlm-804	324	5	s38	s38	PROPN
ajlm-804	324	6	.	.	PUNCT
ajlm-804	325	1	https://doi.org/10.1038/nrmicro2000	https://doi.org/10.1038/nrmicro2000	PROPN
ajlm-804	325	2	world	world	PROPN
ajlm-804	325	3	health	health	PROPN
ajlm-804	325	4	organization	organization	PROPN
ajlm-804	325	5	.	.	PUNCT
ajlm-804	326	1	consolidated	consolidated	ADJ
ajlm-804	326	2	guidelines	guideline	NOUN
ajlm-804	326	3	on	on	ADP
ajlm-804	326	4	the	the	DET
ajlm-804	326	5	use	use	NOUN
ajlm-804	326	6	of	of	ADP
ajlm-804	326	7	antiretroviral	antiretroviral	ADJ
ajlm-804	326	8	drugs	drug	NOUN
ajlm-804	326	9	for	for	ADP
ajlm-804	326	10	treating	treat	VERB
ajlm-804	326	11	and	and	CCONJ
ajlm-804	326	12	preventing	prevent	VERB
ajlm-804	326	13	hiv	hiv	PROPN
ajlm-804	326	14	infection	infection	NOUN
ajlm-804	326	15	:	:	PUNCT
ajlm-804	326	16	recommendations	recommendation	NOUN
ajlm-804	326	17	for	for	ADP
ajlm-804	326	18	a	a	DET
ajlm-804	326	19	public	public	ADJ
ajlm-804	326	20	health	health	NOUN
ajlm-804	326	21	approach	approach	NOUN
ajlm-804	326	22	.	.	PUNCT
ajlm-804	327	1	geneva	geneva	PROPN
ajlm-804	327	2	,	,	PUNCT
ajlm-804	327	3	switzerland	switzerland	PROPN
ajlm-804	327	4	:	:	PUNCT
ajlm-804	327	5	who	who	PRON
ajlm-804	327	6	;	;	PUNCT
ajlm-804	327	7	2016	2016	NUM
ajlm-804	327	8	.	.	PUNCT
ajlm-804	328	1	mandala	mandala	PROPN
ajlm-804	328	2	wl	wl	PROPN
ajlm-804	328	3	,	,	PUNCT
ajlm-804	328	4	ananworanich	ananworanich	PROPN
ajlm-804	328	5	j	j	PROPN
ajlm-804	328	6	,	,	PUNCT
ajlm-804	328	7	apornpong	apornpong	PROPN
ajlm-804	328	8	t	t	PROPN
ajlm-804	328	9	,	,	PUNCT
ajlm-804	328	10	et	et	PROPN
ajlm-804	328	11	al	al	PROPN
ajlm-804	328	12	.	.	PROPN
ajlm-804	328	13	control	control	PROPN
ajlm-804	328	14	lymphocyte	lymphocyte	ADJ
ajlm-804	328	15	subsets	subset	NOUN
ajlm-804	328	16	:	:	PUNCT
ajlm-804	328	17	can	can	AUX
ajlm-804	328	18	one	one	NUM
ajlm-804	328	19	country	country	NOUN
ajlm-804	328	20	’s	’s	PART
ajlm-804	328	21	values	value	NOUN
ajlm-804	328	22	serve	serve	VERB
ajlm-804	328	23	for	for	ADP
ajlm-804	328	24	another	another	DET
ajlm-804	328	25	’s	’s	NOUN
ajlm-804	328	26	?	?	PUNCT
ajlm-804	329	1	j	j	PROPN
ajlm-804	329	2	allergy	allergy	PROPN
ajlm-804	329	3	clin	clin	PROPN
ajlm-804	329	4	immunol	immunol	PROPN
ajlm-804	329	5	.	.	PUNCT
ajlm-804	330	1	2014;134(3):759–761.e8	2014;134(3):759–761.e8	PROPN
ajlm-804	330	2	.	.	PUNCT
ajlm-804	331	1	https://doi.org/10.1016/j.jaci.2014.06.030	https://doi.org/10.1016/j.jaci.2014.06.030	PROPN
ajlm-804	331	2	maini	maini	PROPN
ajlm-804	331	3	mk	mk	PROPN
ajlm-804	331	4	,	,	PUNCT
ajlm-804	331	5	gilson	gilson	PROPN
ajlm-804	331	6	rj	rj	PROPN
ajlm-804	331	7	,	,	PUNCT
ajlm-804	331	8	chavda	chavda	VERB
ajlm-804	331	9	n	n	PRON
ajlm-804	331	10	,	,	PUNCT
ajlm-804	331	11	et	et	PROPN
ajlm-804	331	12	al	al	PROPN
ajlm-804	331	13	.	.	PROPN
ajlm-804	331	14	reference	reference	NOUN
ajlm-804	331	15	ranges	range	VERB
ajlm-804	331	16	and	and	CCONJ
ajlm-804	331	17	sources	source	NOUN
ajlm-804	331	18	of	of	ADP
ajlm-804	331	19	variability	variability	NOUN
ajlm-804	331	20	of	of	ADP
ajlm-804	331	21	cd4	cd4	PROPN
ajlm-804	331	22	counts	count	NOUN
ajlm-804	331	23	in	in	ADP
ajlm-804	331	24	hiv	hiv	PROPN
ajlm-804	331	25	-	-	PUNCT
ajlm-804	331	26	seronegative	seronegative	ADJ
ajlm-804	331	27	women	woman	NOUN
ajlm-804	331	28	and	and	CCONJ
ajlm-804	331	29	men	man	NOUN
ajlm-804	331	30	.	.	PUNCT
ajlm-804	332	1	genitourin	genitourin	PROPN
ajlm-804	332	2	med	med	PROPN
ajlm-804	332	3	.	.	PUNCT
ajlm-804	333	1	1996;72(1):27–31	1996;72(1):27–31	X
ajlm-804	333	2	.	.	PUNCT
ajlm-804	333	3	https://doi.org/10.1136/sti.72.1.27	https://doi.org/10.1136/sti.72.1.27	PROPN
ajlm-804	333	4	glencross	glencross	PROPN
ajlm-804	333	5	dk	dk	PROPN
ajlm-804	333	6	,	,	PUNCT
ajlm-804	333	7	stevens	stevens	PROPN
ajlm-804	333	8	g	g	PROPN
ajlm-804	333	9	,	,	PUNCT
ajlm-804	333	10	scott	scott	PROPN
ajlm-804	333	11	le	le	PROPN
ajlm-804	333	12	,	,	PUNCT
ajlm-804	333	13	mendelow	mendelow	PROPN
ajlm-804	333	14	bv	bv	PROPN
ajlm-804	333	15	,	,	PUNCT
ajlm-804	333	16	stevens	stevens	PROPN
ajlm-804	333	17	w.	w.	PROPN
ajlm-804	333	18	the	the	DET
ajlm-804	333	19	challenge	challenge	NOUN
ajlm-804	333	20	of	of	ADP
ajlm-804	333	21	laboratory	laboratory	NOUN
ajlm-804	333	22	monitoring	monitoring	NOUN
ajlm-804	333	23	of	of	ADP
ajlm-804	333	24	hiv	hiv	PROPN
ajlm-804	333	25	.	.	PUNCT
ajlm-804	334	1	s	s	PROPN
ajlm-804	334	2	afr	afr	PROPN
ajlm-804	334	3	med	med	PROPN
ajlm-804	334	4	j.	j.	PROPN
ajlm-804	334	5	2002;92(4):248	2002;92(4):248	PROPN
ajlm-804	334	6	.	.	PUNCT
ajlm-804	335	1	scott	scott	PROPN
ajlm-804	335	2	le	le	PROPN
ajlm-804	335	3	,	,	PUNCT
ajlm-804	335	4	glencross	glencross	PROPN
ajlm-804	335	5	dk	dk	PROPN
ajlm-804	335	6	.	.	PROPN
ajlm-804	335	7	monitoring	monitoring	NOUN
ajlm-804	335	8	reproducibility	reproducibility	NOUN
ajlm-804	335	9	of	of	ADP
ajlm-804	335	10	single	single	ADJ
ajlm-804	335	11	analysis	analysis	NOUN
ajlm-804	335	12	,	,	PUNCT
ajlm-804	335	13	single	single	ADJ
ajlm-804	335	14	platform	platform	NOUN
ajlm-804	335	15	cd4	cd4	PROPN
ajlm-804	335	16	cell	cell	NOUN
ajlm-804	335	17	counts	count	NOUN
ajlm-804	335	18	in	in	ADP
ajlm-804	335	19	a	a	DET
ajlm-804	335	20	high	high	ADJ
ajlm-804	335	21	volume	volume	NOUN
ajlm-804	335	22	,	,	PUNCT
ajlm-804	335	23	low	low	ADJ
ajlm-804	335	24	resource	resource	NOUN
ajlm-804	335	25	laboratory	laboratory	NOUN
ajlm-804	335	26	setting	set	VERB
ajlm-804	335	27	using	use	VERB
ajlm-804	335	28	sequential	sequential	ADJ
ajlm-804	335	29	bead	bead	NOUN
ajlm-804	335	30	count	count	NOUN
ajlm-804	335	31	rates	rate	NOUN
ajlm-804	335	32	.	.	PUNCT
ajlm-804	336	1	cytometry	cytometry	PROPN
ajlm-804	336	2	b	b	PROPN
ajlm-804	336	3	clin	clin	PROPN
ajlm-804	336	4	cytom	cytom	NOUN
ajlm-804	336	5	.	.	PUNCT
ajlm-804	337	1	2005;67(1):31–32	2005;67(1):31–32	NUM
ajlm-804	337	2	.	.	PUNCT
ajlm-804	338	1	https://doi.org/10.1002/cyto.b.20066	https://doi.org/10.1002/cyto.b.20066	X
ajlm-804	339	1	denny	denny	PROPN
ajlm-804	339	2	t	t	PROPN
ajlm-804	339	3	,	,	PUNCT
ajlm-804	339	4	gelman	gelman	PROPN
ajlm-804	339	5	r	r	PROPN
ajlm-804	339	6	,	,	PUNCT
ajlm-804	339	7	bergeron	bergeron	PROPN
ajlm-804	339	8	m	m	PROPN
ajlm-804	339	9	,	,	PUNCT
ajlm-804	339	10	et	et	PROPN
ajlm-804	339	11	al	al	PROPN
ajlm-804	339	12	.	.	PUNCT
ajlm-804	340	1	a	a	DET
ajlm-804	340	2	multi	multi	ADJ
ajlm-804	340	3	-	-	ADJ
ajlm-804	340	4	lab	lab	ADJ
ajlm-804	340	5	study	study	NOUN
ajlm-804	340	6	of	of	ADP
ajlm-804	340	7	cd4	cd4	PROPN
ajlm-804	340	8	counts	count	NOUN
ajlm-804	340	9	using	use	VERB
ajlm-804	340	10	flow	flow	NOUN
ajlm-804	340	11	cytometric	cytometric	ADJ
ajlm-804	340	12	panleukogating	panleukogating	NOUN
ajlm-804	340	13	(	(	PUNCT
ajlm-804	340	14	plg	plg	NOUN
ajlm-804	340	15	):	):	PUNCT
ajlm-804	340	16	a	a	DET
ajlm-804	340	17	niaid	niaid	NOUN
ajlm-804	340	18	-	-	PUNCT
ajlm-804	340	19	daids	daid	NOUN
ajlm-804	340	20	immunology	immunology	NOUN
ajlm-804	340	21	quality	quality	NOUN
ajlm-804	340	22	assessment	assessment	NOUN
ajlm-804	340	23	program	program	NOUN
ajlm-804	340	24	study	study	NOUN
ajlm-804	340	25	.	.	PUNCT
ajlm-804	341	1	croi	croi	NOUN
ajlm-804	341	2	-	-	PUNCT
ajlm-804	341	3	conference	conference	NOUN
ajlm-804	341	4	on	on	ADP
ajlm-804	341	5	retrovirus	retrovirus	NOUN
ajlm-804	341	6	and	and	CCONJ
ajlm-804	341	7	opportunistic	opportunistic	ADJ
ajlm-804	341	8	infections	infection	NOUN
ajlm-804	341	9	.	.	PUNCT
ajlm-804	342	1	boston	boston	PROPN
ajlm-804	342	2	,	,	PUNCT
ajlm-804	342	3	ma	ma	PROPN
ajlm-804	342	4	;	;	PUNCT
ajlm-804	342	5	2005	2005	NUM
ajlm-804	342	6	.	.	PUNCT
ajlm-804	343	1	zhang	zhang	PROPN
ajlm-804	343	2	j	j	PROPN
ajlm-804	343	3	,	,	PUNCT
ajlm-804	343	4	quessada	quessada	PROPN
ajlm-804	343	5	v	v	PROPN
ajlm-804	343	6	,	,	PUNCT
ajlm-804	343	7	de	de	PROPN
ajlm-804	343	8	castro	castro	PROPN
ajlm-804	343	9	j.	j.	PROPN
ajlm-804	343	10	an	an	DET
ajlm-804	343	11	automated	automate	VERB
ajlm-804	343	12	cell	cell	NOUN
ajlm-804	343	13	preparation	preparation	NOUN
ajlm-804	343	14	method	method	NOUN
ajlm-804	343	15	for	for	ADP
ajlm-804	343	16	flow	flow	NOUN
ajlm-804	343	17	caretm	caretm	NOUN
ajlm-804	343	18	pan	pan	ADJ
ajlm-804	343	19	-	-	ADJ
ajlm-804	343	20	leukocyte	leukocyte	ADJ
ajlm-804	343	21	gating	gating	NOUN
ajlm-804	343	22	(	(	PUNCT
ajlm-804	343	23	plg	plg	NOUN
ajlm-804	343	24	)	)	PUNCT
ajlm-804	343	25	cd4	cd4	PROPN
ajlm-804	343	26	assay	assay	VERB
ajlm-804	343	27	in	in	ADP
ajlm-804	343	28	a	a	DET
ajlm-804	343	29	96	96	NUM
ajlm-804	343	30	-	-	PUNCT
ajlm-804	343	31	well	well	NOUN
ajlm-804	343	32	plate	plate	NOUN
ajlm-804	343	33	offers	offer	VERB
ajlm-804	343	34	increased	increase	VERB
ajlm-804	343	35	throughput	throughput	NOUN
ajlm-804	343	36	and	and	CCONJ
ajlm-804	343	37	ease	ease	NOUN
ajlm-804	343	38	of	of	ADP
ajlm-804	343	39	use	use	NOUN
ajlm-804	343	40	(	(	PUNCT
ajlm-804	343	41	poster	poster	NOUN
ajlm-804	343	42	)	)	PUNCT
ajlm-804	343	43	.	.	PUNCT
ajlm-804	344	1	african	african	ADJ
ajlm-804	344	2	society	society	NOUN
ajlm-804	344	3	for	for	ADP
ajlm-804	344	4	laboratory	laboratory	NOUN
ajlm-804	344	5	medicine	medicine	NOUN
ajlm-804	344	6	(	(	PUNCT
ajlm-804	344	7	aslm	aslm	NOUN
ajlm-804	344	8	)	)	PUNCT
ajlm-804	344	9	.	.	PUNCT
ajlm-804	345	1	cape	cape	NOUN
ajlm-804	345	2	town	town	NOUN
ajlm-804	345	3	,	,	PUNCT
ajlm-804	345	4	south	south	PROPN
ajlm-804	345	5	africa	africa	PROPN
ajlm-804	345	6	;	;	PUNCT
ajlm-804	345	7	2016	2016	NUM
ajlm-804	345	8	.	.	PUNCT
ajlm-804	346	1	world	world	PROPN
ajlm-804	346	2	health	health	PROPN
ajlm-804	346	3	organization	organization	NOUN
ajlm-804	346	4	(	(	PUNCT
ajlm-804	346	5	who	who	PRON
ajlm-804	346	6	)	)	PUNCT
ajlm-804	346	7	.	.	PUNCT
ajlm-804	347	1	emergency	emergency	NOUN
ajlm-804	347	2	scale	scale	NOUN
ajlm-804	347	3	-	-	PUNCT
ajlm-804	347	4	up	up	NOUN
ajlm-804	347	5	of	of	ADP
ajlm-804	347	6	antiretroviral	antiretroviral	ADJ
ajlm-804	347	7	therapy	therapy	NOUN
ajlm-804	347	8	in	in	ADP
ajlm-804	347	9	resource	resource	NOUN
ajlm-804	347	10	-	-	PUNCT
ajlm-804	347	11	limited	limit	VERB
ajlm-804	347	12	settings	setting	NOUN
ajlm-804	347	13	:	:	PUNCT
ajlm-804	347	14	technical	technical	ADJ
ajlm-804	347	15	and	and	CCONJ
ajlm-804	347	16	operational	operational	ADJ
ajlm-804	347	17	recommendations	recommendation	NOUN
ajlm-804	347	18	to	to	PART
ajlm-804	347	19	achieve	achieve	VERB
ajlm-804	347	20	3	3	NUM
ajlm-804	347	21	by	by	ADP
ajlm-804	347	22	5	5	NUM
ajlm-804	348	1	[	[	NOUN
ajlm-804	348	2	homepage	homepage	NOUN
ajlm-804	348	3	on	on	ADP
ajlm-804	348	4	the	the	DET
ajlm-804	348	5	internet	internet	NOUN
ajlm-804	348	6	]	]	PUNCT
ajlm-804	348	7	.	.	PUNCT
ajlm-804	349	1	zambia	zambia	PROPN
ajlm-804	349	2	;	;	PUNCT
ajlm-804	349	3	2003	2003	NUM
ajlm-804	349	4	nov	nov	NOUN
ajlm-804	349	5	18–21	18–21	NUM
ajlm-804	350	1	[	[	X
ajlm-804	350	2	cited	cite	VERB
ajlm-804	350	3	2018	2018	NUM
ajlm-804	350	4	dec	dec	PROPN
ajlm-804	350	5	15	15	NUM
ajlm-804	350	6	]	]	PUNCT
ajlm-804	350	7	.	.	PUNCT
ajlm-804	351	1	available	available	ADJ
ajlm-804	351	2	from	from	ADP
ajlm-804	351	3	:	:	PUNCT
ajlm-804	351	4	https://www.who.int/3by5/publications/documents/en/zambiaen.pdf	https://www.who.int/3by5/publications/documents/en/zambiaen.pdf	PROPN
ajlm-804	351	5	ford	ford	PROPN
ajlm-804	351	6	n	n	CCONJ
ajlm-804	351	7	,	,	PUNCT
ajlm-804	351	8	meintjes	meintjes	ADJ
ajlm-804	351	9	g	g	NOUN
ajlm-804	351	10	,	,	PUNCT
ajlm-804	351	11	pozniak	pozniak	PROPN
ajlm-804	351	12	a	a	X
ajlm-804	351	13	,	,	PUNCT
ajlm-804	351	14	et	et	PROPN
ajlm-804	351	15	al	al	PROPN
ajlm-804	351	16	.	.	PUNCT
ajlm-804	352	1	the	the	DET
ajlm-804	352	2	future	future	ADJ
ajlm-804	352	3	role	role	NOUN
ajlm-804	352	4	of	of	ADP
ajlm-804	352	5	cd4	cd4	PROPN
ajlm-804	352	6	cell	cell	NOUN
ajlm-804	352	7	count	count	NOUN
ajlm-804	352	8	for	for	ADP
ajlm-804	352	9	monitoring	monitor	VERB
ajlm-804	352	10	antiretroviral	antiretroviral	ADJ
ajlm-804	352	11	therapy	therapy	NOUN
ajlm-804	352	12	.	.	PUNCT
ajlm-804	353	1	lancet	lancet	PROPN
ajlm-804	353	2	infect	infect	PROPN
ajlm-804	353	3	dis	dis	PROPN
ajlm-804	353	4	.	.	PUNCT
ajlm-804	354	1	2015;15(2):241–247	2015;15(2):241–247	NUM
ajlm-804	354	2	.	.	PUNCT
ajlm-804	355	1	https://doi.org/10.1016/s1473-3099(14)70896-5	https://doi.org/10.1016/s1473-3099(14)70896-5	PROPN
ajlm-804	355	2	carmona	carmona	PROPN
ajlm-804	355	3	s	s	PROPN
ajlm-804	355	4	,	,	PUNCT
ajlm-804	355	5	bor	bor	PROPN
ajlm-804	355	6	j	j	PROPN
ajlm-804	355	7	,	,	PUNCT
ajlm-804	355	8	nattey	nattey	ADV
ajlm-804	355	9	c	c	AUX
ajlm-804	355	10	,	,	PUNCT
ajlm-804	355	11	et	et	PROPN
ajlm-804	355	12	al	al	PROPN
ajlm-804	355	13	.	.	PUNCT
ajlm-804	356	1	persistent	persistent	ADJ
ajlm-804	356	2	high	high	ADJ
ajlm-804	356	3	burden	burden	NOUN
ajlm-804	356	4	of	of	ADP
ajlm-804	356	5	advanced	advanced	ADJ
ajlm-804	356	6	hiv	hiv	PROPN
ajlm-804	356	7	disease	disease	NOUN
ajlm-804	356	8	among	among	ADP
ajlm-804	356	9	patients	patient	NOUN
ajlm-804	356	10	seeking	seek	VERB
ajlm-804	356	11	care	care	NOUN
ajlm-804	356	12	in	in	ADP
ajlm-804	356	13	south	south	PROPN
ajlm-804	356	14	africa	africa	PROPN
ajlm-804	356	15	’s	’s	PART
ajlm-804	356	16	national	national	PROPN
ajlm-804	356	17	hiv	hiv	PROPN
ajlm-804	356	18	program	program	PROPN
ajlm-804	356	19	:	:	PUNCT
ajlm-804	356	20	data	datum	NOUN
ajlm-804	356	21	from	from	ADP
ajlm-804	356	22	a	a	DET
ajlm-804	356	23	nationwide	nationwide	ADJ
ajlm-804	356	24	laboratory	laboratory	NOUN
ajlm-804	356	25	cohort	cohort	NOUN
ajlm-804	356	26	.	.	PUNCT
ajlm-804	357	1	clin	clin	PROPN
ajlm-804	357	2	inf	inf	PROPN
ajlm-804	357	3	dis	dis	PROPN
ajlm-804	357	4	.	.	PUNCT
ajlm-804	358	1	2018;66	2018;66	NUM
ajlm-804	358	2	suppl	suppl	ADJ
ajlm-804	358	3	2	2	NUM
ajlm-804	358	4	:	:	PUNCT
ajlm-804	358	5	s111	s111	PROPN
ajlm-804	358	6	–	–	PUNCT
ajlm-804	358	7	s117	s117	NUM
ajlm-804	358	8	.	.	PUNCT
ajlm-804	359	1	https://doi.org/10.1093/cid/ciy045	https://doi.org/10.1093/cid/ciy045	VERB
ajlm-804	359	2	coetzee	coetzee	PROPN
ajlm-804	359	3	lm	lm	PROPN
ajlm-804	359	4	,	,	PUNCT
ajlm-804	359	5	cassim	cassim	NOUN
ajlm-804	359	6	n	n	CCONJ
ajlm-804	359	7	,	,	PUNCT
ajlm-804	359	8	glencross	glencross	ADJ
ajlm-804	359	9	dk	dk	PROPN
ajlm-804	359	10	.	.	PROPN
ajlm-804	359	11	analysis	analysis	NOUN
ajlm-804	359	12	of	of	ADP
ajlm-804	359	13	hiv	hiv	PROPN
ajlm-804	359	14	disease	disease	NOUN
ajlm-804	359	15	burden	burden	NOUN
ajlm-804	359	16	by	by	ADP
ajlm-804	359	17	calculating	calculate	VERB
ajlm-804	359	18	the	the	DET
ajlm-804	359	19	percentages	percentage	NOUN
ajlm-804	359	20	of	of	ADP
ajlm-804	359	21	patients	patient	NOUN
ajlm-804	359	22	with	with	ADP
ajlm-804	359	23	cd4	cd4	PROPN
ajlm-804	359	24	counts	count	NOUN
ajlm-804	359	25	<	<	X
ajlm-804	359	26	100	100	NUM
ajlm-804	359	27	cells	cell	NOUN
ajlm-804	359	28	/	/	SYM
ajlm-804	359	29	microl	microl	NOUN
ajlm-804	359	30	.	.	PUNCT
ajlm-804	360	1	across	across	ADP
ajlm-804	360	2	52	52	NUM
ajlm-804	360	3	districts	district	NOUN
ajlm-804	360	4	reveals	reveal	VERB
ajlm-804	360	5	hot	hot	ADJ
ajlm-804	360	6	spots	spot	NOUN
ajlm-804	360	7	for	for	ADP
ajlm-804	360	8	intensified	intensified	ADJ
ajlm-804	360	9	commitment	commitment	NOUN
ajlm-804	360	10	to	to	ADP
ajlm-804	360	11	programmatic	programmatic	ADJ
ajlm-804	360	12	support	support	NOUN
ajlm-804	360	13	.	.	PUNCT
ajlm-804	361	1	s	s	PROPN
ajlm-804	361	2	afr	afr	PROPN
ajlm-804	361	3	med	med	PROPN
ajlm-804	361	4	j.	j.	PROPN
ajlm-804	361	5	2017;107(6):507–513	2017;107(6):507–513	PROPN
ajlm-804	361	6	.	.	PUNCT
ajlm-804	362	1	https://doi.org/10.7196/samj.2017.v107i6.11311	https://doi.org/10.7196/samj.2017.v107i6.11311	PROPN
ajlm-804	362	2	guidelines	guideline	NOUN
ajlm-804	362	3	for	for	ADP
ajlm-804	362	4	managing	manage	VERB
ajlm-804	362	5	advance	advance	NOUN
ajlm-804	362	6	hiv	hiv	PROPN
ajlm-804	362	7	disease	disease	NOUN
ajlm-804	362	8	and	and	CCONJ
ajlm-804	362	9	rapid	rapid	ADJ
ajlm-804	362	10	initiation	initiation	NOUN
ajlm-804	362	11	of	of	ADP
ajlm-804	362	12	antiretroviral	antiretroviral	ADJ
ajlm-804	362	13	therapy	therapy	NOUN
ajlm-804	362	14	,	,	PUNCT
ajlm-804	362	15	july	july	PROPN
ajlm-804	362	16	2017	2017	NUM
ajlm-804	363	1	[	[	X
ajlm-804	363	2	homepage	homepage	NOUN
ajlm-804	363	3	on	on	ADP
ajlm-804	363	4	the	the	DET
ajlm-804	363	5	internet	internet	NOUN
ajlm-804	363	6	]	]	PUNCT
ajlm-804	363	7	.	.	PUNCT
ajlm-804	364	1	geneva	geneva	PROPN
ajlm-804	364	2	:	:	PUNCT
ajlm-804	364	3	world	world	PROPN
ajlm-804	364	4	health	health	PROPN
ajlm-804	364	5	organization	organization	NOUN
ajlm-804	364	6	;	;	PUNCT
ajlm-804	364	7	2017	2017	NUM
ajlm-804	365	1	[	[	PUNCT
ajlm-804	365	2	cited	cite	VERB
ajlm-804	365	3	2018	2018	NUM
ajlm-804	365	4	dec	dec	PROPN
ajlm-804	365	5	15	15	NUM
ajlm-804	365	6	]	]	PUNCT
ajlm-804	365	7	.	.	PUNCT
ajlm-804	366	1	available	available	ADJ
ajlm-804	366	2	from	from	ADP
ajlm-804	366	3	:	:	PUNCT
ajlm-804	366	4	https://www.who.int/hiv/pub/guidelines/advanced-hiv-disease/en/	https://www.who.int/hiv/pub/guidelines/advanced-hiv-disease/en/	PROPN
ajlm-804	366	5	national	national	ADJ
ajlm-804	366	6	consolidated	consolidated	ADJ
ajlm-804	366	7	guidelines	guideline	NOUN
ajlm-804	366	8	for	for	ADP
ajlm-804	366	9	the	the	DET
ajlm-804	366	10	prevention	prevention	NOUN
ajlm-804	366	11	of	of	ADP
ajlm-804	366	12	mother	mother	NOUN
ajlm-804	366	13	-	-	PUNCT
ajlm-804	366	14	to	to	ADP
ajlm-804	366	15	-	-	PUNCT
ajlm-804	366	16	child	child	NOUN
ajlm-804	366	17	transmission	transmission	NOUN
ajlm-804	366	18	of	of	ADP
ajlm-804	366	19	hiv	hiv	PROPN
ajlm-804	366	20	(	(	PUNCT
ajlm-804	366	21	pmtct	pmtct	NOUN
ajlm-804	366	22	)	)	PUNCT
ajlm-804	366	23	and	and	CCONJ
ajlm-804	366	24	the	the	DET
ajlm-804	366	25	management	management	NOUN
ajlm-804	366	26	of	of	ADP
ajlm-804	366	27	hiv	hiv	PROPN
ajlm-804	366	28	in	in	ADP
ajlm-804	366	29	children	child	NOUN
ajlm-804	366	30	,	,	PUNCT
ajlm-804	366	31	adolescents	adolescent	NOUN
ajlm-804	366	32	and	and	CCONJ
ajlm-804	366	33	adults	adult	NOUN
ajlm-804	367	1	[	[	X
ajlm-804	367	2	homepage	homepage	NOUN
ajlm-804	367	3	on	on	ADP
ajlm-804	367	4	the	the	DET
ajlm-804	367	5	internet	internet	NOUN
ajlm-804	367	6	]	]	PUNCT
ajlm-804	367	7	.	.	PUNCT
ajlm-804	368	1	pretoria	pretoria	PROPN
ajlm-804	368	2	,	,	PUNCT
ajlm-804	368	3	south	south	PROPN
ajlm-804	368	4	africa	africa	PROPN
ajlm-804	368	5	:	:	PUNCT
ajlm-804	368	6	department	department	NOUN
ajlm-804	368	7	of	of	ADP
ajlm-804	368	8	health	health	PROPN
ajlm-804	368	9	,	,	PUNCT
ajlm-804	368	10	republic	republic	NOUN
ajlm-804	368	11	of	of	ADP
ajlm-804	368	12	south	south	PROPN
ajlm-804	368	13	africa	africa	PROPN
ajlm-804	368	14	;	;	PUNCT
ajlm-804	368	15	2015	2015	NUM
ajlm-804	368	16	[	[	PUNCT
ajlm-804	368	17	cited	cite	VERB
ajlm-804	368	18	2018	2018	NUM
ajlm-804	368	19	dec	dec	PROPN
ajlm-804	368	20	15	15	NUM
ajlm-804	368	21	]	]	PUNCT
ajlm-804	368	22	.	.	PUNCT
ajlm-804	369	1	available	available	ADJ
ajlm-804	369	2	from	from	ADP
ajlm-804	369	3	:	:	PUNCT
ajlm-804	369	4	https://sahivsoc.org/files/art%20guidelines%2015052015.pdf	https://sahivsoc.org/files/art%20guidelines%2015052015.pdf	PROPN
ajlm-804	369	5	ford	ford	PROPN
ajlm-804	369	6	n	n	CCONJ
ajlm-804	369	7	,	,	PUNCT
ajlm-804	369	8	meintjes	meintjes	ADJ
ajlm-804	369	9	g	g	PROPN
ajlm-804	369	10	,	,	PUNCT
ajlm-804	369	11	vitoria	vitoria	PROPN
ajlm-804	369	12	m	m	PROPN
ajlm-804	369	13	,	,	PUNCT
ajlm-804	369	14	greene	greene	PROPN
ajlm-804	369	15	g	g	PROPN
ajlm-804	369	16	,	,	PUNCT
ajlm-804	369	17	chiller	chiller	NOUN
ajlm-804	369	18	t.	t.	NOUN
ajlm-804	369	19	the	the	DET
ajlm-804	369	20	evolving	evolve	VERB
ajlm-804	369	21	role	role	NOUN
ajlm-804	369	22	of	of	ADP
ajlm-804	369	23	cd4	cd4	PROPN
ajlm-804	369	24	cell	cell	NOUN
ajlm-804	369	25	counts	count	NOUN
ajlm-804	369	26	in	in	ADP
ajlm-804	369	27	hiv	hiv	PROPN
ajlm-804	369	28	care	care	NOUN
ajlm-804	369	29	.	.	PUNCT
ajlm-804	370	1	curr	curr	PROPN
ajlm-804	370	2	opin	opin	PROPN
ajlm-804	370	3	hiv	hiv	PROPN
ajlm-804	370	4	aids	aids	PROPN
ajlm-804	370	5	.	.	PUNCT
ajlm-804	371	1	2017;12(2):123–128	2017;12(2):123–128	X
ajlm-804	371	2	.	.	X
ajlm-804	371	3	https://doi.org/10.1097/coh.0000000000000348	https://doi.org/10.1097/coh.0000000000000348	PROPN
ajlm-804	371	4	moorhouse	moorhouse	PROPN
ajlm-804	371	5	m	m	PROPN
ajlm-804	371	6	,	,	PUNCT
ajlm-804	371	7	conradie	conradie	PROPN
ajlm-804	371	8	f	f	X
ajlm-804	371	9	,	,	PUNCT
ajlm-804	371	10	venter	venter	PROPN
ajlm-804	371	11	f.	f.	PROPN
ajlm-804	372	1	what	what	PRON
ajlm-804	372	2	is	be	AUX
ajlm-804	372	3	the	the	DET
ajlm-804	372	4	role	role	NOUN
ajlm-804	372	5	of	of	ADP
ajlm-804	372	6	cd4	cd4	PROPN
ajlm-804	372	7	count	count	NOUN
ajlm-804	372	8	in	in	ADP
ajlm-804	372	9	a	a	DET
ajlm-804	372	10	large	large	ADJ
ajlm-804	372	11	public	public	ADJ
ajlm-804	372	12	health	health	NOUN
ajlm-804	372	13	antiretroviral	antiretroviral	ADJ
ajlm-804	372	14	programme	programme	NOUN
ajlm-804	372	15	?	?	PUNCT
ajlm-804	373	1	s	s	AUX
ajlm-804	373	2	afr	afr	PROPN
ajlm-804	373	3	j	j	PROPN
ajlm-804	373	4	hiv	hiv	PROPN
ajlm-804	373	5	med	me	VERB
ajlm-804	373	6	.	.	PUNCT
ajlm-804	374	1	2016;17(1):446	2016;17(1):446	NOUN
ajlm-804	374	2	.	.	PUNCT
ajlm-804	375	1	https://doi.org/10.4102/sajhivmed.v17i1.446	https://doi.org/10.4102/sajhivmed.v17i1.446	NOUN